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The total synthesis of natural (4R, 5R)-antillatoxin 4b and its analogue (4S, 5S)-
antillatoxin 4c has been achieved in 9 steps (from bromide 43 and aldehyde 41 -
strategy 2) in 23% overall yield. Our strategy provides practical and easy entry into 
key intermediates and analogues. Notable features of this synthesis include the 
indium-mediated allylation of a secondary allylic bromide with aldehyde in aqueous 
media, and an oxidation-reduction sequence to control the two chiral centres at C4 and 
C5. Especially noteworthy is the convergent nature of this synthetic strategy and the 
incorporation of all the necessary functionalities in the early stages of the synthesis. 
The procedure developed here can be used for large scale synthesis of other 




























































Effects: notochord defect,   
              vascular system
Effects: heart, notochord, brain,                    




Screening of this library of simpler fragments obtained during the process of 
the total synthesis compounds has resulted in the discovery of other potent 
compounds. This simple screen utilizing zebrafish embryos has resulted in the 
discovery of bioactive fragments (4R, 5R)-66b which display similar behavior as (4R, 
5R)-antillatoxin. These interesting results provide further evidence on the ease and 




In Chapter 2, synthetic studies towards the total synthesis of cytochalasans is 
reported. Retrosynthetic analysis of cytochalasans gives the key intermediate 36 with 
a bromine substituent at the C-9 position. Key intermediate 36 was envisaged to be 
constructed from a Lewis acid catalyzed intermolecular Diels-Alder reaction of diene 





















MLn* = BF3.OEt2, 









X = O or C
R = Pri, aspochalasins
R = Ph, cytochalasins









We managed to build the desired six-membered cyclohexane ring system in 
the key fragment 36 with the correct stereochemistry, which is the core ring skeleton 
found in the cytochalasans class of natural products. By treating the crude aldehyde 
81 and diene 23 with BF3.OEt2 in dichoromethane, we obtained cycloadduct 88a as a 
colorless oil in 22% yield after 16 hours of reaction at -60 °C. In the reaction, we 



























C (DEPT), COSY, NOESY, HMQC and HMBC as depicted 
in Figure 2-10. The stereochemistry of the products suggests that due to the secondary 
orbital interaction, the Diels-Alder reaction had proceeded via an endo transition state 















In Chapter 3, the synthetic studies towards the total synthesis of 
tuberostemonine is reported. Our key step relies on the intermolecular Diels-Alder 
reaction between diene 55 and dienophile 56 to construct ring B. An amino group 
would be introduced to the ring system through Curtius rearrangement and followed 
by reductive amination to construct the pyrrolidine ring D. Finally, closure of the 
seven-membered ring C was achieved by the conversion of the protecting group 

































































The core ring B was planned to be achieved from diene 55 and dienophile 56. 
However, no desired products were obtained. Further investigation with aldehyde-
ester 79 as dienophile, only the hetero-Diels-Alder product 80 was obtained from the 
reaction mixture. Exploration with dienophile 82 afforded the mixture of normal 
Diels-Alder cycloadduct 83 and hetero-Diels-Alder product 84. Even though 
cycloadduct 83 is not the desired product for the total synthesis of tuberostemonine, 
 viii 
this finding will still be useful in other synthesis which require more complicated 


























































INDEX OF ABBREVIATIONS 
 
! chemical shift  
((( sonication 
" reflux 
ºC degree centrigrade  
Ac acetyl 





9-BBN 9-borabicyclo[3.3.1]nonane  
Bn benzyl 
BOC tert-butoxycarbonyl 
BOP benzotriazol-1-yloxytris (dimethylamino) phosphonium 
hexafluorophosphate 






CDCl3  deuterated chloroform 
COSY correlated spectroscopy 
Cp cyclopentadienyl 
CSA camphorsulfonic acid 




 inverse centimeter 




dba dibenzylidene acetone 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC 1,3-dicyclohexylcarbodiimide 
dd doublets of doublet 
de diastereomeric excess 




DMP Dess-Martin periodinane 
DMSO dimethyl sulfoxide 
DPPA diphenylphosphoryl azide 
dt doublets of triplet 
dq doublets of quartet 
EDC 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 
ee enantiomeric excess 
EI electron impact ionization 
equiv. equivalent 
ESI electronspray ionization 
Et ethyl 
ether diethyl ether 
Et3N triethylamine 
EtOAc ethyl aceate 
EtOH ethanol  
FAB fast atomic bombardment 
Fmoc 9-fluorenylmethyl 
FTIR Fourier transform infrared spectroscopy  
Gly glycine 
g gram  
h hour 
H hydrogen 
Hex hexane   
HMBC heteronuclear multiple bond correlation 
HMPA hexamethylphosphoramide 
 xi 
HMQC heteronuclear multiple quantum correlation 
HOBt 1-hydroxybenzotriazole 




J coupling constants 
kg kilogram 
LDA lithium diisopropylamide 






 parent ion peak (mass spectrum) 
m multiplet 
m-CPBA meta-chloroperoxybenzoic acid 
Me methyl 






mol moles  
MPM p-methoxyphenyl methyl 
MS mass spectrum  
Ms methanesulfonyl  
N concentration (normality) 
NBS N-bromosuccinimide 
n-Bu n-butyl 
NMR nuclear magnetic resonance 
NOE nuclear overhauser effect 
NOESY nuclear overhauser enhancement spectroscopy 
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OTf trifluoromethanesulfonate 
p page  
 xii 
PBr3 phophorus tribromide 




ppm parts per million 
Py pyridine 
PyBrOP bromotripyrrolidinophosphonium hexafluorophosphate 
q quartet 
rt. room temperature 
RBF round bottom flask 




TBAF tetrabutylammonium fluoride 
TBDMS tert-butyldimethyl silyl 
TBDPS tert-butyldiphenyl silyl 
t-BOC tert-butoxycarbonyl 
t-Bu tert-butyl 
td triplets of doublet 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
THP tetrahydropyran 
TIPS triisopropyl silyl  
TLC thin layer chromatography 
TMSCl trimethylsilyl chloride 
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1.1 Historical Background 
 
Marine cyanobacteriums are well known to be the rich source of structurally 
unique neurotoxic secondary metabolites (eg. Brevetoxin B1 (1), Curacin A2 (2), 
Barbamide3 (3), Antillatoxin4 (4b) etc as shown in Figure 1-1. Antillatoxin (4b) is one 
of this marine toxins, isolated from the pantropical marine cyanobacterium Lyngbya 
majuscula. It is a structurally novel lipopeptide with high degree of methylation and 
without close parallel to any other known marine natural product. To date, it is one of 
the most ichthyotoxic compounds isolated from marine sources. Its toxicity 
measurements with goldfish recorded a LD50 = 0.05 µg/mL, and it is only exceeded in 
potency by brevetoxins (LD50 = 0.003 µg/mL).
4,5 
 
More recently, it has been shown to be neurotoxic in primary cultures of rat 
cerebellar granule cells. In the latter study, morphological evidences of antillatoxin-
induced neurotoxicities included swelling of neuronal somata, thinning of neurites, 
and blebbing of neurite membranes. Lactate dehydrogenase efflux monitoring 
demonstrates that antillatoxin also induced a concentration-dependent cytotoxicity in 
                                                
1 Lin, Y. -Y; Risk, M.; Ray, S. M.; Engen, D. V.; Clardy, J.; Golik, J.; James, J. C.; Nakanish, K. J. 
Am. Chem. Soc. 1981, 103, 6773-6775. 
2 Gerwick, W. H.; Proteau, P. J.; Nagle, D. G.; Hamel, E.; Blokhin, A.; Slate, D. L. J. Org. Chem. 
1994, 59, 1243. 
3 Orjala, J.; Gerwick, W. H. J. Nat. Prod. 1996, 59, 427. 
4 Orjala, J.; Nagle, D. G.; Hsu, V. L.; Gerwick, W. H. J. Am. Chem. Soc. 1995, 117, 8281-8282. 
5 (a) Berman, F. W.; Gerwick, W. H.; Murray, T. F. Toxicon 1999, 37, 1645-1648. (b) Wu, M.; Okino, 
T.; Nogle, L. M.; Marquez, B. L.; Williamson, R. T.; Sitachitta, N.; Berman, F. W.; Murray, T. F.; 
McGough, K.; Jacobs, R. et al. J. Am. Chem. Soc. 2000, 122, 12041-12042. (c) Lin, Y. -Y.; Risk, M.; 
Ray, S. M.; Engen, D.V.; Clardy, J.; Golik, J.; James, J. C.; Nakanishi, K. J. Am. Chem. Soc. 1981,103, 
6773. 
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cerebellar granule neurons. This neurotoxic response of antillatoxin was prevented by 




At the outset of this investigation, we were aware that only small amount of 
antillatoxin had been isolated (1.3 mg, 0.07% of extract).4 The successful outcome of 
synthetic antillatoxin would aid in the production of enough quantities for detailed 
biological evaluations. 
 
The isolation of antillatoxin (4b) was reported by Gerwick and co-workers in 
1995. Based on spectroscopic studies (1D and 2D NMR) and molecular modeling 
using a dynamic simulated annealing protocol with the program XPLOR, they 
deduced that the structure of antillatoxin as 4S, 5R configuration at C4 and C5.
4 
However, the structure was later revised to be 4R, 5R configuration by T. Shiori7 and 
J. Whites8 groups. 
 
                                                
6 (a) Li, W. I.; Berman, F. W.; Okino, T.; Yokokawa, F.; Shioiri, T.; Gerwick, W. H.; Murray, T. F. 
Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 7599-7604. (b) Li, W. I., Marquez, B. L., Okino, T., Yokokawa, 
F., Shioiri, T., Gerwick, W. H., Murray, T. F. J. Nat. Prod. 2004, 67, 559-568.  
7 (a) Yokokawa, F.; Shioiri. T. J. Org. Chem. 1998, 63, 8638-8639; (b) Yokokawa, F.; Fujiwara, H.; 
Shioiri. T. Tetrahedron Lett. 1999, 40, 1915-1916. (c) Yokokawa, F.; Fujiwara, H.; Shioiri. T. 
Tetrahedron 2000, 56, 1759-1775. 
8 White, J. D.; Hanselmann, R.; Wardrop, D. J. Am. Chem. Soc. 1999, 121, 1106-1107. 
  
Chapter 1 : Total Synthesis of Antillatoxin 



















(4S, 5R)-Antillatoxin  (4a)













(4R, 5R)-Antillatoxin  (4b)
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1.2 Previous Synthetic Studies 
 
Being a molecule with unique biological activities and structural complexities, 
antillatoxin has been the target of much synthetic endeavours. In 1998, Shioiri and co-
workers accomplished the first total synthesis of (4S, 5R)-antillatoxin with the 
proposed structure 4a.7a  
 
 
                                                
7a Yokokawa, F.; Shioiri. T. J. Org. Chem. 1998, 63, 8638-8639.  
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From their synthetic strategy, the complex molecule was constructed from two 
subunits, a tripeptide unit and a diene fragment (Scheme 1-1, 1-2, 1-3). The tripeptide 
unit 7 was prepared from alkaline saponification of 6 after a series of peptide coupling 




























Preparation of diene fragment 15a was achieved from alkyne 8 as the starting 
material as shown in Scheme 1-2. The conjugated diene 9 was made from 
hydroboration of alkyne 8 followed by Suzuki coupling with vinyl iodide. Evans’ 
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1) TPAP, NMO, 4ÅMS, CH3CN
2) (CF3CH2O)2P(O)CH2CO2Me
    KHMDS, 18-crown-6, THF










     THF
     -78 ºC, 30 min
























1) LiOOH, aq. THF
2) MeI, KHCO3, DMF
60% (2 steps) TESO OH
1) TESCl, Et3N, 
DMAP, CH2Cl2
2) DIBAL, CH2Cl2












 Lactone ring opening of 15a followed by allyl protecting and esterification 
with tripeptide 7 gave the coupling product 16a. Oxidative elimination of the 
phenylselenyl group, removal of allyl protecting groups and a final 
macrolactamization gave the desired macrocycle antillatoxin 4a. (Scheme 1-3) 
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1) LiOH, aq. THF

























2) DPPA, NaHCO3, 
DMF, 0 ºC, 3 days











(4S, 5R)-Antillatoxin  (4a)
         (proposed)
5
4
 EDCI, DMAP, CH2Cl2




















Gerwick used NOE to confirm the stereochemistries of C4 and C5. In our 
group, we have been working on the synthesis of the isomers of C4 and C5 as NOE 
studies of large rings is known to be unreliable.9 
 
Later, the NMR data of the synthetic (4S, 5R)-antillatoxin (4a) showed 
significant differences from the natural product. These differences led to the 
conclusion that the proposed structure does not accurately reflect the natural 
antillatoxin that was isolated by Gerwick and co-workers. On the basis of the 
assumption that the stereochemistries of the amino acids are secure, the 
stereochemistry at C4 and C5 would be doubtful. 
 
Furthermore, Whites and co-workers (1999)8 reported their work on total 
synthesis of (4S, 5R)-antillatoxin (4a). Their results were also consistent with the 
results reported by T. Shioiri’s.  
                                                
9
 Cao Guo-Qiang, PhD Thesis, 1998. 
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 Similar to Shioiri’s strategy, the tripeptide unit 21 was prepared from the 
coupling of Cbz-protected N-methyl valine 18, methyl glycine and Troc-protected 






























1) H2, Pd/C MeOH
2) Troc-ala-OH, HATU, (i-Pr)2NEt, CH2Cl2









The aldehyde 25 was constructed from an optically pure methyl propionate 22 









1) Me3SiCH2MgCl, CeCl3, THF
2) SiO2, CH2Cl2
             99% (2 steps)














Coupling of aldehyde 25 with diene 27 (synthesized from alkyne 8) gave the 
diene fragment 28. Esterification of 28 with tripeptide 21 with EDCI provided the 
                                                                                                                                      
8 White, J. D.; Hanselmann, R.; Wardrop, D. J. Am. Chem. Soc. 1999, 121, 1106-1107. 
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coupling product 29. Removal of dithiane, oxidation followed by Troc-deprotection 
















  75% (3 steps)
1) Zn, KH2PO4, THF














(4S, 5R)-Antillatoxin  (4a)
         (proposed)
5
4












2) MeI, CaCO3, MeCN-H2O





1) Bu3Sn(Bu)CuCNLi2, THF, -50 ºC
2) MeOH, -50 ºC to -10 oC, overnight
3) I2, Et2O, 0 ºC
t-BuLi, THF, -78 oC
60%
52% (3 steps)











From the analysis of the results obtained, Shioiri’s group7b,7c has finally 
demonstrated that the correct structure should be (4R, 5R) anti configuration and not 
the proposed (4S, 5R) syn configuration. This was further confirmed by their synthesis 
of the (4R, 5R)-antillatoxin. In this new route, boron-mediated asymmetric aldol 
reaction was employed to construct the anti-C4, C5 configurations (Scheme 1-7). It 
was found that the resulting product was identical to the natural antillatoxin by 
comparing NMR, IR and optical rotation data. These series of work demonstrated that 
                                                
7b,7c (b)Yokokawa, F.; Fujiwara, H.; Shioiri. T. Tetrahedron Lett. 1999, 40, 1915-1916. (c) Yokokawa, 
F.; Fujiwara, H.; Shioiri. T. Tetrahedron 2000, 56, 1759-1775. 
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the actual structure of antillatoxin should be revised to the (4R, 5R) configuration 














    2,6-lutidine











1) TPAP, NMO, 4Å MS, CH3CN
2) (CF3CH2O)2P(O)CH2CO2Me
    KHMDS, 18-crown-6, THF














1) LiOH, aq. THF
2) allyl bromide, KHCO3, DMF
3) tripeptide, EDCI, DMAP, CH2Cl2























1) Pd(Ph3P)4, morpholine, THF
2) DPPA, NaHCO3, DMF
    0 ºC, 3 days











(4R, 5R)-Antillatoxin  (4b)


















Although White’s and Shioiri’s group have successfully synthesized 
antillatoxin, their synthetic routes are still long and cumbersome. Our strategy is to 
devise a short and efficient synthetic route to antillatoxin. Hopefully our synthetic 
route to antillatoxin will provide enough material for chemical and pharmacological 
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evaluation. With this in mind, our group embarked on the total synthesis of 
antillatoxin and its analogues. 
 
1.3 Our Retrosynthetic Analysis of Antillatoxin 
 
Our retrosynthetic strategy of (4R, 5R)-antillatoxin 4b is outlined in Scheme 
1-8. Disconnection of the macrocycle ring using the macrolactamization strategy will 
give rise to precursor 32. Retrosynthetic cleavage of the ester bond will lead to two 
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The tripeptide fragment 33 can be obtained from the coupling of three amino 
acids (N-methyl-L-valine (39), glycine (40) and L-alanine (37)) through a series of 





















































The right-wing fragment 34 contains a homoallylic alcohol fragment which 
can be disconnected using a metal-mediated allylation strategy (Scheme 1-10). We 
decided to investigate the use of indium-mediated allylation strategy to carry out this 
transformation in aqueous media. The many advantages of carrying out reaction in 
aqueous media have encouraged us to investigate this transformation reaction on our 
system. Especially noteworthy is the possibility of avoiding protection-deprotection 
sequences such as hydroxy group in organic synthesis. This will shorten the required 
synthetic steps. Furthermore, it also enables large scale production, whereby the need 
to carry out the experiment under strictly anhydrous conditions can be avoided. 
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However, when we started this project, the scope and limitations of this 
reaction have not been well investigated. It is not known whether this reaction will 
work with a conjugated aldehyde, not to mention the possibility of 1,2 vs 1,4 vs 1,6 
attack. Furthermore, the diastereoselectivity studies have not been well established 
and there was no study on the enantioselective version of this reaction. 
 
Two strategies have been proposed as shown in Scheme 1-10.  In strategy 1, it 
is envisaged that the homoallylic alcohol 34 can be obtained from the indium-
mediated allylation reaction of aldehyde 41 and !-substituted bromide 42 to generate 
the two new chiral centers at C4 and C5. It was then followed by one-carbon 
elongation to the proposed 34. Strategy 2 proposed that fragment 34 could be formed 
































The key elements needed in the preparation of fragment 34 are depicted in 
Scheme 1-11. The methylated and conjugated aldehdye 41 could be derived from a 
series of aldol condensations, reductions and oxidations of the commercially available 
trimethylacetaldehyde 50 with methyl propionate 46. Meanwhile, the bromides 
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synthon 42 and 43 can be made from the Baylis-Hilman reaction of acetaldehyde 52 

































































 The crafted synthetic plan of antillatoxin focuses on the control of the pivotal 
chiral centres at C4 and C5. In addition, our strategy aims to realize the molecule 
through linking small and highly functionalized fragments. This would potentially 
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1.4 Results and Discussion 
 
1.4.1 Synthesis of (2E, 4E)-2,4,6,6-tetramethyl-hepta-2,4-dienal (41)  
 
Aldehyde 41 was synthesized from the commercially available 
trimethylacetaldehyde 50 through a series of aldol condensation reactions involving 
methyl propionate 46 (Scheme 1-12).  
 
The aldol condensation of methyl propionate 46 with trimethylacetaldehyde 
49 was carried out in the presence of 1.1 equivalent of sodium sand and catalytic 
amount of absolute ethanol at 0 °C for 2 hours to provide ester 49 in 90% yield. 
Reduction of methyl ester 49 with 2 equivalents of LiAlH4 in ether at 0 °C afforded 
48 in quantitative yield. Further oxidation of the alcohol 48 with pyridinium 
chlorochromate (PCC) in dichloromethane at 0 °C gave 47 in 88% isolated yield. 
Subsequently, repeating the aldol condensation of aldehyde 47 with methyl 
propionate 46 under the same condition mentioned above furnished 45 in 90% yield. 
This was followed by reduction (LiAlH4) and oxidation (DMP) to give the aldehyde 
















0 °C to rt, 12 h
90%
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The stereochemistry of aldehyde 41 was verified by NOE studies (Figure 1-2). 
From the spectrum, a strong NOE (10.7%) was observed between the aldehyde proton 
(9.37 ppm) and ! proton (5.85 ppm). Another strong NOE (6.36%) observed between 
! proton (5.85 ppm) and proton at 6.68 ppm. A small NOE correlation (1.81%) was 
also observed between " and # methyl groups. The correlations verified that the 

























1.4.2 Synthesis of !-substituted Allylic Bromide 42 and Secondary Allylic 
Bromide 43 
 
With building block aldehyde 41 in hand, we turned our attention to the 
synthesis of the allylic bromides 42 and 43 (Scheme 1-13). Both 42 and 43 were 
prepared from commercially available acetaldehyde 52 and methyl acrylate 53. The 
coupling reaction between the two starting materials in the presence of catalytic 
amount of DABCO at room temperature for 7 days gave 51 in 92% yield. Subsequent 
bromination of 51 with PBr3 in anhydrous ether at 0 °C give bromide 42 as a single 
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isomer in 92% yield. On the other hand, bromide 43 can be derived from 51 after a 
series of functional group manipulations. TBDPS protection of secondary alcohol of 
51, followed by DIBAL reduction of the ester group and NBS bromination gave the 
bromide 57 in 71% yield (3 steps). Indium-mediated allylation of formaldehyde with 
57 afforded alcohol 56. Subsequently, desilylation using TBAF followed by selective 
TBDPS protection of the primary alcohol and final NBS bromination provided the 
desired bromide 43 in 70% yield (3 steps). 
 





































































1.4.3 Synthesis of Tripeptide Acid 33 
 
 Tripeptide acid 33 was prepared in 6 steps in high yield from three 
commercially available amino acids, Fmoc-N-methyl-L-valine, glycine and L-alanine 
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using the well-established peptide chemistry10 (Scheme 1-14). Coupling of 
commercially available Fmoc-N-methyl-L-valine (39) with glycine ethyl ester (40) 
using benzotriazol-1-yloxytris (dimethylamino) phosphonium hexafluorophosphate 
(BOP) and diisopropylethylamine (DIEA) afforded the dipeptide 38 in excellent yield 
(95%). Removal of the Fmoc moiety of dipeptide 38 followed by coupling with alloc-
L-alanine (37) in the presence of bromotripyrrolidinophosphonium 
hexafluorophosphate (PyBrOP) furnished the tripeptide ester 35 in 75% yield. 
Subsequent hydrolysis of the ethyl ester 35 using lithium hydroxide afforded the 



















































                                                
10 Frerot, E.; Coste, J.; Pantaloni, A.; Dufour, M. N.; Jouin, P. Tetrahedron 1991, 47, 259. (b) Sennyey, 
G.; Barcelo, G.; Senet, J. P. Tetrahedron Lett. 1987, 28, 5809. (c) Castro, B.; Dormoy, J. R.; Evin, G.; 
Selve, C. Tetrahedron Lett. 1975, 14, 1219. (d) Li, K. W.; Wu, J.; Xing, W.; Simon, J. A. J Am. Chem. 
Soc. 1996, 118, 7237. 
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1.4.4 Synthesis of Fragment 34 Using Indium-Mediated Allylation 
 
1.4.4.1 Synthesis of Fragment 65 - Strategy 1 
 
 With aldehdye 41 and two allylic bromides 42 and 43 in hand, we turn our 
attention to the indium-mediated allylation reaction between 41 and 42, and between 
41 and 43, to produce the corresponding homoallylic alcohols.  
 
In our efforts to develop environmentally friendly methodologies, our group 
has been involved in the pioneering work in the area of allyindium chemistry, 
particularly in aqueous media.11 In our previous synthetic studies towards the total 
synthesis of antillatoxin, various conditions have been carried out. However in all 
















Indium mediated allylation of the bromide 42 and aldehyde 41 was carried out 
in sat. NH4Cl in the presence of indium powder and lanthanum triflate to give the 
homoallylic alcohol 60 in yields of 80% with high diastereoselectivity (syn/anti = 
                                                
11 (a) Wang, R.-B.; Lim, C. -M.; Tan, C. -H.; Lim, B. -K.; Sim, K. -Y.; Loh, T. -P. Tetrahedron 
Asymmetry 1995, 6, 1825. (b) Ho, D. S. -C.; Sim, K. -Y.; Loh, T. -P. Synlett 1996, 263. (c) Li, X. -R.; 
Loh, T. -P. Tetrahedron Asymmetry 1996, 7, 1535. 
12 Syn/anti ratio was determined by comparing with the literature: Loh, T. -P.; Cao, G. -Q.; Pei, J. 
Tetrahedron Lett. 1998, 39, 1453. 
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93/7) (Scheme 1-15). Interestingly, when we performed the reaction in the absence of 
lanthanum triflate, no desired product was observed. Note that no 1,4-addition 
product was observed in this reaction, demonstrating the regioselectivity of this 
procedure. The stereochemical configuration of the syn isomer of homoallylic alcohol 
60 was determined by the relatively intense NOE interaction exhibited by the lactone 
61, which was obtained by treating the homoallylic alcohol 60 with trifluoroacetic 
acid in CH2Cl2 at room temperature for 16 hours. Strong NOE between ! and # 
protons (NOE = 7.5%) was observed. This confirmed that the stereochemistry of the 
two chiral centers (C3 & C4) for the major product was syn. The NOE (2.3%) between 
protons on the conjugated double bonds (C6 & C8) further demonstrated that the 




















As an aside, Paquette’s group14 also reported the same observation as ours. It 
suggests that the allylindium intermediate coordinates with both the aldehyde 
carbonyl and the ester carbonyl functions as shown in Figure 1-3, leading to the syn 
adduct. 
 
                                                
13 Yin Zheng, PhD’s thesis, 2000. 
14 Paquette, L. A.; Rothaar, R. R. J. Org. Chem. 1999, 64, 217. 
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Apart form the above studies, the exploration of an enantioselective route to 
the preparation of homoallylic alcohol 60 was also carried out. Chiral ligand such as 
InCl3-R-BINOL
15 and In(OTf)3-PYBOX
16 were employed for controlling of the 
absolute stereochemistry. The results are summarized in Table 1-1. 
 
 In general, chiral ligand-indium (III) complexes were formed in situ prior to 
the addition of ally tin 42 followed by the addition of aldehyde 41 under anhydrous 
condition in CH2Cl2 at -78 °C and slowly warming up to room temperature. The 
homoallylic alcohol obtained was predominantly in the syn configuration. These 





                                                
15 (a) Teo, Y. -C.; Tan, K. -T.; Loh, T. -P. Chem. Commun. 2005, 1318-1320. (b) Teo, Y. -C.; Loh, T. 
-P. Org. Lett. 2005, 7, 2539-2541. (c) Teo, Y. -C.; Goh, J. -D.; Loh, T. -P. Org. Lett., 2005, 7, 2743-
2745. 
16 (a) Lu, J.; Hong, M. -L.; Ji, S. -J.; Loh, T. -P. Chem. Commun. 2005, 1010-1012. (b) Lu, J.; Ji, S. -J.; 
Teo, Y. -C.; Loh, T. -P. Org. Lett. 2005, 7, 159-161. 
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Entry Metal Chiral ligand Conditions Yields 
1 InCl3 R-BINOL
15 -78 °C 
syn product, 
 75% no ee 
2 InCl3 R-BINOL SnBu3, -78 °C 
syn product, 10% 
 8% ee 
3 In(OTf)3 S,S-PYBOX
16 TMSCl, -78 °C No reaction 
4 In(OTf)3 S,S-PYBOX No TMSCl, -78 °C No reaction 
 
 
From the retrosynthetic analysis, the desired alcohol for the total synthesis of 
(4R, 5R) antillatoxin should be in anti configuration at the C4 and C5 chiral centers. 
However, the stereochemistry of the indium-mediated allylation reaction observed 
was in a syn configuration instead of the desired anti configuration in all cases.  
 
  
Chapter 1 : Total Synthesis of Antillatoxin 
23 Part I   
Therefore, we had to develop a new methodology to obtain the desired anti-
isomer. In this case, oxidation followed by Luche’s reduction17 was employed in order 
to get the anti configuration. Initially, the syn allylation product 60 was reduced to 
diol 62 using DIBAL in CH2Cl2 as solvent. Selective protection of diol 62 with 
TBDPSCl in the presence of imidazole in DMF afforded 63. The homoallylic alcohol 
63 was then oxidized to 64 using Dess-Martin periodinane before it was subsequently 
reduced using CeCl3.7H2O (1 equiv) and NaBH4 (1 equiv) in a THF-H2O (10:1) 
solution. The alcohol anti-65 was obtained in 80% yield with excellent selectivity 

























Scheme 1-17 Reagents and conditions: a) DIBAL, CH2Cl2, 0 °C, 3h; b) TBDPSCl, 
Imidazole, DMF, 0 °C, 1.5h; c) Dess-Martin Periodinane, CH2Cl2, 0 °C, 3h; d) 
NaBH4, CeCl3.7H2O, THF:H2O (10:1), 0 °C, 3h.  
 
 
The preferred stereochemical course for the projected reduction can be 
rationalized using the Cram-Felkin-Anh model. The incoming hydride would 
approach the carbonyl group from the less hindered side and hence fashion the 
required anti relative stereochemistry (Scheme 1-18). 
 
                                                
17 Application of Luche’s reduction in organic synthesis: Luche, J. L. J. Am Chem. Soc. 1978, 100, 
2226-2227. (b) Loh, T. -P.; Hu, Q. -Y. Org. Lett. 2001, 3, 279-281. 
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After furnishing the anti configuration of the alcohol 64, our next task is to 
separate out both enantiomers to determine which enantiomer would lead to the 
natural (4R, 5R) antillatoxin. This was achieved by using chiral resolution with S-(+)-
"-acetoxyphenylacetic acid (Scheme 1-19). In one of our first attempts, protection of 
the secondary alcohol of homoallylic alcohol 65 with S-(+)-"-acetoxyphenylacetic 
acid
18
 in the presence of DCC, DMAP and molecular sieves was carried out. To our 





















Scheme 1-19 Reagents and conditions: a) TBAF, THF, rt; b) Chiral resolution of 66 




                                                
18 For the standard procedure, refer to Whitesell, J. K.; Reynolds, D. J. Org. Chem. 1983, 48, 3548. 
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In spite of our difficulties with the separation, we approached another 
alternative using anti-diol 66, where both free alcohol in anti-diol 66 were protected 
with S-(+)-"-acetoxyphenylacetic acid. The anti-diol 66 was generated from 
desilylation of the TBDPS protecting group of homoallylic alcohol 65 with TBAF in 
THF as solvent (Scheme 1-19). The diastereomers were separated in pure form using 
an optimized solvent system (CH2Cl2:Hex:EA = 3:3:0.2). Enantiopure diol 66b and 



























[!]26D = +25° (c = 2.5, CHCl3)
67b
[!]27D = "14° (c = 4.2, CHCl3)
68b
[!]27D = +7° (c = 5.4, CHCl3)
 69b
[!]26D = +19° (c = 0.7, CHCl3)
 71b
[!]26D = +18° (c = 4.1, CHCl3)
 34b
[!]27D = "18° (c = 11.1, CHCl3)
 
Scheme 1-20 Reagents and conditions: a) EtOCOCl, DMAP, Et3N, CH2Cl2, 0 °C to rt, 
3h; b) TBDPSCl, AgNO3, DMF, 0 °C to rt, 12h; c) 1% K2CO3 / MeOH, rt, 16h; d) 
NBS, PPh3, CH2Cl2, - 78 °C to 0 °C, 3h; e) HCHO, In, La(OTf)3, THF-H2O (1:1), rt, 4 
days; f) (i)TBAF, THF, rt; (ii) TBDPSCl, imidazole, DMF, 0 °C, 1.5h. 
 
 
From the optically pure 66b, one carbon elongation was performed to furnish 
the carbon backbone of the right wing fragment 34b as shown in Scheme 1-20. First 
of all, we protected the primary alcohol with ethyl chloroformate in the presence of 
Et3N and DMAP at 0 °C. Subsequently, the carbonate protected homoallylic alcohol 
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66b was treated with TBDPSCl in the presence of AgNO3 in DMF at 0 °C and 
warmed to room temperature and stirred for 12 hours to afford the TBDPS group at 
the secondary alcohol in 78% yield. Consequently, the carbonate was cleaved 
selectively by basic hydrolysis using 1% K2CO3 methanol solution to afford the 
homoallylic alcohol 69b. NBS bromination was carried out in the presence of PPh3 in 
CH2Cl2 at -78 °C and warmed to 0 °C subsequently for 3 hours to provide the desired 
bromide 70b in 74% yield. 
 
With the bromide 70b in hand, our next target is to perform the one-carbon 
elongation to furnish the carbon backbone of the right wing fragment 34. Using the 
conditions described by our group, this one-carbon elongation reaction proceeded 
smoothly using indium-mediated allyation of bromide 70b with formaldehyde in the 
presence of La(OTf)3 (1 equiv.) in THF-H2O (1:1) at room temperature for 4 days to 
give the desired 71b in 73% yield (Scheme 1-20). 
 
Before we carried out the coupling between fragments 34 and 33, the silicon 
protecting group was switched to primary position by deprotection of the secondary 
TBDPS protected alcohol followed by selective protection of the primary alcohol to 
furnish the fragment 34 for the next coupling reaction. 
 
1.4.4.2 Synthesis of Fragment 65 - Strategy 2 
 
 In another synthetic route, indium mediate allylation with secondary allylic 
bromide 43 was also explored. Allylation reaction of the bromide 43 and aldehyde 41 
in THF-H2O in the presence of indium powder and lanthanum triflate gave the 
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homoallylic alcohol 34 in 74% yield with syn/anti selectivity at 72/28 (Scheme 1-21). 
Similar to the previous study, syn homoallylic alcohol was the major product instead 
of the anti configuration. In order to proceed with the synthetic study, the syn 
configuration was converted to anti using the same method described previously to 
afford the anti-34. Chiral resolution with S-(+)-"-acetoxyphenylacetic acid followed 
by primary TBDPS protection of 73b/73c furnished the fragment 34b/34c in optically 


































Scheme 1-21 Reagents and conditions: a) In, La(OTf)3, THF-H2O (1:1), rt, 16h; b) 
Dess-Martin Periodinane, CH2Cl2, 0 °C, 3h; c) NaBH4, CeCl3.7H2O, THF:H2O (10:1), 
0 °C, 3h; d) TBAF, THF, rt; e) Chiral resolution of 73 was carried out with S-(+)-"-





1.4.3 Coupling Between Fragment 33 and 34 
 
With the pure anti homoallylic alcohol 34b/34c and tripeptide acid 33 in hand, 
returned our attention to the union of these two advanced building blocks. As reported 
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in the earlier works by White’s and Shiori’s group,4 coupling reagent 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC.HCl) has been used to 
couple the two fragments. It had been shown that the reaction proceeded smoothly to 
give the product in good yield.  
 
Using the same protocol, the homoallylic alcohol 34b or 34c was first mixed 
with 2 equivalents of tripeptide acid 33 in dried CH2Cl2 and cooled down to 0 °C in an 
ice bath. 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC.HCl) 
and 4-dimethyl amino pyridine (DMAP) was added in one portion. The resulting 
mixture was stirred at 0 °C and slowly warmed to room temperature for 12 hours to 
give 74b/74c in 90% and 89% yields respectively (Scheme 1-22). 
 
With ample supplies of 74, our next attempt was to free the functional groups 
needed to prepare 75, the projected intermediate that may lead to the 15-membered 
macrocycle 4. Deprotection of the silyl group with tetrabutyl ammonium fluoride 
(TBAF) followed by Dess-Martin and NaClO2 oxidation afforded the corresponding 
acids 75b/75c in 74% and 73% yields (3 steps reaction). Treatment of 75 with 
Pd(PPh3)4 in the presence of morpholine, followed by macrocyclization promoted by 
diphenyl phosphorazidate (DPPA)19 gave (4R, 5R) antillatoxin (4c) and (4S, 5S) 
antillatoxin (4b) in 63% and 62% yields respectively. The product was confirmed by 





 Diphenylphosphoryl azide (DPPA)
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Scheme 1-22: a) EDC.HCl, DMAP, CH2Cl2, 0 °C to rt, 16h; b) TBAF, THF, rt, 0.5h; 
c) Dess-Martin Periodinane, CH2Cl2, rt, 1h; d)  NaClO2, NaH2PO4, MeCH=CMe2, t-
BuOH-H2O, rt, 1h; e) Pd(Ph3P)4, morpholine, THF, rt, 0.5h; f) DPPA, NaHCO3, 
DMF, 0 °C, 3 days. [EDC.HCl = 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride; DMAP = 4-dimethyl amino pyridine; TBAF = tetrabutyl ammonium 
floride; DPPA = Diphenylphosphoryl azide] 
                                                
4 Orjala, J.; Nagle, D. G.; Hsu, V. L.; Gerwick, W. H. J. Am. Chem. Soc. 1995, 117, 8281-8282. 
7 (a)Yokokawa, F.; Shioiri. T. J. Org. Chem. 1998, 63, 8638-8639. (b)Yokokawa, F.; Fujiwara, H.; 
Shioiri. T. Tetrahedron Lett. 1999, 40, 1915-1916. (c) Yokokawa, F.; Fujiwara, H.; Shioiri, T. 
Tetrahedron 2000, 56, 1759-1775. 
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1.5 Biological Evaluation of Antillatoxin and Fragments Using Zebrafish 
Embryo  
 
The recently established forward chemical genetics field has been gaining 
popularity and offers powerful tools to search for novel drug candidates and their 
targets.
20
 It differs from classical genetics by substituting small molecules for 
mutation-inducing agents or X-ray irradiation. Using combinatorial techniques,
21
 one 
is able to rapidly screen a large number of small molecules and identify those that 
induce a novel phenotype in a cellular or embryonic system. Once a phenotypic effect 
is found, the next step is to identify the biological target. 
 
In the age of high-throughput biology, novel genes and proteins are emerging 
quickly. The need for developing organic synthesis-derived methods that allow rapid 
access to polyfunctional, complex natural product-like compounds is growing 
constantly, largely because these small-molecule-based compounds serve as smart, 
powerful tools both in understanding the roles and functions of emerging biological 
targets and in validating their biological responses. 
 
Developing asymmetric synthesis-derived organic reactions allows the 
synthesis of complex natural product-like compounds in a high-throughput manner. 
With few exceptions, the synthesis of complex natural product-like derivatives is still 
in its infancy. Some recent efforts made in this area indicate opportunities yet to be 
explored. Zebrafish (Danio rerio) embryo screening offers a speedy method for the 
                                                
20 (a) Lokey, R. S. Curr. Opin. Chem. Biol. 2003, 7, 91-96. (b) Tan, D. S. Nat. Biotechnol. 2002, 20, 
561-563. (c) Specht, K. M.; Shokat, K. M. Curr. Opin. Cell Biol. 2002, 14, 155-159. (d) Schreiber, S. 
L. Chem. Eng. News 2003, March 3, 51-61. 
21
 (a) Jung, G. Combinatorial chemistry: synthesis, analysis, screening; Wiley-VCH: Weinheim; 
Cambridge, 1999; (b) Nicolaou, K. C.; Hanko, R.; Hartwig, W. Handbook of combinatorial chemistry: 
drugs, catalysts, materials; Wiley-VCH: Weinheim, 2002. 
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identification of compounds with interesting bioactivity. While the use of 
combinatorial methods has been extensively studied, the use of natural products and 
their analogs to search for more active compounds and their targets have attracted 
much less attention. Herein, we describe the utilization of a natural product which has 
known bioactivities, screening for unique phenotypical changes in the zebrafish 
embryo’s development. 
 
We envisage that the phenotype effects for a bioactive natural product can 
provide leads for the search of more bioactive compounds through seeking and cross-
referencing the same phenotype(s) observed. This can be done using closely related 
analogs or simpler fragments of a specific natural product. Once an analog has been 
identified to cause similar phenotype effect(s), further biological studies will be 
carried out. This strategy of utilizing zebrafish embryo screening, will be able to 
provide a rapid route towards the synthesis of more potent targeted analogs in a 
shorter time. Application of this strategy has enabled us to identify specific activities 
of several fragments which are structurally related to the natural (4R, 5R)-antillatoxin 
(4b) we synthesized. 
 
Screening of this library of simpler fragments obtained during the process of 
the total synthesis compounds has resulted in the discovery of potent compound. This 
simple screen utilizing zebrafish embryos (a three day monitoring, after post 
fertilization) followed by monitoring for any defects by visualization has resulted in 
the discovery of bioactive compound which has similar activity as (4R, 5R)-
antillatoxin but with much simpler structure. Interestingly, although the anti-isomer 
(66) of the fragment afforded interesting activity, the syn-isomer (62) has no effect on 
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the zebrafish embryos (Scheme 1-23). Another noteworthy point is that only the 
enantiomer of the anti-isomer 66b which corresponds to the natural product afforded 
the same phenotypes as the natural products. This shows that stereochemistry of this 
key fragment plays an important role in the activity. Furthermore, the 1-carbon 
elongated fragments (73) showed no effect on the zebrafish. Further testing further 
demonstrates the relationship between zebrafish embryos testing
21
 and the 
ichthyotoxicity of the compound. The results of all different analogs are summarized 














62 SYN (RACEMIC) : 1/3 Alive
66 ANTI (RACEMIC) : Dead
66a ANTI (+) : Alive
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Table 1-2 Phenotype screening
21
































































                                                
21 Biological testing conducted by Ms. Wu Yilian (Phenotype screening) and IMA (Phenotype 
screening), Dr. K. N. Sulochana (Transgenic screening - GFP) and Dr. Farooq (Transgenic screening - 
GFP/RFP) in the Department of Biological Sciences, National University of Singapore. 
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Table 1-3 Transgenic screening21 - intersegmental vessels (ISV) effects caused by 



































































                                                
21 Biological testing conducted by Ms. Wu Yilian (Phenotype screening) and IMA (Phenotype 
screening), Dr. K. N. Sulochana (Transgenic screening - GFP) and Dr. Farooq (Transgenic screening - 
GFP/RFP) in the Department of Biological Sciences, National University of Singapore. 
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Molecular 
Structure 
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1.6 Conclusion 
 
In conclusion, the total synthesis of natural (4R, 5R)-antillatoxin and its analogs has 
been achieved in 9 steps (from bromide 43 and aldehyde 41 - strategy 2) in 23% 
overall yield. Our strategy provides practical and easy entry into key intermediates 
and analogues.  Notable features of this synthesis include the indium-mediated 
allylation of a secondary allylic bromide with aldehyde in aqueous media, and an 
oxidation-reduction sequence to control the two chiral centres at C4 and C5. Especially 
noteworthy is the convergent nature of this synthetic strategy and the incorporation of 
all the necessary functionalities in the early stages of the synthesis. The procedure 
developed here can be used for large scale synthesis of other biological interesting 
natural products. 
 
Screening of this library of simpler fragments obtained during the process of 
the total synthesis compounds has resulted in the discovery of other potent 
compounds. This simple screen utilizing zebrafish embryos has resulted in the 
discovery of bioactive fragments (4R, 5R)-66b which display similar activity as (4R, 
5R)-antillatoxin. These interesting results provide further evidence on the ease and 























Effects: notochord defect,   
              vascular system
Effects: heart, notochord, brain,                    
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1.7 Experimental  
 
THF was distilled from sodium/benzophenone. Hexane and dichloromethane were 
distilled from CaH2. TLC was carried out with pre-coated Merck 60 F254 plates. Silica 
gel 60 (Merck, 400-630 mesh) was used for column chromatography. Infrared spectra 
were recorded on a Bio-Rad FTS 165 FTIR spectrometer. Liquid samples were 




C NMR spectra were taken in 
CDCl3 on Bruker DPX300 and Bruker AMX500 and referenced to internal 
tetramethylsilane (SiMe4). Chemical shifts for 
1
H NMR spectra are reported as ! in 
units of parts per million (ppm) downfield from SiMe4 (! 0.0) and relative to the 
signal of chloroform-d (! 7.2600, singlet). Multiplicities were given as: s (singlet); brs 
(broad singlet); d (doublet); t (triplet); q (quartet); dd (doublets of doublet); dt 
(doublets of triplet); dtq (doublets of triplets of quartet); or m (multiplets). The 
number of protons (n) for a given resonance is indicated by nH. Coupling constants 
are reported as a J value in Hz. Carbon nuclear magnetic resonance spectra (
13
C 
NMR) are reported as ! in units of parts per million (ppm) downfield from SiMe4 (! 
0.0) and relative to the signal of chloroform-d (! 77, triplet).  
Mass spectral analyses were carried out on a VG 7035 micromass mass 
spectrophotometer at a source temperature of 200 ºC and at an ion current of 70 eV. 
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To a mixture of methyl propionate (24.1 mL, 0.25 mol) and sodium sand (1.45 g, 
0.063 mol) at 0 °C was added catalytic amount of absolute ethanol (0.4 mL). 
trimethylacetaldehyde (4.3 g, 5.43 mL, 50 mmol) was added dropwise. The reaction 
mixture was stirred at 0 °C to room temperature for 12h. After the reaction was 
completed, the reaction mixture was poured into saturated NH4Cl and extracted with 
ether (x3). The combined organic extracts washed with brine, dried over MgSO4 and 
concentrated. The residue was purified by flash chromatography on silica gel, elution 
with hexane/ethyl acetate, 20:1, to afford the pure 49 as a yellowish oil, 7.78 g (90%). 
Rf 0.78 (hexane/ethyl acetate, 4:1);  
1H NMR (300 MHz, CDCl3): ! 1.18 (9H, s, -C(CH3)3), 1.95 (3H, d, J = 1.4 Hz, -C-
CH3), 3.72 (3H, s, -OCH3), 6.80 (1H, q, J = 1.4 Hz, -CH=C-) ppm; 
13C NMR (75 MHz, CDCl3): ! 13.3 (-CH=C-CH3), 30.1 (-C(CH3)3), 33.0 (-C(CH3)3), 
51.8 (-OMe), 126.4 (-CH=C-), 151.5 (-CH=C-), 169.8 (-CO2Me) ppm; 
IR (neat, cm-1): 2959, 2870, 1716, 1639, 1466, 1436, 1365, 1284, 1251; 









To a mixture of LiAlH4 (0.4 g, 10.5 mmol) in anhydrous ether (20 mL) at 0 °C was 
added 49 (1.56 g, 10 mmol) in ether (10 mL) dropwise. The reaction mixture was 
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stirred at 0 °C and the reaction progress was monitored by TLC. After completion, the 
reaction mixture was quenched with saturated Na2SO4 at 0 °C until white precipitate 
was deposited. The mixture was filtered, washed with ether and dried over MgSO4 
and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel, eluting with hexane/ethyl acetate, 10:1) to afforded 48 as a colorless oil, 
1.28 g (98%).  
Rf 0.47 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.12 (9H, s, -C(CH3)3), 1.78 (3H, d, J = 1.2 Hz, -C-
CH3), 3.92 (2H, s, -CH2-OH), 5.42 (1H, q, J = 1.2 Hz, -CH=C-) ppm;  
13C NMR (75 MHz, CDCl3): ! 14.7 (-CH=C-CH3), 30.9 (-C(CH3)3), 32.2 (-C(CH3)3), 
70.8 (-CH2OH), 133.3 (-CH=C-), 136.6 (-CH=C-) ppm; 
IR (neat cm-1): 3331, 2957, 2867, 1657, 1465, 1363; 











To a mixture of PCC (6.47 g, 30 mmol), 4Å molecular sieve powder (3 g) and silica 
gel (3 g) in anhydrous CH2Cl2 (30 mL) at 0 °C was added 48 (1.28 g, 10.1 mmol) 
prediluted in anhydrous CH2Cl2 (5 mL). The reaction mixture was stirred for 3h. After 
completion (monitored by TLC), the reaction mixture was filtered through silica gel 
to afford the product 47 as a yellowish oil, 1.1 g (88%). 
Rf 0.75 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.24 (9H, s, -C(CH3)3), 1.86 (3H, d, J = 1.3 Hz, -C-
CH3), 6.40 (1H, d, J = 1.3 Hz, -CH=C-), 9.30 (1H, s, -CHO) ppm; 
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13C NMR (75 MHz, CDCl3): ! 9.8 (-CH=C-CH3), 29.7 (-C(CH3)3), 34.2 (-C(CH3)3), 
123.8 (-CH=C-), 138.5 (-CH=C-), 196.8 (-CHO) ppm; 
IR (neat, cm-1): 2961, 2869, 1691, 1643, 1467, 1366, 1231; 
HRMS (EI) m/z (M+): obsd 126.1020, calcd 126.1044 for C8H14O. 
 




NaOEt / EtOH O




To a mixture of methyl propionate (72.3 mL, 0.25 mol) and sodium sand (0.9 g, 39 
mmol) at 0 °C was added catalytic amount of absolute ethanol (0.3 mL). 
Consequently 47 (3.84 g, 30 mmol) was added dropwise. The reaction mixture was 
stirred for 12h. After completion the reaction mixture was poured into sat. NH4Cl at 0 
°C and extracted with ether. The combined etherates was washed with brine, dried 
over anhydrous MgSO4 and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel to afford 45 as a yellowish oil, 5.3 g (90%). 
Rf 0.78 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.16 (9H, s, -C(CH3)3), 1.91 (3H, d, J = 1.3 Hz, -
CH=C-CH3), 1.97 (3H, d, J = 1.3 Hz, -CH=C-CH3), 3.74 (3H, s, -COOCH3), 5.56 
(1H, s, -CH=C-), 7.08 (1H, s, -CH=C-) ppm; 
13C NMR (75 MHz, CDCl3): ! 13.9 (-CH=C-CH3), 17.3 (-CH=C-CH3), 30.7 (-
C(CH3)3), 33.0 (-C(CH3)3), 51.8 (-OMe), 124.9 (-CH=C-), 130.8 (-CH=C-), 145.3 (-
CH=C-), 145.5 (-CH=C-), 169.7 (-CO2Me) ppm; 
IR (neat, cm-1): 2956, 2888, 1713, 1625, 1465, 1435, 1386, 1363; 
HRMS (EI) m/z (M+): obsd 196.1457, calcd 196.1463 for C12H20O2. 
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To a mixture of LiAlH4 (0.8 g, 21 mmol) in anhydrous ether (30 mL) at 0 °C was 
added 45 (2.52 g, 12 mmol) in ether (30 mL) dropwise. The reaction mixture was 
stirred at 0 °C and the reaction progress was monitored by TLC. After completion, the 
reaction mixture was quenched with saturated Na2SO4 at 0 °C until white precipitate 
was deposited. The mixture was filtered, washed with ether and dried over MgSO4 
and concentrated in vacuo. The residue was purified by flash chromatography on 
silica gel, eluting with hexane/ethyl acetate, 10:1) to afforded 44 as a colorless oil, 
2.02 g (100%).  
Rf 0.44 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.15 (9H, s, -C(CH3)3), 1.79 (3H, d, J = 1.35 Hz, -C-
CH3), 1.83 (3H, d, J = 1.35 Hz, -C-CH3), 4.03 (2H, s, -CH2-OH), 5.33 (1H, brs, -
CH=C-), 5.85 (1H, brs, -CH=C-) ppm; 
13C NMR (75 MHz, CDCl3): ! 15.2 (-CH=C-CH3), 17.9 (-CH=C-CH3), 31.0 (-
C(CH3)3), 32.6 (-C(CH3)3), 69.5 (-CH2OH), 130.9 (-CH=C-), 131.5 (-CH=C-), 133.8 
(-CH=C-), 140.6 (-CH=C-) ppm; 
IR (neat cm-1): 3332, 2956, 1645, 1465, 1362; 
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To a solution of Dess-Martin reagent (8.66 g, 20.4 mmol) in anhydrous CH2Cl2 (40 
mL) was added dropwise 44 (2.86 g, 17 mmol) prediluted in CH2Cl2 (20 mL) at 0 °C.  
The reaction mixture was stirred under nitrogen at 0 °C for 3h. After completion, the 
reaction mixture was diluted with ether and poured slowly into a Na2S2O3 : NaHCO3 
(1:1) solution and stirred for 10 minutes and extracted with ether.  The combine 
etherate layer was washed with NaHCO3, brine and dried over anhydrous MgSO4.  
Solvent was removed by concentration in vacuo. The residue was purified by flash 
chromatography on silica gel to provide 41 as a yellowish oil, 2.54 g (90%). 
Rf  0.78 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.20 (9H, s, -C(CH3)3), 1.93 (3H, d, J = 1.3 Hz, -C-
CH3), 2.05 (3H, d, J = 1.3 Hz, -C-CH3), 5.85 (1H, brs, -CH=C-), 6.68 (1H, brs, -
CH=C-), 9.37 (1H, s, -CHO) ppm; 
13C NMR (75 MHz, CDCl3): ! 10.7 (-CH=C-CH3), 17.1 (-CH=C-CH3), 30.6 (-
C(CH3)3), 33.3 (-C(CH3)3), 132.0 (-CH=C-), 135.4 (-CH=C-), 150.2 (-CH=C-), 157.3 
(-CH=C-), 196.3 (-CHO) ppm; 
IR (neat, cm-1): 2959, 2868, 1727, 1683, 1609, 1466, 1364; 
HRMS (EI) m/z (M+): obsd 166.1368, calcd 166.1358 for C11H18O. 
 
Methyl 3-hydroxy-2-methylenebutanoate (51) 












To a mixture of methyl acrylate (50 mL, 0.556 mol) and acetaldehyde (47 mL, 0.832 
mol) was added 5% mol of DABCO (3.12 g, 0.027 mol). The reaction mixture was 
stirred at room temperature for 7 days. After completion, CH2Cl2 was added and the 
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mixture was treated with 1M HCl, sat. NaHCO3 solution, brine, dried over anhydrous 
MgSO4 and concentrated in vacuo. Purification through flash column chromatography 
with 10 % ethyl acetate in hexane to afford the product 51 as colorless oil in 92% 
(66.6 g) of yield. 
Rf 0.31 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.38 (3H, d, J = 6.5 Hz, -CH-CH3), 2.82 (1H, brs, -
OH), 3.79 (3H, s, -COOCH3), 4.61 (1H, q, J = 6.5 Hz, -CH-OH), 5.84 (1H, d, J = 
0.55 Hz, -C=CH2), 6.22 (1H, d, J = 0.55 Hz, -C=CH2) ppm; 
13C NMR (75 MHz, CDCl3): ! 22.1 (-CH-CH3), 51.9 (-CO2Me), 67.1 (-CHOH), 
124.2 (-C=CH2), 143.5 (-C=CH2), 167.1 (-CO2Me) ppm; 
IR (neat, cm-1): 3426, 2978, 1713, 1630, 1440, 1368; 
HRMS (EI) m/z (M+) : obsd 130.0628, calcd 130.0630 for C6H10O3. 
 







 0 °C, 1h
92%  
To a solution of 51 (26 g, 0.2 mol) in anhydrous ether (100 mL) at 0 °C was added 
phosphorus tribromide (19 mL, 0.2 mol) dropwise. The mixture was stirred at 0 °C 
for 1h. After the reaction completed (monitored by TLC), the mixture was poured into 
ice water. The solution was extracted with ether and the combined etherate was 
washed with sat. NaHCO3 solution, brine, dried over anhydrous MgSO4 and 
concentrated in vacuo. The residue was purified by flash chromatography to afford 42 
as a colorless oil, 35.4 g (92%). 
Rf 0.70 (hexane/ethyl acetate, 4:1); 
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1H NMR (300 MHz, CDCl3): ! 1.92 (3H, d, J = 7.25 Hz, -CH-CH3), 3.80 (3H, s, -
COOCH3), 4.24 (2H, s, -CH2-Br), 7.06 (1H, q, J = 7.25 Hz, -CH=C-) ppm; 
13C NMR (75 MHz, CDCl3): ! 14.5 (-CH-CH3), 24.0 (-CH2Br), 52.1 (-CO2Me), 
130.3 (-C=CH-), 143.4 (-C=CH-), 166.0 (-CO2Me) ppm; 
IR (neat, cm-1): 2991, 2952, 1716, 1645, 1382; 
HRMS (EI) m/z (M+): obsd 191.9814, calcd 191.9786 for C6H9
79BrO2. 
 








DMF, 0 °C to rt, 10 h
90%  
To a stirred solution of 51 (1.07 g, 8.25 mmol) in anhydrous DMF (20 mL) was added 
in imidazole (0.9 g, 13 mmol) followed by tert-butyldiphenylsilyl chloride (2.5 mL, 
9.5 mmol) at 0 °C under nitrogen. The reaction mixture was stirred for 10h at room 
temperature. After completion, the reaction mixture was poured into H2O and 
extracted with ethyl acetate. The combined organic extracted were washed with brine, 
dried over anhydrous MgSO4 and concentrated in vacuo. The residue was purified by 
flash chromatography on silica gel, eluting with hexane-ethyl acetate (20:1) to 
afforded 59 as a colorless oil, 2.73 g (90%). 
Rf 0.69 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.09 (9H, s, -C(CH3)3), 1.18 (3H, d, J = 6.24 Hz, -
CH-CH3), 3.70 (3H, s, -CO2Me), 4.74 (1H, q, J = 6.24 Hz, -CH-CH3), 6.11 (1H, t, J = 
1.38 Hz, -C=CH2), 6.24 (1H, t, J = 1.05 Hz, -C=CH2), 7.34-7.43 (6H, m, -Ph-H), 
7.59-7.70 (4H, m, -Ph-H) ppm; 
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13C NMR (75 MHz, CDCl3): ! 19.3 (-C(CH3)3), 24.5 (-CHCH3), 27.0 (-C(CH3)3), 
51.6 (-OMe), 67.8 (-CH-OTBDPS), 123.9 (-C=CH2), 127.6, (Ph-C x4), 129.7 (Ph-C 
x2), 134.1 (Ph-Cq x2), 135.9 (Ph-C x4), 145.1 (-C=CH2), 166.5 (-CO2Me) ppm; 
IR (neat, cm-1): 3076, 2962, 2941, 1729, 1430; 
HRMS (EI) m/z [(M-C4H9)
+]: obsd 311.1102, calcd 311.1103 for C18H19O3Si. 
 








0 °C, 2 h
85%  
To a solution of 59 (9.20 g, 25 mmol) in anhydrous CH2Cl2 (150 mL) was added 
dropwise 1.0 M solution of DIBAL-H (50 mL, 50 mmol) at 0 °C under N2. The 
reaction progress was monitored by TLC. After completion, saturated Na2SO4 
solution was added dropwise until white precipitate was deposited and the mixture 
was stirred for another 10 minutes at room temperature. The resulting slurry 
precipitate was filtered and washed with ether. The combined organic layers was 
dried over anhydrous MgSO4, filtered and concentrated in vacuo. The residue was 
purified by flash chromatogaraphy on silica gel, eluting with hexane-ethyl acetate 
(10:1) to afford 58 as a colorless oil, 7.21 g (85%). 
Rf 0.56 (hexane/ethyl acetate, 4:1) 
1H NMR (300 MHz, CDCl3): ! 1.07 (9H, s, -C(CH3)3), 1.19 (3H, d, J = 6.6 Hz, -CH-
CH3), 4.11 (1H, dd, J = 13.41, 6.96 Hz, -CH2-OH), 4.29 (1H, dd, J = 13.41, 4.53 Hz, -
CH2-OH), 4.43 (1H, q, J = 6.6 Hz, -CH-CH3), 4.99 (2H, dd, J = 1.38, 1.05 Hz, -
C=CH2), 7.34-7.44 (6H, m, -Ph-H), 7.64-7.71 (4H, m, -Ph-H) ppm; 
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13C NMR (75 MHz, CDCl3): ! 19.2 (-C(CH3)3), 23.6 (-CHCH3), 27.0 (-C(CH3)3), 
63.3 (-CH2OH), 72.2 (-CH-OTBDPS), 110.5 (-C=CH2), 127.6 (Ph-C x4), 129.7 (Ph-
C x2), 133.5(Ph-Cq), 134.0 (Ph-Cq), 135.9 (Ph-C x4), 151.3 (-C=CH2) ppm; 
IR (neat, cm-1): 3386, 3073, 3052, 2961, 2932, 1473, 1428; 
HRMS (EI) m/z [(M-C4H9)









 -78 °C to  0 °C
92%  
To a solution of 58 (6.8 g, 20 mmol) in anhydrous CH2Cl2 (100 mL) at 0 °C was 
added PPh3 (6.4 g, 24 mmol) in one portion. The reaction mixture was stirred at 0 °C 
for 10 minutes. After all of the PPh3 has dissolved, NBS (4 g, 22 mmol) was added in 
one portion at -78 °C. The resulting solution was stirred at -78 °C for 30 minutes then 
transfer to an ice bath at 0 °C. The reaction progress was monitored by TLC. After 
completion, ether and H2O were added subsequently. The mixture was partitioned, 
and the organic layer was washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo. The residue was purified by flash chromatography on silica 
gel, eluting with hexane-ethyl acetate (40:1) to afford 57 as a colorless oil, 7.4 g 
(92%). 
Rf 0.90 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.08 (9H, s, -C(CH3)3), 1.21 (3H, d, J = 6.42 Hz, -
CH-CH3), 3.98 (2H, s, -CH2-Br), 4.51 (1H, q, J = 6.42 Hz, -CH-CH3), 5.24 (1H, s, -
C=CH2), 5.32 (1H, s, -C=CH2), 7.34-7.44 (6H, m, -Ph-H), 7.64-7.71 (4H, m, -Ph-H) 
ppm; 
  
Chapter 1 : Total Synthesis of Antillatoxin - Experimental 
55 Part I  
13C NMR (75 MHz, CDCl3): ! 19.3 (-C(CH3)3), 23.6 (-CHCH3), 27.0 (-C(CH3)3), 
32.2 (-CH2Br), 70.4 (-CH-OTBDPS), 115.2 (-C=CH2), 127.6 (Ph-C x4), 129.7 (Ph-C 
x2), 133.6 (Ph-Cq), 134.3 (Ph-Cq), 135.9 (Ph-C x4), 148.9 (-C=CH2) ppm; 
IR (neat, cm-1): 3075, 3052, 2965, 2932, 2859, 1473, 1428; 
HRMS (EI) m/z [(M-C4H9)











To a mixture of 57 (6.0 g, 14.8 mmol) and formaldehyde solution (35%-40% in 
water) (40 mL) in THF (40 mL) were added indium (3.41 g, 29.6 mmol). The mixture 
was stirred vigorously at room temperature for 12h, after which the reaction mixture 
was extracted with ethyl acetate. The organic extracts were washed with H2O, brine, 
dried over anhydrous Na2SO4 and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel, eluting with hexane-ethyl acetate 
(10:1) to afforded 56 as colorless oil, 4.74 g (90%). 
Rf 0.39 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.07 (9H, s, -C(CH3)3), 1.15 (3H, d, J = 6.44 Hz, -
CH-CH3), 2.24 (1H, dt, J = 14.81, 5.55 Hz, -CH2CH2OH), 2.39 (1H, dt, J = 14.81, 
6.63 Hz, -CH2CH2OH), 3.58-3.74 (2H, m, -CH2-OH), 4.27 (1H, q, J = 6.44 Hz, , -
CH-CH3), 4.81 (1H, s, C=CH2), 5.03 (1H, s, -C=CH2), 7.34-7.45 (6H, m, -Ph-H), 
7.64-7.70 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 19.2 (-C(CH3)3), 23.2 (-CHCH3), 27.0 (-C(CH3)3), 
34.8 (-CH2CH2OH), 61.5 (-CH2OH), 73.0 (-CH-OTBDPS), 111.9 (-C=CH2), 127.6 
  
Chapter 1 : Total Synthesis of Antillatoxin - Experimental 
56 Part I  
(Ph-C x4),  129.7 (Ph-C x2), 133.7 (Ph-Cq), 134.1 (Ph-Cq), 135.9 (Ph-C x4), 149.3 (-
C=CH2) ppm; 
IR (neat, cm-1): 3441, 3369, 3075, 3052, 2965, 2931, 2858, 1473, 1428; 
HRMS (EI) m/z [(M-C4H9)











To a solution of 56 (1.0 g, 2.8 mmol) in THF (6 mL) was treated with TBAF (4.2 mL, 
1.0 M in THF solution, 4.2 mmol) at room temperature. The mixture was stirred for 
30 minutes. After the reaction was completed (monitor by TLC), THF was removed 
in vacuo. The residue was purified by flash chromatography on silica gel, eluting with 
hexane-ethyl acetate (2:1 to 1:1). The diol 55 was obtained as a colorless oil, 0.30 g 
(95%). 
Rf 0.12 (hexane/ethyl acetate, 1:1); 
1H NMR (300 MHz, CDCl3): ! 1.30 (3H, d, J = 6.27 Hz, -CH-CH3), 2.29 (1H, dt, J = 
14.21, 5.22 Hz, -CH2CH2OH), 2.42 (1H, dt, J = 14.21, 6.09 Hz, -CH2CH2OH), 3.66-
3.82 (2H, m, -CH2-OH), 4.30 (1H, q, J = 6.27 Hz, -CH-CH3), 4.90 (1H, s, -C=CH2), 
5.10 (1H, s, -C=CH2) ppm; 
13C NMR (75 MHz, CDCl3): ! 22.0 (-CH-CH3), 35.0 (-CH2CH2OH), 62.3 (-
CH2OH), 70.9 (-CH-OH), 112.2 (-C=CH2), 150.1 (-C=CH2) ppm; 
IR (neat, cm-1): 3386, 2976, 2936, 2887; 
HRMS (EI) m/z [(M-H2O)
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OH DMF, rt, 2h
TBDPSCl,Imidazole
82%  
To a solution of 55 (0.60 g, 5 mmol) in anhydrous DMF (30 mL) at 0 °C was added 
imidazole (0.70 g, 10 mmol) in one portion. After the imidazole has dissolved, tert-
butyldiphenylsilyl chloride (1.5 mL, 5.75 mmol) was added in. After the reaction was 
completed (monitor by TLC), the reaction mixture was poured into ice water and 
extracted with ethyl acetate. The combined organic extract was washed with brine, 
dried over anhydrous MgSO4 and concentrated in vacuo. The residue was purified by 
flash chromatography on silica gel to afford 54 as a colorless oil, 1.45 g (82%). 
Rf 0.66 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.05 (9H, s, -C(CH3)3), 1.27 (3H, d, J = 6.45 Hz, -
CH-CH3), 2.27 (1H, dt, J = 14.26, 5.58 Hz, -CH2CH2OTBDPS), 2.45 (1H, dt, J = 
14.26, 6.63 Hz, -CH2CH2OTBDPS), 3.73-3.83 (2H, m, -CH2OTBDPS), 4.27 (1H, q, J 
= 6.45 Hz, -CH-OH), 4.83 (1H, s, -C=CH2), 5.07 (1H, s, -C=CH2), 7.36-7.46 (6H, m, 
-Ph-H), 7.66-7.71 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 19.1 (-C(CH3)3), 22.3 (-CHCH3), 26.8 (-C(CH3)3), 
34.7 (-CH2CH2OTBDPS), 63.1 (-CH2OTBDPS), 70.8 (-CHOH), 111.2 (-C=CH2), 
127.7 (Ph-C x4), 129.8 (Ph-C x2), 133.4 (Ph-Cq), 134.8 (Ph-Cq), 135.6 (Ph-C x4), 
150.6 (-C=CH2) ppm; 
IR (neat, cm-1): 3398, 3072, 3053, 2960, 2931, 2858, 1472, 1458; 
HRMS (EI) m/z [(M-C4H9)
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CH2Cl2, -78 °C to 0 °C
90%  
To a solution of 54 (1.05 g, 3 mmol) in anhydrous CH2Cl2 (9 mL) at 0 °C was added 
PPh3 (0.96 g, 3.6 mmol) in one portion. The reaction mixture was stirred at 0 °C for 
10 minutes. After all PPh3 has dissolved, NBS (0.6 g, 3.3 mmol) was added in one 
portion at -78 °C. The resulting solution was stirred at -78 °C for 30 minutes then 
transferred to ice bath at 0 °C. After completion (monitored by TLC), ether and H2O 
were added subsequently. The mixture was partitioned, and the organic layer was 
washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The residue 
was purified by flash chromatography on silica gel, eluting with hexane-ethyl acetate 
(40:1) to afford 43 as a colorless oil, 1.12 g (90%). 
Rf 0.85 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.07 (9H, s, -C(CH3)3), 1.77 (3H, d, J = 6.9 Hz, -CH-
CH3), 2.40-2.60 (2H, m, -CH2-C=), 3.84 (2H, t, J = 6.6 Hz, -CH2-O-), 4.69 (1H, q, J = 
6.9 Hz, -CH-CH3), 4.95 (1H, s, C=CH2), 5.21 (1H, s, -C=CH2), 7.37-7.46 (6H, m, -
Ph-H), 7.67-7.70 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 19.2 (-C(CH3)3), 24.2 (-CHCH3), 26.9 (-C(CH3)3), 
35.7 (-CH2CH2OTBDPS), 52.5 (-CHBr), 63.1 (-CH2OTBDPS), 113.3 (-C=CH2), 
127.7 (Ph-C x4), 129.7 (Ph-C x2), 133.7 (Ph-Cq), 133.8 (Ph-Cq), 135.6 (Ph-C x4), 
147.5 (-C=CH2) ppm; 
IR (neat, cm-1): 3072, 2958, 2931, 2858, 1590, 1428; 
HRMS (EI) m/z [(M-C4H9)
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To a mixture of N-methyl Fmoc protected L-valine (1 g, 2.8 mmol), glycine ethyl 
ester hydochloride salt (0.43 g, 3.1 mmol) in CH2Cl2 (5 mL) was added benzotriazol-
1-yloxytris(dimethylamino)phophonium hexafluorophosphate (BOP) (1.25 g, 2.8 
mmol).  After the BOP had dissolved, diisopropylethylamine (DIEA) (1.5 mL) was 
added dropwise. The mixture was stirred at room temperature for 1h.  After the 
reaction was completed (monitor by TLC), the reaction mixture was concentrated in 
vacuo. The residue was purified by flash chromatography on silica gel, eluting with 
hexane/ethyl acetate  (4:1 to 2:1) to afford the dipeptide 38 as a colorless oil, 1.17 g 
(95%).  
Rf 0.68 (hexane/ethyl acetate, 1:1);  
["]28D = -88.1° (c = 1.0, MeOH);  
1H NMR (300 MHz, CDCl3): ! 0.84 (3H, d, J = 6.4 Hz, Val-CH3), 0.96 (3H, d, J = 
6.4 Hz, Val-CH3), 1.25 (3H, t, J = 7.0 Hz, -CH2-CH3), 2.19-2,42 (1H, m, -CH-
(CH3)2), 2.89 (3H, s, -N-CH3), 3.51 (1H, m, -NH-CH2-), 3.96 (1H, m, -NH-CH2-), 
4.12 (2H, q, J = 7.0 Hz, -OCH2-CH3), 4.22 (1H, d, J = 7.0 Hz, -N-CH-), 4.44 (1H, t, J 
= 7.0 Hz, -CH-CH2-O-), 4.68-4.76 (2H, m, -O-CH2-CH-), 6.57 (1H, brs, -NH), 7.30-
7.43 (4H, m, -Ph-H), 7.55-7.63 (2H, m, -Ph-H), 7.73-7.81 (2H, m, -Ph-H) ppm;  
13C NMR (75 MHz, CDCl3): ! 14.1 (-OCH2CH3), 18.5 (-CH3), 19.4 (-CH3), 26.1 (-
CH(CH3)2), 29.7 (-N-CH3), 41.0 (-CH-Ph), 47.2 (-NH-CH2-), 61.9 (-OCH2CH3), 64.6 
(-N-CH-), 67.6 (-O-CH2-), 119.9 (-Ph-C), 124.9 (-Ph-C), 126.9 (-Ph-C), 127.6 (-Ph-
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C), 141.2 (-Ph-C), 143.8 (-Ph-C), 157.3 (-C=O), 169.3 (-C=O), 170.5 (-CONH-) 
ppm;  
IR (neat, cm-1): 3342, 3060, 2955, 2872, 1746, 1737, 1708, 1696, 1666, 1537, 1519;  
HRMS (EI) m/z (M+): obsd 438.2158, calcd 438.2155 for C25H30N2O5. 
 














L-alanine (0.40 g, 4.5 mmol), diallydicarbonate (1 g, 5.4 mmol) was dissolved in 
dioxane (5 mL) and water (5 mL).  The mixture was refluxed for 12h under nitrogen. 
After the reaction was completed (monitored by TLC), the reaction mixture was 
cooled to room temperature and extracted with ether.  The combined ether phase was 
washed with saturated NaHCO3.  The combined aqueous layer was acidified with 
concentrated HCl until pH=1 at 0 °C and extracted with ethyl acetate.  The combined 
ethyl acetate was washed with saturated NH4Cl and brine until pH=7, dried over 
anhydrous Na2SO4 and concentrated in vacuo to afford the Alloc protected alanine as 
a pale yellow liquid, 0.66 g (85%).  
Rf 0.11 (hexane/ethyl acetate, 1:1); 
["]30D = -14.0° (c = 3.2, CH2Cl2);  
1H NMR (300 MHz, CDCl3): ! 1.47 (3H, d, J = 7.2 Hz, -CH-CH3), 4.40 (1H, q, J = 
7.2 Hz, -CH-CH3), 4.57-4.65 (2H, m, -O-CH2-), 5.21-5.34 (3H, m, -CH=CH2, -NH), 
5.84-5.97 (1H, m, -CH=CH2), 6.53 (1H, brs, -COOH) ppm;  
13C NMR (75 MHz, CDCl3): ! 18.1 (-CH-CH3), 49.3 (-NH-CH-), 65.9 (-O-CH2-), 
117.8 (-CH=CH2), 132.3 (-CH=CH2), 155.9 (-C=O), 176.8 (-COOH) ppm;  
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IR (neat, cm-1): 3417, 1643, 1546, 1530;  
HRMS (EI) m/z (M+): obsd 173.0681, calcd 173.0688 for C7H11NO4. 
 
Tripeptide Alloc-(S)-Ala-(S)-Me-Val-Gly-OEt (35) 





















38 (1.387 g, 3.16 mmol) was dissolved in CH3CN (33 mL) and diethylamine (1.65 
mL, 15.8 mmol) (5% v/v based on CH3CN). The mixture was stirred at room 
temperature for 3h. After the rection was completed (monitor by TLC), the reaction 
mixture was concentrated in vacuo to remove the solvent and the residue was used in 
the next step without further purification. 
To the residue was added CH2Cl2 (3.5 mL), N-Alloc alanine 37 (0.49 g, 2.84 mmol) 
and bromotripyrrolidino phosphonium hexafluorophosphate (PyBrOP) (2.21 g, 4.31 
mmol) in one portion.  After PyBrOP had dissolved, diisopropylethylamine (DIEA) 
(1.1 mL, 6.1 mmol) was added dropwise. The mixture was stirred at room 
temperature for 3h.  The reaction progress was monitored by TLC. After completion, 
the reaction mixture was concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel, eluting with hexane/ethyl acetate (4:1 to 1:1). The 
tripeptide 35 was obtained as a colorless oil, 0.78 g (75%).  
Rf 0.38 (Hexane/ethyl acetate, 1:1); 
["]28D = -58.8° (c = 0.57, CH2Cl2);  
1H NMR (300 MHz, CDCl3): ! 0.84 (3H, d, J = 6.6 Hz, Val-CH3), 0.98 (3H, d, J = 
6.3 Hz, Val-CH3), 1.26 (3H, t, J = 7.3 Hz, -CH2-CH3), 1.35 (3H, d, J = 6.6 Hz, Ala-
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CH3), 2.26-2.38 (1H, m, Val-(CH3)2-CH-), 3.03 (3H, s, -N-CH3), 3.83 (1H, dd, J = 
17.8, 5.3 Hz, Gly-CH2-), 4.08 (1H, dd, J = 17.8, 6.6 Hz, Gly-CH2-), 4.18 (2H, q, J = 
7.3 Hz, -CH2-CH3), 4.48-4.70 (4H, m,  Ala-"-H, CH2=CH-CH2-, Val-"-H), 5.19-5.33 
(2H, m,  -CH=CH2), 5.65 (1H, d, J = 7.7 Hz, Ala-NH), 5.82-5.97 (1H, m, -CH=CH2), 
6.55 (1H, brs, Gly-NH) ppm;  
13C NMR (75 MHz, CDCl3): ! 14.0 (-OCH2CH3), 18.4 (-CH3), 19.4 (-CH3), 25.5 (-
CH(CH3)2), 30.4 (-N-CH3), 40.9 (-NH-CH2-), 47.1 (-NH-CH-), 61.2 (-OCH2CH3), 
62.4 (-N-CH-), 65.5 (-OCH2-), 117.5 (-CH=CH2), 132.7 (-CH=CH2), 155.4 (-C=O), 
169.5 (-C=O), 170.1 (-N-C=O), 174.0 (-N-C=O) ppm;  
IR (neat, cm-1): 3415, 1722, 1640, 1547;  
HRMS (EI) m/z (M+): obsd 371.2081, calcd 371.2056 for C17H29N3O6. 
 


















To a solution of 35 (0.57 mg, 1.53 mmol) in THF (3 mL) at 0 °C was added a solution 
of LiOH (229 mg, 5.46 mmol) in water (3 mL). The resulting mixture was stirred at 0 
°C for 30 minutes. After dilution with H2O, the reaction mixture was washed with 
ether. The aqueous layer was acidified to pH = 3 by the addition of 1M HCl and 
salted out. The mixture was extracted with ether (x3). The combined organic extract 
was dried over anhydrous Na2SO4, filtered and concentrated to afford the desired 
product 33 as colorless oil, 0.51 g (97%). 
Rf 0.11 (hexane/ethyl acetate, 1:1); 
["]30D = -112.8° (c = 0.37, CH2Cl2); 
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1H NMR (300 MHz, CDCl3): ! 0.82 (3H, d, J = 6.4 Hz, Val-CH3), 0.95 (3H, d, J = 
6.4 Hz, Val-CH3), 1.29 (3H, d, J = 6.8 Hz, Ala-CH3), 2.25-2.38 (1H, m, Val-(CH3)2-
CH-), 3.03 (3H, s, -N-CH3), 3.83-3.94 (1H, m, Val-"-H), 4.03-4.19 (1H, m, Ala-"-
H), 4.53 (2H, d, J = 5.2 Hz, CH2=CH-CH2-), 4.62 (2H, d, J = 11.2 Hz, Gly-CH2-), 
4.50-5.20 (1H, brs, COOH), 5.17 -5.31(2H, m, CH2=CH-CH2-), 5.78-5.95 (1H, m, -
CH=CH2), 6.36 (1H, brs, Ala-NH), 6.96 (1H, brs, Gly-NH) ppm; 
13C NMR (75 MHz, CDCl3): ! 17.9 (-CH3), 18.4 (-CH3), 19.4 (-CH3), 25.6 (-
CH(CH3)2), 30.6 (-N-CH3), 40.9 (-NH-CH2-), 47.3 (-NH-CH-), 62.8 (-N-CH-), 65.7 
(-OCH2-), 117.7 (-CH=CH2), 132.6 (-CH=CH2), 155.6 (-C=O), 170.0 (-COOH), 
172.4 (-N-C=O), 174.6 (-N-C=O) ppm;  
IR (neat, cm-1): 3316, 1712, 1682, 1636, 1588, 1470; 
















To a stirred solution of 42 (3.65 mL, 28 mmol) in sat. NH4Cl solution (50 mL) were 
added indium (2.18 g, 18.9 mmol). After vigorous stirred for 30 minutes at room 
temperature, La(OTf)3 (5.5 g, 9 mmol) and 41 (1.57 g, 9.46 mmol) were subsequently 
added. The mixture was stirred vigorously at room temperature for 16h. After the 
reaction was completed (monitored by TLC), the reaction mixture was extracted with 
ethyl acetate. The organic extracts were combined and washed with sat. NaHCO3 
solution, brine, dried over anhydrous Na2SO4, and concentrated in vacuo. The crude 
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product was purified by flash chromatography on silica gel, eluting with 5% ethyl 
acetate in hexane gave 60 as a colorless oil (2.12 g, 80%), the syn/anti isomer were 
obtain in the ratio of 93:7. 
Rf 0.47 (hexane/ethyl acetate, 4:1); 
Syn isomer: 
1H NMR (500 MHz, CDCl3): ! 1.11 (3H, d, J = 6.95 Hz, -CH-CH3), 1.13 (9H, s, -
C(CH3)3), 1.72 (3H, d, J = 1.4 Hz, -C-CH3), 1.78 (3H, d, J = 0.9 Hz, -C-CH3), 2.99 
(1H, ddd, J = 6.95, 4.15, 0.95 Hz -CH-CH3), 3.75 (3H, s, -COOCH3), 4.08 (1H, d, J = 
4.15 Hz, -CH-OH), 5.24 (1H, d, J = 1.30 Hz, -C=CH2), 5.64 (1H, d, J = 0.95 Hz, -
C=CH-), 5.82 (1H, d, J = 1.30 Hz, -C=CH2), 6.24 (1H, d, J = 0.95 Hz, -C=CH-) ppm;  
13C NMR (125 MHz, CDCl3): ! 13.8 (-CH3), 13.8 (-CH3), 17.8 (-CH3), 30.9 (-
C(CH3)3), 32.5 (-C(CH3)3), 38.9 (-CH-CH3), 51.7 (-OMe), 78.9 (-CHOH), 125.4 (-
C=CH2), 130.8 (-C=CH-), 131.8 (-C=CH-), 134.5 (-C=CH-), 139.8 (-C=CH-), 143.2 
(-C=CH2), 167.6 (C=O) ppm;  
IR (neat, cm-1): 3440, 2954, 1717, 1625, 1437;  











To a mixture of syn 60 (0.7 g, 2.5 mmol) in anhydrous CH2Cl2 (5 mL), was added 
DIBAL-H (5 mL, 5 mmol) at 0 °C and stirred for 3h.  After reduction was completed 
(monitored by TLC), sat. Na2SO4 solution was added until white precipitate was 
deposited. The mixture was filtered, dried over anhydrous MgSO4 and concentrated in 
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vacuo. The residue was purified by flash chromatography on silica gel (hexane ethyl / 
acetate, 4:1) to afford the pure syn 62 as a colorless oil, 0.58 g (92%).  
Rf 0.40 (hexane/ethyl acetate, 2:1); 
1H NMR (500 MHz, CDCl3): ! 1.02 (3H, d, J = 6.96 Hz, -CH-CH3), 1.27 (9H, s, -
C(CH3)3), 1.70 (3H, d, J = 1.05 Hz, -C-CH3), 1.79 (3H, d, J = 1.05 Hz, -C-CH3), 2.54 
(1H, dq, J = 6.96, 3.84 Hz, -CH-CH3), 2.63 (2H, brs, -CH2OH, -CHOH), 4.04 (1H, d, 
J = 3.84 Hz, -CH-OH), 4.06 (1H, d, J = 13.23 Hz, -CH2-OH), 4.14 (1H, d, J = 13.23 
Hz, -CH2-OH), 4.99 (1H, brs, -C=CH-), 5.13 (brs, 1H, -C=CH2), 5.25 (1H, d, J = 1.38 
Hz, -C=CH2), 5.87 (1H, brs, -C=CH-) ppm;  
13C NMR (125 MHz, CDCl3): ! 12.7 (-CH-CH3), 14.8 (-C-CH3), 18.0 (-C-CH3), 30.9 
(-C(CH3)3), 32.5 (-C(CH3)3), 41.2 (-CH-CH3), 64.7 (-CH2OH), 78.8 (-CHOH), 112.7 
(-C=CH2), 130.9 (-C=CH-), 131.3 (-C=CH-), 134.3 (-C=CH-), 140.0 (-C=CH-), 
151.4 (-C=CH2) ppm;  
IR (neat, cm-1): 3354, 2958, 1713, 1651, 1644;  










DMF, 0 ºC, 1.5h
96%  
To a solution of syn 62 (0.73 g, 2.89 mmol) in anhydrous DMF (9 mL) was added 
imidazole (0.40 g, 5.78 mmol) and tert-butyldiphenylsilyl chloride (0.85 mL, 3.18 
mmol) at 0 °C under N2. The mixture was stirred at 0 °C to room temperature for 
1.5h. After completion, the mixture was poured into water and extracted with ethyl 
acetate (x3). The combined organic extract was washed with brine, dried (MgSO4), 
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concentrated and purified by flash chromatography on silica gel to afford 63 as a 
colorless oil, 1.36 g (96%).  
Rf  0.46 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.01 (3H, d, J = 6.96 Hz, -CH-CH3), 1.06 (9H, s, -
C(CH3)3), 1.14 (9H, s, -C(CH3)3), 1.67 (3H, d, J = 1.05 Hz, -C-CH3), 1.79 (3H, d, J = 
1.38 Hz, -C-CH3), 2.50 (1H, dq, J = 6.96, 4.5 Hz, -CH-CH3), 3.97 (1H, d, J = 4.5 Hz, 
-CH-OH), 4.12 (1H, d, J = 13.6 Hz, -CH2-O-), 4.19 (1H, d, J = 13.6 Hz, -CH2-O-), 
5.00 (1H, s, -C=CH2), 5.26 (2H, d, J = 1.41 Hz, -C=CH-, -C=CH2), 5.88 (1H, s, -
C=CH-), 7.38-7.44 (6H, m, -Ph-H), 7.66-7.70 (4H, m, -Ph-H) ppm;  
13C NMR (75 MHz, CDCl3): ! 13.0 (-CH3), 14.6 (-CH3), 18.0 (-CH3), 19.2 (-
C(CH3)3), 26.8 (-C(CH3)3), 29.6 (-C(CH3)3), 30.9 (-C(CH3)3), 40.1 (-CHCH3), 65.9 (-
CH2OTBDPS), 77.8 (-CHOH), 111.2 (-C=CH2), 127.7 (-Ph-C), 129.7 (-Ph-C), 131.0 
(-C=CH-), 131.3 (-C=CH-), 133.4 (-Ph-C), 134.1 (-C=CH-), 135.5 (-Ph-C), 139.8 (-
C=CH-), 150.5 (-C=CH2) ppm;  
IR (neat, cm-1): 3434, 2929, 1646;  
HRMS (EI) m/z [(M-C4H9)












To a solution of Dess-Martin reagent (1.75 g, 4.12 mmol) in anhydrous CH2Cl2 (15 
mL) was added dropwise of 63 (1.35 g, 2.75 mmol) prediluted in CH2Cl2 (5 mL) at 0 
°C.  The reaction mixture was stirred under nitrogen at 0 °C for 3h. After completion, 
the reaction mixture was diluted with ether and poured slowly into a Na2S2O3 : 
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NaHCO3 (1:1) solution and stirred for 10 minutes and extract with ether.  The 
combine etherate layer was washed with NaHCO3, brine and dried over anhydrous 
MgSO4.  Solvent was removed in vacuo. The residue was purified by flash 
chromatography on silica gel to provide 64 as a colorless oil, 1.09 g (81%). 
Rf 0.66 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.09 (9H, s, -C(CH3)3), 1.17 (9H, s, -C(CH3)3), 1.22 
(3H, d, J = 6.96 Hz, -CH-CH3), 1.88 (3H, d, J = 1.05 Hz, -C-CH3), 1.91 (3H, d, J = 
1.05 Hz, -C-CH3), 4.03 (1H, q, J = 6.96 Hz, -CH-CH3), 4.16 (1H, d, J = 13.5 Hz, -
CH2-O-), 4.22 (1H, d, J = 13.5 Hz, -CH2-O-), 4.93 (1H, brs, -C=CH2), 5.23 (1H, d, J 
= 1.05 Hz, -C=CH2-), 5.54 (1H, brs, -C=CH-), 6.99 (1H, brs, -C=CH-), 7.36-7.44 
(6H, m, -Ph-H), 7.68-7.70 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 13.4 (-CH3), 16.9 (-CH3), 17.4 (-CH3), 19.2 (-
C(CH3)3), 26.8 (-C(CH3)3), 30.6 (-C(CH3)3), 32.9 (-C(CH3)3), 42.4 (-CHCH3), 65.8 (-
CH2OTBDPS), 111.1 (-C=CH2), 127.7 (-Ph-C x4), 129.7 (-Ph-C x2), 130.9 (Ph-Cq 
x2), 133.3 (-C=CH), 133.7 (-C=CH), 135.4 (-Ph-C x4), 144.9 (-C=CH-), 145.3 (-
C=CH-), 148.4 (-C=CH2), 203.1 (-C=O) ppm;  
IR (neat, cm-1): 2960, 1663, 1648, 1634;  
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To a solution of 64 (490 mg, 1 mmol) in THF:H2O (10:1) (5 mL) was added 
CeCl3.7H2O (130 mg, 1.5 mmol) at 0 °C. After the mixture was stirred at 0 °C for 15 
minutes, NaBH4 (60 mg, 1.5 mmol) was added and the reaction was stirred for 3h. 
After the reaction was completed (monitored by TLC), THF was removed under 
vacuo. H2O was added and the mixture was extracted with ether. The combined 
etherate layer was washed with brine, dried over MgSO4, concentrated and purified 
through flash chromatography on silica gel to afford 65 as a colorless oil, 396 mg 
(80%). (anti:syn > 99:1) 
Rf 0.46 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 0.87 (3H, d, J = 6.96 Hz, -CH-CH3), 1.07 (9H, s, -
C(CH3)3), 1.13 (9H, s, -C-(CH3)3), 1.71 (3H, d, J = 1.40 Hz, -C-CH3), 1.79 (3H, d, J = 
1.05 Hz, -C-CH3), 2.39 (1H, dq, J = 9.40, 6.96 Hz, -CH-CH3), 3.80 (1H, dd, J = 9.40, 
2.45 Hz, -CH-OH),  4.14 (2H, s, -CH2-O-), 5.09 (1H, s, -C=CH2), 5.30 (1H, d, J = 
1.40 Hz, -C=CH2-), 5.32 (1H, d, J = 1.40 Hz, -C=CH-), 5.80 (1H, s, -C=CH-), 7.36-
7.44 (6H, m, -Ph-H), 7.69-7.72 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 11.9 (-CH3), 17.5 (-CH3), 17.9 (-CH3), 19.1 (-
C(CH3)3), 26.8 (-C(CH3)3), 29.6 (-C(CH3)3), 30.9 (-C(CH3)3), 41.8 (-CHCH3), 66.0 (-
CH2OTBDPS), 82.0 (-CHOH), 111.2 (-C=CH2), 127.7 (-Ph-C x4), 129.8 (-Ph-C x2), 
130.6 (-C=CH-), 133.1 (Ph-Cq x2), 134.1 (-C=CH), 134.3 (-C=CH-), 135.6 (-Ph-C 
x4), 140.2 (-C=CH), 150.3 (-C=CH2) ppm;  
IR (neat, cm-1): 3428, 2957, 2930, 1649, 1558;  
HRMS (EI) m/z [(M-C4H9)
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To a solution of 65 (0.5 g, 1.02 mmol) in THF (2 mL) was added TBAF (1.5 mL, 1.0 
M in THF, 1.5 mmol). The mixture was stirred for 30 minutes at room temperature. 
After the reaction was completed (monitored by TLC), the mixture was concentrated 
in vacuo to remove the THF. The residue was purified by flash chromatography on 
silica gel to afford 66 as a colorless oil, 0.24 g (93%). 
Rf 0.40 (hexane/ethyl acetate, 2:1); 
1H NMR (500 MHz, CDCl3): ! 0.94 (3H, d, J = 6.95 Hz, -CH-CH3), 1.13 (9H, s, -
C(CH3)3), 1.73 (3H, d, J = 1.4 Hz, -C-CH3), 1.81 (3H, d, J = 0.95 Hz, -C-CH3), 2.27 
(2H, brs, -CH2OH, -CHOH), 2.48 (1H, dq, J = 9.25, 6.95 Hz, -CH-CH3), 3.82 (1H, d, 
J = 9.25 Hz, -CH-OH), 4.10 (1H, dd, J = 12.47, 0.95 Hz, -CH2-OH), 4.15 (1H, dd, J = 
12.47, 0.95 Hz, -CH2-OH), 5.05 (1H, s, -C=CH-), 5.19 (1H, d, J = 0.95 Hz, -C=CH2), 
5.31 (1H, d, J = 0.95 Hz, -C=CH2), 5.83 (1H, s, -C=CH-) ppm;  
13C NMR (125 MHz, CDCl3): ! 12.1 (-CH-CH3), 17.6 (-C-CH3), 17.9 (-C-CH3), 30.9 
(-C(CH3)3), 32.6 (-C(CH3)3), 41.2 (-CH-CH3), 65.6 (-CH2OH), 83.1 (-CHOH), 112.8 
(-C=CH2), 130.7 (-C=CH-), 134.3 (-C=CH-), 134.5 (-C=CH-), 140.6 (-C=CH-), 
151.5 (-C=CH2) ppm;  
IR (neat, cm-1): 3353, 2958, 1743, 1643;  
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(1S,1'S)-2,2'-((3R,4R,5E,7E)-3,5,7,9,9-pentamethyl-2-methylenedeca-5,7-diene-
1,4-diyl)bis(oxy)bis(2-oxo-1-phenylethane-2,1-diyl) diacetate (R,R)-B and 
(1S,1'S)-2,2'-((3S,4S,5E,7E)-3,5,7,9,9-pentamethyl-2-methylenedeca-5,7-diene-































(R,R)-B [!]25D = +55° (c = 4.0, CHCl3) (S,S)-C [!]
26
D = +62° (c = 3.2, CHCl3)  
To a mixture of anti (±)-66 (0.24 g, 0.95 mmol), S-(+)-"-acetoxyphenylacetic acid 
(0.56 g, 2.85 mmol) and DMAP (12 mg, 0.095 mmol) in dried CH2Cl2 (4 mL) was 
added DCC (0.39 g, 1.9 mmol) prediluted in 1 mL CH2Cl2 dropwise at 0 °C. The 
reaction mixture was stirred at room temperature for 12h. After completion, CH2Cl2 
was removed via rotary evaporator and the crude product was directly subjected to 
column chromatography. Purification by flash chromatography on silica gel 
(Hex:CH2Cl2:EA (3:3:0.2) afforded two pure enantiomers as colorless oil with 96% 
overall yield.  
(R,R)-B  
Rf 0.36 (hexane/CH2Cl2/ethyl acetate, 3:3:0.25); 
["]25D = +55.4° (c = 4.0 , CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.72 (3H, d, J = 7.4 Hz, -CH-CH3), 1.12 (9H, s, -
C(CH3)3), 1.64 (3H, d, J = 1.4 Hz, -C-CH3), 1.76 (3H, d, J = 1.35 Hz, -C-CH3), 2.14 
(3H, s, -OAc), 2.19 (3H, s, -OAc), 2.33 (1H, dq, J = 9.7, 7.4 Hz, -CH-CH3), 4.11 (1H, 
d, J = 12.95 Hz, -CH2-O-), 4.19 (1H, d, J = 12.95 Hz, -CH2-O-), 4.62 (1H, s, -C=CH2-
), 4.68 (1H, s, -C=CH2), 4.99 (1H, d, J = 9.7 Hz, -CH-O-), 5.24 (1H, t, J = 1.35 Hz, -
C=CH-), 5.85 (1H, s, -C=CH-), 5.87 (1H, s, -CH-OAc), 5.92 (1H, s, -CH-OAc), 
7.26-7.27 (3H, m, -Ph-H), 7.33-7.35 (2H, m, -Ph-H), 7.38-7.39 (3H, m, -Ph-H), 7.45-
7.47 (2H, m, -Ph-H) ppm;  
  
Chapter 1 : Total Synthesis of Antillatoxin - Experimental 
71 Part I  
13C NMR (125 MHz, CDCl3): ! 12.7 (-C-CH3), 16.9 (OAc), 17.7 (OAc), 20.6 (-C-
CH3), 30.8 (-C(CH3)3), 32.5 (-C(CH3)3), 38.9 (-CH-CH3), 67.3 (-CH2O-), 74.3 (-CH-
OAc), 74.4 (-CH-OAc), 84.2 (-CH-O-), 114.5 (-C=CH2), 127.6 (-Ph-Cm), 127.7 (-Ph-
Cm), 128.5 (-Ph-Co), 128.7 (-Ph-Co), 129.0 (-Ph-Cp), 129.2 (-Ph-Cp), 129.4 (-
HC=C-CH3), 130.3 (-HC=C-CH3), 133.7 (-Ph-Cq), 134.0 (-Ph-Cq), 136.3 (-CH=C-
CH3), 140.8 (-CH=C-CH3), 143.9 (-C=CH2), 167.6 (C=O), 168.3 (C=O), 169.9 
(C=O), 170.1 (C=O) ppm;  
HRMS (ESI) m/z (M+Na)+: obsd. 627.2928, calcd 627.2934 for C36H44NaO8; 
 
(S,S)-C 
Rf 0.27 (hexane/CH2Cl2/ethyl acetate, 3:3:0.25); 
["]26D = +62.2° (c = 3.2, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.82 (3H, d, J = 6.95 Hz, -CH-CH3), 1.09 (9H, s, -
C(CH3)3), 1.28 (3H, d, J = 1.4 Hz, -C-CH3), 1.64 (3H, d, J = 0.95 Hz, -C-CH3), 2.15 
(3H, s, -OAc), 2.20 (3H, s, -OAc), 2.35 (1H, dq, J = 9.75, 6.95 Hz, -CH-CH3), 4.57 
(1H, d, J = 12.95 Hz, -CH2-O-), 4.66 (1H, d, J = 12.95 Hz, -CH2-O-), 4.95 (1H, d, J = 
9.75 Hz, -CH-O-), 4.98 (1H, s, -C=CH2-), 5.01 (1H, s, -C=CH2), 5.06 (1H, t, J = 1.4 
Hz, -C=CH-), 5.62 (1H, s, -C=CH-), 5.88 (1H, s, -CH-OAc), 5.98 (1H, s, -CH-OAc), 
7.32-7.34 (3H, m, -Ph-H), 7.36-7.39 (5H, m, -Ph-H), 7.48-7.50 (2H, m, -Ph-H) ppm;  
13C NMR (125 MHz, CDCl3): ! 12.4 (-C-CH3), 16.7 (OAc), 17.5 (OAc), 20.6 (-C-
CH3), 30.8 (-C(CH3)3), 32.5 (-C(CH3)3), 38.4 (-CH-CH3), 67.9 (-CH2O-), 74.3 (-CH-
OAc), 74.5 (-CH-OAc), 84.5 (-CH-O-), 114.5 (-C=CH2), 127.6 (-Ph-Cm), 127.7 (-Ph-
Cm), 128.5 (-Ph-Co), 128.7 (-Ph-Co), 129.0 (-Ph-Cp), 129.2 (-Ph-Cp), 129.4, (-
HC=C-CH3), 130.3 (-HC=C-CH3), 133.7 (-Ph-Cq), 134.0 (-Ph-Cq), 136.3 (-CH=C-
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CH3), 140.8 (-CH=C-CH3), 143.9 (-C=CH2), 167.6 (C=O), 168.2 (C=O), 169.9 
(C=O), 170.1 (C=O) ppm;  








THF / H2O 
(4:1)













To a solution of (R,R)-B (40 mg, 0.066 mmol) in THF (1 mL) at 0 °C was added a 
solution of LiOH (6 mg, 0.14 mmol) in water (1 mL). The resulting mixture was 
stirred at room temperature for 12h prior to workup. The mixture was extracted with 
ethyl acetate (x5). The combined organic extract was dried over anhydrous Na2SO4, 
filtered and concentrated to afford the desired product 66b as a white amorphous 
solid, 15.6 mg (93%). 
Rf 0.40 (hexane/ethyl acetate, 2:1); 
["]26D = -59° (c = 1.5, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.94 (3H, d, J = 6.95 Hz, -CH-CH3), 1.13 (9H, s, -
C(CH3)3), 1.73 (3H, d, J = 1.4 Hz, -C-CH3), 1.81 (3H, d, J = 0.95 Hz, -C-CH3), 2.27 
(2H, brs, -CH2OH, -CHOH), 2.48 (1H, dq, J = 9.25, 6.95 Hz, -CH-CH3), 3.82 (1H, d, 
J = 9.25 Hz, -CH-OH), 4.10 (1H, dd, J = 12.47, 0.95 Hz, -CH2-OH), 4.15 (1H, dd, J = 
12.47, 0.95 Hz, -CH2-OH), 5.05 (1H, s, -C=CH-), 5.19 (1H, d, J = 0.95 Hz, -C=CH2), 
5.31 (1H, d, J = 0.95 Hz, -C=CH2), 5.83 (1H, s, -C=CH-) ppm;  
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13C NMR (125 MHz, CDCl3): ! 12.1 (-CH-CH3), 17.6 (-C-CH3), 17.9 (-C-CH3), 30.9 
(-C(CH3)3), 32.6 (-C(CH3)3), 41.2 (-CH-CH3), 65.6 (-CH2OH), 83.1 (-CHOH), 112.8 
(-C=CH2), 130.7 (-C=CH-), 134.3 (-C=CH-), 134.5 (-C=CH-), 140.6 (-C=CH-), 
151.5 (-C=CH2) ppm;  
IR (neat, cm-1): 3353, 2958, 1743, 1643;  








THF / H2O 
(4:1)













Follow the same hydrolysis procedure for 66b, 66c was obtained as a white 
amorphous solid in 93% yield. 
Rf 0.40 (hexane/ethyl acetate, 2:1); 
["]26D = +55° (c = 1.1, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.94 (3H, d, J = 6.95 Hz, -CH-CH3), 1.13 (9H, s, -
C(CH3)3), 1.73 (3H, d, J = 1.4 Hz, -C-CH3), 1.81 (3H, d, J = 0.95 Hz, -C-CH3), 2.27 
(2H, brs, -CH2OH, -CHOH), 2.48 (1H, dq, J = 9.25, 6.95 Hz, -CH-CH3), 3.82 (1H, d, 
J = 9.25 Hz, -CH-OH), 4.10 (1H, dd, J = 12.47, 0.95 Hz, -CH2-OH), 4.15 (1H, dd, J = 
12.47, 0.95 Hz, -CH2-OH), 5.05 (1H, s, -C=CH-), 5.19 (1H, d, J = 0.95 Hz, -C=CH2), 
5.31 (1H, d, J = 0.95 Hz, -C=CH2), 5.83 (1H, s, -C=CH-) ppm;  
13C NMR (125 MHz, CDCl3): ! 12.1 (-CH-CH3), 17.6 (-C-CH3), 17.9 (-C-CH3), 30.9 
(-C(CH3)3), 32.6 (-C(CH3)3), 41.2 (-CH-CH3), 65.6 (-CH2OH), 83.1 (-CHOH), 112.8 
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(-C=CH2), 130.7 (-C=CH-), 134.3 (-C=CH-), 134.5 (-C=CH-), 140.6 (-C=CH-), 
151.5 (-C=CH2) ppm;  
IR (neat, cm-1): 3353, 2958, 1743, 1643;  




 65b [!]26D = -19° (c = 0.7, CHCl3)
TBDPSCl, Imidazole,









Follow the same protecting procedure for 63, 65b was obtained as colorless oil. 
Rf 0.46 (hexane/ethyl acetate, 4:1); 
["]26D = -19° (c = 0.7 , CHCl3); 
1H NMR (300 MHz, CDCl3): ! 0.87 (3H, d, J = 6.96 Hz, -CH-CH3), 1.07 (9H, s, -
C(CH3)3), 1.13 (9H, s, -C-(CH3)3), 1.71 (3H, d, J = 1.40 Hz, -C-CH3), 1.79 (3H, d, J = 
1.05 Hz, -C-CH3), 2.39 (1H, dq, J = 9.40, 6.96 Hz, -CH-CH3), 3.80 (1H, dd, J = 9.40, 
2.45 Hz, -CH-OH),  4.14 (2H, s, -CH2-O-), 5.09 (1H, s, -C=CH2), 5.30 (1H, d, J = 
1.40 Hz, -C=CH2-), 5.32 (1H, d, J = 1.40 Hz, -C=CH-), 5.80 (1H, s, -C=CH-), 7.36-
7.44 (6H, m, -Ph-H), 7.69-7.72 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 11.9 (-CH3), 17.5 (-CH3), 17.9 (-CH3), 19.1 (-
C(CH3)3), 26.8 (-C(CH3)3), 29.6 (-C(CH3)3), 30.9 (-C(CH3)3), 41.8 (-CHCH3), 66.0 (-
CH2OTBDPS), 82.0 (-CHOH), 111.2 (-C=CH2), 127.7 (-Ph-C x4), 129.8 (-Ph-C x2), 
130.6 (-C=CH-), 133.1 (Ph-Cq x2), 134.1 (-C=CH), 134.3 (-C=CH-), 135.6 (-Ph-C 
x4), 140.2 (-C=CH), 150.3 (-C=CH2) ppm;  
IR (neat, cm-1): 3428, 2957, 2930, 1649, 1558;  
HRMS (EI) m/z [(M-C4H9)
+]: obsd 433.2535, calcd 433.2563 for C28H37O2Si. 
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Anti-ethyl (3R,4R,5E,7E)-4-hydroxy-3,5,7,9,9-pentamethyl-2-methylenedeca-5,7-
dienyl carbonate (67b) 










CH2Cl2, 0 ºC to rt, 3h
79%
 
To a solution of anti 66b (0.31 g, 1.23 mmol), anhydrous triethyl amine (0.51 mL, 
3.69 mmol) and DMAP (0.15 g, 1.23 mmol) in CH2Cl2 (12 ml) at 0 °C was added 
ethyl chloroformate (0.117 ml, 1.23 mmol) dropwise. The reaction progress was 
monitored by TLC.  After completion, the reaction mixture was poured into ice water 
and extracted with ethyl acetate (x3). The combined organic extracts were washed 
with NaHCO3, brine, dried (MgSO4) and concentrated in vacuo. Purification by flash 
chromatography on silica gel afforded 67b as colorless oil, 0.31 g (79%).  
Rf 0.42 (hexane/ethyl acetate, 4:1); 
["]27D = -14° (c = 4.2, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.95 (3H, d, J = 7.40 Hz, -CH-CH3), 1.14 (9H, s, -
C(CH3)3), 1.31 (3H, t, J = 6.95 Hz, -OCH2-CH3), 1.73 (3H, d, J = 1.40 Hz, -C-CH3), 
1.81 (3H, d, J = 1.40 Hz, -C-CH3), 2.45 (1H, dq, J = 9.25, 7.4 Hz, -CH-CH3), 3.85 
(1H, d, J = 9.25, 1.85 Hz, -CHOH), 4.21 (2H, q, J = 6.95 Hz, -CH2-CH3-), 4.66 (2H, 
s, -CH2-O-), 5.15 (1H, s, -C=CH2), 5.25 (1H, d, J = 0.95 Hz, -C=CH2), 5.31 (1H, d, J 
= 0.95 Hz, -C=CH-), 5.83 (1H, s, -C=CH-) ppm;  
13C NMR (75 MHz, CDCl3): ! 11.9 (-CH3), 14.2 (-CH3), 16.9 (-CH3), 17.8 (-CH3), 
30.9 (-C(CH3)3), 32.5 (-C(CH3)3), 41.8 (-CHCH3), 64.1 (-OCH2CH3), 68.7 (-
CH2OCO2Et), 81.8 (-CHOH), 113.9 (-C=CH2), 130.6 (-HC=C-), 133.9 (-HC=C-), 
134.4 (-C=CH-), 140.4 (-C=CH-), 145.9 (-C=CH2), 155.0 (C=O) ppm;  
IR (neat, cm-1): 3500, 2959, 1747, 1732, 1651;  
  
Chapter 1 : Total Synthesis of Antillatoxin - Experimental 
76 Part I  
HRMS (EI) m/z (M+): obsd 324.2295, calcd 324.2310 for C19H32O4. 
 
Anti-(3R,4R,5E,7E)-4-(tert-butyldiphenylsilyloxy)-3,5,7,9,9-pentamethyl-2-
methylenedeca-5,7-dienyl ethyl carbonate (68b) 









To a solution of 67b (0.2 g, 0.6 mmol) in 1 mL DMF was added AgNO3 (0.2 g, 1.2 
mmol) followed by TBDPSCl (0.18 mL, 0.66 mmol). After the reaction was 
completed (monitored by TLC), the reaction mixture was poured into ice water and 
extracted with ethyl acetate. The combined organic layer was washed with brine, 
dried over anhydrous MgSO4, concentrated in vacuo and purified by flash 
chromatography to afford 68b as a colorless oil, 0.263 g (78%). 
Rf 0.55 (hexane/ethyl acetate, 4:1); 
["]27D = +7° (c = 5.4, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.84 (3H, d, J = 7.35 Hz, -CH-CH3), 1.02 (9H, s, -
C(CH3)3), 1.08 (9H, s, -C(CH3)3), 1.31 (3H, t, J = 6.95 Hz, -OCH2CH3), 1.55 (3H, s, -
C-CH3), 1.57 (3H, dd, J = 4.15, 1.4 Hz, -C-CH3), 2.42 (1H, dq, J = 8.30, 7.35 Hz, -
CH-CH3), 3.94 (1H, d, J = 8.30 Hz, -CH-O-), 4.19 (2H, q, J = 6.95 Hz, -OCH2CH3), 
4.43 (1H, d, J = 13.45 Hz, -CH2OCO2Et),  4.52 (1H, d, J = 13.45 Hz, -CH2OCO2Et), 
4.91 (1H, s, -C=CH2-), 4.98 (1H, t, J = 1.40 Hz, -C=CH-), 5.08 (1H, d, J = 0.95 Hz, -
C=CH2-), 5.39 (1H, s, -C=CH-), 7.28-7.41 (6H, m, -Ph-H), 7.58-7.64 (4H, m, -Ph-H) 
ppm; 
13C NMR (75 MHz, CDCl3): ! 13.0 (-CH3), 14.2 (-CH3), 16.9 (-CH3), 17.6 (-CH3), 
19.4 (-C(CH3)3), 27.1 (-C(CH3)3), 30.9 (-C(CH3)3), 32.4 (-C(CH3)3), 42.1 (-CHCH3), 
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63.7 (-OCH2-), 69.9 (-CH2O-), 83.7 (-CHOTBDPS), 113.0 (-C=CH2), 127.0 (Ph-C 
x4), 129.3 (Ph-C x2), 130.5 (-CH=C-),133.7 (Ph-Cq x2), 133.9 (-C=CH-), 134.2 (-
C=CH-), 136.2 (Ph-C x4), 139.7 (-CH=C-), 145.8 (-C=CH2), 154.9 (C=O) ppm; 
IR (neat cm-1): 2929, 2859, 1756, 1663; 















68b (0.25 g, 0.44 mmol) was dissolved in 1% K2CO3 in MeOH solution at room 
temperature. The solution was stirred at room temperature for 16h. After the reaction 
was completed (monitored by TLC), the solution was neutralized to pH=7 using 1M 
HCl. The mixture was extracted with ethyl acetate. The combined organic extracts 
were washed with brine, dried over anhydrous MgSO4 and concentrated in vacuo. The 
residue was purified by flash chromatography on silica gel to afford 69b as colorless 
oil, 0.20 g (94%). 
Rf 0.22 (hexane/ethyl acetate, 4:1); 
["]26D = +19° (c = 0.7, CHCl3); 
1H NMR (300 MHz, CDCl3): ! 0.83 (3H, d, J = 6.96 Hz, -CH-CH3), 1.04 (9H, s, -
C(CH3)3), 1.10 (9H, s, -C-(CH3)3), 1.59 (3H, s, -C-CH3), 1.62 (3H, s, -C-CH3), 2.46 
(1H, dq, J = 8.7, 6.96 Hz, -CH-CH3), 3.90 (1H, d, J = 14.28 Hz, -CH2OH), 3.93 (1H, 
d, J = 8.7 Hz, -CH-O-), 4.03 (1H, d, J = 14.28 Hz, -CH2OH), 4.84 (1H, s, -C=CH2), 
5.01 (2H, d, J = 1.38 Hz, -C=CH-,-C=CH2), 5.38 (1H, s, -C=CH-), 7.29-7.43 (6H, m, 
-Ph-H), 7.60-7.68 (4H, m, -Ph-H) ppm; 
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13C NMR (75 MHz, CDCl3): ! 12.3 (-CH3), 17.2 (-CH3), 17.6 (-CH3), 19.4 (-
C(CH3)3), 27.1 (-C(CH3)3), 30.9 (-C(CH3)3), 32.4 (-C(CH3)3), 41.5 (-CHCH3), 65.7 (-
CH2OTBDPS), 84.4 (-CHOH), 110.0 (-C=CH2), 127.1 (Ph-C x2), 127.2 (Ph-C x2), 
129.4 (Ph-C x1), 129.5 (Ph-C x1), 130.6 (-C=C-), 133.8 (-C=C-), 133.9 (-C=C-), 
134.0 (-C=C-), 134.3 (-C=CH-), 136.3 (Ph-C x2), 136.3 (Ph-C x2), 139.8 (-C=CH-), 
151.4 (-C=CH2) ppm; 
IR (neat cm-1): 3354, 2958, 2874, 1654; 










- 78 ºC to 0 ºC, 3h
74%69b
 
To a solution of 69b (97.6 mg, 0.21 mmol) in anhydrous CH2Cl2 (3 mL) at -78 °C was 
added triphenyphosphine (81 mg, 0.31 mmol) in one portion. The mixture was stirred 
at -78 °C for 10 minutes until all the triphenylphospine dissolved and NBS (47 mg, 
0.264 mmol) was added in one portion. The resulting solution was stirred at -78 °C 
for 30 minutes and 0 °C for 15 minutes. After all the starting material had been 
consumed (monitored by TLC), ether and H2O was added in. The mixture was 
partitioned. The organic layer was washed with brine, dried over anhydrous MgSO4 
and concentrated in vacuo. Purification through flash chromatography on silica gel 
afforded 70b as a colorless oil, 88.6 mg (74%). 
Rf 0.79 (hexane/ethyl acetate; 4:1); 
["]26D = +25° (c = 2.5, CHCl3); 
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1H NMR (500 MHz, CDCl3): ! 0.93 (3H, d, J = 6.95 Hz, -CH-CH3), 1.06 (9H, s, -
C(CH3)3), 1.12 (9H, s, -C-(CH3)3), 1.60 (3H, s, -C-CH3), 1.63 (3H, s, -C-CH3), 2.62 
(1H, dq, J = 8.3, 6.95 Hz, -CH-CH3),  3.92 (1H, d, J = 9.75 Hz, -CH2-Br), 3.98 (1H, 
d, J = 8.3 Hz, -CH-O-), 4.02 (1H, J = 9.75 Hz, -CH2-Br), 4.94 (1H, s, -C=CH2-), 5.02 
(1H, s, -C=CH-), 5.19 (1H, s, -C=CH2), 5.43 (1H, s, -C=CH-), 7.33-7.43 (6H, m, Ph-
H), 7.62-7.67 (4H, m, Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 13.1 (-CH3), 17.6 (-CH3), 17.9 (-CH3), 27.2 (-
C(CH3)3), 30.9 (-C(CH3)3), 31.9 (-C(CH3)3), 32.5 (-C(CH3)3), 38.8 (-CH2Br), 41.9 (-
CHCH3), 84.9 (-CHOTBDPS), 115.6 (-C=CH2), 127.1 (Ph-C x2), 127.2 (Ph-C x2), 
129.4 (Ph-C), 129.5 (Ph-C), 130.5 (-C=C-), 133.8 (-C=C-), 133.9 (-C=C-), 134.1 (-
C=C-), 134.4 (-C=CH-), 136.2 (Ph-C x2), 136.2 (Ph-C x2), 139.9 (-C=CH-), 148.7 (-
C=CH2) ppm; 
IR (neat cm-1): 2957, 2859, 1636, 1479; 
HRMS (EI) m/z [M-(C4H9)











THF-H2O (1:1), rt, 
4 days, 73% 70b
 
To a mixture of 70b (0.4 g, 0.72 mmol) and formaldehyde solution (35-40% in water) 
(1 ml) in THF (1 mL) were added indium (88 mg, 0.72 mmol) and La(OTf)3 (0.42 g, 
0.72 mmol). The mixture was stirred vigorously at room temperature for 4 days. After 
the reaction was completed (monitored by TLC), the reaction mixture was extracted 
with ethyl acetate. The organic extracts were combined and washed with NaHCO3 
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solution, brine and dried over anhydrous MgSO4 and concentrated in vacuo. The 
crude product was purified by flash chromatography on silica gel. Elution with 5% 
ethyl acetate in hexane resulted 71b as a colorless oil, 0.27 g (73%).  
Rf 0.31 (hexane/ethyl acetate, 4:1); 
["]26D = +18° (c = 4.1, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.84 (3H, d, J = 7.4 Hz, -CH-CH3), 1.08 (9H, s, -
C(CH3)3), 1.14 (9H, s, -C-(CH3)3), 1.63 (3H, d, J = 1.4 Hz, -C-CH3), 1.65 (3H, d, J = 
0.9 Hz, -C-CH3), 2.06 (1H, dt, J = 14.75, 5.55 Hz, -CH2-CH2-OH), 2.21 (1H, dt, J = 
14.75, 6.95 Hz, -CH2-CH2-OH), 2.43 (1H, dq, J = 8.3, 7.4 Hz, -CH-CH3), 3.61 (2H, 
td, J = 7.15, 1.4 Hz, -CH2-OH), 4.00 (1H, d, J = 8.3 Hz, -CH-OTBDPS), 4.81 (1H, d, 
J = 1.4 Hz, -C=CH2-), 4.89 (1H, s, -C=CH-), 5.06 (1H, t, J = 1.4 Hz, -C=CH2), 5.46 
(1H, s, -C=CH-), 7.32-7.43 (6H, m, -Ph-H), 7.64-7.72 (4H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 13.3 (-CH3), 16.8 (-CH3), 17.6 (-CH3), 19.4 (-
C(CH3)3), 27.1 (-C(CH3)3), 30.9 (-C(CH3)3), 32.4 (-C(CH3)3), 38.2 (-CH2CH2OH), 
44.7 (-CHCH3), 60.6 (-CH2OH), 83.2 (-CHOTBDPS), 111.8 (-C=CH2), 127.0 (-Ph-C 
x2), 127.2 (-Ph-C x2), 129.2 (-Ph-C), 129.3 (-Ph-C), 130.6 (-C=C-), 133.8 (-C=C-), 
134.1 (-C=CH-), 134.2 (-Ph-Cq), 134.2 (-Ph-Cq), 136.2 (-Ph-C x2), 136.3 (-Ph-C 
x2), 139.7 (-C=CH-), 148.5 (-C=CH2) ppm; 
IR (neat cm-1): 3436, 2935, 2843, 1638, 1457; 
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Anti-(4R,5R,6E,8E)-4,6,8,10,10-pentamethyl-3-methyleneundeca-6,8-diene-1,5-
diol (73b) 













Follow the standard desilylation of the TBDPS protecting group with TBAF in THF, 
73b was obtained as a colourless oil in 92% yield. 
Rf 0.39 (hexane/ethyl acetate, 2:1); 
["]27D = -52° (c = 4.7, CHCl3); 
1H NMR (300 MHz, CDCl3): ! 0.85 (3H, d, J = 7.32 Hz, -CH-CH3), 1.12 (9H, s, -
C(CH3)3), 1.71 (3H, s, -C-CH3), 1.79 (3H, s, -C-CH3), 2.22-2.38 (2H, m, -CH2-
CH2OH), 2.39 (1H, dq, J = 10.08, 7.32 Hz, -CH-CH3), 2.51 (1H, brs, -OH), 3.00 (1H, 
brs, -OH), 3.69-3.80 (2H, m, -CH2-OH), 3.83 (1H, d, J = 10.08 Hz, -CH-OH), 4.99 
(1H, s, -C=CH2-), 5.04 (1H, s, -C=CH2), 5.29 (1H, s, -C=CH-), 5.81 (1H, s, -C=CH-) 
ppm; 
13C NMR (75 MHz, CDCl3): ! 11.8 (-CH3), 17.5 (-CH3), 17.8 (-CH3), 30.8 (-
C(CH3)3), 32.5 (-C(CH3)3), 37.0 (-CH2CH2OH), 43.4 (-CHCH3), 60.8 (-CH2OH), 82.0 
(-CHOH), 112.9 (-C=CH2), 130.6 (-C=CH), 134.1 (-C=CH), 134.6 (-C=CH), 140.5 (-
C=CH), 149.2 (-C=CH2) ppm; 
IR (neat, cm-1): 3364, 2958, 2863, 2384, 2349, 1641, 1459, 1442; 
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Anti-(4R,5R,6E,8E)-1-(tert-butyldiphenylsilyloxy)-4,6,8,10,10-pentamethyl-3-
methyleneundeca-6,8-dien-5-ol (34b) 










DMF, 0 ºC, 1.5h
89% 73b
 
Follow the standard procedure for TBDPS protection with TBDPSCl and imidazole in 
DMF, 34b was obtained as a colourless oil in 89% yield. 
Rf 0.78 (hexane/ethyl acetate, 4:1); 
["]27D = -18° (c = 11.1, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.83 (3H, d, J = 6.95 Hz, -CH-CH3), 1.05 (9H, s, -
C(CH3)3), 1.15 (9H, s, -C-(CH3)3), 1.72 (3H, d, J = 1.4 Hz, -C-CH3), 1.82 (3H, d, J = 
1.4 Hz, -C-CH3), 2.23-2.30 (2H, m, -CH2-C-), 2.33 (1H, dq, J = 9.70, 6.95 Hz, -CH-
CH3), 3.74 (1H, d, J = 9.70 Hz, -CH-OH), 3.77-3.86 (2H, m, -CH2OTBDPS), 4.94 
(1H, s, -C=CH-), 5.01 (1H, s, -C=CH2), 5.32 (1H, s, -C=CH2-), 5.81 (1H, s, -C=CH-), 
7.37-7.43 (6H, m, -Ph-H), 7.68-7.70 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 12.0 (-CH3), 16.9 (-CH3), 18.0 (-CH3), 19.2 (-
C(CH3)3), 26.9 (-C(CH3)3), 31.0 (-C(CH3)3), 32.6 (-C(CH3)3), 36.2 (-
CH2CH2OTBDPS), 44.9 (-CH-CH3), 62.9 (-CH2OTBDPS), 81.0 (-CHOH), 113.3 (-
C=CH2), 127.7 (-Ph-C x4), 129.7 (-Ph-C x2), 130.8 (-C=CH-), 133.8 (-C=CH-), 
133.9 (-Ph-Cq x2), 134.5 (-C=CH-), 135.6 (-Ph-C x4), 140.3 (-C=CH-), 148.6 (-
C=CH2) ppm; 
IR (neat, cm-1): 3426, 3073, 3051, 2960, 2931, 1639, 1462, 1428; 
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To a stirred solution of 43 (1.25 g, 3 mmol) in THF/H2O (1:1) (10 mL) was added 
indium (0.52 g, 4.5 mmol). After vigorous stirring for 30 minutes at room 
temperature, La(OTf)3 (1.76 g, 3 mmol) and 41 (0.5 g, 3 mmol) were added. The 
mixture was stirred vigorously at room temperature for 16h. After the reaction was 
completed (monitored by TLC), the reaction mixture was extracted with ethyl acetate. 
The organic extracts were combined and washed with sat. NaHCO3 solution, brine, 
dried over anhydrous Na2SO4, and concentrated in vacuo. The crude product was 
purified by flash chromatography on silica gel, eluting with 1% ethyl acetate in 
hexane resulted 34 as a colorless oil (1.12 g, 74%), syn/anti isomer is in the ratio of 
72:28. 
Rf 0.75 (hexane/ethyl acetate, 4:1); 
1H NMR (300 MHz, CDCl3): ! 0.95 (3H, d, J = 6.96 Hz, -CH-CH3), 1.05 (9H, s, -
C(CH3)3), 1.14 (9H, s, -C(CH3)3), 1.65 (3H, d, J = 1.05 Hz, -C-CH3), 1.78 (3H, d, J = 
1.05 Hz, -C-CH3), 2.28-2.42 (3H, m, -CH2CH2OTBDPS, -CH-CH3), 3.78 (2H, t, J = 
6.96 Hz, -CH2OTBDPS), 3.94 (1H, d, J = 4.89 Hz, -CH-OH), 4.88 (1H, d, J = 1.05 
Hz, -C=CH2-), 4.90 (1H, d, J = 1.05 Hz, -C=CH2), 5.25 (1H, t, J = 1.05 Hz, -C=CH-), 
5.86 (1H, s, -C=CH-), 7.36-7.43 (6H, m, -Ph-H), 7.66-7.69 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 13.0 (-CH3), 14.4 (-CH3), 18.1 (-CH3), 19.2 (-
C(CH3)3), 26.9 (-C(CH3)3), 31.0 (-C(CH3)3), 32.6 (-C(CH3)3), 37.8 (-
CH2CH2OTBDPS), 43.1 (-CH-CH3), 63.4 (-CH2OTBDPS), 81.0 (-CHOH), 112.1 (-
C=CH2), 127.7 (-Ph-C x4), 129.6 (-Ph-C x2), 131.1 (-C=CH-), 131.3 (-C=CH-), 
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133.8 (-C=CH-), 134.1 (-Ph-Cq), 135.6 (-Ph-C x4), 139.8 (-C=CH-), 149.0 (-C=CH2) 
ppm; 
IR (neat, cm-1): 3466, 3073, 2958, 2860, 1742, 1641, 1469, 1428; 










CH2Cl2, 0 ºC, 3h
 
To a solution of Dess-Martin reagent (1.39 g, 3.27 mmol) in anhydrous CH2Cl2 (10 
mL) was added dropwise of 34 (1.1 g, 2.18 mmol) prediluted in CH2Cl2 (5 mL) at 0 
°C.  The reaction mixture was stirred under nitrogen at 0 °C for 3h. After completion, 
the reaction mixture was diluted with ether and poured slowly into a Na2S2O3 : 
NaHCO3 (1:1) solution and stirred for 10 minutes and extract with ether.  The 
combine etherate layer was washed with NaHCO3, brine and dried over anhydrous 
MgSO4.  Solvent was removed by concentration in vacuo. The residue was purified 
by flash chromatography on silica gel to provide 72 as a colorless oil, 0.99 g (90%). 
Rf 0.85 (hexane/ethyl acetate; 4:1); 
1H NMR (300 MHz, CDCl3): ! 1.04 (9H, s, -C(CH3)3), 1.16 (9H, s, -C(CH3)3), 1.19 
(3H, d, J = 6.96 Hz, -CH-CH3), 1.87 (3H, d, J = 1.05 Hz, -C-CH3), 1.88 (3H, d, J = 
1.41 Hz, -C-CH3), 2.23 (1H, dt, J = 14.64, 6.96 Hz, -CH2CH2OTBDPS), 2.34 (1H, dt, 
J = 14.64, 6.96 Hz, -CH2CH2OTBDPS), 3.77 (2H, t, J = 6.96 Hz, -CH2OTBDPS), 
3.89 (1H, q, J = 6.96 Hz, -CH-CH3), 4.87 (2H, s, -C=CH2), 5.52 (1H, s, -C=CH-), 
6.92 (1H, s, -C=CH-), 7.35-7.45 (6H, m, -Ph-H), 7.65-7.68 (4H, m, -Ph-H) ppm; 
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13C NMR (75 MHz, CDCl3): ! 13.5 (-CH3), 17.0 (-CH3), 17.5 (-CH3), 19.2 (-
C(CH3)3), 26.9 (-C(CH3)3), 30.7 (-C(CH3)3), 33.1 (-C(CH3)3), 37.6 (-
CH2CH2OTBDPS), 46.8 (-CH-CH3), 63.1 (-CH2OTBDPS), 112.8 (-C=CH2), 127.7 (-
Ph-C x4), 129.6 (-Ph-C x2), 131.0 (-C=CH-), 133.9 (-Ph-Cq x2), 134.0 (-C=CH-), 
135.6 (-Ph-C x4), 144.8 (-C=CH-), 145.3 (-C=CH-), 146.8 (-C=CH2), 203.5 (-C=O) 
ppm; 
IR (neat, cm-1): 3067, 3051, 2958, 2930, 2858, 1736, 1586, 1429; 
HRMS (EI) m/z [M-(C4H9)]















To a solution of 72 (1.1 g, 2.2 mmol) in THF:H2O (10:1) (10 mL) was added in 
CeCl3.7H2O (1.64 g, 4.4 mmol) at 0 °C. After the mixture was stirred at 0 °C for 15 
minutes, NaBH4 (0.16 g, 4.4 mmol) was added and the reaction was stirred for 3h. 
After the reaction was completed (monitored by TLC), THF was removed under 
vacuo. H2O was added in and the mixture was extracted with ether. The combined 
etherate layer was washed with brine, dried over MgSO4, concentrated and purified 
through flash chromatography on silica gel to afford anti 34 as a colorless oil, 0.94 g 
(85%). (anti:syn > 99:1) 
Rf 0.78 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 0.83 (3H, d, J = 6.95 Hz, -CH-CH3), 1.05 (9H, s, -
C(CH3)3), 1.15 (9H, s, -C-(CH3)3), 1.72 (3H, d, J = 1.4 Hz, -C-CH3), 1.82 (3H, d, J = 
1.4 Hz, -C-CH3), 2.23-2.30 (2H, m, -CH2-C-), 2.33 (1H, dq, J = 9.70, 6.95 Hz, -CH-
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CH3), 3.74 (1H, d, J = 9.70 Hz, -CH-OH), 3.77-3.86 (2H, m, -CH2OTBDPS), 4.94 
(1H, s, -C=CH-), 5.01 (1H, s, -C=CH2), 5.32 (1H, s, -C=CH2-), 5.81 (1H, s, -C=CH-), 
7.37-7.43 (6H, m, -Ph-H), 7.68-7.70 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 12.0 (-CH3), 16.9 (-CH3), 18.0 (-CH3), 19.2 (-
C(CH3)3), 26.9 (-C(CH3)3), 31.0 (-C(CH3)3), 32.6 (-C(CH3)3), 36.2 (-
CH2CH2OTBDPS), 44.9 (-CH-CH3), 62.9 (-CH2OTBDPS), 81.0 (-CHOH), 113.3 (-
C=CH2), 127.7 (-Ph-C x4), 129.7 (-Ph-C x2), 130.8 (-C=CH-), 133.8 (-C=CH-), 
133.9 (-Ph-Cq x2), 134.5 (-C=CH-), 135.6 (-Ph-C x4), 140.3 (-C=CH-), 148.6 (-
C=CH2) ppm; 
IR (neat, cm-1): 3426, 3073, 3051, 2960, 2931, 1639, 1462, 1428; 












Follow the standard desilylation procedure using TBAF in THF afforded anti 73 as 
colourless oil in 93% yield. 
Rf 0.39 (hexane/ethyl acetate, 2:1); 
1H NMR (300 MHz, CDCl3): ! 0.85 (3H, d, J = 7.32 Hz, -CH-CH3), 1.12 (9H, s, -
C(CH3)3), 1.71 (3H, s, -C-CH3), 1.79 (3H, s, -C-CH3), 2.22-2.38 (2H, m, -CH2-
CH2OH), 2.39 (1H, dq, J = 10.08, 7.32 Hz, -CH-CH3), 2.51 (1H, brs, -OH), 3.00 (1H, 
brs, -OH), 3.69-3.80 (2H, m, -CH2-OH), 3.83 (1H, d, J = 10.08 Hz, -CH-OH), 4.99 
(1H, s, -C=CH2-), 5.04 (1H, s, -C=CH2), 5.29 (1H, s, -C=CH-), 5.81 (1H, s, -C=CH-) 
ppm; 
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13C NMR (75 MHz, CDCl3): ! 11.8 (-CH3), 17.5 (-CH3), 17.8 (-CH3), 30.8 (-
C(CH3)3), 32.5 (-C(CH3)3), 37.0 (-CH2CH2OH), 43.4 (-CHCH3), 60.8 (-CH2OH), 82.0 
(-CHOH), 112.9 (-C=CH2), 130.6 (-C=CH), 134.1 (-C=CH), 134.6 (-C=CH), 140.5 (-
C=CH), 149.2 (-C=CH2) ppm;  
IR (neat, cm-1): 3364, 2958, 2863, 2384, 2349, 1641, 1459, 1442; 
HRMS (EI) m/z (M+): obsd 266.2244, calcd 266.2246 for C17H30O2. 
 
Anti-(1S,1'S)-2,2'-((4R,5R,6E,8E)-4,6,8,10,10-pentamethyl-3-methyleneundeca-





























0 °C to rt
+HO
(R,R)-B (S,S)-C  
To a mixture of anti (±)-66 (0.19 g, 0.71 mmol), S-(+)-"-acetoxyphenylacetic acid 
(0.42 g, 2.13 mmol) and DMAP (9 mg, 0.071 mmol) in dried CH2Cl2 (3 mL) was 
added in DCC (0.37 g, 1.77 mmol) prediluted in 1 mL CH2Cl2 dropwise at 0 °C. The 
reaction mixture was stirred at 0 °C to room temperature for 12h. After completion, 
CH2Cl2 was removed via rotary evaporator and the crude product was directly 
subjected to column chromatography. Purification by flash chromatography on silica 
gel (Hex:CH2Cl2:EA, 3:3:0.2) afforded two pure enantiomer as colorless oil with 97% 
overall yield.  
(R,R)-B 
Rf 0.37 (hexane/CH2Cl2/ethyl acetate, 3:3:0.2); 
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1H NMR (300 MHz, CDCl3): ! 0.76 (3H, d, J = 7.29 Hz, -CH-CH3), 1.14 (9H, s, -
C(CH3)3), 1.70 (3H, d, J = 1.05 Hz, -C-CH3), 1.78 (3H, d, J = 1.05 Hz, -C-CH3), 2.13 
(3H, s, -OAc), 2.19 (3H, s, -OAc), 2.23-2.40 (3H, m, -CH2CH2O-, -CH-CH3), 3.82 
(1H, dt, J = 10.44, 7.65 Hz, -CH2CH2O-), 3.97 (1H, dt, J = 10.44, 7.32 Hz, -
CH2CH2O-), 4.34 (1H, s, -C=CH2-), 4.57 (1H, s, -C=CH2), 4.97 (1H, d, J = 10.08 Hz, 
-CH-O-), 5.27 (1H, s,  -C=CH-), 5.85 (1H, s, -CH-OAc), 5.88 (1H, s, -CH-OAc), 
5.89 (1H, s, -C=CH-), 7.26-7.28 (3H, m, -Ph-H), 7.35-7.40 (5H, m, -Ph-H), 7.45-7.47 
(2H, m, -Ph-H) ppm;  
13C NMR (75 MHz, CDCl3): ! 12.8 (-CH3), 16.8 (-CH3), 17.7 (-CH3), 20.6 (-CH3), 
30.8 (-C(CH3)3), 32.1 (-CH2CH2O-), 32.5 (-C(CH3)3), 42.0 (-CH-CH3), 63.9 (-CH2O-
), 74.4 (-CH-OAc), 74.5 (-CH-OAc), 84.1 (-CH-O-), 111.8 (-C=CH2), 127.6 (-Ph-Cm 
x2), 127.8 (-Ph-Cm x2), 128.5 (-Ph-Co x2), 128.7 (-Ph-Co x2), 129.0 (-Ph-Cp), 129.1 
(-Ph-Cp), 129.6 (-HC=C-CH3), 130.4 (-HC=C-CH3), 133.7 (-Ph-Cq), 134.1 (-Ph-Cq), 
136.4 (-CH=C-CH3), 140.8 (-CH=C-CH3), 145.6 (-C=CH2), 167.6 (C=O), 168.6 
(C=O), 169.9 (C=O), 170.2 (C=O) ppm;  
 
(S,S)-C  
Rf 0.26 (hexane/CH2Cl2/ethyl acetate, 3:3:0.2); 
1H NMR (300 MHz, CDCl3): ! 0.85 (3H, d, J = 7.32 Hz, -CH-CH3), 1.12 (9H, s, -
C(CH3)3), 1.36 (3H, d, J = 1.05 Hz, -C-CH3), 1.68 (3H, d, J = 1.05 Hz, -C-CH3), 2.16 
(3H, s, -OAc), 2.20 (3H, s, -OAc), 2.40-2.71 (3H, m, -CH2CH2O-, -CH-CH3), 4.21-
4.30 (2H, m, -CH2-O-), 4.75 (1H, s, -C=CH2-), 4.88 (1H, s, -C=CH2), 5.02 (1H, d, J = 
10.11 Hz, -CH-O-), 5.11 (1H, s, -C=CH-), 5.73 (1H, s, -C=CH-), 5.89 (1H, s, -CH-
OAc), 5.96 (1H, s, -CH-OAc), 7.33-7.41 (6H, m, -Ph-H), 7.49-7.52 (4H, m, -Ph-H) 
ppm;  
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13C NMR (125 MHz, CDCl3): ! 12.3 (-CH3), 16.8 (-CH3), 17.5 (-CH3), 20.5 (-CH3), 
30.7 (-C(CH3)3), 32.4 (-C(CH3)3), 33.3 (-CH2CH2O-), 41.3 (-CH-CH3), 63.9 (-CH2O-
), 74.2 (-CH-OAc), 74.4 (-CH-OAc), 84.3 (-CH-O-), 112.3 (-C=CH2), 127.5 (-Ph-Cm 
x2), 127.6 (-Ph-Cm x2), 128.4 (-Ph-Co x2), 128.6 (-Ph-Co x2), 128.9 (-Ph-Cp), 129.0 
(-Ph-Cp), 129.4, (-HC=C-CH3), 130.2 (-HC=C-CH3), 133.8 (-Ph-Cq), 133.9 (-Ph-
Cq), 136.2 (-CH=C-CH3), 140.5 (-CH=C-CH3), 145.9 (-C=CH2), 167.6 (C=O), 168.7 

























Follow the standard hydrolysis procedure, 73b was obtained as a colourless oil in 
94% yield. 
Rf 0.39 (hexane/ethyl acetate, 2:1); 
["]27D = -54° (c = 5.5, CHCl3); 
1H NMR (300 MHz, CDCl3): ! 0.85 (3H, d, J = 7.32 Hz, -CH-CH3), 1.12 (9H, s, -
C(CH3)3), 1.71 (3H, s, -C-CH3), 1.79 (3H, s, -C-CH3), 2.22-2.38 (2H, m, -CH2-
CH2OH), 2.39 (1H, dq, J = 10.08, 7.32 Hz, -CH-CH3), 2.51 (1H, brs, -OH), 3.00 (1H, 
brs, -OH), 3.69-3.80 (2H, m, -CH2-OH), 3.83 (1H, d, J = 10.08 Hz, -CH-OH), 4.99 
(1H, s, -C=CH2-), 5.04 (1H, s, -C=CH2), 5.29 (1H, s, -C=CH-), 5.81 (1H, s, -C=CH-) 
ppm; 
13C NMR (75 MHz, CDCl3): ! 11.8 (-CH3), 17.5 (-CH3), 17.8 (-CH3), 30.8 (-
C(CH3)3), 32.5 (-C(CH3)3), 37.0 (-CH2CH2OH), 43.4 (-CHCH3), 60.8 (-CH2OH), 82.0 
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(-CHOH), 112.9 (-C=CH2), 130.6 (-C=CH), 134.1 (-C=CH), 134.6 (-C=CH), 140.5 (-
C=CH), 149.2 (-C=CH2) ppm; 
IR (neat, cm-1): 3364, 2958, 2863, 2384, 2349, 1641, 1459, 1442; 

























Follow the standard hydrolysis procedure, 73c was obtained as a colourless oil in 92% 
yield.  
Rf 0.39 (hexane/ethyl acetate, 2:1); 
["]26D = +50° (c = 4.0, CHCl3); 
1H NMR (300 MHz, CDCl3): ! 0.85 (3H, d, J = 7.32 Hz, -CH-CH3), 1.12 (9H, s, -
C(CH3)3), 1.71 (3H, s, -C-CH3), 1.79 (3H, s, -C-CH3), 2.22-2.38 (2H, m, -CH2-
CH2OH), 2.39 (1H, dq, J = 10.08, 7.32 Hz, -CH-CH3), 2.51 (1H, brs, -OH), 3.00 (1H, 
brs, -OH), 3.69-3.80 (2H, m, -CH2-OH), 3.83 (1H, d, J = 10.08 Hz, -CH-OH), 4.99 
(1H, s, -C=CH2-), 5.04 (1H, s, -C=CH2), 5.29 (1H, s, -C=CH-), 5.81 (1H, s, -C=CH-) 
ppm; 
13C NMR (75 MHz, CDCl3): ! 11.8 (-CH3), 17.5 (-CH3), 17.8 (-CH3), 30.8 (-
C(CH3)3), 32.5 (-C(CH3)3), 37.0 (-CH2CH2OH), 43.4 (-CHCH3), 60.8 (-CH2OH), 82.0 
(-CHOH), 112.9 (-C=CH2), 130.6 (-C=CH), 134.1 (-C=CH), 134.6 (-C=CH), 140.5 (-
C=CH), 149.2 (-C=CH2) ppm; 
IR (neat, cm-1): 3364, 2958, 2863, 2384, 2349, 1641, 1459, 1442; 
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DMF, 0 ºC, 1.5h
86% 73c
 
Follow the standard TBDPS protection using TBDPSCl and imidazole in DMF, 34c 
was obtained as a colourless oil in 86% yield. 
Rf 0.78 (hexane/ethyl acetate, 4:1); 
["]27D = +15° (c = 9.0, CHCl3);  
1H NMR (500 MHz, CDCl3): ! 0.83 (3H, d, J = 6.95 Hz, -CH-CH3), 1.05 (9H, s, -
C(CH3)3), 1.15 (9H, s, -C-(CH3)3), 1.72 (3H, d, J = 1.4 Hz, -C-CH3), 1.82 (3H, d, J = 
1.4 Hz, -C-CH3), 2.23-2.30 (2H, m, -CH2-C-), 2.33 (1H, dq, J = 9.70, 6.95 Hz, -CH-
CH3), 3.74 (1H, d, J = 9.70 Hz, -CH-OH), 3.77-3.86 (2H, m, -CH2OTBDPS), 4.94 
(1H, s, -C=CH-), 5.01 (1H, s, -C=CH2), 5.32 (1H, s, -C=CH2-), 5.81 (1H, s, -C=CH-), 
7.37-7.43 (6H, m, -Ph-H), 7.68-7.70 (4H, m, -Ph-H) ppm; 
13C NMR (75 MHz, CDCl3): ! 12.0 (-CH3), 16.9 (-CH3), 18.0 (-CH3), 19.2 (-
C(CH3)3), 26.9 (-C(CH3)3), 31.0 (-C(CH3)3), 32.6 (-C(CH3)3), 36.2 (-
CH2CH2OTBDPS), 44.9 (-CH-CH3), 62.9 (-CH2OTBDPS), 81.0 (-CHOH), 113.3 (-
C=CH2), 127.7 (-Ph-C x4), 129.7 (-Ph-C x2), 130.8 (-C=CH-), 133.8 (-C=CH-), 
133.9 (-Ph-Cq x2), 134.5 (-C=CH-), 135.6 (-Ph-C x4), 140.3 (-C=CH-), 148.6 (-
C=CH2) ppm; 
IR (neat, cm-1): 3426, 3073, 3051, 2960, 2931, 1639, 1462, 1428; 
HRMS (EI) m/z (M+): obsd 504.3420, calcd 504.3424 for C33H48SiO2.
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(5S,8S)-((4R,5R,6E,8E)-1-(tert-butyldiphenylsilyloxy)-4,6,8,10,10-pentamethyl-3-
methyleneundeca-6,8-dien-5-yl) 5-isopropyl-6,8-dimethyl-4,7,10-trioxo-11-oxa-




74b [!]27D = -68° (c = 1.6, CHCl3), 90%;



























CH2Cl2, 0 °C to rt, 
16h, 90%
 
The anti homoallylic alcohol 34b (0.8 g, 1.58 mmol) and tripeptide acid 33 (1.36 g, 
3.96 mmol) were dissolved in CH2Cl2 (3 ml), and EDC.HCl (0.76 g, 3.96 mmol) was 
added followed by the addition of DMAP (0.097 g, 0.79 mmol) at 0 °C. The mixture 
was stirred for 12h at room temperature. After completion, monitored by TLC, the 
reaction mixture was diluted with ether.  The combined organic layer was washed 
with 5% KHSO4, water, saturated NaHCO3, brine and finally dried over anhydrous 
MgSO4.  After filtration, it was concentrated and purified by flash chromatography on 
silica gel to give 74b as a colorless oil (1.18 g, 90%). 
74b 
Rf 0.15 (hexane/ethyl acetate, 4:1); 
["]27D = -68º (c = 1.6, CHCl3);  
1H NMR (500 MHz, CDCl3): ! 0.82 (6H, dd, J = 6.95, 0.9 Hz, C13-CH3, Val-CH3), 
0.95 (3H, d, J = 6.45 Hz, Val-CH3), 1.04 (9H, s, -C(CH3)3), 1.13 (9H, s, -C(CH3)3), 
1.30 (3H, d, J = 6.95 Hz, Ala-CH3), 1.65 (3H, d, J = 1.4 Hz, C14-CH3), 1.77 (3H, d, J 
= 1.4 Hz, -C15-CH3), 2.24 (1H, d, J = 6.95 Hz, C2-H), 2.26 (1H, d, J = 6.95 Hz, C2-H), 
2.29 (1H, m, C4-H), 2.44 (1H, m, Val-(CH3)2CH), 3.00 (3H, s, N-CH3), 3.73 (3H, m, 
Gly-CH2, -CH2-O-), 3.86 (1H, dd, J = 18.27, 6.00 Hz, Gly-CH2), 4.54 (2H, d, J = 5.1 
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Hz, CH2=CHCH2-), 4.62 (1H, d, J = 11.05 Hz, Val-"-H), 4.66 (1H, dq, J = 7.85, 6.95 
Hz, Ala-"-H), 4.77 (1H, s, C12-H), 4.82 (1H, s, C12-H), 5.02 (1H, d, J = 10.2 Hz, C5-
H), 5.19 (1H, dd, J = 10.20, 1.35 Hz, CH2=CHCH2-), 5.27 (1H, s, C9-H), 5.28 (1H, 
dd, J = 15.95, 1.40 Hz, CH2=CHCH2-), 5.76 (1H, d, J = 7.85 Hz, Ala-NH), 5.86 (1H, 
s, C7-H), 5.90 (1H, m, CH2=CHCH2-), 6.56 (1H, brs, Gly-NH), 7.38 (6H, m, -Ph-H), 
7.67 (4H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.7 (-CH3), 16.7 (-CH3), 17.7 (-CH3), 18.2 (-CH3), 
18.4 (-CH3), 19.1 (-C(CH3)3), 19.5 (-CH3), 25.4 (-CH-(CH3)2), 26.8 (-C(CH3)3), 30.3 
(-N-CH3), 30.8 (-C(CH3)3), 32.5 (-C(CH3)3), 37.5 (-CH2-), 40.7 (-CH2-), 42.0 (-CH-), 
47.1 (-CH-), 62.5 (-N-CH-), 63.3 (-CH2-O-), 65.5 (-CH2-O-), 84.1 (-CH-O-), 111.8 (-
C=CH2), 117.5 (-CH=CH2), 127.5 (-Ph-C x4), 129.5 (-Ph-C x2), 129.9 (-C=CH-), 
130.3 (-C=CH-), 132.7 (-CH=CH2), 133.8 (-Ph-Cq x2), 135.5 (-Ph-C x4), 136.4 (-
CH=C-), 141.0 (-CH=C-), 147.6 (-C=CH2-), 155.4 (-C=O), 168.2 (-C=O), 169.8 (-
C=O), 173.9 (-C=O) ppm;  
IR (neat, cm-1): 3313, 3073, 2961, 1726, 1689,1640, 1529, 1464, 1428;  
HRMS (ESI) m/z (M++Na): obsd 852.4972, calcd 852.4959 for C48H71NaN3O7Si. 
 
74c 
Rf 0.15 (hexane/ethyl acetate, 4:1); 
["]27D = -52° (c = 0.8, CHCl3);  
1H NMR (500 MHz, CDCl3): ! 0.82 (6H, d, J = 6.95 Hz, C13-CH3, Val-CH3), 0.94 
(3H, d, J = 6.50 Hz, Val-CH3), 1.04 (9H, s, -C(CH3)3), 1.13 (9H, s, -C(CH3)3), 1.31 
(3H, d, J = 6.95 Hz, Ala-CH3), 1.65 (3H, d, J = 1.4 Hz, C14-CH3), 1.77 (3H, d, J = 0.9 
Hz, -C15-CH3), 2.23 (1H, d, J = 6.9 Hz, C2-H), 2.24 (1H, d, J = 6.95 Hz, C2-H), 2.28 
(1H, m, C4-H), 2.43 (1H, m, Val-(CH3)2CH), 3.00 (3H, s, N-CH3), 3.66 (1H, dd, J = 
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18.02, 4.65 Hz, Gly-CH2), 3.74 (2H, m, -CH2-O-), 3.94 (1H, dd, J = 18.02, 6.05 Hz, 
Gly-CH2), 4.55 (2H, d, J = 5.1 Hz, CH2=CHCH2-), 4.61 (1H, d, J = 11.10 Hz, Val-"-
H), 4.66 (1H, dq, J = 8.30, 6.95 Hz, Ala-"-H), 4.76 (1H, s, C12-H), 4.81 (1H, s, C12-
H), 5.02 (1H, d, J = 10.15 Hz, C5-H), 5.19 (1H, dd, J = 10.4, 1.4 Hz, CH2=CHCH2-), 
5.27 (1H, s, C9-H), 5.29 (1H, dd, J = 18.45, 1.85 Hz, CH2=CHCH2-), 5.72 (1H, d, J = 
8.30 Hz, Ala-NH), 5.86 (1H, s, C7-H), 5.90 (1H, m, CH2=CHCH2-), 6.46 (1H, brs, 
Gly-NH), 7.40 (6H, m, -Ph-H), 7.67 (4H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.7 (-CH3), 16.8 (-CH3), 17.7 (-CH3), 18.3 (-CH3), 
18.4 (-CH3), 19.1 (-C(CH3)3), 19.6 (-CH3), 25.4 (-CH-(CH3)2), 26.8 (-C(CH3)3), 30.4 
(-N-CH3), 30.9 (-C(CH3)3), 32.6 (-C(CH3)3), 37.4 (-CH2-), 40.8 (-CH2-), 42.1 (-CH-), 
47.1 (-CH-), 62.5 (-N-CH-), 63.3 (-CH2-O-), 65.6 (-CH2-O-), 84.2 (-CH-O-), 111.7 (-
C=CH2), 117.5 (-CH=CH2), 127.6 (-Ph-C x4), 129.6 (-Ph-C x2), 129.9 (-C=CH-), 
130.4 (-C=CH-), 132.7 (-CH=CH2), 133.9 (-Ph-Cq x2), 135.5 (-Ph-C x4), 136.5 (-
CH=C-), 141.0 (-CH=C-), 147.8 (-C=CH2-), 155.4 (-C=O), 168.3 (-C=O), 169.8 (-
C=O), 173.9 (-C=O) ppm;  
IR (neat, cm-1): 3313, 3073, 2961, 1726, 1689,1640, 1529, 1464, 1428;  
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(5S,8S)-((4R,5R,6E,8E)-1-hydroxy-4,6,8,10,10-pentamethyl-3-methyleneundeca-
6,8-dien-5-yl) 5-isopropyl-6,8-dimethyl-4,7,10-trioxo-11-oxa-3,6,9-triazatetradec-
13-en-1-oate (75b) and (5S,8S)-((4S,5S,6E,8E)-1-hydroxy-4,6,8,10,10-
pentamethyl-3-methyleneundeca-6,8-dien-5-yl) 5-isopropyl-6,8-dimethyl-4,7,10-
trioxo-11-oxa-3,6,9-triazatetradec-13-en-1-oate (75c) 
75b [!]27D = -85° (c = 4.5, CHCl3), 88%;





























To a solution of 74 (0.092 g, 0.11 mmol) in THF (0.5 mL) was added TBAF (0.22 
mL, 1.0 M in THF, 0.22 mmol). The mixture was stirred for 30 minutes at room 
temperature. After the reaction was completed (monitored by TLC), the mixture was 
concentrated in vacuo to remove the THF. The residue was purified by flash 
chromatography on silica gel to afford 75 as a colorless oil, 0.057 g (88%). 
75b 
Rf 0.20 (hexane/ethyl acetate, 1:1); 
["]27D = -85° (c = 4.5, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.80 (3H, d, J = 6.50 Hz, Val-CH3), 0.88 (3H, d, J = 
6.95 Hz, C13-CH3), 0.92 (3H, d, J = 6.45 Hz, Val-CH3), 1.10 (9H, s, -C(CH3)3), 1.31 
(3H, d, J = 6.95 Hz, Ala-CH3), 1.67 (3H, s, C14-CH3), 1.76 (3H, s, -C15-CH3), 2.24 
(2H, t, J = 6.00 Hz, C2-H), 2.22-2.29 (1H, m, Val-(CH3)2CH), 2.49 (1H, dq, J = 10.15, 
6.95 Hz, C4-H,), 3.00 (3H, s, N-CH3), 3.69-3.78 (3H, m, Gly-CH2, -CH2-OH), 3.98 
(1H, dd, J = 17.83, 6.00 Hz, Gly-CH2), 4.52 (2H, d, J = 5.10 Hz, CH2=CHCH2O-), 
4.55 (1H, d, J = 11.10 Hz, Val-"-H), 4.65 (1H, dq, J = 8.35, 6.95 Hz, Ala-"-H), 4.88 
(1H, s, C12-H), 4.90 (1H, s, C12-H), 5.10 (1H, d, J = 10.15 Hz, C5-H), 5.17 (1H, d, J = 
10.15 Hz, CH2=CHCH2O-), 5.26 (1H, s, C9-H), 5.27 (1H, d, J = 12.00 Hz, 
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CH2=CHCH2O-), 5.72 (1H, d, J = 8.35 Hz, Ala-NH), 5.88 (1H, s, C7-H), 5.84-5.92 
(1H, m, CH2=CHCH2O-), 6.83 (1H, broad t, J = 5.05 Hz, Gly-NH) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.5 (-CH3), 16.9 (-CH3), 17.7 (-CH3), 18.2 (-CH3), 
18.3 (-CH3), 19.5 (-CH3), 25.4 (-CH-(CH3)2), 30.4 (-N-CH3), 30.8 (-C(CH3)3), 32.5 (-
C(CH3)3), 37.0 (-CH2-CH2OH), 41.1 (NH-CH2-), 42.0 (-CH-CH3), 47.2 (-NH-CH-
CH3), 60.2 (-CH2-O-), 62.6 (-N-CH-CH(CH3)2), 65.6 (-CH2-O-), 83.9 (-CH-O-), 
111.8 (-C=CH2), 117.6 (-CH=CH2), 129.7 (-C=CH-), 130.3 (-C=CH-), 132.7 (-
CH=CH2), 136.8 (-CH=C-), 141.1 (-CH=C-), 147.4 (-C=CH2-), 155.4 (-C=O), 168.3 
(-C=O), 170.1 (-C=O), 174.1 (-C=O) ppm;  
IR (neat, cm-1): 3320, 3073, 2961, 1727, 1641, 1523, 1464;  
HRMS (ESI) m/z (M++Na): obsd 614.3765, calcd 614. 3781 for C32H53NaN3O7. 
 
75c 
Rf 0.20 (hexane/ethyl acetate, 1:1); 
["]27D = -68° (c = 2.6, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.81 (3H, d, J = 6.50 Hz, Val-CH3), 0.90 (3H, d, J = 
6.95 Hz, C13-CH3), 0.95 (3H, d, J = 6.45 Hz, Val-CH3), 1.12 (9H, s, -C(CH3)3), 1.29 
(3H, d, J = 6.95 Hz, Ala-CH3), 1.67 (3H, s, C14-CH3), 1.77 (3H, s, -C15-CH3), 2.23-
2.31 (3H, m, C2-H, Val-(CH3)2CH), 2.50 (1H, dq, J = 10.65, 6.95 Hz, C4-H), 3.02 
(3H, s, N-CH3), 3.71-3.80 (3H, m, Gly-CH2, -CH2-OH), 4.04 (1H, dd, J = 17.55, 6.45 
Hz, Gly-CH2), 4.53 (2H, d, J = 6.90 Hz, CH2=CHCH2O-), 4.54 (1H, d, J = 10.60 Hz, 
Val-"-H), 4.64 (1H, dq, J = 8.30, 6.95 Hz, Ala-"-H), 4.89 (1H, s, C12-H), 4.91 (1H, s, 
C12-H), 5.13 (1H, d, J = 10.65 Hz, C5-H), 5.19 (1H, d, J = 10.65 Hz, CH2=CHCH2O-), 
5.27 (1H, s, C9-H), 5.28 (1H, dd, J = 17.25, 1.35 Hz, CH2=CHCH2O-), 5.68 (1H, d, J 
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= 8.30 Hz, Ala-NH), 5.85-5.90 (1H, m, CH2=CHCH2O-), 5.92 (1H, s, C7-H), 7.14 
(1H, broad t, J = 5.05 Hz, Gly-NH) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.5 (-CH3), 17.3 (-CH3), 17.7 (-CH3), 18.3 (-CH3), 
18.4 (-CH3), 19.5 (-CH3), 25.6 (-CH-(CH3)2), 30.5 (-N-CH3), 30.8 (-C(CH3)3), 32.6 (-
C(CH3)3), 37.5 (-CH2-CH2OH), 41.1 (NH-CH2-), 41.4 (-CH-CH3), 47.1 (-NH-CH-
CH3), 59.7 (-CH2-O-), 62.7 (-N-CH-CH(CH3)2), 65.6 (-CH2-O-), 84.1 (-CH-O-), 
111.6 (-C=CH2), 117.6 (-CH=CH2), 129.6 (-C=CH-), 130.3 (-C=CH-), 132.7 (-
CH=CH2), 136.9 (-CH=C-), 141.2 (-CH=C-), 147.5 (-C=CH2-), 155.4 (-C=O), 168.3 
(-C=O), 169.6 (-C=O), 174.1 (-C=O) ppm;  
IR (neat, cm-1): 3320, 3073, 2961, 1727, 1641, 1523, 1464;  




20-oic acid (76b) and (7S,10S,16S,17S)-10-isopropyl-7,9,17-trimethyl-18-
methylene-5,8,11,14-tetraoxo-16-((2E,4E)-4,6,6-trimethylhepta-2,4-dien-2-yl)-
4,15-dioxa-6,9,12-triazaicos-1-en-20-oic acid (76c) 
76b [!]27D = -103° (c = 1.7, CHCl3, 84%;


























1) Dess-Martin Periodinane,  
    CH2Cl2, rt, 1h; 
2) NaClO2, NaH2PO4,   
    MeCH=CMe2, 
    t-BuOH-H2O, rt, 1h;
 
Dess-Martin periodinane oxidation: To a solution of Dess-Martin reagent (48 mg, 
0.114 mmol) in anhydrous CH2Cl2 (1 mL) was added dropwise of 75b in CH2Cl2 at 0 
°C.  The reaction mixture was stirred under nitrogen at 0 °C for 2h. After completion, 
the reaction mixture was diluted with ether and poured slowly into a 
Na2S2O3:NaHCO3 (1:1) solution and stirred for 5 minutes and extract with ether. The 
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combine etherate layer was washed with NaHCO3, brine and dried over anhydrous 
MgSO4. Concentration in vacuo provided the aldehyde and directly used for next step 
without purification.  
The crude aldehyde was dissolved in a mixture of t-BuOH and 2-methyl-2-butene 
(3:1, 9 mL), and pH=4 NaH2PO4 water solution (3 mL) was added, followed by 
NaClO2 (9.3 mg, 0.084 mmol). The mixture was stirred at room temperature for half 
an hour, pour into ice-water and extracted with ethyl acetate (3x). The combine 
organic layer was washed with brine, dried over MgSO4 and concentrated. 
Purification through flash column chromatography provided 76b as a colorless oil 
(38.6 mg, 84%). 
 
76b  
Rf 0.02 (hexane/ethyl acetate, 1:1); 
["]27D = -103° (c = 1.7, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.83 (3H, d, J = 6.95 Hz, Val-CH3), 0.93 (3H, d, J = 
7.4 Hz, C13-CH3), 0.94 (3H, d, J = 6.45 Hz, Val-CH3), 1.12 (9H, s, -C(CH3)3), 1.30 
(3H, d, J = 6.95 Hz, Ala-CH3), 1.60 (3H, d, J = 1.4 Hz, C14-CH3), 1.77 (3H, d, J = 
1.35 Hz, C15-CH3), 2.27 (1H, m, C4-H), 2.65 (1H, m, Val-(CH3)2CH), 3.13 (3H, s, N-
CH3), 3.61 (1H, dd, J = 17.35, 3.70 Hz, Gly-CH2), 4.32 (1H, dd, J = 18.05, 7.85 Hz, 
Gly-CH2), 4.54 (2H, d, J = 4.65 Hz, CH2=CHCH2-), 4.71 (1H, d,  J = 11.55 Hz, Val-
"-H),  4.71 (1H, m, Ala-"-H), 5.03 (1H, s, C12-H), 5.07 (1H, s, C12-H), 5.10 (1H, d, J 
= 11.1 Hz, C5-H), 5.20 (1H, d, J = 10.15 Hz, CH2=CHCH2-), 5.27 (1H, d, J = 0.95 
Hz, C9-H), 5.30 (1H, dd, J = 9, 1.4 Hz, CH2=CHCH2-), 5.60 (1H, d, J = 7.85 Hz, Ala-
NH), 5.88 (1H, m, CH2=CHCH2-), 5.93 (1H, s, C7-H), 7.19 (1H, brs,  J = 4.65 Hz, 
Gly-NH) ppm; 
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13C NMR (125 MHz, CDCl3): ! 12.4 (-CH3), 17.7 (-CH3), 18.1 (-CH3), 18.5 (-CH3), 
19.3 (-CH3), 26.1 (-CH-(CH3)2), 26.3 (-CH3), 30.8 (-C(CH3)3), 30.9 (-CH3), 32.6 (-
C(CH3)3), 40.2 (-CH2-), 41.3 (-CH-), 42.2 (-CH2-), 47.2 (-CH-), 62.8 (-CH-), 65.7 (-
CH2-O-), 84.2 (-CH-O-), 114.8 (-C=CH2), 117.8 (-CH=CH2), 129.3 (-C=CH-), 130.3 
(-C=CH-), 132.6 (-CH=CH2), 137.3 (-CH=C-), 141.3 (-CH=C-), 144.3 (-C=CH2-), 
155.5 (-C=O), 167.9 (-C=O), 169.9 (-C=O), 174.5 (-C=O), 174.6 (-C=O) ppm; 
IR (neat, cm-1): 3317, 3086, 2965, 2877, 1722, 1634, 1538, 1455, 1413;  
HRMS (ESI) m/z (M++Na): obsd 628.3562, calcd 628.3574 for C32H51NaN3O8. 
 
76c 
Rf 0.02 (hexane/ethyl acetate, 1:1); 
["]27D = -45° (c = 2.2, CHCl3); 
1H NMR (500 MHz, CDCl3): ! 0.83 (3H, d, J = 6.9 Hz, Val-CH3), 0.92 (3H, d, J = 
6.9 Hz, C13-CH3), 0.97 (3H, d, J = 6 Hz, Val-CH3), 1.12 (9H, s, -C(CH3)3), 1.33 (3H, 
d, J = 6.45 Hz, Ala-CH3), 1.66 (3H, d, J = 1.4 Hz, C14-CH3), 1.78 (3H, d, J = 0.95 Hz, 
C15-CH3), 2.29 (1H, m, C4-H), 2.65 (1H, m, Val-(CH3)2CH), 3.07 (3H, s, N-CH3), 
3.78 (1H, dd, J = 16.88, 4.6 Hz, Gly-CH2), 4.11 (1H, dd, J = 18.05, 6.45 Hz, Gly-
CH2), 4.55 (2H, d, J = 4.65 Hz, CH2=CHCH2-), 4.66 (1H, d,  J = 11.1 Hz, Val-"-H),  
4.69 (1H, m, Ala-"-H), 5.04 (1H, s, C12-H), 5.07 (1H, s, C12-H), 5.12 (1H, d, J = 
10.65 Hz, C5-H), 5.20 (1H, dd, J = 10.63, 1.4 Hz, CH2=CHCH2-), 5.28 (1H, d, J = 
1.35 Hz, C9-H), 5.28 (1H, m, CH2=CHCH2-), 5.61 (1H, d, J = 7.4 Hz, Ala-NH), 5.88 
(1H, m, CH2=CHCH2-), 5.93 (1H, s, C7-H), 6.97 (1H, brt,  J = 5.05 Hz, Gly-NH) 
ppm; 
13C NMR (125 MHz, CDCl3): ! 12.4 (-CH3), 17.9 (-CH3), 18.4 (-CH3), 19.5 (-CH3), 
19.6 (-CH3), 25.8 (-CH-(CH3)2), 25.9 (-CH3), 30.8 (-C(CH3)3), 30.9 (-CH3), 32.6 (-
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C(CH3)3), 40.8 (-CH2-), 41.4 (-CH2-), 41.4 (-CH-), 47.2 (-CH-), 63.0 (-CH-), 65.7 (-
CH2-O-), 83.8 (-CH-O-), 115.1 (-C=CH2), 117.7 (-CH=CH2), 129.4 (-C=CH-), 130.4 
(-C=CH-), 132.6 (-CH=CH2), 137.1 (-CH=C-), 141.3 (-CH=C-), 144.0 (-C=CH2-), 
155.5 (-C=O), 167.8 (-C=O), 169.5 (-C=O), 174.1 (-C=O), 174.7 (-C=O) ppm; 
IR (neat, cm-1): 3317, 3086, 2965, 2877, 1722, 1634, 1538, 1455, 1413;  
HRMS (ESI) m/z (M++Na): obsd 628.3562, calcd 628.3574 for C32H51NaN3O8. 
 
(4R,5R)-antillatoxin (4b) 
4b [!]26D = -149° (c = 0.85, MeOH), 63%;
Literature value : 4b : [!]21D = -147° (c = 0.23, MeOH);

























1) Pd(Ph3P)4, morpholine, 
    THF, rt, 0.5h;
 2) DPPA, NaHCO3,
    DMF, 0 ºC, 3 days.
 
To a solution of the acid 76b (78 mg, 0.128 mmol) in 1 mL THF was added 
morpholine (0.11 mL, 1.28 mmol) and Pd(PPh3)4 (15 mg, 0.015 mmol).  After stirring 
for 30 min at room temperature, the mixture was diluted with pH=6 buffer solution 
and extracted with CHCl3 (x3). The combine organic extract was dried (Na2SO4), 
filtered and concentrated to afford the crude amino acid. 
The crude amino acid was dissolved in DMF (50 mL) and cooled to 0 °C.  NaHCO3 
(50 mg, 0.706 mmol) and DPPA (72 µL, 0.321 mmol) were added, the mixture 
solution was stirred at 0 °C for 3 days. The solution was diluted with ethyl acetate, 
wash with KHSO4 solution, H2O, NaHCO3 and brine. The organic layer was dried 
(Na2SO4), filtered and concentrated. The crude product was purified by flash 
chromatography on silica gel (Hexane/ethyl acetate, 5:1 to 2:1) to give the desired 
product as a colorless oil (40.7 mg, 63%). 
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(4R, 5R)-antillatoxin (4b) 
Rf 0.62 (hexane/ethyl acetate, 1:1); 
["]26D = -149°
 (c = 0.85, MeOH);  
1H NMR (500 MHz, CDCl3): ! 0.85 (3H, d, J = 6.95 Hz, Val-CH3), 0.86 (3H, d, J = 
7.4 Hz, C13-CH3, 0.96 (3H, d, J = 6.05 Hz, Val-CH3), 1.11 (9H, s, -C(CH3)3), 1.40 
(3H, d, J = 6.5 Hz, Ala-CH3), 1.54 (3H, d, J = 1.4 Hz, C14-CH3), 1.77 (3H, d, J = 1.4 
Hz, C15-CH3), 2.17 (1H, m, C4-H), 2.42 (1H, m, Val-(CH3)2CH), 2.83 (1H, d, J = 13.4 
Hz, C2-H), 2.85 (3H, s, N-CH3), 2.97 (1H, d, J = 12.95 Hz, C2-H), 3.47 (1H, dd, J = 
18.28, 1.4 Hz, Gly-CH2), 4.25 (1H, d, J = 11.05 Hz, Val-"-H), 4.67 (1H, dd, J = 
18.28, 9.92 Hz, Gly-CH2), 4.99 (1H, s, C12-H), 5.04 (1H, s, C12-H), 5.16 (1H, d, J = 
11.1 Hz, C5-H), 5.28 (1H, s, C9-H), 5.33 (1H, m, Ala-"-H), 5.92 (1H, s, C7-H), 6.76 
(1H, d, J = 9.25 Hz, Ala-NH), 7.96 (1H, d, J = 9.25 Hz, Gly-NH) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.4 (-CH3), 17.7 (-CH3), 18.5 (-CH3), 18.6 (-CH3), 
18.9 (-CH3), 19.3 (-CH3), 26.1 (-CH(CH3)2), 28.7 (-CH3), 30.8 (-C(CH3)3), 32.6 (-
C(CH3)3), 38.9 (-CH-), 41.1 (-CH2-), 43.0 (-CH-), 46.5 (-CH2-), 67.1 (-CH-), 83.4 (-
CH-O-), 113.7 (-C=CH2), 129.1 (-C=CH-), 130.4 (-C=CH-), 137.2 (-CH=C-), 141.4 
(-CH=C-), 144.8 (-C=CH2-), 167.6 (-C=O), 167.8 (-C=O), 171.0 (-C=O), 173.1 (-
C=O) ppm; 
IR (neat, cm-1): 3304, 1744, 1682, 1622, 1547;  
HRMS (ESI) m/z [(M+Na)+]: obsd 526.3258, calcd 526.3257 for C28H45N3O5Na. 
 
(4S, 5S)-antillatoxin (4c)  
["]25D = -8.7° (c = 0.1, MeOH);  
1H NMR (CDCl3, 500 MHz): ! 0.85 (3H, d, J = 7.0 Hz, Val-CH3), 0.90 (3H, d, J = 
7.0 Hz, C13-CH3), 0.95 (3H, m, Val-CH3), 0.99 (1H, d, J = 6.7 Hz, C4-H), 1.14 (9H, s, 
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-C(CH3)3), 1.38 (3H, d, J = 6.7 Hz, Ala-CH3), 1.78 (3H, s, C14-CH3), 1.88 (3H, s, C15-
CH3), 2.40 (1H, m, Val-(CH3)2CH), 2.86 (3H, s, N-CH3), 3.00 (1H, m, C2-H), 3.15 
(1H, m, C2-H), 3.94 (1H, dd, J = 10.4, 7.3 Hz, Gly-CH2), 4.03 (1H, dd, J = 17.4, 4.6 
Hz, Val-"-H), 4.52 (1H, d, J = 11.3 Hz, Gly-CH2), 4.89 (1H, s, C12-H), 4.93 (1H, s, 
C9-H), 5.21 (2H, m, C5-H,C12-H), 5.32 (1H, m, Ala-"-H), 6.01 (1H, s, C7-H), 6.52 
(1H, d, J = 10.1 Hz, Ala-NH), 7.54 (1H, br, Gly-NH) ppm.  
13C NMR (125 MHz, CDCl3): ! 12.9 (-CH3), 17.8 (-CH3), 18.3 (-CH3), 18.5 (-CH3), 
19.3 (-CH3), 26.5 (-CH3), 29.1 (-CH-(CH3)2), 29.7 (-CH3), 30.9 (-C(CH3)3), 34.2 (-
C(CH3)3), 40.6 (-CH-), 42.9 (-CH2-), 43.2 (-CH-), 43.5 (-CH2-), 65.9 (-CH-), 83.7 (-
CH-O-), 105.3 (-C=CH2), 129.4 (-C=CH-), 130.4 (-CH=C-), 136.8 (-C=CH-), 141.3 
(-CH=C-), 146.0 (-C=CH2-), 166.4 (-C=O), 168.2 (-C=O), 171.6 (-C=O), 172.7 (-
C=O) ppm.  
IR (neat, cm-1): 3304, 1744, 1682, 1622, 1547;  
HRMS (ESI) m/z [(M+Na)+]: obsd 526.3258, calcd 526.3257 for C28H45N3O5Na. 
 
General procedure to synthesis the diol for zebra fish testing: 
OH
+
1) In/La(OTf)3, sat. NH4Cl, rt, 16h
2) DIBAL, CH2Cl2, 0 ºC
3) TBDPSCl, Im., CH2Cl2, 0 ºC
4) DMP, CH2Cl2, 0 ºC










To a 25 mL rounded bottom flask were added indium (0.11 g, 1 mmol), sat. NH4Cl 
solution (3 mL) and allylic bromide (0.58 g, 3 mmol). After the mixture was stirred at 
room temperature for 30 minutes, La(OTf)3 (0.58 g, 1 mmol) and aldehyde (1 mmol) 
were subsequently added. The mixture was stirred vigorously at room temperature for 
16h. After the reaction was completed (monitored by TLC), the reaction mixture was 
extracted with ethyl acetate. The organic extracts were combined and washed with 
  
Chapter 1 : Total Synthesis of Antillatoxin - Experimental 
103 Part I  
sat. NaHCO3 solution, brine, dried over anhydrous Na2SO4, and concentrated in 
vacuo. The crude product was purified by flash chromatography on silica gel followed 
by DIBAL reduction to give the syn-diol as a colorless oil. The anti isomer was 
obtained in the following way: selective TBDPSCl protection in the presence of 
imidazole in DMF, DMP oxidation in CH2Cl2 followed by Luche’s reduction with 





syn ±  
Rf 0.31 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.02 (3H, d, J = 7.32 Hz, -CH-CH3), 1.35 (3H, d, J = 
6.96 Hz, -CH-CH3), 2.17 (1H, dq, J = 6.96, 2.88 Hz, -CH-CH3), 2.84 (1H, dq, J = 
8.86, 7.32 Hz, -CH-CH3), 3.40 (2H, brs, -CH2-OH, -CH-OH), 3.75 (1H, dd, J = 8.86, 
2.88 Hz, -CH-OH), 3.98 (1H, d, J = 13.23 Hz, -CH2-OH), 4.07 (1H, d, J = 13.23 Hz, -
CH2-OH), 4.84 (1H, s, -C=CH2), 5.07 (1H, d, J = 1.05 Hz, -C=CH2), 7.14-7.34 (5H, 
m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 11.2 (-CH-CH3), 18.9 (-CH-CH3), 40.1 (-CH-CH3), 
43.2 (-CH-CH3), 64.2 (-CH2OH), 78.5 (-CHOH), 112.6 (-C=CH2), 126.3 (Ph-C x2), 
127.4 (-Ph-C x2), 128.6 (-Ph-Cp), 144.9 (-Ph-Cq), 151.7 (-C=CH2) ppm; 
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anti ±  
Rf 0.32 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.14 (3H, d, J = 6.96 Hz, -CH-CH3), 1.27 (3H, d, J = 
6.96 Hz, -CH-CH3), 2.66 (1H, dq, J = 6.96, 2.65 Hz, -CH-CH3), 2.86 (1H, dq, J = 
8.96, 6.96 Hz, -CH-CH3), 3.72 (1H, dd, J = 8.96, 2.65 Hz, -CH-OH), 4.05 (1H, d, J = 
13.23 Hz, -CH2-OH), 4.18 (1H, d, J = 13.23 Hz, -CH2-OH), 5.03 (1H, s, -C=CH2), 
5.15 (1H, s, -C=CH2), 7.21-7.35 (5H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 11.3 (-CH-CH3), 18.5 (-CH-CH3), 40.0 (-CH-CH3), 
43.4 (-CH-CH3), 64.6 (-CH2OH), 78.2 (-CHOH), 113.4 (-C=CH2), 126.9 (Ph-C x2), 
127.9 (-Ph-C x2), 128.7 (-Ph-Cp), 143.9 (-Ph-Cq), 151.9 (-C=CH2) ppm; 








Rf 0.30 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 0.96 (3H, d, J = 6.96 Hz, CH-CH3), 2.68 (1H, dq, J = 
6.96, 3.84 Hz, -CH-CH3), 3.69 (2H, brs, -CH-OH, -CH2-OH), 3.79 (3H, s, -Ph-
OCH3), 3.96 (1H, d, J = 13.23 Hz, -CH2-OH), 4.07 (1H, d, J = 13.23 Hz, CH2-OH), 
4.95 (1H, s, -C=CH2), 4.99 (1H, d, J = 3.84 Hz, CH-OH), 5.06 (1H, s, -C=CH2), 6.82 
(1H, d, J = 8.37 Hz, -Ph-Ho), 6.92 (1H, t, J = 7.48 Hz, -Ph-Hp), 7.20 (1H, td, J = 
7.83, 1.74 Hz, -Ph-Hm), 7.36 (1H, dd, J = 7.48, 1.56 Hz, -Ph-Hm) ppm.  
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13C NMR (125 MHz, CDCl3): ! 12.0 (-CH-CH3), 42.6 (-CH-CH3), 55.1 (-Ar-OCH3), 
64.5 (-CH2OH), 71.8 (-CHOH), 110.0 (-Ph-C), 112.3 (-C=CH2), 120.2 (-Ph-C), 127.3 
(-Ph-C), 127.7 (-Ph-C), 130.9 (-C=CH2), 151.2 (-C=CH2), 155.7 (-C-OMe); 








Rf 0.24 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 0.94 (3H, d, J = 7.32 Hz, -CH-CH3), 2.76 (1H, dq, J 
= 7.32, 8.73 Hz, -CH-CH3), 2.99 (2H, brs, -CH-OH, -CH2-OH), 3.85 (3H, s, -Ph-
OCH3), 4.06 (1H, d, J = 12.54 Hz, -CH2-OH), 4.18 (1H, d, J = 12.54 Hz, -CH2-OH), 
4.83 (1H, d, J = 8.73 Hz, -CH-OH), 5.01 (1H, s, -C=CH2), 5.19 (1H, d, J = 1.41 Hz, -
C=CH2), 6.88 (1H, d, J = 8.01 Hz, -Ph-Ho), 6.95 (1H, td, J = 7.48, 1.05 Hz, -Ph-Hp), 
7.25 (1H, td, J = 8.10, 1.74 Hz, -Ph-Hm), 7.30 (1H, dd, J = 7.68, 1.74 Hz, -Ph-Hm) 
ppm.  
13C NMR (125 MHz, CDCl3): ! 17.4 (-CH-CH3), 44.7 (-CH-CH3), 55.3 (-Ph-OMe), 
65.3 (-CH2OH), 74.3 (-CHOH), 110.5 (-Ph-C), 113.3 (-C=CH2), 120.7 (-Ph-C), 127.9 
(-Ph-C), 128.5 (-Ph-C), 130.8 (-C=CH2), 151.2 (-C=CH2), 156.7 (-C-OMe) ppm; 
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Rf 0.26 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.13 (3H, d, J = 7.32 Hz, -CH-CH3), 2.34 (1H, brs, -
CH-OH), 2.67 (1H, dq, J = 7.30, 4.44 Hz, -CH-CH3), 3.38 (3H, s, -C-OCH3), 3.41 
(3H, s, -C-OCH3), 3.50 (1H, dd, J = 6.60, 4.44 Hz, -CH-OH), 3.86 (1H, brs, -CH-
OH), 3.93 (1H, d, J = 12.54 Hz, -CH2-OH), 4.11 (1H, d, J = 12.54 Hz, -CH2-OH), 
4.21 (1H, d, J = 6.60 Hz, -CH-OMe), 4.96 (1H, d, J = 2.1 Hz, -C=CH2), 5.10 (1H, 
brs, -C=CH2) ppm; 
13C NMR (125 MHz, CDCl3): ! 16.6 (-CH-CH3), 40.2 (-CH-CH3), 54.5 (-OMe), 
54.9 (-OMe), 63.8 (-CH2OH), 73.8 (-CHOH), 105.0 (-CH-OMe), 115.6 (-C=CH2), 
149.1 (-C=CH2) ppm; 









Rf 0.13 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.08 (3H, d, J = 6.96 Hz, -CH-CH3), 2.37 (1H, brs, -
CH-OH), 2.54 (1H, dq, J = 6.96, 3.81 Hz, -CH-CH3), 3.06 (1H, brs, -CH-OH), 3.37 
(3H, s, -C-OCH3), 3.40 (3H, s, -C-OCH3), 3.64 (1H, dd, J = 6.27, 3.81 Hz, -CH-OH), 
4.00 (1H, d, J = 13.26 Hz, -CH2-OH), 4.11 (1H, d, J = 13.26 Hz, -CH2-OH), 4.24 
(1H, d, J = 6.27 Hz, -CH-OMe), 4.95 (1H, brs, -C=CH2), 5.08 (1H, d, J = 1.38 Hz, -
C=CH2) ppm; 
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13C NMR (125 MHz, CDCl3): ! 13.1 (-CH-CH3), 39.1 (-CH-CH3), 54.4 (-OMe), 
54.5 (-OMe), 64.6 (-CH2OH), 73.1 (-CHOH), 104.5 (-CH-OMe), 112.8 (-C=CH2), 
151.0 (-C=CH2) ppm; 






syn ±  
Rf 0.27 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.08 (3H, d, J = 7.32 Hz, -CH-CH3), 2.23 (3H, s, -C-
CH3), 2.73 (1H, dq, J = 7.32, 4.53 Hz, -CH-CH3), 3.68 (1H, brs, -CH2-OH), 3.93 (1H, 
d, J = 13.23 Hz, -CH2-OH), 4.05 (1H, d, J = 13.23 Hz, -CH2-OH), 4.65 (1H, d, J = 
4.53 Hz, -CH-OH), 4.94 (1H, s, -C=CH2), 5.07 (1H, s, -C=CH2), 5.85 (1H, brs, -
CH=C), 6.06 (1H, d, J = 3.15 Hz, -CH=C) ppm; 
13C NMR (125 MHz, CDCl3): ! 13.4 (-CH-CH3), 13.8 (-CH-CH3), 42.8 (-CH-CH3), 
64.8 (-CH2OH), 71.4 (-CHOH), 105.9 (-CH=C-), 107.0 (-CH=C-), 113.3 (-C=CH2), 
150.2 (-C=CH2), 151.0 (-CH=C-), 153.6 (-CH=C-) ppm; 
HRMS (ESI) m/z [M+]: calcd 196.1099 obsd 196.1093 for C11H16O3. 
 




anti ±  
Rf 0.21 (hexane/ethyl acetate, 4:1); 
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1H NMR (500 MHz, CDCl3): ! 0.95 (3H, d, J = 6.99 Hz, -CH-CH3), 2.27 (3H, s, -C-
CH3), 2.81 (1H, dq, J = 8.71, 6.99 Hz, -CH-CH3), 3.12 (1H, brs, -CH2-OH), 4.06 (1H, 
d, J = 12.87 Hz, -CH2-OH), 4.15 (1H, d, J = 12.87 Hz, -CH2-OH), 4.48 (1H, d, J = 
8.71 Hz, -CH-OH), 5.07 (1H, s, -C=CH2), 5.19 (1H, s, -C=CH2), 5.88 (1H, d, J = 2.4 
Hz, -CH=C), 6.13 (1H, d, J = 3.12 Hz, -CH=C) ppm; 
13C NMR (125 MHz, CDCl3): ! 13.5 (-CH-CH3), 17.2 (-CH-CH3), 43.3 (-CH-CH3), 
65.0 (-CH2OH), 71.7 (-CHOH), 105.9 (-CH=C-), 108.2 (-CH=C-), 113.8 (-C=CH2), 
150.3 (-C=CH2), 151.7 (-CH=C-), 153.3 (-CH=C-) ppm; 





syn ±  
Rf 0.15 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.07 (3H, d, J = 7.4 Hz, CH-CH3), 1.18-1.23 (4H, m, 
c-C6H11), 1.42-1.48 (1H, m, c-C6H11), 1.61-1.68 (2H, m, c-C6H11), 1.74-1.80 (4H, m, 
c-C6H11), 2.53 (1H, dq, J = 7.40, 6.90 Hz, -CH-CH3), 2.60 (2H, brs, -CH-OH, CH2-
OH), 3.26 (1H, dd, J = 7.40, 6.90 Hz, CH-OH), 4.02 (1H, d, J = 12.95 Hz, CH2-OH), 
4.13 (1H, d, J = 12.95 Hz, -CH2-OH), 4.99 (1H, s, -C=CH2), 5.14 (1H, d, J = 0.95 Hz, 
-C=CH2) ppm; 
13C NMR (125 MHz, CDCl3): ! 17.4 (-CH-CH3), 26.0 (-CH2-), 26.1 (-CH2-), 26.4 (-
CH2-), 26.5 (-CH2-), 30.5 (-CH2-), 40.2 (-CH-CH3), 41.0 (-CH-CH-OH), 64.7 (-
CH2OH), 79.2 (-CHOH), 113.8 (-C=CH2), 151.2 (-C=CH2) ppm; 
HRMS (ESI) m/z [(M++Na)]: calcd 221.1517 obsd 221.1516 for C12H22O2Na. 
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anti ±  
Rf 0.15 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.03 (3H, d, J = 7.4 Hz, -CH-CH3), 1.15-1.27 (4H, 
m, c-C6H11), 1.38-1.43 (1H, m, c-C6H11), 1.64-1.67 (2H, m, c-C6H11), 1.73-1.76 (2H, 
m, c-C6H11), 1.99-2.02 (2H, m, c-C6H11), 2.14 (2H, brs, -CH-OH, -CH2-OH), 2.52 
(1H, dq, J = 7.4, 3.25 Hz, -CH-CH3), 3.27 (1H, dd, J = 8.32, 3.25 Hz, -CH-OH), 4.07 
(1H, d, J = 12.95 Hz, -CH2-OH), 4.13 (1H, d, J = 12.95 Hz, -CH2-OH), 4.98 (1H, s, -
C=CH2), 5.16 (1H, s, -C=CH2) ppm; 
13C NMR (125 MHz, CDCl3): ! 11.6 (-CH-CH3), 25.9 (-CH2-), 26.1 (-CH2-), 26.4 (-
CH2-), 29.4 (-CH2-), 29.4 (-CH2-), 39.2 (-CH-CH3), 40.3 (-CH-CH-OH), 64.8 (-
CH2OH), 77.6 (-CHOH), 112.5 (-C=CH2), 151.1 (-C=CH2) ppm; 





syn ±  
Rf 0.12 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.01 (3H, d, J = 6.9 Hz, -CH-CH3), 2.71 (1H, dq, J = 
6.9, 3.7 Hz, -CH-CH3), 3.96 (1H, d, J = 12.95 Hz, -CH2-OH), 4.07 (1H, d, J = 12.95 
Hz, -CH2-OH), 4.25 (2H, brs, -CH-OH, -CH2-OH), 4.90 (1H, d, J = 3.7 Hz, -CH-
OH), 4.94 (1H, s, -C=CH2), 5.11 (1H, d, J = 0.95 Hz, -C=CH2), 7.41 (1H, dd, J = 1.4, 
8.32 Hz, -Ph-H), 7.47 (2H, m, -Ph-H), 7.79 (4H, m, -Ph-H) ppm; 
  
Chapter 1 : Total Synthesis of Antillatoxin - Experimental 
110 Part I  
13C NMR (125 MHz, CDCl3): ! 12.6 (-CH-CH3), 45.0 (-CH-CH3), 64.8 (-CH2OH), 
76.4 (-CHOH), 113.7 (-C=CH2), 124.5 (-Ph-C), 124.8 (-Ph-C), 125.5 (-Ph-C), 125.8 
(-Ph-C), 127.4 (-Ph-C), 127.5 (-Ph-C), 127.8 (-Ph-C), 132.6 (-Ph-Cq), 132.9 (-Ph-
Cq), 140.1 (-Ph-Cq), 150.3 (-C=CH2) ppm; 





anti ±  
Rf 0.08 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 0.93 (3H, d, J = 6.95 Hz, -CH-CH3), 2.73 (1H, dq, J 
= 8.80, 6.95 Hz, -CH-CH3), 4.14 (1H, d, J = 12.93 Hz, -CH2-OH), 4.22 (1H, d, J = 
12.93 Hz, -CH2-OH), 4.68 (1H, d, J = 8.8 Hz, -CH-OH), 5.10 (1H, s, -C=CH2), 5.24 
(1H, d, J = 0.95 Hz, -C=CH2), 7.47 (3H, m, -Ph-H), 7.82 (4H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 17.5 (-CH-CH3), 45.7 (-CH-CH3), 65.4 (-CH2OH), 
78.9 (-CHOH), 113.7 (-C=CH2), 124.5 (-Ph-C), 125.4 (-Ph-Cq), 125.9 (-Ph-C), 126.0 
(-Ph-C), 126.1 (-Ph-C), 127.7 (-Ph-C), 127.9 (-Ph-C), 128.2 (-Ph-C), 133.2 (-Ph-Cq), 
140.3 (-Ph-Cq), 150.8 (-C=CH2) ppm; 





syn ±  
Rf 0.14 (hexane/ethyl acetate, 4:1); 
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1H NMR (500 MHz, CDCl3): ! 0.88 (3H, d, J = 6.45 Hz, -CH-(CH3)2), 0.91 (3H, d, J 
= 6.45 Hz, -CH-(CH3)2), 1.07 (3H, d, J = 7.4 Hz, -CH-CH3), 1.24-1.28 (1H, m, -CH-
CH2-), 1.76-1.84 (1H, m, -CH-CH2-), 2.27 (1H, dq, J = 7.4, 6.95 Hz, -CH-CH3), 2.39 
(1H, t, J = 7.85 Hz, -CH-(CH3)2), 3.02 (2H, brs, -CH-OH, -CH2-OH), 3.56 (1H, td, J 
= 6.95, 3.25 Hz, -CH-OH), 3.99 (1H, d, J = 12.95 Hz, -CH2-OH), 4.11 (1H, dd, J = 
12.95, 0.9 Hz, -CH2-OH), 4.95 (1H, d, J = 1.4 Hz, -C=CH2), 5.13 (1H, d, J = 0.9 Hz, -
C=CH2) ppm; 
13C NMR (125 MHz, CDCl3): ! 16.9 (-CH3), 21.7 (-CH3), 23.8 (-CH3), 24.5 (-
CH(CH3)2), 44.3 (-CH2CHOH), 45.3 (-CH-CH3), 64.3 (-CH2OH), 72.7 (-CHOH), 
114.0 (-C=CH2), 150.4 (-C=CH2) ppm; 





anti ±  
Rf 0.14 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 0.90 (3H, d, J = 6.95 Hz, -CH-(CH3)2), 0.92 (3H, d, J 
= 6.95 Hz, -CH-(CH3)2), 1.05 (3H, d, J = 7.40 Hz, -CH-CH3), 1.36-1.43 (1H, m, -CH-
CH2-), 1.70-1.78 (1H, m, -CH-CH2-), 2.33 (1H, dq, J = 7.40, 3.25 Hz, -CH-CH3), 
2.40 (1H, t, J = 7.85 Hz, -CH-(CH3)2), 2.75 (2H, brs, -CH-OH, -CH2-OH), 3.70 (1H, 
td, J = 6.9, 3.25 Hz, -CH-OH), 4.03 (1H, dd, J = 12.95, 0.95 Hz, -CH2-OH), 4.11 (1H, 
d, J = 12.95 Hz, -CH2-OH), 4.93 (1H, s, -C=CH2), 5.12 (1H, d, J = 1.4 Hz, -C=CH2) 
ppm; 
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13C NMR (125 MHz, CDCl3): ! 12.9 (-CH3), 22.0 (-CH3), 23.5 (-CH3), 24.8 (-
CH(CH3)2), 43.3 (-CH2CHOH), 43.3 (-CH-CH3), 65.3 (-CH2OH), 71.9 (-CHOH), 
112.7 (-C=CH2), 151.4 (-C=CH2) ppm; 







Rf 0.11 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.11 (3H, d, J = 7.32 Hz, -CH-CH3), 2.60 (1H, dq, J 
= 3.46, 7.32 Hz, -CH-CH3), 3.13 (2H, brs, -CH-OH, -CH2-OH), 4.09 (1H, d, J = 
12.72 Hz, -CH2-OH), 4.17 (1H, d, J = 12.72 Hz, -CH2-OH), 4.33 (1H, dd, J = 6.63, 
3.46 Hz, -CH-OH), 4.99 (1H, s, -C=CH2), 5.19 (1H, s, -C=CH2), 6.22 (1H, dd, J = 
15.66, 6.63 Hz, -CH=CH-), 6.58 (1H, d, J = 15.66 Hz, -CH=CH-), 7.21-7.41 (5H, m, 
-Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 14.8 (-CH-CH3), 44.1 (-CH-CH3), 66.7 (-CH2OH), 
76.1 (-CHOH), 114.6 (-C=CH2), 127.2 (-Ph-C x2), 128.3 (-Ph-C), 129.3 (-Ph-C x2), 







Rf 0.11 (hexane/ethyl acetate, 4:1); 
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1H NMR (500 MHz, CDCl3): ! 1.12 (3H, d, J = 7.32 Hz, -CH-CH3), 2.48 (1H, dq, J 
= 7.29, 7.32 Hz, -CH-CH3), 2.59 (2H, brs, -CH-OH, -CH2-OH), 4.12 (1H, d, J = 
12.45 Hz, -CH2-OH), 4.20 (1H, d, J = 12.45 Hz, -CH2-OH), 4.21 (1H, dd, J = 7.29, 
6.96 Hz, -CH-OH), 5.07 (1H, s, -C=CH2), 5.22 (1H, d, J = 1.05 Hz, -C=CH2), 6.21 
(1H, dd, J = 16.02, 6.96 Hz, -CH=CH-), 6.61 (1H, d, J = 16.02 Hz, -CH=CH-), 7.28-
7.40 (5H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 17.7 (-CH-CH3), 45.3 (-CH-CH3), 65.8 (-CH2OH), 
77.4 (-CHOH), 114.7 (-C=CH2), 127.2 (-Ph-C x2), 128.4 (-Ph-C), 129.3 (-Ph-C x2), 





syn ±  
Rf 0.16 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.08 (3H, d, J = 7.23 Hz, -CH-CH3), 1.72-1.83 (2H, 
m, -CH2-CH2-), 2.39 (1H, dq, J = 7.23, 3.6 Hz, -CH-CH3), 2.51 (2H, brs, -CH-OH, -
CH2-OH), 2.60-2.70 (1H, m, -CH2-CH2-), 2.79-2.89 (1H, m, -CH2-CH2-), 3.62-3.68 
(1H, m, -CH-OH), 4.04 (1H, d, J = 12.64 Hz, -CH2-OH), 4.12 (1H, d, J = 12.64 Hz, -
CH2-OH), 4.95 (1H, s, -C=CH2), 5.14 (1H, d, J = 1.2 Hz, -C=CH2), 7.19-7.31 (5H, m, 
-Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 13.7 (-CH-CH3), 33.5 (-CH2-), 36.8 (-CH2-), 43.8 (-
CH-CH3), 66.2 (-CH2OH), 73.9 (-CHOH), 113.6 (-C=CH2), 126.6 (-Ph-C), 129.1 (-
Ph-C x4), 142.7 (-Ph-Cq), 151.9 (-C=CH2) ppm; 
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Rf 0.16 (hexane/ethyl acetate, 4:1); 
1H NMR (500 MHz, CDCl3): ! 1.09 (3H, d, J = 6.96 Hz, -CH-CH3), 1.64-1.79 (1H, 
m, -CH2-CH2-), 1.82-1.94 (1H, m, -CH2-CH2-), 2.37 (1H, quintet, J = 6.96 Hz, -CH-
CH3), 2.49 (2H, brs, -CH-OH, -CH2-OH), 2.62-2.74 (1H, m, -CH2-CH2-), 2.83-2.94 
(1H, m, -CH2-CH2-), 3.51-3.60 (1H, m, -CH-OH), 4.04 (1H, d, J = 12.71 Hz, -CH2-
OH), 4.15 (1H, dd, J = 12.71, 1.02 Hz, -CH2-OH), 5.01 (1H, s, -C=CH2), 5.17 (1H, d, 
J = 1.02 Hz, -C=CH2), 7.18-7.29 (5H, m, -Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 17.5 (-CH-CH3), 32.9 (-CH2-), 37.5 (-CH2-), 45.6 (-
CH-CH3), 65.3 (-CH2OH), 74.8 (-CHOH), 114.9 (-C=CH2), 126.5 (-Ph-C), 129.1 (-





syn ±  
Rf 0.14 (hexane/ethyl acetate, 4:1);  
1H NMR (300 MHz, CDCl3): ! 1.03 (3H, d, J = 7.32 Hz, -CH-CH3), 2.38 (2H, brs, -
CH-OH, -CH2-OH), 2.64 (1H, dq, J = 4.53, 7.32 Hz, -CH-CH3), 4.00 (1H, d, J = 
13.41 Hz, -CH2-OH), 4.11 (1H, d, J = 13.41 Hz, -CH2-OH), 4.81 (1H, d, J = 4.53 Hz, 
-CH-OH), 4.98 (1H, s, -C=CH2), 5.17 (1H, d, J = 1.02 Hz, -C=CH2), 7.26-7.34 (5H, 
m, -Ph-H) ppm; 
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13C NMR (125 MHz, CDCl3): ! 12.8 (-CH-CH3), 45.1 (-CH-CH3), 65.2 (-CH2OH), 
76.6 (-CHOH), 113.6 (-C=CH2), 126.2 (-Ph-C x2), 127.1 (-Ph-C), 127.9 (-Ph-C x2), 





anti ±  
Rf 0.14 (hexane/ethyl acetate, 4:1);  
1H NMR (500 MHz, CDCl3): ! 0.89 (3H, d, J = 6.95 Hz, -CH-CH3), 2.60 (1H, dq, J 
= 8.80, 6.95 Hz, -CH-CH3), 2.81 (2H, brs, -CH-OH, -CH2-OH), 4.09 (1H, d, J = 
12.95 Hz, -CH2-OH), 4.17 (1H, d, J = 12.95 Hz, -CH2-OH), 4.50 (1H, d, J = 8.80 Hz, 
-CH-OH), 5.05 (1H, s, -C=CH2), 5.21 (1H, s, -C=CH2), 7.26-7.34 (5H, m, -Ph-H) 
ppm; 
13C NMR (125 MHz, CDCl3): ! 17.3 (-CH-CH3), 45.8 (-CH-CH3), 65.0 (-CH2OH), 
78.5 (-CHOH), 113.6 (-C=CH2), 126.7 (-Ph-C x2), 127.6 (-Ph-C), 128.2 (-Ph-C x2), 
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2.1 Introduction 
 
Cytochalasans are a group of fungal secondary metabolites produced by 
several different and unrelated fungal species. They are related by structure and 
biological activity. For example, Cytochalasins A (1) and B (2) are metabolites of 
Helminthosporium dematioideum;1 Cytochalasins C (3) and D (4) are isomeric 
metabolites of Metarrhizium anisopliae;2 Cytochalasin E (5) is a metabolite of 
Rosellinia necatrix; Cytochalasin F (6) is a minor metabolite of Helminthosporium 
dematioideum;3 Cytochalasins H (7) and J (8) are metabolites of Phomopsis paspali 
found on Paspalum scrobiculatum.4 
 
The cytochalasans were discovered in 1964 by the Pharmaceuticals Division 
of Imperial Chemicals Industries, Ltd. The name cytochalasin comes from the Greek 
words (cytos = cell; chalasis = relaxation) and is coined to describe the unique effects 
which the compounds produce on mammalian cells in tissue culture.5  
                                                
1 Aldridge, D. C.; Armstrong, J. J.; Speaks, R. N.; Turner, W. B. J. Chem. Soc. 1967, 1667. 
2 Aldridge, D. C.; Turner, W. B. J. Chem. Soc. 1969, 923. 
3 (a) Aldridge, D. C.; Burrows, F. F.; Turner, W. B. Chem. Commun. 1972, 148. (b) Aldridge, D. C.; 
Greatbanks, D.; Turner, W. B. Chem. Commun. 1973, 551. 
4 (a) Pendse, G. S. Experientia 1974, 30, 107. (b) Padwardhan, S. A.; Pandey, R. C.; Dev, S.; Pendse, 
G. S. Phytochemistry 1974, 13, 1985. (c) Deshmukh, P. G.; Kanitkar, U. K.; Pendse, G. S. Acta 
Microbiol. Acad. Sci. Hung. 1975, 22, 253. 
5 Carter, S. B. Nature, 1967, 213, 261. 
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Figure 2-1 Examples of cytochalasans 
 
The cytochalasans can be divided into three general groups based on whether 
they contain either an indole, phenyl or isopropyl moiety at position 10 of the 
perhydroisoindole ring system as shown in Figure 2-2. Those that contain an indole 
moiety are generally referred to as the chaetoglobosins (10). Cytochalasans 
containing phenyl and isopropyl moieties are referred to as cytochalasins (3) and 
aspochalasins (11) respectively6 (Figure 2-2). 
                                                
6 (a) Cole, R.; Cox, R. H. Handbook of toxic Fungal Metabolites, Academic Press; New York, 1981, 
264-343; (b) Turner, W. B. Fungal Metabolites; Academic Press,!New York, 1971, pp 352; (c) Turner, 
W. B.; Aldridge, D. C. Fungal Metabolites II; Academic Press,!New York, 1983, pp 459; (d) Himes, 
R. H. Biochim. Biophys. Res. Commun. 1976, 68, 1362; (e) Fox, E. B.; Phillips, D. R. Nature, 1981, 
292. 
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Figure 2-2 Types of cytochalasans 
 
2.2 Biological Activities 
 
Cytochalasans show a number of unusual, interesting and characteristic effects 
on the cell. It is known that cytochalasans generally possess distinctive biological 
effects including inhibiting the division of cytoplasm, reversible inhibition of cell 
movement, inducing nuclear extrusion,7 inhibiting processes such as phagocytosis,8 
platelet aggregation, clot retraction,9 glucose transport,10 thyroid secretion11 and 
release of growth hormone.12 More recently, some of these compounds have been 
recognized for their potential as mycotoxins.13 
 
                                                
7 (a) Carter, S. B. Nature 1967, 13, 1985. (b) Krishan, A. J. Cell Biol. 1972, 54, 657. (c) Prescott, D. 
M.; Myerson, D.; Wallace, J. Exp. Cell Res. 1972, 71, 480. (d) Carter, S. B. Endeavour 1972, 31, 77. 
8 (a) Allison, A. C.; Davies, P.; De Petris, S. Nature New Biol. 1971, 232, 153. (b) Davis, A. T.; 
Estensen, R. D.; Quie, P. G. Proc. Soc. Exp. Biol. Med. 1971, 137, 161. (c) Axline, S. G.; Reaven, E. J. 
Clin. Invest. 1972, 51, 6a. 
9 (a) Shepro, D.; Belamarich, F. A.; Robblee, L. Chao, F. C. J. Cell Biol. 1970, 47, 544. (b) White, J. 
G. Roussel Conference on Platelet Aggregation, Masson, Paris, 4th March,1971 (c) Haslam, R. J. 
Biochem. J. 1972, 127, 34P. (d) Majno, G.; Bouvier, C. A.; Gabbiani, G.; Ryan, C. B.; Statkov, P. 
Thromb Diath. Haemorrh. 1972, 28, 49. 
10 (a) Kletzien, R. F.; Perdue, J. F.; Springer, A. J. Biol. Chem. 1972, 247, 2964. (b) Mizel, S. B.; 
Wilson, L. J. Biol. Chem. 1972, 247, 4102. (c) Estensen, R. D.; Plagemann, P. G. Proc. Nat. Acad. Sci. 
U.S.A. 1972, 69, 1430. 
11 Williams, J. A.; Wolff, J. Biochem. Biophys. Res. Commun. 1971, 44, 422. 
12 (a) Schofield, J. G. Nature New Biol. 1971, 234, 215. (b) McPherson, M.A.; Schofield, J.G. F.E.B.S. 
Lett. 1972, 24, 45. 
13 Glinsukon, T.; Shank, R. C.; Wogan, G. N.; Newberne, P. M. Toxical. Appl. Pharmacol. 1975, 32, 
135. 
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Cytochalasin A (1) is sulfhydryl-reactive, and was shown to inhibit growth 
and sugar uptake in a Saccharomyces strain.14 Cytochalasin D (4) possesses 
antibiotic15 and antitumor activities.16 Cytochalasins H (7) and J (8) have been shown 
to have CNS activity.17 Dihydrocytochalasin B (9) (dihydro-CB), the saturated 
derivative of Cytochalasin B (2), induces changes in morphology and motility, but has 
little effect on sugar transport.18,19 Chaetoglobosins C shown cytotoxic to HeLa cells 
and chaetoglobosin K is a growth inhibitor of wheat colcoptiles.6 Phomacins (eg. 13), 
which are structurally related to aspochalasins, have been found to exhibit potent 
inhibitory activity against the HT29 colonic adenocarcinoma cell line20 (Figure 2-3).  
 
Since their commercial availability in the early 1970's, this group of 
compounds has become the subject of intense cytological research, which has led to 
the discovery of many new effects and a large number of synthetic cytochalasan 
derivatives. The literature abounds in reports and reviews of various aspects of their 
pharmacology. 
                                                
14 Kuo, S. -C.; Lampen, J. O. Ann. N.Y. Acad. Sci. 1974, 235, 137. 
15 Betina, V.; Micekova, D. Z. Allg. Mikrobiol. 1972, 12, 355; Chem Abstr. 1972, 77,160508q. 
16 Katagiri, K.; Matsuura, S. J. Antifiot. 1971, 24, 722. 
17 Kuo, S. -C.; Lampen, J. O. Biochim Biophys. Acta 1975, 389, 145. 
18 (a) Atlas, S. J.; Lin, S. J. Cell Biol. 1978, 76, 360; Lin, S.; Lin, D. C.; Flanagan, M. D. Proc. Nat. 
Acad. Sci. U.S.A. 1978, 75, 329. (b) Lin, S.; Spudich, J. A. J. Biol. Chem. 1974, 249, 5778. 
19 (a) Lin, D. C.; Lins, S. J. Biol. Chem. 1978, 253, 1415. (b) Rampal, A. L; Pinkovsky, H. B.; Jung, C. 
Y. Biochemistry 1980, 19, 679. 
20 Alvi, K. A.; Nair, B.; Pu, H.; Ursino, R.; Gallo, C.; Mocek, U. J. Org. Chem. 1997, 62, 2148. 
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cytochalasin A (1)
(inhibits growth and sugar 
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cytochalasin E (5)

















                                                
5 Carter, S. B. Nature, 1967, 213, 261. 
6 (a) Cole, R.; Cox, R. H. Handbook of toxic Fungal Metabolites, Academic Press; New York, 1981, 
264-343; (b) Turner, W. B. Fungal Metabolites; Academic Press,!New York, 1971, pp 352; (c) Turner, 
W. B.; Aldridge, D. C. Fungal Metabolites II; Academic Press,!New York, 1983, pp 459; (d) Himes, 
R. H. Biochim. Biophys. Res. Commun. 1976, 68, 1362; (e) Fox, E. B.; Phillips, D. R. Nature, 1981, 
292. 
20 Alvi, K. A.; Nair, B.; Pu, H.; Ursino, R.; Gallo, C.; Mocek, U. J. Org. Chem. 1997, 62, 2148. 
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Due to the unique biological activities and structural complexities of this 
group of compounds, cytochalasans have been the targets of much synthetic 
endeavors. The common strategies used in previous syntheses usually involved a 
thermal Diels-Alder reaction (either intermolecular or intramolecular) as the key step 
to form the six-membered core ring system together with the macrocyclic lactone or 
carbocyclic ring. 
 
2.3.2 Literature Reviews 
 
Stork and coworkers21 synthesized cyctochalasin B (2) via intramolecular 
Diels-Alder reaction to construct the six-membered ring closure from tetraene 16 
(Scheme 2-1). Tetraene 16 was heated at 180-190 °C using a base-washed, silylated, 
sealed tube for 6 d to give the cycloadducts 17. The cycloadducts 17 were obtained as 
a 4:1 diastereomeric mixture where the major diastereomer was the desired product 
17b. The diastereomers were separated using column chromatography after 
deacetylation. Subsequent synthetic manipulations gave cytochalasin B (2). 
 
                                                
21 Stork, G.; Nakamura, E. J. Am. Chem. Soc. 1983, 105, 5510. 
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 Using a similar path, Thomas et. al22 carried out the intramolecular Diels-
Alder reaction using a long chain triene-pyrrolinone 18 (Scheme 2-2). A solution of 
the triene 18 in toluene was heated in a sealed tube for 12 d to afford the product in 
50-55% yield with a diastereomeric ratio of 52:48. The major isomer 19b was the 
desired product. After a series of synthetic transformations, they completed the first 
total synthesis of proxiphomin 20. 
 
                                                
22 (a) Thomas, E. J.; Tapolczay, D. J.; Whitehead, J. W. F. J. Chem. Soc., Chem. Commun. 1985, 143.  
(b) Thomas, E. J.; Whitehead, J. W. F. J. Chem. Soc., Chem. Commun. 1986, 724. 
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 Four years later, Thomas et al23 reported the synthesis of cytochalasin H (7) by 
using a similar approach as previous studies. Cyclization of the Diels-Alder precursor 
21 was carried out by heating in toluene at 100 °C for 5h to give the desired 
































                                                
23 (a) Thomas, E. J.; Whitehead, J. W. F. J. Chem. Soc., Perk. Trans. I. 1989, 507; (b) Thomas, E. J.; 
Whitehead, J. W. F. J. Chem. Soc., Perk. Trans. I. 1989, 519. 
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 Hungate et al24 synthesized the core ring structure of cytochalasans by a 
thermal intermolecular Diels-Alder reaction using diene 23 and a symmetrical 
dienophile 24.25 After cyclization, another seven steps were needed to give the 
























 Vedejs et al26 employed an intermolecular thermal Diels-Alder reaction in the 
total synthesis of cytochalasin D analogs 30 and zygoporin G (31) (Scheme 2-5). The 
reaction between triene 27 and a reactive dienophile 28 was carried out at room 
temperature to give a >15:1 mixture of the desired adduct 29. The ring expansion 
strategy to incorporate the last four carbons of the 11-membered carbocycle was 
solved by using thioaldehyde technology. Cytochalasin D analogs 30 and zygoporin 
G (31) were synthesized in sixteen and thirteen steps from 29 respectively. 
 
                                                
24 Hungate, R. W.; Chen, J. L.; Starbuck, K. E.; Macaluso, S. A.; Rubino, R. S. Tetrahedron Lett. 
1996, 37, 4113. 
25 Weinreb, S. M.; Starlett Jr., J. E.; Kim, Y. M. J. Org. Chem. 1981, 46, 5383. 
26 (a) Vedejs, E.; Reid, J. G. J. Am. Chem. Soc. 1984, 106, 4618; (b) Vedejs, E.; Rodgers, J. D.; 
Wittenberger, S. J. J. Am. Chem. Soc. 1988, 110, 4822; (c) Vedejs, E.; Rodgers, J. D.; Wittenberger, S. 
J. J. Am. Chem. Soc. 1990, 112, 4351. 
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 All the reported syntheses of cytochalasans involved the use of thermal 
intramolecular or intermolecular Diels-Alder reaction as the key step, thus requiring 
harsh conditions which are difficult to carry out. These reported syntheses are long 
and required tedious synthetic manipulations. Besides, these methodologies cannot be 
employed with heat- or acid-sensitive compounds that are often featured in complex 
and multi-step syntheses.27 Furthermore, the precursors needed for the cyclizations 







                                                
27 Kobayashi, S.; Hachiya, I.; Takahori, T.; Araki, M.; Ishitani, H. Tetrahedron Lett. 1992, 33, 6815. 
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2.4 Our Synthetic Plan 
 
Our strategy is to employ a Lewis acid catalyst and intermolecular Diels-Alder 
reaction to construct the six-membered ring. Lewis acid catalysts allow the reaction to 
proceed under mild conditions (at room temperature or below) with satisfactory 
yields. Reactions with less reactive dienes and dienophiles are also made possible, 
and the cycloaddition products are often highly regio- and stereo-selective. 
Furthermore, Lewis acids are capable of increasing both the reaction rate and 
selectivity, contrary to other catalyzed reactions where an increase in reaction rate is 




R = Pri, 36a to aspochalasins
R = Ph, 36b to cytochalasins








MLn* = BF3.OEt2, SnCl4 













R = Pri, 38a gives aspochalasin A (11),
       phomacin C (15)
R = Ph, 38b gives zygoporin G (31)






R = Pri, 37a 
      gives phomacin A (13),  B (14)
R = Ph, 37b 









incorporation of Pri or Ph or indole group 




                                                
28 Fringuelli, F.; Taticchi, A. The Diels-Alder Reaction Selected Practical Methods, Wiley & Sons, 
England, 2002, 99. 
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 The key feature of our synthetic plan is the versatility of the key intermediates 
35 as shown in Scheme 2-6. This versatile key intermediate 35 will allow us to 
synthesize almost all the known cytochalasans. The phenyl, isopropyl and indole 
groups can be incorporated from an imine containing functionality in intermediate 35 
to afford key intermediates 36a, 36b and 36c for the syntheses of aspochalasins, 
cytochalasins and chaetoglobosins respectively. The presence of bromide in the six-
membered core ring system will enable us to introduce oxygen or carbon substituents 
in the C-9 position affording key intermediate 37a, 37b, 37c and 38a, 38b, 38c for the 
syntheses of cytochalasans with the macrocyclic lactone or carbocyclic rings (Scheme 
2-6).  
 
Further synthetic manipulations on the cyclohexane ring of 37a, 37b and 37c 
will enable us to obtain the key intermediates for the syntheses of cytochalasin A (1), 







R = Pri, 39a
R = Ph, 39b gives cytochalasin F (6)
R = Indole, 39c
R = Pri, 37a
R = Ph, 37b






R = Pri, 40a
R = Ph, 40b 
      gives cytochalasin A (1), B (2)











Similar strategy can be used on the cyclohexane ring of 38a, 38b, and 38c to 
give the key intermediates for the syntheses of chaetoglobosin C (10) and K (12), 
cytochalasin C (3), D (4), E (5), H (7) and J (8) (Scheme 2-8). 
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R = Pri, 41a
R = Ph, 41b gives cytochalasin   
       E (5) 
R = Indole, 41c gives       
      chaetoglobosin C (10), K (12)
R = Pri, 38a
R = Ph, 38b






R = Pri, 42a
R = Ph, 42b gives cytochalasin C (3)














R = Pri, 43a
R = Ph, 43b gives cytochalasin D (4), H (7), J (8)




Two retrosynthetic approaches to cytochalasans are listed in Scheme 2-9. In 
both synthetic approaches, the cytochalasans are envisioned to arise from six-
membered ring system with a bromide substituted at the C-9 position. The presence of 
bromide in the six-membered core ring system will enable us to introduce oxygen or 
carbon substituents in the C-9 position affording key intermediate for the syntheses of 
cytochalasans with the desired macrocyclic ring systems. 
 
The main difference between the two approaches was on the substituents on 
the amine group. In approach A, the substituents on the amine group were 
incorporated in the diene’s synthesis while in approach B, it was introduced in the 
later part of the synthesis (Scheme 2-9). 
  
Chapter 2 : Synthetic Studies Towards The Total Synthesis of Cytochalasans 
















R = Pri, 36a
R = Ph, 36b
R = Indole, 36c
X = O or C
R = Pri, aspochalasins
R = Ph, cytochalasins







R = Pri, 44a
R = Ph, 44b



























In our previous synthetic studies towards the total synthesis of cytochalasans,29 
several Lewis acids catalyzed and thermal intermolecular Diels-Alder reaction using 
diene 23, 48 and dienophile 45a have been carried out, unfortunately, no cycloadduct 
was obtained (Table 2-1). It was also found that the ester functionality on dienophile 
45a is not sufficiently electron-withdrawing for promoting the Diels-Alder reactions 
and attempts to make the more reactive dienophile had failed. Since this approach did 
not yield any desired product, we discarded synthetic approach A and proceeded with 
synthetic approach B. 
                                                
29 Lim Zeyi, Honours thesis, 1998 - unpublished results. 
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Table 2-1 
 
R  =  Bn, 23












Entry Dienes Conditions Yield 
1 R = TBS In(OTf)3 
2 R = Bn In(OTf)3 
3 R = TBS La(OTf)3 
4 R = Bn La(OTf)3 
5 R = TBS InCl3 
6 R = Bn InCl3 
7 R = TBS SnCl4 
8 R = Bn SnCl4 
9 R = TBS TiCl4 
10 R = Bn TiCl4 
11 R = TBS 
Sealed tube 
Toluene, reflux 














2.4.1 Approach B 
 
In our synthetic approach B, the substituents on the amine group are 
introduced in the later part of the synthesis. Thus, we envisaged that the phenyl, 
isopropyl and indole groups can be incorporated from an imine containing 
functionality in intermediate 35 to afford key intermediates 36a, 36b and 36c for the 
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syntheses of aspochalasins, cytochalasins and chaetoglobosins respectively (Scheme 
2-10). The use of a chiral Lewis acid30 in the Diels-Alder reaction will enable us to 




























MLn* = BF3:OEt2, SnCl4 













Retrosynthetic analyses of key intermediates 36a, 36b and 36c using a 
sequence of functional group interconversions leads to 34 via compound 49 and 50 
(Scheme 2-11). Retrosynthetic disassembly of the six-membered ring system 34 
provide diene 32 and dienophile 33. It is projected that the construction of the six-
membered ring could be achieved using Lewis acid catalyzed intermolecular Diels-
Alder reaction between diene 32 and dienophile 33.  
                                                
30 Loh, T. P.; Corey, E. J.; Tetrahedron Lett. 1993, 34, 3979. 
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Dienophile 33 can be derived from 51 via a bromination-elimination reaction, 
preceded with monoprotected alcohol 52 and finally from a commercially available 
cis 1,4-butendiol 53. Meanwhile diene 32 can be obtained form tiglic aldehyde 47 and 




























R = Pri, 36a
       Ph, 36b












Despite the dramatic improvements on the development of Diels-Alder 
technology for the construction of six-membered rings, the utility of Lewis acid-
catalyzed intermolecular Diels-Alder reaction for the syntheses of complex molecules 
using open-chain dienes is not well established. This is probably due to the fact that 
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open-chain dienes are usually not very reactive in the Lewis acid-catalyzed 
intermolecular Diels-Alder reaction. In addition to that, the Lewis acid-catalyzed 
reaction does not work with acid-sensitive dienes and dienophiles. Therefore, there is 
still a need to develop more active catalysts (Lewis acids) which can effect this 
reaction for unreactive systems, such as those involving open-chain dienes. 
 
2.5 Results and Discussions 
 
Before attempting the Diels-Alder reaction on the real system of the molecule 
(Scheme 2-12), a model study was carried out using simple and commercially 
available dienes and dienophiles. Several Lewis acid-catalyzed conditions were 









MLn* = BF3.OEt2, SnCl4 





2.5.1 Methodology Studies 
 
With the plan in mind, we proceed to the syntheses of the diene and 
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2.5.1.1 Synthesis of Diene 23 
 
Synthesis of diene 23 was described in Scheme 2-13. Diene 23 was prepared 
in four steps from tiglic aldehyde (47). Treatment of 47 with 
carb(ethoxymethylene)triphenylphosphorane (56) in THF at 60 °C gave ester 55 in 
93% yield. As expected, the trans isomer was the only product been isolated. When 
ester 55 was reduced using lithium aluminium hydride in ether at 0 °C, alcohol 54 
was obtained in 92% yield. Protection of the alcohol functionality was carried out 
using benzyl bromide in the presence of sodium hydride in THF at 0 °C, giving the 







0 °C to rt
OH OBnCO2Et
THF, NaH, 







2.5.1.2 Synthesis of Dienophile 51 and 33 
 
Synthesis of dienophile 51 and 33 was carried out from a commercially 
available cis 1,4-buten-2-diol 53 (Scheme 2-14). Diol 53 was reacted with t-
butyldiphenylsilylchloride (TBDPSCl) in the presence of triethylamine and DMAP in 
CH2Cl2 at 0 °C to give monoprotected alcohol 52 in 39% yield. Oxidation of alcohol 
52 with pyridinium chlorochromate (PCC) in CH2Cl2 at 0 °C afforded dienophile 51 
in 44% yield. Only the more stable trans isomer of dienophile 51 was obtained. 
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Further bromination of aldehyde 51 with bromine in CH2Cl2 followed by 
dehydrobromination by triethylamine at -78 °C gave dienophile 33 as a cis-isomer in 










0 ºC to rt, 39%
PCC, silica gel, 4A MS,











2.5.1.3 In(OTf)3 Catalysed Diels-Alder Reaction in CH2Cl2 
 
In the past few years, indium (III) complexes have been extensively used in 
organic synthesis as an efficient Lewis acid catalyst for various C-C bond formations 
and important transformations.31 Especially noteworthy is indium triflate (In(OTf)3) 
which our group is currently involved in exploiting its application in organic 
synthesis. 
                                                
31 For reviews, see: (a) Chauhan, K. K.; Frost, C. G. J. Chem. Soc., Perkin Trans. 1. 2000, 3015. (b) 
Babu, G.; Perumal, P. T. Aldrichim. Acta 2000, 33, 16. For recent examples, see: (c) Mukaiyama, T.; 
Ohno, T.; Nishimura, T.; Han, J. S.; Kobayashi, S. Chem. Lett. 1990, 2239. (d) Trost, B. M.; Sharma, 
S.; Schmidt, T. J. Am. Chem. Soc. 1992, 114, 7903. (e) Loh, T. -P.; Pei, J.; Cao, G. -Q. J. Chem. Soc., 
Chem. Commun. 1996, 1819. (f) Loh, T. -P.; Pei, J.; Lin, M. J. Chem. Soc., Chem. Commun. 1996, 
2315. (g) Loh, T. -P.; Chua, G. -L.; Vittal, J. J.; Wong, M. -W. J. Chem. Soc., Chem. Commun. 1998, 
861. (h) Loh, T. -P.; Wei, L. -L. Tetrahedron Lett. 1998, 39, 323. (i) Loh, T. -P.; Huang, J. -M.; Goh, 
S. H.; Vittal, J. J. Org. Lett. 2000, 2, 1291. (j) Yang, J.; Li, C. -J. Synlett 1999, 717. (k) Viswanathan, 
G. S.; Yang, J.; Li, C. -J. Org. Lett. 1999, 1, 993. (l) Ranu, B. C.; Jana, U. J. Org. Chem. 1998, 63, 
8212. (m) Ranu, B. C.; Hajra, A.; Jana, U. J. Org. Chem. 2000, 65, 6270. (n) Ali, T.; Chauhan, K. K.; 
Frost, C. G. Tetrahedron Lett. 1999, 40, 5621. (o) Chauhan, K. K.; Frost, C. G.; Love, I.; Waite, D. 
Synlett 1999, 1743. (p) Tsuchimoto, T.; Maeda, T.; Shirakawa, E.; Kawakami, Y. J. Chem. Soc., Chem. 
Commun. 2000, 1573. (q) Gadhwal, S.; Sandhu, J. S. J. Chem. Soc., Perkin Trans. 1. 2000, 2827. 
  
Chapter 2 : Synthetic Studies Towards The Total Synthesis of Cytochalasans 
137 Part II  
Our group had published and described the In(OTf)3-catalyzed conversion of 
!-adduct homoallylic alcohol to its corresponding "-isomer through 2-oxonium [3,3]-
sigmatropic rearrangement,32 in the kinetic resolution reaction.33 Recently, In(OTf)3 
was used in the preparation of a chiral catalyst with PYBOX as a ligand for a wide 
range of organic reactions such as allylation with aldehydes and ketones, and 
Mukaiyama-aldo reaction. High yields and enantiomeric excesses were reported.34 
 
 The preceding research prompted us to investigate the In(OTf)3-catalyzed 
Diels-Alder reaction. In our initial experiment, isoprene (57) and bromoacrolein (58) 
were used as the substrates with In(OTf)3 (0.2 equiv) as the catalyst, and CH2Cl2 (0.66 
M) as the solvent. The reaction was first initiated at -78 °C and the reaction progress 
was monitored by TLC. No reaction occurred at -78 °C and upon slowly warming up 
the reaction mixture to -15 °C, the reaction proceeded and was complete after 
allowing the reaction to continue overnight. After reaction was completed, the Diels-
Alder adduct was isolated in moderate yield. With this procedure, a series of dienes 








                                                
32 Loh, T. -P.; Hu, Q. -Y.; Ma, L. -T. J. Am. Chem. Soc. 2001, 123, 2450-2451. 
33 Chen, S. -L.; Hu, Q. -Y.; Loh, T. -P. Org. Lett. 2004, 6, 3365-3367. 
34 (a) Lu, J.; Hong, M. -L.; Ji, S. -J.; Loh, T. -P. Chem. Commun. 2005, 1010-1012. (b) Lu, J.; Ji, S. -J.; 
Teo, Y. -C.; Loh, T. -P. Org. Lett. 2005, 7, 159-161. 
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2.5.1.4 In(OTf)3 Catalyzed Diels-Alder Reaction in Ionic Liquid 
 
Lately, a wide range of studies of Diels-Alder reaction in different reaction 
media has been extensively investigated, especially in matrices that are 
environmentally friendly as part of the general tend towards “Green Chemistry”. One 
of the approaches is to use water instead of organic solvent as the reaction medium.35 
Recently, ionic liquids have attracted great interest among the synthetic organic 
chemists because they have been shown to have potential applications as 
environmentally friendly solvents in synthesis.36 This is due to their interesting 
properties, notably their nonvolatile nature, non-flammability, reusability and 
insolubility in some solvents as well as their ability to dissolve catalysts.  
 
Herein, we describe the indium triflate catalyzed Diels-Alder reactions 
between various dienes and dienophiles in ionic liquids. The reaction with the catalyst 
showed high endo:exo selectivity and only one regioisomer has been formed. It also 
gave good yields and the In(OTf)3 can reused without losing its catalytic property.   
 
We initiated our Diels-Alder study by using isoprene (57) and bromoacrolein 
(58) as substrates in various types of ionic liquids. In(OTf)3 (0.2 equiv) was added to 
the ionic liquid (1 mL) followed by bromoacrolein (58) (1 mmol) and isoprene (57) (3 
mmol) in ice bath. After complete consumption of starting material (monitered by 1H 
NMR), the reaction mixture was extracted with ether (15 mL x5) to leave the ionic 
liquid containing In(OTf)3. The above procedure was used for a series of 
                                                
35 Loh, T. -P.; Pei, J.; Lin, M. J. Chem. Soc., Chem Commun. 1996, 2315. 
36 (a) Wasserscheid, P.; Keim, W. Angew. Chem. Int. Ed. Engl. 2000, 39, 3772 and references cited 
therein; (b) Zhao, D. B.; Wu, M.; Kou, Y.; Min, E. Catal. Today 2002, 74, 157; (c) Sheldon, R. Chem 
Commun. 2001, 2399 and references cited therein. 
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imidazolium-based ionic liquids. The results are summarized in Table 2-3. It was 
found that Diels-Alder reactions proceeded smoothly in [BF4
-] and [PF6
-] type ionic 
liquids to give the corresponding adducts in good yields. However, this procedure 

















Ionic liquid Yield (%) 
[hmim][BF4
-] , n = 5 79  
[bmim][BF4
-], n = 3 74  
[hmim][PF6
-] , n = 5 65  
[hmim][PF6
-] , n = 3 75  
[hmim][Cl-] , n = 5 5  
 
 
With the use of [hmim][BF4
-] as the reaction media, we proceeded with further 
investigation using various dienes and dienophiles. The results  are  shown in  Table 
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66 13 : 87 
 CHO 
46 single regioisomer 
 CHO 
77 single regioisomer 
 
CHO 
52 89 : 11 
 CHO 
61 single regioisomer 
 CHO 
60 single regioisomer 
 
CHO 
67 6 : 94 
 
The endo : exo ratio of the aldehyde was determined using 1H NMR spectroscopy. 
 
With the successful of above reactions, we continued our study by exploring 
the recyclability of the catalyst. We carried out our study by using the reaction of 
isoprene and bromoacrolein in [hmim][BF4
-] as a model study. After the reaction was 
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completed, the reaction mixture was extracted with ether (15 mL x5). The residue was 
concentrated, isoprene (57) and bromoacrolein (58) was added in and the reaction 
mixture was stirred in an ice bath. This process was repeated up to five times and it 
was found that the desired Diels-Alder adduct could still be obtained with comparable 
yields (Table 2-5). 
 
Table 2-5 















Times Yield (%) Yield (%) 
1 79  88  
2 71  76  
3 64  80  
4 66  85  
5 63  - 
 
 
 In summary, indium triflate in ionic liquids had been found to be an efficient 
and reusable catalyst in Diels-Alder reactions. Furthermore, the use of the 
environmentally benign ionic liquids would further enhance the applicability of this 
procedure in the ever environmentally conscious manufacturing industry. Most 
importantly, since Diels-Alder reaction as one of the most powerful structural 
transformations in organic synthesis, this methodology will provide a useful entry into 
a wide range of natural products. 
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2.5.1.5 BF3.(OEt)2 Catalyzed Diels-Alder Reaction 
 
Apart from the preceding study, we also explored the Diels-Alder reaction 
with several dienes and dienophiles using BF3.OEt2 as Lewis acid. A comparison 
between BF3.OEt2 and In(OTf)3 was carried out and the results were summarized in 







57 51 62  
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The Diels-Alder reaction was carried out successfully with both boron 
trifluoride dietherate (BF3.OEt2) and indium triflate (In(OTf)3) as catalysts, yielding 
the cycloadducts in moderately high yields. The regiochemistry and relative 
stereochemistry of the products were determined by NOESY spectroscopy. Results 
show that the conventional Diels-Alder reaction stereochemical outcome was 

























Having studied both Lewis acids as the catalyst for the Diels-Alder reaction in 
Table 2-6, we found that BF3.OEt2 gave better yields and shorter times compared to 
In(OTf)3. Hence, we initiated the investigation of the Diels-Alder reaction using 
BF3.OEt2 as the Lewis acid with diene 23 and dienophiles 51 and 33. We start the 
reaction at low temperature (-78 °C). However, no reaction occurred when we 
monitored with TLC. Thus, we warm up the reaction slowly to -20 °C. No desired 
product was observed from the reaction mixture but the diene 23 was decomposed 
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slowly. Even with increased amounts of diene 23 used to compensate for its 
decomposition, the desired product was not obtained. 
 
Other Lewis acids were also been studied with this reaction system (Table 2-
7). They are SnCl4, AlCl3, In(OTf)3 and Sm(OTf)3 were tried. It was found that the 
diene decomposed even under mildly acidic condition. Hence, slightly milder Lewis 
acids such as MacMillan’s catalysts37 were employed but no desired product were 
obtained (entry 11 and 12). The thermal condition was also employed to this reaction 
system (entry 13 and14). Same as others entries, no product was obtained but resulted 
in the decomposition of diene 23. 
 
Since the proposed dienophiles 51 and 33 does not yield the desired 
cycloadduct, other alternatives were explored. One of the alternatives is to synthesis a 
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R =  Br (33); H(51)23 34  
 
Entry Dienophile Conditions Yield 
1 R = H 
BF3.OEt2 (0.5 to 1 equiv) 
CH2Cl2 
-78 °C to -20 °C 
Diene decomposed 
2 R = Br 
BF3.OEt2 (0.5 to 1 equiv) 
CH2Cl2 
-78 °C to -20 °C 
Diene decomposed 
3 R = H 
SnCl4 (0.5 to 1 equiv) 
CH2Cl2 
-78 °C to -20 °C 
Diene decomposed 
4 R = Br 
SnCl4 (0.5 to 1 equiv) 
CH2Cl2 
-78 °C to -20 °C 
Diene decomposed 
5 R = H 
AlCl3 (0.5 to 1 equiv) 
CH2Cl2 
-78 °C to -20 °C 
Diene decomposed 
6 R = Br 
AlCl3 (0.5 to 1 equiv) 
CH2Cl2 
-78 °C to -20 °C 
Diene decomposed 
7 R = H 
In(OTf)3 (0.2  to 1 equiv) 
CH2Cl2, -20 °C 
Diene decomposed 
8 R = Br 
In(OTf)3 (0.2 to 1 equiv) 
CH2Cl2, -20 °C 
Diene decomposed 
9 R = H 
Sm(OTf)3 (0.2  to 1 equiv) 
CH2Cl2, -10 °C 
Diene decomposed 
10 R = Br 
Sm(OTf)3 (0.2 to 1 equiv) 
CH2Cl2, -10 °C 
Diene decomposed 
11 R = H 
MacMillan catalysts  
(0.2  to 1 equiv) 
CH3CN:H2O, rt 
No reaction  
12 R = Br 
MacMillan catalysts  
(0.2  to 1 equiv) 
CH3CN:H2O, rt 
No reaction  
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2.5.2  Application of Model Study Towards the Syntheses of the Six-Membered 
Rings in Cytochalasans 
 
Recently, Corey’s group38 reported that aldehyde-esters 66 and 67 are good 
dienophile in the synthesis of estrone 70 and desogestrel 71. The reaction was carried 
out using Dane’s diene 65 and aldehyde-esters 66 and 67. High yield and 
enantiomeric excess (scheme 2-15) was obtained. Hence, we went on to try this 










































                                                
38 (a) Hu, Q. -Y.; Rege, P. D.; Corey, E. J. J. Am Chem. Soc. 2004, 126, 5984-5986. (b) Hu, Q. -Y.; 
Zhou, G.; Corey, E. J. J. Am Chem. Soc. 2004, 126, 13708-13713. 
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2.5.2.1 Synthesis of dienophile 66 
 
Dienophile 66 was prepared in 83% yield by Horner-Emmons reaction of 
commercially available 1,1-dimethoxyacetone (72) and ethyl 2-(diethoxyphosphoryl) 















1. K2CO3, H2O, rt, 24h






2.5.2.2  Synthesis of dienophile 75 and 76 
 
Dienophile 75 was prepared in 78% yield by Horner-Emmons reaction of 
commercially available 1,1-dimethoxyacetaldehyde (74) and ethyl 2-
(diethoxyphosphoryl) acetate (73), followed by acid hydrolysis with 3N HCl-CH2Cl2 
at 0 °C for 3h. Further bromination of aldehyde 75 with bromine in CH2Cl2 followed 
by dehydrobromination by triethylamine at -78 °C gave dienophile 76 as a cis-isomer 














1. K2CO3, H2O, rt, 24h
2.HClaq, CH2Cl2, 0 ºC, 3h
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With regards to Diels-Alder reactions using multifunctional diene and 
dienophile, less reactive diene and dienophile may not yield the desired results.  On 
the other hand, multifunctional diene and dienophile such as ours have not been 
widely studied in Diels-Alder cycloaddition in the presence of Lewis acid. Since 
Lewis acid BF3.OEt2 afforded better result of the cycloaddition as compared to 
In(OTf)3 (Table 2-6, section 2.5.1.5), we thus used BF3.OEt2 for further studies. A 
series of aldehyde-ester were tested and the results are shown in Table 2-8. Two 
competing reactions; [4 + 2] cycloaddition and hetero Diels-Alder were observed 


























Diene Dienophile Yield (%) Ratio a : b : c 
CHO
EtO2C  
82  0 : 1 : 1 
CHOBr
EtO2C  







23  Only c observed 
 
 
The regiochemistry and relative stereochemistry of the cycloadduct 77b was 
as shown in Figure 2-5. The stereochemistry of the products suggests that due to 
secondary orbital interaction, the Diels-Alder reaction had proceeded by an endo 
transition state to give product 77b (Scheme 2-18). 
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The relative stereochemistry of cycloadduct 77b was confirmed by NOESY 
experiment showing the interaction between corresponding protons (Figure 2-5). We 
are unable to observe the interaction between H-6 and H-1 due to the overlapping 
between the two protons. By using 1D and 2D NMR experimental data, we concluded 
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While seeking to access this aldehyde-ester in our synthetic plan, a study was 
conducted on aldehyde-ester 76 with a series of dienes and the results are shown in 
Table 2-9. As predicted, the product obtained depends on the reactivity of the diene 
used. Reactive diene such as cyclopentadiene (entry 3) give rise to normal 
cycloadduct only, whereas uncreative diene 23 (entry 4) gave rise to heteroadduct as 
the only product. Expectedly, 2,3-dimethyl butadiene (entry 1) and isoprene (entry 2) 
























Entry Diene Dienophile 
Yield 
(%) 
Ratio b : c Reactivity  
1 
 
95 1 : 2 2nd 
2 
 
58 1 : 8 3rd 
3 
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Even though we managed to construct the cyclohexane ring 77b (Scheme 2-
19), the stereochemistry at C5 was not the desired one (Figure 2-6). It appears that 
CHO and CO2Et functionalities should be at the same side instead of the anti-
position. Anti dienophile will leading to the undesired cycloadduct during the Diels-
















 In order to obtain the correct cycloadduct to carry on the cyctochalasans 
synthesis, our next approach is to synthesize the syn dienophile, where the CHO and 
ester are at the same side. Firstly, we examined the E and Z mixture (4:1) of 
dienophile 66 with diene 23 in the presence of BF3.OEt2 and CH2Cl2 as solvent at -60 
°C for overnight. Cycloadduct 79a was isolated in 35% yield from the crude mixture 
(Scheme 2-19). After NMR study, we found that the stereochemistry on C5 was in the 
correct form. The cycloadduct 79a also proceeded by an endo transition state (will 
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With cycloadduct 79a in hand, we still need to carry some problems. One of 
the major problems is that the methyl group at C6 was very difficult to functionalized 
to the proposed compound as mention in our retroanalysis plan (Figure 2-7). To 
overcome this problem, we plan to make the more elegant dienophile which can be 
applied to our system. Our initial attempt was to make the dialdehyde 80 as shown in 
Figure 2-7. However, no desired product was obtained. So, we changed our focus to 
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2.5.2.3 Synthesis of Dienophile 81 
 
Synthesis of dienophile 81 was completed in 6 steps from the commercially 
available formadehyde 83 and methyl acrylate 82 (Scheme 2-20). Alcohol 84 was 
prepared by Baylis Hilman reaction between formaldehyde 83 and methyl acrylate 82 
in the presence of a catalytic amount of DABCO. Protection of alcohol 84 with 
TBDMSCl and pyridine in CH2Cl2 gave the protected alcohol 85 in 88% yield. 
Ozonolysis followed by Wittig reaction with a stabilized ylide 56 afforded 88% yield 
of ", #-unsaturated ester 86 in two steps. The silicon protecting group was removed 
and oxidized to the corresponding aldehyde 81. Since the aldehyde 81 is very 











0 ºC to rt
neat, 6d
36%
1. O3, DMS, CH2Cl2
Ph3P CO2Et





















0 ºC to rt






4    :    1
Z - 87 only        ratio    Z : E  (86)






From the NMR studies (NOE) on 86, 87 and 81 (Figure 2-8), we found that 
the main product obtained from the Wittig reaction gave the (Z)-isomer. After 
desilylation, alcohol 87 was obtained as a single isomer, which is the (Z) 
configuration. The desired (E)-isomer was only obtained as a minor product during 
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the DMP oxidation when the isomerization occurred. The NMR shown two aldehyde 


































 When we treated the crude aldehyde 81 and diene 23 with BF3.OEt2 in 
dichoromethane, we obtained cycloadduct 88a as colorless oil in 22% yield after 16h 
of reaction at -60 °C (Scheme 2-21). We found that besides our desired cycloadduct 
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Since our desired dienophile is (E)-isomer 81, we needed to seek for other 
alternatives in order to carry on this synthesis. One of the alternatives is to change the 
methyl ester to t-butyl ester. We expect that the steric hindrance provided by the 
bulky t-butyl group would give the desired (E)-isomer as the major product. 
 
2.5.2.4 Synthesis of Dienophile 94 
 
Efforts to synthesis the (E)-isomer was carried out as shown in Scheme 2-22. 
Alcohol 90 was prepared by a Baylis-Hilman reaction between formadehyde 83 and t-
butyl acrylate 89 in the presence of a catalytic amount of DABCO. Protection of the 
alcohol 90 was carried out with acetic anhydride with pyridine in CH2Cl2, giving the 
protected alcohol 91 in 90% yield. Ozonolysis followed by Wittig reaction with a 
stabilized ylide 56 gave the ", #-unsaturated ester 92 in 73% yield (2 steps) with 1:4 
ratio, where the major is the desired E isomer. With diester 92 in hand, several 








73% in 2 steps
        ratio    Z : E (92) 











0 ºC to rt
CH2Cl2, 6h



























Z - 93 only
89 83 90 91
56
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The desired (E)-isomer was obtained as a major product from the Wittig 
reaction (Figure 2-9). However, all attempts to subject E-92 to deprotection failed or 
resulted in decomposition. In some cases, the undesired cyclized product was 
obtained.  
 




















Other alternative routes were employed. Return to alcohol 90 as starting 
material, protection with several different protecting moieties has been tried. It was 
hope that other deprotection method would give the alcohol-ester E-93, which will 
then oxidize to aldehyde-ester 94. However, the deprotection failed and only the 
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Table 2-10 






E - 93  
Entry R Conditions Results 
1 Ac K2CO3 / MeOH Transesterification occured, 
cyclized product 
 
2 Ac KCN / EtOH No desired product 
 
3 TMS - TMS cleavage during 
ozonolysis 
 
4 TBDMS TBAF / THF Some cyclized product, 
decomposition 
 




 The regiochemistry and relative stereochemistry of the cycloadducts 79a, 88a, 
95a, 95b, 95d, and 95e were elucidated by 1H NMR, 13C (DEPT), COSY, NOESY, 
HMQC and HMBC as depicted in Figure 2-10. The stereochemistry of the products 
suggests that due to secondary orbital interaction, the Diels-Alder reaction had 




Chapter 2 : Synthetic Studies Towards The Total Synthesis of Cytochalasans 











































R = CO2Me (88a), CO2But (95a)
R = CO2Me (88b), CO2But (95b)
R = CO2Me (88d), CO2But (95d)














Due to the bulkiness of either CO2Me/CHO or CO2But/CHO groups, the 
desired cycloadduct A was only obtained as minor product compared to cycloadduct 
D and E. The formation of cycloadduct D and E suggested that the CH2OBn group 
and the 3-methyl group have a greater directive effect than the 4-methyl group on 
diene 23. This also shows that the CO2Et group also partakes in the cycloaddition 
reaction even in the presence of the reactive CHO group. Furthermore, only trace 
amount of cycloadduct B was obtained from the reaction mixture. This is due to the 
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The relative stereochemistries of cycloadducts 79a, 88a and 95(a-e) were 
confirmed by 2D NOESY and are consistent with the proposed structure. Cycloadduct 
A shows a high degree of interaction between the aldehydic proton and that of the 
neighbouring protons H-5 and H-1 attached to the newly formed ring system. The 
anomalous NOE effect of H-5 and H-1 can explained by the boat conformation 
adopted due to restriction about the alkene bond, effectively causing the molecule to 
adopt a bent axis about the C3-CH3 or CO2Me/CHO and CO2But/CHO groups, so that 
interaction is now possible but with reduced observed NOE interaction. Strong NOE 
correlation between H-6 to H-1 and H-6 to H-4 confirm the stereochemistries of 
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2.6 Conclusion 
 
In conclusion, we have successfully developed a new methodology which may 
be applied to the synthesis of cytochalasans using Lewis acid catalyzed 
intermolecular Diels-Alder reaction as the key step. We manage to build the desired 
six-membered cyclohexane ring with correct stereochemistry that is the core ring 
skeleton found in the cytochalasans class of natural products.  
 
2.7 Future works 
 
Since cycloadduct 88a only obtained as a minor product, effort to optimized 
the conditions and yields need to be done. Future work in this area would be to 
achieve the synthesis of (E)-dienophile 94 which is the desired dienophile for the 
cycloaddition to occur. With this, hopefully the yield can be optimized. 
 
Having achieved a synthesis of cycloadduct 88a, the next target in our 
synthetic exploration focuses on the development of strategies for the introduction of 
the lactam ring contain either indole, phenyl or isopropyl which will allow us to 
synthesize almost all the known cytochalasans. 
 
The exploration of an enantioselective synthesis route is also needed. This 
entails the stereoselective synthesis of cycloadduct 88a. The enantioselective version 
of Diels-Alder reaction can be explored by the usage of a chiral ligand such as 
derivatives of CBS-catalyst (Corey-Bakshi-Shibata-catalyst, 96) in the form of 
oxazoborolidinium cations (scheme 2-24).  
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2.8 Experimental 
 
 (2E,4E)-Ethyl-4-methyl-2,4-hexadienoate (55) 
CHO
Ph3P CO2Et+






Tiglic aldehyde 37 (10 g, 0.12 mol, 11.5 mL) was added to a solution of 
carb(ethoxymethylene) triphenyl phosphorane 56 (60 g, 0.18 mol) in THF (250 mL) 
at 60 °C. The reaction was stirred overnight at 60 °C. The reaction mixture was 
filtered. The filtrate was concentrated in vacuo. Purification via column 
chromatography afforded 68% (11.3 g) product 55.  
Rf = 0.77 (Hexane:EtOAc, 1:1); 
1
H NMR (300 MHz, CDCl3): ! 1.26 (3H, t, J = 6.87 Hz, -OCH2CH3), 1.74 (3H, s, 
H3CHC=CCH3), 1.78 (3H, d, J = 7.05 Hz, H3CHC=CCH3), 4.17 (2H, q, J = 6.87 Hz, 
-OCH2CH3), 5.75 (1H, d, J = 15.4 Hz, HC=CHCO2Et), 5.95 (1H, q, J = 7.05 Hz, 
H3CHC=CCH3), 7.28 (1H, d, J = 15.4 Hz, HC=CHCO2Et) ppm; 
13
C NMR (75 MHz, CDCl3): ! 11.7 (CH3), 14.3 (-CH3), 14.4 (-CH3), 60.0 (-OCH2-), 




): 2985, 2940, 2870, 1704, 1621, 1446; 
HRMS (EI [M]
+
): m/e calculated for [C9H14O2]
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(2E,4E)-Ethyl-4-methyl-2,4-hexadien-1-ol (54) 
ether, LiAlH4




55 54  
55 (16.8 g, 0.12 mol) in dry ether (15 mL) was added dropwise to a suspension of 
lithium aluminium hydride at 0 °C under nitrogen. The reaction mixture was warmed 
slowly to room temperature and stirred for 4h. The mixture was quenched by adding 
saturated Na2SO4 solution dropwise at 0 °C. The mixture was filtered and the residue 
washed with ethyl acetate. The organic layer was dried over anhydrous MgSO4 and 
rotary evaporated to give 73% (9.81 g) product 54. 
Rf = 0.52 (Hexane:EtOAc, 1:1); 
1
H NMR (300 MHz, CDCl3): ! 1.60 (3H, s, H3CHC=CCH3), 1.72 (3H, d, J = 6.77 
Hz, H3CHC=CCH3), 4.17 (2H, d, J = 6.18 Hz, -CH2OH), 5.56 (1H, q, J = 6.77 Hz, 
CH3HC=CCH3), 5.69 (1H, dt, J = 15.6, 6.18 Hz, -CH=CHCH2OH), 6.24 (1H, d, J = 
15.6 Hz, -CH=CHCH2OH) ppm; 
13
C NMR (75 MHz, CDCl3): ! 11.9 (-CH3), 13.7 (-CH3), 63.8 (-CH2OH), 124.6 (-
CH=C-), 127.4 (-CH=CH-), 133.7 (-CH=CH-), 136.2 (-CH=C-) ppm; 
FTIR (neat, cm
-1
): 3401, 2988, 2926, 2866, 1671, 1452; 
HRMS (EI [M]
+
): m/e calculated for [C7H12O]





BnBr, 0 °C to rt,
83%
54 23  
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54 (4.00 g, 36 mmol) was added to a solution of sodium hydride (8.72 g, 0.36 mol) in 
THF (100 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 30 minutes after 
which benzyl bromide (6.82 g, 39 mmol, 4.8 mL) was added. The reaction was 
warmed slowly to room temperature and stirred for 3h. Saturated NH4Cl solution was 
added drop-wise at 0 °C to quench the reaction. The reaction mixture was filtered, and 
washed with ethyl acetate. The combined organic layer was washed with water (1 x 
100 mL), brine (1 x 100 mL), dried over anhydrous MgSO4. The solvent was removed 
in vacuo. Purification via flash column chromatography yielded 83% (6.05 g) of 
product 23. 
Rf = 0.84 (Hexane:EtOAc, 2:1); 
1
H NMR (300 MHz, CDCl3): ! 1.25 (3H, s, H3CHC=CCH3), 1.76 (3H, d, J = 6.81 
Hz, H3CHC=CCH3), 4.10 (2H, d, J = 6.35 Hz, -CH2OBn), 4.54 (2H, s, OCH2C6H5), 
5.59 (1H, q, J = 6.81 Hz, H3CHC=CCH3), 5.69 (1H, dt, J = 15.76, 6.35 Hz, 
HC=CHCH2OBn), 6.29 (1H, d, J = 15.76 Hz, HC=CHCH2OBn), 7.30 – 7.39 (5H, m, 
-OCH2C6H5) ppm; 
13
C NMR (75 MHz, CDCl3): ! 11.9 (-CH3), 13.7 (-CH3), 71.0 (-OCH2-), 71.8 (-
OCH2-), 122.1 (-CH-), 127.3 (-CH-), 127.4 (-CH-), 127.5 (-CH-), 127.7 (-CH-), 
128.2 (-CH-), 133.8 (-C-), 137.9 (-C-) ppm; 
FTIR (neat, cm
-1
): 3040, 2997, 2920, 2853, 1709, 1452;  
HRMS (EI [M]
+
): m/e calculated for [C14H18O]






0 ºC - rt, 39%
5253  
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Triethylamine (11.1 g, 0.11 mol, 16 mL) was added to a solution of dimethyl 
aluminium hydride (1.4 g, 0.01 mol) in CH2Cl2 (150 mL). But-2-ene-1,4 diol 53 (10.0 
g, 0.11 mol, 9.5 mL) was added to the reaction mixture followed by t-
butyldiphenylsilylchloride (31.2 g, 0.11 mol, 30 mL) at 0 °C. The mixture was stirred 
overnight. The reaction was quenched by adding ice water. The aqueous layer was 
extracted with CH2Cl2 (3 x 100 mL). The combined organic layer was washed with 
water (1 x 50 mL), brine (1x 50 mL) and dried over anhydrous MgSO4. The solvent 
was removed in vacuo. Purification via column chromatography eluted the pure 
product 52 in 39% (14.1 g) yield. 
Rf = 0.45 (Hexane:EtOAc, 2:1); 
1
H NMR (300 MHz, CDCl3): ! 1.08 (9H, s, OSi(C6H5)2C(CH3)3), 1.91 (1H, brs, 
OH), 4.02 (2H, d, J = 5.70 Hz, CH2OH), 4.29 (2H, d, J = 4.62 Hz, CH2OTBDPS), 
5.60 -5.69 (1H, m, CHCH2OH), 5.71 – 5.77 (1H, m, CHCH2OTBDPS), 7.40 – 7.76 
(10H, m, OSi(C6H5)2C(CH3)3) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.0 (-C(CH3)3), 26.7 (-C(CH3)3), 58.5 (-OCH2-), 
60.1 (-OCH2-), 127.6 (-CH-), 129.7 (-CH-), 129.8 (-CH-), 130.7 (-CH-), 133.3 (-CH-
), 135.5 (-C-) ppm; 
FTIR (neat, cm
-1
): 3447, 3019, 2928, 2861, 1428;  
HRMS (EI [M-C4H9]
+
): m/e calculated for [C16H17O2Si]






PCC, silica gel, 4Å MS,
CH2Cl2, 0 ºC to rt
44%52 51  
  
Chapter 2 : Synthetic Studies Towards The Total Synthesis of Cytochalasans 
167 Part II  
52 (9.07 g, 28 mmol) in CH2Cl2 (30 mL) was added to pyridinium chlorochromate 
(56 g, 56 mmol), 4Å molecular sieve (9 g) and silica gel (9 g) in CH2Cl2 (150 mL) at 
0 °C. The reaction mixture was warmed slowly to room temperature and stirred for 
4h. The reaction mixture was filtered through a sintered glass funnel packed with 
silica gel and washed with CH2Cl2. The filtrate was dried over MgSO4 and rotary 
evaporated. Purification through column chromatography yielded 34% (3.1 g) product 
51. 
Rf = 0.63 (Hexane:EtOAc, 2:1); 
1
H NMR (300 MHz, CDCl3): ! 1.08 (9H, s, -C(CH3)3), 4.45 (2H, d, J = 2.37, -
CH2OTBDPS), 6.57 (1H, dd, J = 15.5, 8.10 Hz, -CHCHO), 6.84 (1H, dt, J = 15.5, 
2.37 Hz, -CHCH2OTBDPS), 7.40-7.67 (10H, m, -Ph-H), 9.60 (1H, d, J = 8.10 Hz, -
CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.1 (-C(CH3)3), 26.6 (-C(CH3)3), 62.8 (-OCH2-), 
127.7 (-CH-), 129.8 (-CH-), 130.6 (-CH-), 132.6 (-CH-), 135.3 (-C-), 155.8 (-CH-), 
193.0 (-C=O) ppm; 
FTIR (neat, cm
-1
): 3073, 2965, 2939, 2860, 1658, 1472;  
HRMS (EI [M]
+
): m/e calculated for [C20H24O2Si]











51 39  
To a solution of 51 (0.60 g, 1.8 mmol) in CH2Cl2 (20 mL) was treated with Br2 (0.29 
g, 1.8 mmol) at -78 ºC. The resulting colourless solution was treated with additional 
Br2 until reddish brown colour persisted. The reaction mixture was warmed to 0 ºC 
and stirred for 20 minutes. The mixture was then cooled to -78 ºC and Et3N (0.18 g, 
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1.8 mmol) was added dropwise with vigorous stirring. After completed, the reaction 
mixture was filtered through sintered glass funnel and the residue was washed with 
copious amount of dry ether. The filtrate was washed with saturated Na2S2O3 
solution, brine, dried over anhydrous MgSO4 and concentrated. The residue was 
chromatographed (hexane:ether = 99:1) affording 1.38 g of 39 as a colourless oil 
(56%). 
Rf = 0.50 (Hexane:Ether, 6:1); 
1
H NMR (300 MHz, CDCl3): ! 1.10 (9H, s, -C(CH3)3), 4.62 (2H, d, J = 4.79 Hz, -
CH2-OTBDPS), 7.31 (1H, t, J = 4.79 Hz, -C=CH-), 7.39-7.69 (10H, m, -Ph-H), 9.15 
(s, 1H -CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.1 (-C(CH3)3), 26.6 (-C(CH3)3), 63.9 (-OCH2-), 
122.0 (-CH-), 127.8 (-CH-), 130.0 (-C-), 132.6 (-CH-), 135.4 (-C-), 154.5 (-CH-), 
185.0 (-C=O) ppm; 
FTIR (neat, cm
-1
): 3057, 2963, 2930, 2858, 1709, 1622, 1428;  
HRMS (EI [M-C4H9]
+
): m/e calculated for [C16H14O2Si









A flame-dried 250 mL three-necked flask equipped with a mechanical stirrer and an 
addition funnel was charged with a solution of acrolein (33.5 mL, 0.5 mol) in 
dichloromethane (20 mL). The mixture was cooled to -78 ºC and bromine (25.8 mL, 
0.5 mol) was added dropwise through the addition funnel. The resulting colorless 
solution was treated with additional bromine, dropwise, until a reddish brown color 
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persisted. Acrolein was then added dropwise through the addition funnel until the 
reddish brown color disappeared. The solution was stirred at 0 ºC for 20 min. The 
solution was cooled to -78 ºC and triethylamine (70.0 mL, 1.0 mol) was added slowly 
with vigorous mechanical stirring. Dropwise addition of triethylamine and efficient 
cooling are essential to prevent decomposition of product during the highly 
exothermic reaction. Copious salt precipitation was observed and the solid suspension 
was treated with 200 mL ether. The suspension was rapidly filtered, and the solids 
were repeatedly washed with 300 mL ether. The filtrate was washed once with 50 mL 
saturated sodium thiosulfate and twice with brine. The organic layer was dried 
thoroughly with MgSO4, filtered and solvent removed on a rotary evaporator with the 
bath temperature kept at 0 ºC. Distillation of the crude product at 10-20 mmHg using 
an oil bath maintained at 90 ºC and a receiver temperature at -78 ºC yielded 34 g 
(62%) product 58 as a pale yellow oil. 
Rf = 0.57 (Hexane:EtOAc, 2:1); 
1
H NMR (300 MHz, CDCl3): ! 6.89 (2H, s, -C=CH2), 9.23 (1H, s, -CHO) ppm; 
13




): 3070, 2989, 2835, 1698;  
HRMS (EI [M]
+
): m/e calculated for [C3H3O
79Br]+ = 133.9367 found = 133.9367. 
 













1. K2CO3, H2O, rt, 24h
2.HClaq, CH2Cl2, 0 °C, 3h
+
73 66  
A mixture of 1,1-dimethoxyacetone (72) (5.91 g, 50 mmol) and ethyl 2-
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(17.28 g) in 10 mL of water at room temperature. After the 
addition was complete, stirring was continued at room temperature for an additional 
24h. The insoluble matter was then removed by filtration and washed with ether. The 
organic phase was separated and washed with brine to neutrality. After drying and 
evaporation of solvent, the product was purified by distillation under vacuum, which 
yields a mixture of E and Z acetal esters as a colorless oil.  
HCl (3 N, 15 mL) was added dropwise to a solution of the above obtained E and Z 




at 0 °C. The resulting mixture was stirred for another 
2h at 0 °C. The organic layer was separated and washed with a saturated aqueous 
solution of NaHCO
3 




. Solvent was 
removed under vacuum. The crude product was purified by vacuum distillation to 
yield 7.1 g of the E isomer of 66 (yield: 85%). 
Rf = 0.45 (Hexane:EtOAc, 4:1); 
1H NMR (300 MHz, CDCl
3
): ! 1.34 (3H, t, J = 7.03 Hz, -OCH2CH3), 2.16 (3H, d, J 
= 1.76 Hz, -CCH3), 4.28 (2H, q, J = 7.03 Hz, -OCH2CH3), 6.50 (1H, q, J = 1.76 Hz, -
CH=C-), 9.55 (1H, s, CHO) ppm; 
 













1. K2CO3, H2O, rt, 24h
2.HClaq, CH2Cl2, 0 °C, 3h
       












Following the described procedure for the preparation of dienophile 66; dienophile 75 
was obtained in 78% (2 steps) and dienophile 76 was obtained in 30% yield. 
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(E)-ethyl 4-oxobut-2-enoate (75) 
O
H
EtO2C 75  
Rf = 0.43 (Hexane:EtOAc, 4:1); 
1H NMR (300 MHz, CDCl
3
): ! 1.34 (3H, t, J = 6.96 Hz, -OCH2CH3), 4.30 (2H, q, J 
= 6.96 Hz, -OCH2CH3), 6.72 (1H, q, J = 16.02 Hz, -CH=CH-), 6.97 (1H, dd, J = 7.65, 
16.02 Hz, -CH=CH-), 9.76 (1H, dd, J = 7.65, 0.69 Hz, -CHO) ppm 
 






Rf = 0.62 (Hexane:EtOAc, 4:1); 
1H NMR (300 MHz, CDCl
3
): ! 1.36 (3H, t, J = 7.32 Hz, -OCH2CH3), 4.34 (2H, q, J 
= 7.32 Hz, -OCH2CH3), 7.28 (1H, s, -C=CH-), 9.26 (1H, s, -CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 13.9 (-OCH2CH3), 61.8 (-OCH2CH3), 133.9 (-C=CH-
), 136.0 (-C=CH-), 163.1 (-CO2Et), 185.9 (-CHO) ppm; 
 








0 ºC to rt
neat, 6d
36%82 83 84  
Methyl acrylate (82) (1 mol, 86.1 g), DABCO (0.1 mol, 11.2 g) and formaldehyde 
(83) (1.5 mol, 41,7 mL) were stirred at room temperature for six days. The product 
was extracted with ethyl acetate (x3). The organic extracts were washed with brine, 
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dried with anhydrous MgSO4, concentrated in vacuo and purified by distillation, 
affording 41.8 g of pure 84 as colourless oil (36% yield). Bp: 105 ºC / 4.5 mmHg. 
Rf = 0.25 (Hexane:EtOAc, 2:1); 
1
H NMR (300 MHz, CDCl3): ! 3.75 (3H, s, -CH3), 4.30 (2H, d, J = 5.57 Hz, -
CH2OH), 5.82 (1H, d, J = 1.21 Hz, -C=CH2-), 6.22 (1H, s, -C=CH2-) ppm; 
13
C NMR (75 MHz, CDCl3): ! 51.8 (-OCH3), 62.2 (-CH2OH), 125.6 (-C=CH2), 
139.4 (-C=CH2), 166.7 (-C=O) ppm 
 
4-ethyl 1-methyl 2-((tert-butyldimethylsilyloxy)methyl)but-2-enedioate (86) 
CO2Me
OH
1. TBDMSCl, imidazole, 
    0 ºC to rt, CH2Cl2, 6h
2. O3, DMS,CH2Cl2





78% in 3 steps
        ratio    Z : E  (86)




To a solution of 84 (5 g, 43 mmol) in CH2Cl2 (100 mL) was added imidazole (5.85 g, 
86 mmol) at 0 °C. After imidazole was dissolved, TBDMSCl (7.13 g, 47.3 mmol) was 
added to the reaction mixture. The mixture was at 0 ºC to room temperature for 6h. 
The reaction was poured into ice water and extracted with ethyl acetate (x3). The 
combined organic layer was washed with brine and dried over anhydrous MgSO4. The 
solvent was removed in vacuo. The crude product was then used for ozonolysis at -78 
ºC in CH2Cl2 as the solvent. The reaction was quenched by adding DMS (3 equiv) and 
let it stirred for overnight at room temperature. After washed with water, dried over 
MgSO4 and concentrated, the crude product was further subjected for Wittig reaction 
with 56 (22.47 g, 64.5 mmol) in THF at 60 ºC for 12h. The solvent was removed and 
purification via column chromatography eluted the pure product 86 in 78% (10.15 g) 
yield in 3 steps. (Z:E = 8.4:1) 
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Z isomer: 
Rf = 0.73 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 0.07 (6H, s, -Si-(CH3)2), 0.89 (9H, s, -C(CH3)3), 1.27 
(3H, t, J = 7.1 Hz, -OCH2CH3), 3.78 (3H, s, -CO2Me), 4.18 (2H, t, J = 7.1 Hz, -
OCH2CH3), 4.36 (2H, d, J = 2.05 Hz, -CH2OTBDMS), 6.15 (1H, t, J = 2.05 Hz, -
C=CH-) ppm; 
13
C NMR (75 MHz, CDCl3): ! -5.6 (-Si(CH3)2), 14.1 (-CH3), 18.2 (-C(CH3)3), 25.7 
(-C(CH3)3), 52.2 (-OMe), 60.9 (-OCH2-), 62.5 (-OCH2-), 120.1 (-CH=C-), 147.1 (-
CH=C-), 165.5 (-C=O), 167.2 (-C=O) ppm; 
 









Z - 8786  
 To a solution of 86 (0.91 g, 3 mmol) in THF (9 mL) was treated with TBAF (4.5 mL, 
1.0 M in THF solution, 4.5 mmol) at room temperature. The mixture was stirred for 
30 minutes. After the reaction was completed (monitor by TLC), THF was removed 
in vacuo. The residue was purified by flash chromatography on silica gel to afford 
alcohol 87 as a colorless oil, 0.43 g (76%). 
Rf = 0.15 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.29 (3H, t, J = 7.1 Hz, -OCH2CH3), 3.82 (3H, s, -
CO2Me), 4.21 (2H, q, J = 7.1 Hz, -OCH2CH3), 4.39 (2H, d, J = 1.6 Hz, -CH2OH), 
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4    :    1
Z - 87 only
 
To a solution of Dess-Martin reagent (0.64 g, 1.5 mmol) in anhydrous CH2Cl2 (3 mL) 
was added dropwise of 87 (0.19 g, 1 mmol) prediluted in CH2Cl2 (1 mL) at 0 °C.  The 
reaction mixture was stirred under nitrogen at 0 °C for 30 minutes. After completion, 
the reaction mixture was filtered through selite and rinse with ether.  The combine 
etherate layer was washed with brine, dried over anhydrous MgSO4 and concentrated 
in vacuo to give 81 as a colorless oil (81 was sensitive to purification, NMR 
determination was done from the crude product 1H NMR). 
Rf = 0.43 (Hexane:EtOAc, 4:1); 
major 
1
H NMR (500 MHz, CDCl3): ! 1.32 (3H, t, J = 7.1 Hz, -OCH2CH3), 3.88 
(3H, s, -CO2Me), 4.28 (2H, q, J = 7.1 Hz, -OCH2CH3), 6.74 (1H, s, -C=CH-), 9.65 
(1H, s, -CHO) ppm 
minor 
1
H NMR (500 MHz, CDCl3): ! 1.32 (3H, t, J = 7.1 Hz, -OCH2CH3), 3.86 
(3H, s, -CO2Me), 4.28 (2H, q, J = 7.1 Hz, -OCH2CH3), 7.09 (1H, s, -C=CH-), 10.17 
(1H, s, -CHO) ppm 
 












83 90  
Tert-butyl acrylate (10 mL, 68.9 mmol), DABCO (7.7 g, 68.9 mmol) and 
formaldehyde (0.689 mol, 100 mL) were stirred at room temperature for six days. The 
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product was extracted with ether (x5). The organic extracts was washed with brine, 
dried with anhydrous MgSO4, concentrated in vacuo and purified by column 
chromatography, affording 6.54 g of pure 90 as colourless oil (60% yield).  
Rf = 0.41 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.51 (9H, s, -C(CH3)3), 4.28 (2H, d, J = 6.83 Hz, -
CH2OH), 5.74 (1H, d, J = 1.21 Hz, -C=CH2-), 6.15 (1H, s, -C=CH2-) ppm 
13
C NMR (75 MHz, CDCl3): ! 28.0 (-OC(CH3)3), 62.7 (-CH2OH), 81.3 (-
OC(CH3)3), 124.7 (-C=CH2), 140.9 (-C=CH2), 165.7 (-C=O) ppm 
 











To a solution of 90 (6.4 g, 40.4 mmol) in CH2Cl2 (100 mL) was added pyridine (6.54 
mL, 80.8 mmol) at 0 °C. After stirred for 10 minutes, acetic anhydride (7.7 mL, 80.8 
mmol) was added to the reaction mixture. The mixture was at 0 ºC to room 
temperature for 6h. The reaction was poured into ice water and extracted with ether 
(x3). The combined organic layer was washed with copper sulfate solution, water, 
brine and dried over anhydrous MgSO4. The solvent was removed in vacuo. 
Purification by column chromatography provided 91 in 90% yield (7.30 g). 
Rf = 0.57 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.46 (9H, s, -C(CH3)3), 2.06 (3H, s, OAc), 4.73 (2H, 
s, -CH2OAc), 5.69 (1H, s, -C=CH2-), 6.21 (1H, s, -C=CH2-) ppm 
13
C NMR (75 MHz, CDCl3): ! 20.7 (-OAc), 27.9 (-OC(CH3)3), 62.5 (-OCH2-), 81.2 
(-OC(CH3)3), 125.9 (-C=CH2), 136.8 (-C=CH2), 164.2 (-C=O), 170.2 (-C=O) ppm 
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1-tert-butyl 4-ethyl 2-(acetoxymethyl)maleate (92) 
        ratio    Z : E (92) 










2. THF, 60 ºC






To a solution of 91 (5 g, 25 mmol) in CH2Cl2 was subjected for ozonolysis at -78 ºC. 
After completion (~30 minutes), the reaction was quenched by adding DMS (3 equiv) 
and let it stirred for overnight at room temperature. After washed with water, dried 
over MgSO4 and concentrated, the crude product was further subjected for Wittig 
reaction with 56 (13 g, 37.5 mmol) in THF at 60 ºC for 12h. The solvent was removed 
and purification via column chromatography eluted the pure product 92 in 73% (10.15 





Rf = 0.59 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.30 (3H, t, J = 7.2 Hz, -OCH2CH3), 1.53 (9H, s, -
C(CH3)3), 2.12 (3H, s, -OAc), 4.23 (2H, q, J = 7.2 Hz, -OCH2CH3), 4.79 (2H, d, J = 
1.55 Hz, -CH2OAc), 6.07 (1H, t, J = 1.65 Hz, -C=CH-) ppm; 
13
C NMR (125 MHz, CDCl3): ! 14.1 (-CH3), 20.6 (-CH3), 27.9 (-OC(CH3)3), 61.0 (-
OCH2-), 63.1 (-OCH2-), 83.0 (-OC(CH3)3), 122.5 (-CH=C-), 141.8 (-CH=C-), 164.4 






Rf = 0.63 (Hexane:EtOAc, 4:1); 
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1
H NMR (500 MHz, CDCl3): ! 1.32 (3H, t, J = 7.1 Hz, -OCH2CH3), 1.51 (9H, s, -
C(CH3)3), 2.06 (3H, s, -OAc), 4.26 (2H, q, J = 7.1 Hz, -OCH2CH3), 5.21 (2H, s, -
CH2OAc), 6.82 (1H, s, -C=CH-) ppm 
13C NMR (125 MHz, CDCl3): ! 14.1 (-CH3), 20.7 (-CH3), 28.0 (-OC(CH3)3), 58.1 (-
OCH2-), 61.2 (-OCH2-), 82.5 (-OC(CH3)3), 130.0 (-CH=C-), 141.6 (-CH=C-), 164.3 
(-C=O), 164.9 (-C=O), 170.2 (-C=O) ppm 
 
Diels-Alder Reactions 
General Procedure using In(OTf)3 as Catalyst 
The dienophile (1 mmol) in CH2Cl2 (1 mL) was added dropwise to a stirred mixture 
of 4Å molecular sieve (100 mg, excess) and indium triflate (0.28 mg, 0.5 mmol) in 
CH2Cl2 (1 mL) at 0 °C. Subsequently, the diene (3 mmol) pre-diluted in CH2Cl2 (1 
mL) was added dropwise. The whole reaction was maintained at 0 °C with constant 
stirring. The reaction was quenched with saturated NaHCO3 (2 mL). The organic 
layer was extracted with CH2Cl2 (3 x 5 mL), washed with saturated NaHCO3 (2 x 5 
mL), and dried over anhydrous MgSO4. The filtrate was filtered and concentrated. 
Purification by flash column chromatography afforded the pure compound. 
 
General Procedure using BF3.OEt2 as Catalyst 
The dienophile (1 mmol) in CH2Cl2 (1 mL) was added dropwise to a stirred solution 
of 4Å molecular sieve (100 mg, excess) and cooled to -78 °C for 15 minutes. Then 
boron trifluoride dietherate (0.06 mL, 0.5 mmol) was added dropwise. Subsequently, 
the diene (3 mmol) pre-diluted in CH2Cl2 (1 mL) was added dropwise. The whole 
reaction was maintained at -78 °C with constant stirring for 16h. The reaction was 
quenched with saturated NaHCO3 (2 mL). The organic layer was extracted with 
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CH2Cl2 (3 x 5 mL), washed with saturated NaHCO3 (2 x 5 mL), and dried over 
anhydrous MgSO4. The filtrate was filtered and concentrated. Purification by flash 






Colorless oil (74%);  
Rf = 0.65 (hexane/ethyl acetate, 4:1);  
1
H NMR (300 MHz, CDCl3): ! 1.32 (1H, d, J = 9.4 Hz, -CH2-), 1.42-1.59 (2H, m, -
CH2-), 2.65 (1H, dd, J = 13.6, 3.5 Hz, -CH2- ), 2.97 (1H, brs, -CH-), 3.25 (1H, brs, -
CH-), 6.14 (1H, dd, J = 5.6, 3.1 Hz, -HC=CH-), 6.45 (1H, dd, J = 5.6, 3.1 Hz, -
HC=CH-), 9.54 (1H, s, exo CHO); 
13
C NMR (75 MHz, CDCl3): ! 36.9 (-CH2-), 42.4 (-CH-), 46.7 (-CH-), 49.6 (-CH2-), 
72.6 (-C-CHO), 133.8 (-CH=CH-), 140.0 (-CH=CH-), 191.9 (-CHO); 
FTIR (neat, cm
–1
): 2978, 1722;  
HRMS (EI [M
+
]): m/e calculated for [C8H19BrO]






Colorless oil (64%);  
Rf = 0.67 (hexane/ethyl acetate, 4:1); 
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1
H NMR (300 MHz, CDCl3): ! 1.67 (3H, brs, -CH3), 2.28-2.09 (4H, m, -CH2-CH2-
C-CHO), 2.62 (1H, bd, J = 18.0 Hz, -CH2-C-CHO), 2.79 (1H, brd, J = 18.1 Hz, -CH2-
C-CHO), 5.33 (1H, brs, -C=CH-), 9.36 (1H, s, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 23.1 (-CH3), 28.5 (-CH2-), 30.9 (-CH2-), 34.4 (-CH2-
), 67.0 (-C-CHO), 117.0 (-C=CH-), 134.0 (-C=CH-), 192.2 (-C=O); 
FTIR (neat, cm
–1
): 2916, 1726, 1638;  






Colorless oil (68%);  
Rf = 0.67 (hexane/ethyl acetate, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.62 (3H, s, -CH3), 1.65 (3H, s, -CH3), 2.27-2.08 
(4H, m, -CH2-CH2-C-CHO), 2.56 (1H, brd, J = 17.8 Hz, -CH2CHO), 2.74 (1H, brd, J 
= 17.4 Hz, -CH2CHO), 9.34 (1H, s, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 18.6 (-CH3), 19.0 (-CH3), 29.9 (-CH2-), 31.2 (-CH2-), 
40.0 (-CH2-), 67.7 (-C-CHO), 122.2 (-C=C-), 125.4 (-C=C-), 192.2 (-C=O); 
FTIR (neat, cm
–1
): 2916, 1726, 1641;  
HRMS (ESI [M
+





Colorless oil (60%);  
Rf = 0.64 (hexane/ethyl acetate, 4:1); 
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1
H NMR (300 MHz, CDCl3): ! 1.61 (3H, s, -C=C-CH3), 1.65 (3H, s, -C=C-CH3), 
1.94 - 2.51 (7H, m, -CH2C-CHO, -CH-CHO, -CH2-CH2-C-CH3), 9.67 (1H, d, J = 
1.41 Hz, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 18.9 (-CH3), 19.0 (-CH3), 22.8 (-CH2-), 30.1 (-CH2-), 
30.5 (-CH2-), 46.9 (-CH-CHO), 123.4 (-C=C-), 125.8 (-C=C-), 204.7 (-C=O); 
FTIR (neat, cm
–1
): 2916, 1725, 1641;  
HRMS (ESI [M
+





Colorless oil (64%);  
Rf = 0.65 (hexane/ethyl acetate, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.64 (3H, s, -CH=C-CH3), 1.94-2.49 (7H, m, -CH2C-
CHO, -CH-CHO, -CH2-CH2-C-CH3), 5.38 (1H, brs, -CH=C-), 9.66 (1H, brs, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 22.4 (-CH2-), 23.4 (-CH3), 24.4 (-CH2-), 28.4 (-CH2-
), 45.8 (-CH-CHO), 118.6 (-C=CH-), 134.2 (-C=CH-), 204.6 (-C=O); 
FTIR (neat, cm
–1
): 2913, 1725, 1640;  
HRMS (ESI [M
+





Colorless oil (70%);  
Rf = 0.67 (hexane/ethyl acetate, 4:1); 
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1
H NMR (300 MHz, CDCl3): ! 1.02 (3H, d, J = 6.27 Hz, -C-CH3), 1.64 (3H, s, -
CH=C-CH3), 2.02-2.18 (6H, m, -CH2C-CHO, -CH-CHO, -CH-CH3, -CH2-C-CH3), 
5.37 (1H, brs, -CH=C-), 9.62 (1H, d, J = 2.79 Hz, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 19.7 (-CH3), 23.4 (-CH-CH3), 24.1 (-CH3), 28.3 (-
CH2-), 36.9 (-CH2-), 52.3 (-CH-CHO), 117.8 (-C=CH-), 133.5 (-C=CH-), 205.4 (-
C=O); 
FTIR (neat, cm–1): 2918, 1731, 1644;  
HRMS (ESI [M
+





Colorless oil (77%);  
Rf = 0.64 (hexane/ethyl acetate, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.99 (3H, d, J = 6.27 Hz, -C-CH3), 1.59 (3H, s, -
C=C-CH3), 1.63 (3H, s, -C=C-CH3), 1.85-2.16 (6H, m, -CH2C-CHO, -CH-CHO, -
CH-CH3, -CH2-C-CH3), 9.60 (1H, d, J = 3.15 Hz, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 18.6 (-CH3), 18.8 (-CH3), 19.5 (-CH3), 28.7 (-CH-
CH3), 30.3 (-CH2-), 38.9 (-CH2-), 53.5 (-CH-CHO), 122.6 (-C=C-), 125.1 (-C=C-), 
205.3 (-C=O); 
FTIR (neat, cm–1): 2918, 1725, 1641;  
HRMS (ESI [M
+
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Colorless oil (52%);  
Rf = 0.67 (hexane/ethyl acetate, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.17 (3H, d, J = 6.87 Hz, -C-CH3), 1.43-1.61 (2H, m, 
-CH2-), 1.77-1.85 (1H, m, -CH-CH3), 2.22-2.34 (3H, m, -CH2-, -CH-CHO), 2.55 (1H, 
brs, -CH-), 3.12 (1H, brs, -CH-), 6.04 (1H, dd, J = 5.91, 2.79 Hz, -CH=CH-), 6.29 
(1H, dd, J = 5.55, 3.15 Hz, -CH=CH-), 9.37 (1H, d, J = 3.15 Hz, -CHO); 
13
C NMR (75 MHz, CDCl3): ! 20.7 (-CH3), 36.2 (-CH-), 45.3 (-CH-), 46.1 (-CH2-), 
48.9 (-CH-), 61.2 (-CH-CHO), 132.5 (-HC=CH-), 138.9  (-HC=CH-), 204.9 (-C=O); 
FTIR (neat, cm–1): 2978, 1724;  
HRMS [M
+







Yield = 83% (BF3.OEt2); 77% (In(OTf)3); 
Rf = 0.68 (Hexane:EtOAc, 8:1); 
1
H NMR (500 MHz, CDCl3): ! 1.13 (9H, d, J = 0.9 Hz, -SiC(CH3)3), 1.66 (3H, s, -
CH=C-CH3), 1.78 (1H, dd, J = 17.57, 6.95 Hz, -CH=C-CH2-), 2.01 (1H, dd, J = 
17.57, 5.05 Hz, -CH=C-CH2-), 2.12 (1H, brd, J = 17.55 Hz, -C=CH-CH2-), 2.31 (1H, 
ddd, J = 17.55, 5.05, 2.3 Hz, -C=CH-CH2-), 2.41 (1H, dq, J = 6.95, 6.45 Hz, -
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CHCH2OTBDPS), 2.57 (1H, ddd, J = 6.95, 6.45, 2.8 Hz, -CHCHO), 3.64 (1H, dd, J 
=  9.25, 8.8 Hz, -CH2OTBDPS), 3.72 (1H, dd, J = 9.25, 5.55 Hz, -CH2OTBDPS), 
5.42 (1H, brs, -C=CHCH2), 7.43-7.47 (6H, m, Ph-H), 7.73-7.74 (4H, m, Ph-H), 9.76 
(1H, d, J = 2.8 Hz, CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.1 (-C(CH3)3), 23.2 (-C=CH-CH2-), 23.3 (-CH=C-
CH3), 26.7 (-C(CH3)3), 30.4 (-CH=C-CH2-), 36.4 (-CH-CH2OTBDPS), 48.3 (-CH-
CHO), 66.1 (-CH2OTBDPS), 118.0 (-CH=C-CH3), 127.6 (Ph-Cm x4), 129.6 (Ph-Cp 
x2), 132.7 (Ph-Cq x2), 133.2 (-CH=C-CH3), 135.4 (Ph-Co x4), 204.2 (CHO) ppm; 
FTIR (neat, cm
-1
): 3030, 2856, 1720, 1435;  
HRMS (ESI [M+Na]
+
): m/e calculated for [C25H32NaO2Si]









Yield = 75% (BF3.OEt2); 69% (In(OTf)3); 
Rf = 0.71 (Hexane:EtOAc, 8:1); 
1
H NMR (300 MHz, CDCl3): ! 1.07 (9H, s, -SiC(CH3)3), 1.58 (3H, s, -C=CCH3), 
1.64 (3H, s, -C=CCH3), 1.76 (1H, dd, J = 16.98, 6.39 Hz, -C=CCH2-), 1.95 (2H, brd, 
J = 16.98 Hz, -C=CCH2-, -C=CCH2-), 2.13-2.34 (2H, m, -CHCH2OTBDPS, -
C=CCH2-), 2.48-2.55 (1H, m, -CHCHO), 3.55 (1H, dd, J = 10.44, 7.65 Hz, -
CH2OTBDPS), 3.65 (1H, dd, J = 10.44, 5.22 Hz, -CH2OTBDPS), 7.37-7.44 (6H, m, 
Ph-H), 7.64-7.67 (4H, m, Ph-H), 9.70 (1H, d, J = 3.21 Hz, CHO) ppm; 
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13
C NMR (75 MHz, CDCl3): ! 18.6 (-C=C-CH3), 18.8 (-C=C-CH3), 19.1 (-
C(CH3)3), 26.7 (-C(CH3)3), 29.5 (-C=C-CH2-), 32.3 (-C=C-CH2-), 36.9 (-CH-
CH2OTBDPS), 49.6 (-CH-CHO), 66.3 (-CH2OTBDPS), 122.9 (-C=C-CH3), 124.4 (-
C=C-CH3), 127.6 (Ph-Cm x4), 129.6 (Ph-Cp x2), 133.3 (Ph-Cq x2), 135.5 (Ph-Co 
x4), 204.4 (CHO) ppm; 
FTIR (neat, cm
-1
): 3069, 2856, 1724, 1427;  
HRMS (ESI [M+Na]
+
): m/e calculated for [C26H34NaO2Si]
+ = 429.2226; found = 
429.2221. 
 





Yield = 94% (BF3.OEt2); 68% (In(OTf)3); 
Rf = 0.48 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.11 (3H, d, J = 6.95 Hz, -CHCH3), 1.69 (1H, dd, J = 
15.25, 10.15 Hz, -CH2C-CHO), 1.73 (3H, d, J = 0.95 Hz, -CH=C-CH3), 2.22 (1H, 
ddd, J = 15.25, 6.05, 1.85 Hz, -CH2C-CHO), 2.44 (1H, brs, -CHCH3), 3.06 (1H, t, J = 
10.2 Hz, -CH2OBn), 3.18 (1H, brs, -CHCH2OBn), 3.40 (1H, dd, J = 10.2 Hz, 3.70 
Hz, -CH2OBn), 4.32 (1H, d, J = 11.55 Hz, -OCH2Ph), 4.40 (1H, d, J = 11.55 Hz, -
OCH2Ph), 5.23 (1H, dt, J = 5.05, 1.35 Hz, -CH=CCH3), 7.26-7.30 (3H, m, Ph-H), 
7.33-7.36 (2H, m, Ph-H), 9.54 (1H, s, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 18.8 (-CH-CH3), 20.9 (-CH=C-CH3), 32.9 (-CH-
CH3), 34.1 (-CH2-C-CHO), 46.5 (-CH-CH2OBn), 71.4 (-CH2OBn), 72.3 (-C-CHO), 
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73.1 (-OCH2Ph), 117.0 (-C=CH-), 127.8 (Ph-Cp), 127.8 (Ph-Co x2), 128.4 (Ph-Cm 
x2), 137.2 (Ph-Cq), 140.7 (-CH=C-CH3), 190.6 (CHO) ppm; 
FTIR (neat, cm
-1
): 3084, 3030, 2932, 2866, 1732, 1645,1454;  
HRMS (EI [M
+
-Br]): m/e calculated for C17H21O2  = 257.1541; found = 257.1550. 
 






Yield = 42%; 
Rf = 0.44 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.09 (3H, d, J = 6.9 Hz, CHCH3), 1.30 (3H, dd, J = 
6.9, 7.4 Hz, -OCH2CH3), 1.67 (3H, d, J = 1.4 Hz, -CH=CCH3), 2.25 (1H, dq, J = 7.9, 
7.4 Hz, -CHCH3), 2.50 (1H, dd, J = 10.2, 9.7 Hz, -CHCO2Et), 3.03-3.09 (2H, m, -
CHCHO, -CHCH2OBn), 3.11 (1H, q, J = 8.8 Hz, -CH2OBn), 3.40 (1H, dd, J = 8.8, 
2.3 Hz, -CH2OBn), 4.20 (2H, ddd, J = 14.3, 7.16, 1.4 Hz, -OCH2CH3), 4.30 (1H, d, J 
= 11.55 Hz, OCH2C6H5), 4.40 (1H, d, J = 12 Hz, OCH2C6H5), 5.38 (1H, d, J = 3.70, 
1.35 Hz, -CH=C-), 7.26-7.35 (5H, m, OCH2C6H5), 9.72 (1H, s, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 14.2 (-OCH2CH3), 17.5 (-CH-CH3), 21.2 (-CH=C-
CH3), 36.7 (-CHCH2OBn), 37.6 (-CH-CH3), 44.2 (-CHCO2Et), 52.1 (-CHCHO), 60.6 
(-OCH2CH3), 70.3 (-CH-CH2OBn), 73.0 (-OCH2Ph), 120.1 (-CH=C-CH3), 127.6 
(Ph-Cp), 127.8 (Ph-Co x2), 128.3 Ph-Cm x2), 137.6 (Ph-Cq), 139.5 (-CH=C-CH3), 
175.5 (CO2Et), 200.9 (CHO) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C20H26O4]
+ = 330.1831, found = 330.1821. 
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Yield = 41%; 
Rf = 0.48 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.93 (3H, d, J = 6.96 Hz, CHCH3), 1.29 (3H, t, J = 
7.32 Hz, -OCH2CH3), 1.74 (3H, s, -C=CCH3), 1.94-1.99 (1H, m, CHCH3), 3.47 (1H, 
dd, J = 9.93, 4.71, Hz, -CH2OBn), 3.55 (1H, dd, J = 10.11, 6.63 Hz, -CH2OBn), 4.20 
(2H, q, J = 7.32 Hz, -OCH2CH3), 4.29-4.32 (1H, m, -OCHCH=CH-), 4.37-4.40 (1H, 
m, -CHCH2OBn), 4.58 (1H, d, J = 12.54 Hz, -OCH2C6H5), 4.63 (1H, d, J = 12.54 Hz, 
-OCH2C6H5), 5.32 (1H, s, -CH=C-), 6.14 (1H, dd, J = 15.66, 1.74 Hz, -
CH=CHCO2Et), 6.90 (1H, dd, J = 15.66, 3.84 Hz, -CH=CHCO2Et), 7.26-7.35 (5H, 
m, -OCH2C6H5) ppm; 
13
C NMR (125 MHz, CDCl3): ! 13.4 (-CH-CH3), 14.2 (-OCH2CH3), 21.5 (-CH=C-
CH3), 37.4 (-CH-CH3), 60.1 (-OCH2CH3), 73.1 (-CHCH2OCH2Ph), 73.3 (-
CHCH2OBn), 74.9 (-OCHCH2OBn), 75.3 (-OCHCH=CHCO2Et), 120.0 (-CH=C-
CH3), 120.8 (-CH=CHCO2Et), 127.4 (Ph-Cp), 127.6 (Ph-Co x2), 128.2 (Ph-Cm x2), 
138.3 (-CH=CCH3), 139.2 (Ph-Cq), 146.5 (-CH=CHCO2Et), 166.5 (CO2Et) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C20H26O4]
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Yield = 56%; 
Diastereomer 1: 
Rf = 0.57 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 0.90 (3H, d, J = 6.9 Hz, CHCH3), 1.32 (3H, dd, J = 
6.95, 6.90 Hz, -OCH2CH3), 1.78 (3H, s, -CH=CCH3), 2.45 (1H, d, J = 6.9 Hz, -
CHCH3), 3.48 (1H, dd, J = 9.95, 4.65 Hz, -CH2OBn), 3.55 (1H, dd, J = 9.95, 6.45 Hz, 
-CH2OBn), 4.24 (2H, q, J = 6.95 Hz, -OCH2CH3), 4.30 (1H, brs, -CHCH2OBn), 4.41 
(1H, brs, -OCHC-Br), 4.61 (2H, s, -OCH2C6H5), 5.33 (1H, s, -CH=C-), 6.83 (1H, s, -
C=CHCO2Et), 7.28-7.36 (5H, m, -OCH2C6H5) ppm; 
13
C NMR (125 MHz, CDCl3): ! 12.4 (-CHCH3), 14.2 (-OCH2CH3), 21.7 (-CH=C-
CH3), 35.7 (-CHCH3), 60.4 (-OCH2CH3), 72.9 (-OCH2Ph), 73.3 (-CH2OBn), 75.7 (-
OCHCH2OBn), 80.4 (-OCHC=CHCO2Et), 119.0 (-CH=C-), 119.7 (-C=CH-), 127.5 
(Ph-Cp), 127.6 (Ph-Co x2), 128.3 (Ph-Cm x2), 137.9 (Cq), 138.2 (Cq), 139.2 (Cq), 
164.4 (-CO2Et) ppm; 
Diastereomer 2: 
1
H NMR (500 MHz, CDCl3): ! 1.05 (3H, d, J = 6.95 Hz, CHCH3), 1.32 (3H, dd, J = 
7.40, 6.95 Hz, -OCH2CH3), 1.75 (3H, s, -CH=CCH3), 2.50 (1H, d, J = 6.9 Hz, -
CHCH3), 3.49 (1H, dd, J = 9.70, 4.15 Hz, -CH2OBn), 3.57 (1H, dd, J = 9.70, 6.5 Hz, 
-CH2OBn), 4.14 (1H, d, J = 5.55 Hz, -CHCH2OBn), 4.23 (2H, q, J = 6.95 Hz, -
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OCH2CH3), 4.39 (1H, brs, -OCHCBr-), 4.59 (2H, s, -OCH2C6H5), 5.29 (1H, s, -
CH=C-), 6.47 (1H, s, -C=CHCO2Et), 7.28-7.35 (5H, m, -OCH2C6H5) ppm; 
13
C NMR (125 MHz, CDCl3): ! 14.1 (-CHCH3), 16.2 (-OCH2CH3), 21.2 (-CH=C-
CH3), 35.4 (-CHCH3), 60.7 (-OCH2CH3), 71.7 (-OCHCH2OBn), 72.0 (-OCH2Ph), 
73.2 (-CH2OBn), 81.4 (-OCHC=CHCO2Et), 119.9 (-CH=C-), 122.1 (-C=CH-), 127.6 
(Ph-Cp), 127.8 (Ph-Co x2), 128.3 (Ph-Cm x2), 135.8 (Cq), 138.2 (Cq), 139.6 (Cq), 
164.1 (CO2Et) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C20H25BrO4]








Yield = 35% 
Rf = 0.41 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.06 (3H, d, J = 7.4 Hz, CHCH3), 1.21(3H, s, -
CCH3), 1.26 (3H, dd, J = 7.4, 6.95 Hz, -OCH2CH3), 1.78 (3H, d, J = 0.95 Hz, -
CH=CCH3), 2.35 (1H, m, -CHCH2OBn), 2.62 (1H, dq, J = 7.4, 6.95 Hz, -CHCH3), 
2.96 (1H, d, J = 6.45 Hz, -CHCO2Et), 3.32 (1H, dd, J = 6.95, 6.95 Hz, -CH2OBn), 
3.55 (1H, dd, J = 9.25, 4.15 Hz, -CH2OBn), 4.15 (2H, ddd, J = 14.32, 7.15, 0.95 Hz, -
OCH2CH3), 4.40 (1H, d, J = 12.05 Hz, -OCH2C6H5), 4.44 (1H, d, J = 12.00 Hz, -
OCH2C6H5), 5.47 (1H, d, J = 1.4 Hz, -CH=C-), 7.26-7.34 (5H, m, -OCH2C6H5), 9.91 
(1H, s, CHO) ppm; 
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13
C NMR (125 MHz, CDCl3): ! 14.1 (-OCH2CH3), 16.4 (-CH-CH3), 20.5 (-C-CH3), 
21.7 (-CH=C-CH3), 34.9 (-CH-CH3), 45.7 (-CH-CH2OBn), 48.5 (-C-CHO), 54.6 (-
CH-CO2Et), 60.5 (-OCH2CH3), 69.9 (-CH-CH2OBn), 73.1 (-CH-CH2OCH2Ph), 121.8 
(-CH=C-CH3), 127.5 (Ph-Cp), 127.6 (Ph-Co x2), 128.3 (Ph-Cm x2), 135.6 (-CH=C-
CH3), 138.0 (Ph-Cq), 172.6 (-CO2Et), 203.2 (CHO) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C21H28O4]








Yield = 9%; 
Rf = 0.54 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.85 (3H, d, J = 6.7 Hz, -CH3), 1.30 (3H, t, J = 7.1 
Hz, -OCH2CH3), 1.77 (3H, s, -CH3), 2.11 (3H, s, -CH3), 2.30-2.34 (1H, m, -CHCH3), 
3.49 (1H, dd, J = 10.1, 4.85, Hz, -CH2OBn), 3.50 (1H, dd, J = 10.1, 6.25 Hz, -
CH2OBn), 4.06 (1H, brs, -OCH-), 4.14-4.21 (2H, m, -OCH2CH3), 4.37 (1H, brs, -
OCH-), 4.43-4.51 (1H, m, -OCH-), 4.63 (2H, s, -OCH2C6H5), 5.37 (1H, s, -CH=C-), 
6.13 (1H, s, -CH=CHCO2Et), 7.27-7.38 (5H, m, -OCH2C6H5) ppm; 
13
C NMR (125 MHz, CDCl3): ! 12.9 (-CH3), 14.4 (-CH3), 15.9 (-CH3), 21.8 (-CH3), 
35.8 (-CH-), 59.6 (-OCH-), 73.2 (-OCH-), 73.4 (-CH-), 75.2 (-OCH2-), 79.4 (-OCH2-
), 115.1 (-CH=C-), 120.2 (-C=CH-), 127.6 (Ph-Cp), 127.7 (Ph-Co x2), 128.4 (Ph-Cm 
x2), 138.4 (-CH=C-), 139.3 (Ph-Cq), 155.8 (-C=CH-), 167.1 (-CO2Et) ppm; 
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Yield = 22% 
Rf = 0.30 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.21 (3H, d, J = 6.95 Hz, CHCH3), 1.24 (3H, dd, J = 
7.4, 6.95 Hz, -OCH2CH3), 1.69 (3H, s, -CH=CCH3), 2.64 (1H, dq, J = 7.85, 6.95 Hz, 
-CHCH3), 3.04 (1H, d, J = 9.25 Hz, -CHCO2Et), 3.18 (1H, m, -CHCH2OBn), 3.29 
(1H, dd, J = 8.8, 8.3 Hz, 1H, -CH2OBn), 3.45 (1H, dd, J = 10.17, 3.25 Hz, -
CH2OBn), 3.71 (3H, s, CO2Me), 4.16 (2H, dd, J = 12.0, 7.4 Hz, -OCH2CH3), 4.35 
(1H, d, J = 11.55 Hz, OCH2C6H5), 4.41 (1H, d, J = 12.05 Hz, -OCH2C6H5), 5.28 (1H, 
d, J = 6.05 Hz, -CH=C-), 7.26-7.35 (5H, m, -OCH2C6H5), 9.89 (1H, s, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 13.9 (-OCH2CH3), 19.8 (-CHCH3), 21.3 (-CH=C-
CH3), 34.3 (-CHCH3), 42.0 (-CHCH2OBn), 46.3 (-CHCO2Et), 52.2 (-CO2Me), 61.0 
(-OCH2CH3), 61.9 (-C-CHO), 69.9 (-CHCH2OBn), 72.8 (-CHCH2OCH2Ph), 117.8 (-
CH=C-CH3), 127.6 (Ph-Cp), 127.7 (Ph-Co x2), 128.3 (Ph-Cm x2), 137.4 (Ph-Cq), 
140.5 (-CH=C-CH3), 170.6 (-CO2Me), 173.0 (-CO2Et), 198.1 (CHO) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C22H28O6]
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Rf = 0.31 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.22 (3H, d, J = 6.9 Hz, -CHCH3), 1.26 (3H, t, J = 
7.2 Hz, -OCH2CH3), 1.43 (9H, s, -OC(CH3)3), 1.71 (3H, s, -CH=CCH3), 2.64 (1H, 
dq, J = 14.1, 7.2 Hz, -CH-), 3.05 (1H, d, J = 9.0 Hz, -CH-), 3.17 (1H, brs , -
CHCO2Et), 3.32 (1H, dd, J = 10.5, 8.4 Hz, 1H, -CH2OBn), 3.44 (1H, dd, J = 10.5, 3.9 
Hz, -CH2OBn), 4.17 (2H, q, J = 7.2 Hz, -OCH2CH3), 4.38 (1H, d, J = 12.0 Hz, -
OCH2C6H5), 4.44 (1H, d, J = 12.0 Hz, -OCH2C6H5), 5.34 (1H, d, J = 6.0 Hz, -CH=C-
), 7.28-7.37 (5H, m, -OCH2C6H5), 9.89 (1H, s, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 14.0 (-OCH2CH3), 20.2 (-CHCH3), 21.3 (-CH=C-
CH3), 27.8 (-C(CH3)3), 34.6 (-CHCH3), 42.2 (-CHCH2OBn), 46.3 (-CHCO2Et), 60.8 
(-C-CHO), ), 62.2 (-OCH2CH3),  70.0 (-CHCH2OBn), 72.8 (-CHCH2OCH2Ph), 82.1 
(-OC(CH3)3), 118.4 (-CH=C-CH3), 127.7 (Ph-Cp), 127.8 (Ph-Co x2), 128.3 (Ph-Cm 




): m/e calculated for [C22H28O6]
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Rf = 0.35 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.87 (3H, d, J = 7.2 Hz, -CHCH3), 1.30 (3H, dd, J = 
7.2, 6.9 Hz, -OCH2CH3), 1.40 (9H, s, -OC(CH3)3), 1.70 (3H, s, -CH=CCH3), 2.64-
2.73 (2H, m, -CHCH3, -CHCH2OBn), 3.51 (1H, d, J = 6.3 Hz, -CHCO2Et), 3.59 (1H, 
dd, J = 9.3, 3.9 Hz, 1H, -CH2OBn), 3.79 (1H, t, J = 9 Hz, -CH2OBn), 4.21 (2H, ddd, J 
= 9.9, 7.2, 2.7 Hz, -OCH2CH3), 4.45 (1H, d, J = 12.3 Hz, OCH2C6H5), 4.53 (1H, d, J 
= 12.3 Hz, -OCH2C6H5), 5.53 (1H, brs, -CH=C-), 7.22-7.32 (5H, m, -OCH2C6H5), 
10.11 (1H, d, J = 1.5 Hz, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 14.1 (-OCH2CH3), 14.8 (-CHCH3), 21.2 (-CH=C-
CH3), 27.7 (-C(CH3)3), 34.7 (-CHCH3), 43.4 (-CHCH2OBn), 52.4 (-CHCO2Et), 59.1 
(-C-CHO), ), 60.9 (-OCH2CH3),  70.3 (-CHCH2OBn), 72.9 (-CHCH2OCH2Ph), 82.8 
(-OC(CH3)3), 121.7 (-CH=C-CH3), 127.4 (Ph-Cp), 127.6 (Ph-Co x2), 128.2 (Ph-Cm 




): m/e calculated for [C22H28O6]
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Rf = 0.35 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.18 (3H, dd, J = 7.2, 6.9 Hz, -OCH2CH3), 1.19 (3H, 
d, J = 7.2 Hz, -CHCH3), 1.49 (9H, s, -OC(CH3)3), 1.78 (3H, s, -CH=CCH3), 2.53-
2.61 (1H, m, -CHCH3) 2.97-3.07 (1H, m, -CHCH2OBn), 3.24-3.39 (2H, m, -
CH2OBn), 3.55 (1H, d, J = 6.6 Hz, -CHCO2Et), 3.88 (1H, dq, J = 10.8, 7.2 Hz, -
OCH2CH3), 4.06 (1H, dq, J = 10.5, 6.9 Hz, -OCH2CH3), 4.37 (1H, d, J = 12.0 Hz, -
OCH2C6H5), 4.41 (1H, d, J = 12.0 Hz, -OCH2C6H5), 5.35 (1H, brs, -CH=C-), 7.26-
7.35 (5H, m, -OCH2C6H5), 10.15 (1H, d, J = 1.5 Hz, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 13.3 (-OCH2CH3), 13.9 (-CHCH3), 21.4 (-CH=C-
CH3), 27.8 (-C(CH3)3), 37.5 (-CHCH3), 39.5 (-CHCH2OBn), 48.9 (-CHCO2Et), 60.8 
(-C-CHO), ), 61.3 (-OCH2CH3),  70.9 (-CHCH2OBn), 73.0 (-CHCH2OCH2Ph), 82.8 
(-OC(CH3)3), 119.8 (-CH=C-CH3), 127.5 (Ph-Cp), 127.7 (Ph-Co x2), 128.2 (Ph-Cm 




): m/e calculated for [C22H28O6]








Chapter 2 : Synthetic Studies Towards The Total Synthesis of Cytochalasans 
194 Part II  







Hetero-Diels-Alder Normal Diels-Alder  
Yield = 95% (hetero : normal = 2:1); 
 






Rf = 0.51 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.28 (3H, t, J = 6.95 Hz, -OCH2CH3), 1.63 (6H, d, J 
= 2.3 Hz, -H3CC=CCH3-, -H3CC=CCH3-), 2.11 (1H, d, J = 17.1 Hz, -C=CCH2CH-), 
2.29 (1H, d, J = 17.1 Hz, -C=CCH2CH-), 4.07 (2H, brs, -CHOCH2-), 4.13-4.17 (-
CHOCH2-), 4.20 (2H, q, J = 6.95 Hz, -OCH2CH3), 6.70 (1H, d, J = 0.9 Hz, -C=CH-); 
13
C NMR (125 MHz, CDCl3): ! 13.6 (-CH3), 14.1 (-CH3), 18.2 (-CH3), 35.6 (-CH2-
), 60.5 (-OCH2CH3), 70.0 (-CH2-O-), 78.2 (-OCH-), 118.3 (-CH=C-Br), 123.0 (-
C=C-), 124.1 (-C=C-), 139.6 (-CH=C-Br), 164.4 (-CO2Et) ppm; 
 






Rf = 0.51 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.26 (3H, t, J = 6.95 Hz, -OCH2CH3), 1.63 (6H, d, J 
= 2.3 Hz, -H3CC=CCH3-, -H3CC=CCH3-), 2.11 (1H, d, J = 17.1 Hz, -C=CCH2CH-), 
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2.29 (1H, d, J = 17.1 Hz, -C=CCH2CH-), 2.58 (1H, d, J = 18.25 Hz, -CH2CCHO), 
2.82 (1H, d, J = 18.25 Hz, -CH2CCHO), 3.12 (1H, dd, J = 7.85, 7.40 Hz, -CHCO2Et), 
4.20 (2H, q, J = 6.95 Hz, -OCH2CH3), 9.64 (1H, s, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 14.0 (-CH3), 18.1 (-CH3), 18.3 (-CH3), 32.3 (-CH2-
), 41.2 (-CH2-), 46.5 (-CH-CO2Et), 61.2 (-OCH2CH3), 68.3 (-C-CHO), 121.9 (-C=C-
), 123.6 (-C=C-), 170.8 (-CO2Et), 195.7 (-CHO) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C12H17BrO3]
+ = 288.0361, found = 288.0347. 
 







Hetero-Diels-Alder Normal Diels-Alder  
Yield = 58% (hetero : normal = 8:1) 
 





Rf = 0.53 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.28 (3H, t, J = 6.96 Hz, -OCH2CH3), 1.72 (3H, s, -
H3CC=CCH3-), 1.98-2.29 (2H, m, -C=CCH2CH-), 2.56-2.80 (2H, m, -CH2CCHO), 
3.18 (1H, dd, J = 7.65, 7.32 Hz, -CHCO2Et), 4.11-4.25 (2H, m, -OCH2CH3), 5.28 
(1H, brs, -HC=C-), 9.67 (1H, s, CHO) ppm; 
13
C NMR (125 MHz, CDCl3): ! 195.9 (-CHO) ppm; 
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Rf = 0.53 (Hexane:EtOAc, 4:1); 
1
H NMR (500 MHz, CDCl3): ! 1.28 (3H, t, J = 6.95 Hz, -OCH2CH3), 1.72 (3H, s, -
HC=CCH3-), 1.97-2.15 (2H, m, -C=CCH2CH-), 4.20 (2H, q, J = 6.95 Hz, -
OCH2CH3), 4.12-4.29 (3H, m, -CHOCH2-, -CHOCH2-), 5.42 (1H, brs, -HC=C-), 
6.73 (1H, d, J = 1.4 Hz, -C=CHCO2Et-); 
13
C NMR (125 MHz, CDCl3): ! 14.1 (-OCH2CH3), 22.7 (-CH=C-CH3), 34.9 (-CH2-
CH-O-), 60.5 (-OCH2CH3), 66.3 (-CH2-O-), 77.8 (-OCH-), 118.4 (-CH=C-Br), 119.2 
(-CH=C-CH3-), 131.2 (-C=C-CH3), 139.5 (-CH=C-Br), 164.4 (-CO2Et) ppm; 
 





Yield = 72% (endo : exo = 11 : 89) 
Rf = 0.55 (Hexane:EtOAc, 4:1); 
major (exo): 
1
H NMR (300 MHz, CDCl3): ! 1.22 (3H, dd, J = 6.9, 7.32 Hz, -
OCH2CH3), 1.33 (1H, d, J = 9.39 Hz, -CHCH2CH-), 1.60 (1H, d, J = 9.39 Hz, -
CHCH2CH-), 3.15 (1H, s, -CHCH2CH-), 3.29 (1H, s, -CHCH2CH-), 3.67 (1H, d, J = 
3.12 Hz, -CH-CO2Et), 4.11 (2H, q, J = 6.97 Hz, -OCH2CH3), 6.11 (1H, dd, J = 5.58, 
3.12 Hz, -CH=CH-), 6.68 (1H, dd, J = 5.58, 3.12 Hz, -CH=CH-), 9.51 (1H, s, CHO) 
ppm; 
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13
C NMR (75 MHz, CDCl3): ! 14.1 (-OCH2CH3), 44.6 (-CH-), 45.5 (-CH2-), 49.2 (-
CH-), 50.2 (-CH-), 60.8 (-OCH2CH3), 75.2 (-C-CHO), 133.1 (-CH=CH-), 139.7 (-




H NMR (300 MHz, CDCl3): ! 1.26 (3H, dd, J = 6.9, 7.32 Hz, -
OCH2CH3), 1.33 (1H, d, J = 9.39 Hz, -CHCH2CH-), 1.60 (1H, d, J = 9.39 Hz, -
CHCH2CH-), 3.15 (1H, s, -CHCH2CH-), 3.29 (1H, s, -CHCH2CH-), 3.67 (1H, d, J = 
3.12 Hz, -CH-CO2Et), 4.18 (2H, q, J = 7.29 Hz, -OCH2CH3), 6.01 (1H, dd, J = 5.58, 
3.15 Hz, -CH=CH-), 6.29 (1H, dd, J = 5.58, 3.15 Hz, -CH=CH-), 9.33 (1H, s, CHO) 
ppm; 
13
C NMR (75 MHz, CDCl3): ! 14.1 (-OCH2CH3), 46.0 (-CH-), 47.9 (-CH2-), 48.9 (-
CH-), 53.0 (-CH-), 61.1 (-OCH2CH3), 75.2 (-C-CHO), 133.4 (-CH=CH-), 140.5 (-
CH=CH-), 170.3 (-CO2Et), 188.7 (CHO) ppm; 
HRMS (EI [M]
+
): m/e calculated for [C11H13BrO3]
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3.1 Introduction 
 
Tuberostemonine (1) is the prototype of Stemona alkaloids isolated from 
Stemonaceae species.
1 
The chemical investigation of Stemona alkaloids was initiated 
by their use in Chinese and Japanese folk medicine in the treatment of respiratory 
diseases such as pulmonary tuberculosis and bronchitis as well as insecticides.
2
 
Especially the tuberous roots of S. tuberosa, S. japonica and S. sessilifolia have a long 
history of usage in the Chinese and Japanese traditional medicine. The extracts from 
the fleshy tuberous roots are still used in the treatment of respiratory disorders, 
including pulmonary tuberculosis and bronchitis, but are also recommended against 
different insect pests or ecto - and endo-parasites.
3
 The basic methanolic extracts 
























                                                
1
 (a) Gotz, M.; Edwards, O. E. in The Alkaloids, Vol. IX, Academic Press, New York, 1967, p. 545. (b) 
Gotz, M.; Strunz, G. M. in Alkaloids: MTP International Review of Sciences, Series One, Vol. IX, 
Butterworth, London, 1973, p. 143. (c)  Shinozaki, H.; Ishida, M. Brain. Res. 1985, 334, 33. 
2
 (a)  Uyeo, S.; Irie, H.; Harada, H. Chem. Pharm. Bull. 1967, 15, 768. (b)  Harada, H,; Irie, H.; 
Masaki, N.; Osaki, K.; Uyeo, S.  Chem. Commun. 1967, 460. (c)  Edwards, O. E.; Feniak, G.; Handa, 
K. L. Can. J. Chem. 1962, 40, 455. (d) Lin, W. H.; Ye, Y.; Xu, R. S. J. Nat. Prod. 1992, 55, 571. (e) 
Brem, B.; Seger, C.; Pacher, P.; Hofer, O.; Vajrodaya, S.; Gerger, H. J. Agric. Food Chem. 2002, 50, 
6383-6388.  (f) Maruyama, M.; Takeda, K. Comp. Biochem. Physiol., C: Pharmacol., Toxicol. 
Endocrinol. 1994, 107C, 105-110. 
3
 Terada, M.; Sano, M.; Ishii, A. I.; Kino, H.; Fukushima, S.; Noro, T. Nippon Yakurigku Zasshi 1982, 
79, 93-103.  
4
 Sakata, K.; Aoki, K.; Chang, C. F.; Sakura, A.; Tamura, S.; Murakoshi, S. Agric. Biol. Chem. 1978, 
42, 457. 
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Tuberostemonine (1) was the first Stemona alkaloid belonging to the group of 
stenine (3) to have its biological activity tested, and its anthelmintics activity was 
detected when tested against Angiostrogylus cantonensis, Dipylidium caninum and 




It was also found that tuberostemonine (1) depressed glutamate-induced 
responses at the crayfish neuromuscular junction at similar concentration to those of 
established glutamate inhibitors.
2f
 These pharmacological properties indicate that 
some of the effects of the crude extracts may be attributed to tuberostemonine (1) and 
that this alkaloid may be a useful tool in the field of neuropharmacology. 
 
The genus Stemona (Stemonaceae) is known as a rich source of structurally 
complex alkaloids with mainly saturated ring systems of unknown biogenetical origin. 
Pili and coworkers
5
 have separated the Stemona alkaloids into five groups according 
to their structural features, i.e. stenine (3), stemoamide (4), tuberostemo-spironine (5), 
stemonamine (6), tuberostemonamide (7) as shown in Figure 3-2. 
 
                                                
1a
 Gotz, M.; Edwards, O. E. in The Alkaloids, Vol. IX, Academic Press, New York, 1967, p.545. 
5
 (a) Pili, R. A.; de oliveira, M. C. F.  Nat. Prod. Rep. 2000, 17, 117-127. (b) Xu, R. S.; Lu, Y. J.; Chu, 
J. H.; Iwashita, T.; Naoki, H.; Naya, Y.; Nakanishi, K.; Tetrahedron 1982, 38, 2667. (c) Lin, W.; Ye, 
Y.; Xu, R. Chem. Abstr. 1992, 116, 148183w. (d) Ky, P. T.; Kim, V. N.; Dung, N. X. Chem. Abstr. 
1992, 117, 108076c. (e) Ye, Y.; Qin, G. W.;  Xu, R. S. J. Nat. Prod. 1994, 57, 665. (f) Ye, Y.; Qin, G. 
W.; Xu, R. S. Phytochemistry 1994, 37, 1205. (g) Qin, G. W.; Xu, R. S.  Med. Res. Rev. 1998, 18, 375. 
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So far, more than 50 alkaloids of this family have been isolated, presenting a 
large structural diversity. Nevertheless, all the Stemona alkaloids are polycyclic and 
almost all present a common structural feature - a nucleus of 1-
azabicyclo[5.3.0]decane (2). Most of them contain also one or more substructures of 
!-methyl-"-butyrolactone, bound to the azabicyclic core either in spiranic or fused 
form or as a substituent of the pyrrolidine. All the Stemona alkaloids have several 
stereogenic centers. Their peculiar and complex structures, along with their potential 
bioactivity make them extremely attractive as synthetic targets. To date, there are 
several reports on the total synthesis of stenine (3) and recently a first total synthesis 
of tuberostemonine (1) has reported. 
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3.2 Previous Synthetic Works 
 
In general, strategies used in previous total synthesis of stenine (3) can be classified 
into two categories: 
1. The highly functionalized six-membered ring B with the pre-requisite 
stereochemistry of the substituents is formed through an intramolecular Diels-
Alder reaction catalyzed by Lewis acids, either thermally or at lower 






































Chapter 3 : Synthetic Studies Towards the Total Synthesis of Tuberostemonine 
Part II 203 
2. Functionalization of readily available six-membered ring to generate the 















3.2.1 Strategy 1: Intramolecular Diels-Alder Reaction for the Formation of 
Multifunctionalized Ring B 
 
The total synthesis of stenine (3) was attempted by Hart and Chen in 1990.
6
 
They envisaged that iodolactone 12 would be a reasonable precursor for stenine (3) 
(Scheme 3-3).  They planned to form the seven membered ring at the later stages of 
the synthesis.  The C-14 methyl group was to be introduced using an alkylation, while 
the ethyl group was to be introduced using intermolecular free-radical carbon-carbon 
bond-forming reaction.  It was anticipated that iodolactone 12 would be prepared 
from the tertiary amide 13, which in turn would be prepared from 14 using an 
Eschenmoser-Claisen rearrangement.  The terminal hydroxyl group in intermediate 15 
was to serve as a handle for introducing the cyclohexenol moiety in intermediate 14, 
and the cyclohexene ring in 15 was to be constructed using an intramolecular Diels-
Alder reaction. 
 
                                                
6
 (a) Chen, C. Y.; Hart, D. J.  J. Org. Chem. 1990, 55, 6236. (b) Chen, C. Y.; Hart, D. J.  J. Org. Chem.  
1993, 58, 3840-3849. 
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As shown in Scheme 3-4, the six membered ring B (9) was made from 
intramolecular Diels-Alder reaction of 8 catalyzed by diethylaluminium chloride in 
chloroform at 85 °C as a single stereoisomer.  The nitrogen was introduced through a 
Curtius rearrangement of 17 to carbamate 18.  Then, it was followed by Eschenmoser-
Claisen rearrangement of 19 to 20 and stereoselective free radical allylation of 12 to 
21. 
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 Morimoto and co-workers (1996) have also applied the intramolecular Diels-
Alder cycloaddition in an asymmetric synthesis of (-)-stenine as shown in Scheme 3-
5.
7
 They planned to construct the seven-membered ring in the last step of the 
synthesis through an intramolecular N-alkylation of the corresponding deprotected 
amine 22.  It was anticipated that tricyclic ring system 22 would be prepared from the 
bicyclic ketone 23 by oxidative cleavage of the C2-C12 bond, followed by cyclization 
of A and D rings.   
 
An intramolecular asymmetric Diels-Alder reaction of (E,E,E)-triene 10, 
containing Evan’s chiral auxiliary was applied to the construction of ring B together 
                                                
7
 Moromoto, Y.; Iwahashi, M.; Nishida, K.; Hayashi, Y.; Shirahama, H. Angew. Chem. Int. Ed Engl.  
1996, 35, 904. 
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with the four stereogenic centers in 23. The desired Diels-Alder precursor 10 was in 
turn assembled by convergent coupling of three fragments (dienyl chloride 24, 


























































 First, an intramolecular asymmetric Diels-Alder reaction of the triene 10 
prepared in a convergent fashion from three readily available components 24, 25 and 
26. This was followed by an oxidative cleavage of C2-C12 bond in trimethylsily enol 
ether 29 with m-chloroperbenzoic acid and orthoperiodic acid to afford an 
intermediary carboxylic acid derivative. Finally, an in situ iodolactonization 
stereoselectively formed the A, B and D ring system 30.  (Scheme 3-6) 
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1. nBuLi, THF, 24, HMPA
2. p-TsOH.H2O
1. SO3.Py, DMSO, Et3N
2. 26, LiCl, Et3N, THF
TMSCl, NaI
1. m-CPBA



























3.2.2 Strategy 2: Functionalization of Readily Available Six-Membered Ring 
 
In 1995, Wipf and co-workers anticipated the first asymmetric synthesis of (-)-
stenine starting from L-Tyrosine (12).
8
  They envisioned that the trans-fused 
perhydroindole present in 3 could be effectively transformed from the conversion of 
32 through #-allylpalladium chemistry.  (Scheme 3-7) 
                                                
8
 Wipf, P.; Kim, Y.; Goldstein, D. M. J. Am. Chem. Soc. 1995, 117, 11106. 
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They carried out the synthesis of (-)-stenine (3) starting from L-tyrosine (26). 
The bicyclic 32 was constructed stereochemically pure in a single step from 26 
(Scheme 3-9). The high selectivity of this diastereotopic end-group-differentiating 
cyclization is due to the destabilizing steric interactions in conformer 34, owing to the 
A
1,3
-strain between the amide oxygen and the methyl ester (E) substituent, and the 
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In their synthesis, !-allypalladium chemistry was applied in the conversion of 
the cis-hydroxyindole ring system 36 to the trans-fused perhydroindole 13 in which 
the optimum condition was achieved by using catalytic tris(dibenzylidene-acetone)-
dipalladium (0) chloroform complex (2.5 mol%), tributylphosphine (10 mol%), and 
triethylammonium formate at 60 °C under strictly anaerobic conditions.  
 
Intermediate 38 was obtained via Keck allylation in neat allyltributylstannane 
in 77% yield. Methylation of the lactone, and subsequent conversion of the allyl to a 
vinyl group by a Johnson-Lemieux oxidation, reduction, and Grieco-elimination 
sequence provided tricycle 39 in 54% yield. After a series of functional group 
manipulations, they completed the total synthesis of (-)-stenine (3) with an overall 















































1. I2, pH 5.5
2. Allyl-SnBu3, 

















3. NaBH4, -40 °C
4. o-(NO2)PhSeCN, 
    Bu3P; H2O2
 
Scheme 3-9 
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Later in 2002, Wipf and co-workers reported the first total synthesis of 
tuberostemonine (1). The key synthetic sequence of their retrosynthetic analysis is a 
ring-closing metathesis reaction to form the azepane to 40 followed by the addition of 
a lithiated ortho ester 41 to introduce the right-side butyrolactone (Scheme 3-10). 
Bicycle 36, which is obtained in three steps from Cbz-L-tyrosine as described in their 
stenine synthesis,
9
 served as a scaffold for installation of nine of the ten stereogenic 
carbons of tuberostemonine, including the fused leftside butyrolactone which is 

















































Their synthesis began from bicycle 36, which is subjected to a series of 
transformations to obtain intermediate 42 (Scheme 3-11). It was followed by an 
azepine ring-closing metathesis by refluxing 42 in CH2Cl2 in the presence of 2-5 
mol% of the ruthenium catalyst 44. The resulting double bond in azepine 45 was 
                                                
9
 (a) Wipf, P.; Kim, Y.; Goldstein, D. M. J. Am. Chem. Soc. 1995, 117, 11106-11112. (b) Wipf, P.; 
Methot, J. -L. Org. Lett. 2000, 2, 4213-4216. (c) Wipf, P.; Mareska, D. A. Tetrahedron Lett. 2000, 41, 
4723-4727. (d) Wipf, P.; Li, W. J. Org. Chem. 1999, 64, 4576-4577. 
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removed in a three-step sequence to give tricycle 46 after transient protection of the 
enone double bond by conjugate addition-elimination of thiophenol. Ester 46 was 
obtained as a single diastereomer after Luche’s reduction and TBDMS protection. 
The right-side butyrolactone was later introduced to afford the desired lactone 47 as a 
single diastereomer in 70% yield. This reaction accomplished by first isomerizing the 
allyl group followed by cross-metathesis propenylvinyl exchange in the presence of 
ruthenium catalyst. The pentacyclic Stemona alkaloid tuberostemonine was prepared 



































1. PhI(OAc)2, NaHCO3, MeOH, 54%
2. Bz2O, NEt3
3. NaBH4, CeCl3.7H2O,
    89% over 2 steps
1. Pd2(dba)3.CHCl3, NEt3, HCOOH,
    Bu3P, THF, 65 °C, 93%
    





























1. PhSecl, MeCN/H2O, 0 °C, 67%
2. AIBN, Allyl-SnPh3 (neat), 70%
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 The retrosynthetic approach to tuberostemonine is shown in Scheme 3-12.  
Our approach relies on an intermolecular Diels-Alder reaction to construct and control 
stereochemistries of the substituents around ring B.  Indium-mediated allylation 
reaction was employed as the key step to synthesize the corresponding diene for the 
intermolecular Diels-Alder reaction. 
 
 From the retrosynthetic analysis (Scheme 3-12), tuberostemonine (1) was 
envisioned to arise from a six-membered B ring system 54 where rings C and D are 
formed from the extensions about ring B.  Ring D was planned to be constructed via 
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reductive amination and later on ring C by a SN2 reaction on the amino group.  50 was 
prepared through a Curtius rearrangement from 51.  It was anticipated that the A ring 
in lactone 51 would be prepared from a lactonization of 52 which in turn can be 
prepared from a stereoselective reduction of 53.  Cleavage of triisopropylsilyl 
protecting group on molecule 54 will furnish us with ketone 53.  Cycloadduct 54 
could be formed via a Lewis acid-catalyzed intermolecular Diels-Alder reaction 
between diene 55 and dienophile 56. 
 
 The !,$-unsaturated aldehyde 56 can be obtained from the Wittig reaction of 
the 1,3-propionaldehyde 58, with stabilized ylide 59, followed by a reduction-
oxidation sequence of 57.  Aldehyde 58 in turn, can be obtained from commercially 
















 Synthesis of diene 55 can be achieved by applying the highly efficient indium-
mediated allylation reaction (Scheme 3-14).  The !,$-unsaturated aldehyde 63 was 
prepared by a reduction-oxidation sequence from the !,$-unsaturated ester 66 which 
can be synthesized from a Wittig reaction of aldehyde 67 and the stabilized ylide 68 
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obtained from bromo ethylbutyrate.  Aldehyde 67 in turn could be prepared from 
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Our synthetic routes are as follows: 
1. The core ring B may be derived from a Diels-Alder approach with the 
triisopropylsilyl group (TIPS) used as a protecting group for the diene and 
whose electron-donating properties would assist in the 1,4 direction of the 
intermolecular Diels-Alder reaction.  In addition, the Diels-Alder reaction 
would proceed via the well-established endo transition state affording the 
product with the control of the four stereo centers in one step on the six-





















2. A Curtius rearrangement would allow for the introduction of amino group 
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3. Reductive amination or intermolecular SN2 reaction to construct the pyrolidine 

























4. The construction of the seven-membered ring C after conversion of the 
protecting group R2 to a tosylate group followed by a SN2 reaction on the 
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3.4 Results and Discussions  
 
The dienophile 56 was available in 5 steps from commercially available 1,3-
propanediol 60 (Scheme 3-19). Protection of 1,3-propanediol 60 with TBDPSCl, 
followed by PCC oxidation afforded aldehyde 58 in 26% yield (2 steps). Ester 57 was 
constructed via Wittig reaction of aldehyde 58 and stabilized ylide 59. After an 











1. TBDPSCl, Et3N, DMAP  
    CH2Cl2, 0 ºC to rt, 36% 
2. PCC, silica gel, 4Å MS,
    CH2Cl2, 0 ºC to rt, 72%
1. DIBAL, ether, 0 ºC, 60%
2. PCC, silica gel, 4Å MS,








Diene 55 was synthesized from commercially available 1,5-pentanediol (69) 
as shown in Scheme 3-20. A selective protection on 1,5-pentanediol (69) with 
potassium hydroxide and allyl bromide (72) afforded the monoprotected alcohol 73 in 
61% yield. Allyl bromide (72) was used as the protecting group as allylic ethers are 
known to be stable in both moderately acidic and basic conditions. Furthermore, the 
allyl group can be easily removed by refluxing with cerium (III) chloride and sodium 
iodide in acetonitrile with high chemoselectivity without strongly acidic or basic 
conditions. 
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Oxidation of alcohol 73 using pyridinium chlorochromate (PCC) gave 
aldehyde 67 in 69% yield. Wittig reaction was carried out between aldehyde 67 and a 
pre-stabilized ylide 68 to give the !,$-unsaturated ester 66 in 86% yield. The ester 66 
was then reduced to the corresponding alcohol 65 using diisobutylaluminium hydride 
(DIBAL) in 87% yield. Oxidation of alcohol 65 with PCC furnished the desired 


































































With aldehyde 63 in hand, we continued to embark on the synthesis of diene 
55 via an indium-mediated allylation reaction with methyl 2-(bromomethyl) acrylate 
(64) in aqueous media as the key step (Scheme 3-18). In the previous synthetic study 
towards the total synthesis of tuberostemonine (1), allylation reaction in THF/sat. 
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NH4Cl (1/4) was shown to give the best result. The product was obtained as racemic 
hydroxyl ester 62 in good yield (79%). 
 
 Treatment of alcohol 62 with NaBH4 (excess) gave the diol 61 in 93% yield. 
Selective protection of the primary alcohol of 61 with t-butyldiphenylsilylchloride 
(TBDPSCl) gave alcohol 74 in 92% yield. Dess-Martin periodinane oxidation of 
alcohol 74 gave ketone 75 in 77% yield. 
 
Finally the synthesis of diene 55 was achieved through the formation of (Z)-
enolate from ketone 75 using lithium bis(trimethylsilyl)amide (LiHMDS) and 
triisopropylsilyl triflate (TIPSOTf) in 90% yield. The stereochemistry of diene 55 was 












 After successfully obtaining diene 55, we proceeded to explore the Diels-
Alder reaction with the dienophile 56. Using the same reaction condition as described 
in Chapter 2, the Diels-Alder reaction was carried out with dienophile 56 and dienes 
55 with boron trifluoride dietherate (BF3.OEt2) as the Lewis acid in CH2Cl2. In order 
to prevent the TIPS protecting group from being cleaved during the reaction, proton 
scavengers such as 2,6-di-t-butylpyridine was added during the reaction. The reaction 
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was first started at -78 °C and warmed up slowly. The progress of the reaction was 
monitored using TLC. No desired product was detected from the crude mixture and 
diene 55 decomposed in most cases. Several other conditions had also been tried and 






















Entry Dienophile Lewis Acid  Conditions Results 
1 BF3.OEt2 
0.5 equiv 






























The reaction was then attempted with a more activated dienophile, 
bromoacrolein 76. When bromoacrolein 76 was reacted with diene 55, the 
cycloadducts 77a and 77b were obtained in 28% and 45% yields respectively 
(Scheme 3-21). The regiochemistry and relative stereochemistry of 77 was 
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determined by NOESY spectroscopy. It showed that the reaction had proceeded by 




















































From the study done in chapter 2, we have successfully synthesized the 
cycloadduct 77b using BF3.OEt2 as the Lewis acid (Scheme 2-18, Chapter 2). Thus, 
we explored the possibility of synthesizing aldehyde-ester 81 using our established 
system. However, only hetero-Diels-Alder product 80 was obtained in 77% yield 
from the reaction. (Scheme 3-22) 
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Since BF3.OEt2 in CH2Cl2 does not yield any desired cycloadduct, other 
reaction conditions were studied. Non-polar solvents such as toluene was used in hope 
that it could suppress the hetero-Diels-Alder reaction. Again, only the hetero-Diels-
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Table 3-2 
Entry Lewis acid Solvent Conditions Product 
1 BF3.OEt2 CH2Cl2 
-78 °C to -60 °C for 
overnight 
Hetero product only 
2 BF3.OEt2 Toluene 
-78 °C to -60 °C for 
overnight 
Hetero product only 
3 TiCl4 CH2Cl2 
-78 °C to -60 °C for 
overnight 
Hetero product only 
4 TiCl4 Toluene 
-78 °C to -60 °C for 
overnight 
Hetero product only 
 
 
Apart from dienophile 79, we also explored dienophile 82 using the same 
reaction condition. The reaction was performed in CH2Cl2 with BF3.OEt2 as catalyst, 
and cycloadduct 83 was detected in the reaction mixture. Same as previous results, 
two competing reaction occurred. The hetero-cycloaddition yielded the major product 
84 (Scheme 3-23). The stereochemistry of adduct 83 was suggested in Figure 3-3 
based on the NOESY spectroscopy. This suggestion follows the conventional Diels-
Alder reaction stereochemical outcome, endo-preference to give the product 83. This 
is also consistent with our previous studies described in Chapter 2. 
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3.5 Conclusion 
 
In conclusion, we have successfully synthesized multifunctionalized diene 55 
in 10 steps from commercially available 1,5-pentanediol in 16% overall yield. 
Unfortunately, no desired products were obtained in the reaction between the 
proposed diene 55 and dienophile 56. A series of Lewis acids (BF3.OEt2, SnCl4, 
TiCl4, AlCl3, In(OTf)3, Sm(OTf)3, InCl3) were tried. However, no desired cycloadduct 
was obtained. One possible explanation is that the multifunctionalized open chain 
diene was too bulky which hindered the cycloaddition process. Besides, the $-
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When we perform the Diels-Alder reaction with the more reactive dienophile 
such as aldehyde ester 79, only the hetero-Diels-Alder product was obtained from the 
reaction mixture. Condition optimizations were carried out using different Lewis acid 
or less polar solvent such as toluene. Likewise, only hetero product was obtained. 
Using dienophile 82, we manage to synthesis the cycloadduct 83. Even though 
cycloadduct 83 is not the desired product for the total synthesis of tuberostemonine, 
this finding is useful in other synthesis which require more complicated dienes such 
as diene 55. Besides, intermolecular Diels-Alder reaction with multifunctionalized 
diene and dienophile using Lewis acid catalyst to synthesize the six membered 
cyclohexane ring has not been reported. 
 
3.6 Future Works 
 
The exploration of more efficient Lewis acid is needed. Due to time 
constraint, exploration on chiral Lewis acids has not been studied. A versatile 
oxazoborolidine chiral ligand such as derivative of CBS-catalyst (Corey-Bakshi-
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KOH, 61% 7369  
To commercially available 1,5-pentanediol 69 (60.0 mL, 0.58 mol) in 100 mL THF 
was added potassium hydroxide (32.2 g, 0.58 mol) and catalytic amount of phase-
transfer catalyst, t-butyl ammonium bromide, pre-dissolved in water (60 mL), 
dropwise at 0 °C. Allyl bromide (44.6 mL, 0.52 mol) dissolved in CH2Cl2 was then 
added at 0 °C and stirred for 3 days at room temperature. The product was extracted 
with CH2Cl2 (3 x 100 mL), washed with brine (2 x 100 mL) and dried over anhydrous 
MgSO4. The solvent was removed in vacuo. Purification via column chromatography 
with 20% ethyl acetate in hexane gave the product 73 in 61% (41.8 g) yield.  
Rf = 0.125 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.34-1.41 (2H, m, -CH2CH2CH2CH2CH2), 1.48-1.61 
(4H, m, -CH2CH2CH2CH2CH2), 2.50 (1H, brs, OH), 3.39 (2H, t, J = 6.27 Hz, -
CH2OH), 3.56 (2H, t, J = 6.27 Hz, -CH2O-allyl), 3.91 (2H, d, J = 5.57 Hz, -
OCH2CH=CH2), 5.10 (1H, dd, J = 10.5, 1.05 Hz, -CH=CH2), 5.18 (1H, dd, J = 17.20, 
1.39 Hz, -CH=CH2), 5.79-5.92 (1H, m, -CH=CH2) ppm; 
13
C NMR (75 MHz, CDCl3): ! 22.3 (-CH2CH2CH2OH), 29.3 (-CH2CH2OCH2-), 
32.3 (-CH2CH2OH), 62.4 (-CH2CH2OH), 70.2 (-CH2O-ally), 71.7 (-OCH2CH=CH2), 
116.8 (-CH=CH2), 134.8 (-CH=CH2) ppm; 
FTIR (neat, cm
-1
): 3391, 2938, 2864, 1458, 1421; 
HRMS (EI [M]
+
): m/e calculated for [C8H16O2]
+ = 114.1150, found = 114.1135. 
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73 67  
To 4Å molecular sieve (40 g) and silica gel (40 g), both pre-dried in the oven and 
cooled under vacuum, was added pyridium chlorochromate (244 g, 1.05 mol) and dry 
CH2Cl2 (450 mL). The suspension was stirred at 0 °C for 10 minutes prior to addition 
of 73 (41.8 g, 0.31 mol) pre-diluted with dry CH2Cl2 (50 mL) drop-wise. The mixture 
was allowed to stir at 0 °C for 6 hours prior to work-up. The reaction mixture was 
filtered through a sintered glass funnel packed with silica gel and washed with 
copious CH2Cl2. The filtrate was dried over anhydrous MgSO4. The solvent was 
removed in vacuo. Product 67 was obtained in 89% (39.2 g) yield.  
Rf = 0.25 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.59-1.77 (4H, m, -CH2CH2CH2CH2), 2.46 (2H, td, J 
= 6.97, 1.05 Hz, -CH2CHO), 3.43 (2H, t, J = 6.27 Hz, -CH2O-allyl), 3.95 (2H, d, J = 
5.57 Hz, -OCH2CH=CH2), 5.16 (1H, dd, J = 10.50, 0.70 Hz, -CH=CH2), 5.26 (1H, 
dd, J = 17.2, 1.39 Hz, -CH=CH2), 5.82-5.96 (1H, m, -CH=CH2), 9.76 (1H, s, -CHO) 
ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.0 (-CH2CH2CHO), 29.1 (-CH2CH2CH2CHO), 
43.6 (-CH2CHO), 69.7 (-CH2O-ally), 71.8 (-OCH2CH=CH2), 116.9 (-CH=CH2), 
134.9 (-CH=CH2), 202.6 (-CHO) ppm; 
FTIR (neat, cm
-1
): 2942, 2865, 2788, 1735, 1457, 1422;  
HRMS (EI [M]
+
): m/e calculated for [C8H14O2]
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To pre-form stabilized ylide (7.58 g, 0.17 mol) and anhydrous sodium carbonate (20.0 
g) in dry THF (100 mL) was added 67 (15.7 g, 0.11 mol), pre-diluted in dry THF (30 
mL). The resulting mixture was refluxed at 80 °C for 24 hours. THF was removed in 
vacuo. Purification via column chromatography with 3% ethyl acetate in hexane gave 
the product 66 in 86% (22.8 g) yield. Only the E-isomer was obtained. 
Rf = 0.55 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.95 (3H, t, J = 7.63 Hz, CH3CH2C=CH-), 1.23 (3H, 
t, J = 7.23 Hz, -OCH2CH3), 1.42-1.62 (4H, m, -C=CHCH2CH2CH2), 2.15 (2H, q, J = 
7.23 Hz, -C=CHCH2), 2.25 (2H, q, J = 7.63 Hz, CH3CH2CH=CH2), 3.38 (2H, t, J = 
6.42 Hz, -CH2CH2O-), 3.90 (2H, d, J = 5.64 Hz, -OCH2CH=CH2), 4.13 (2H, q, J = 
7.23 Hz, -OCH2CH3), 5.10 (1H, dd, J = 10.20, 1.61 Hz, -CH=CH2), 5.20 (1H, dd, J = 
17.30, 1.61 Hz, -CH=CH2), 5.79-5.91 (1H, m, -CH=CH2), 6.65 (1H, t, J = 7.63 Hz, -
C=CHCH2) ppm; 
13
C NMR (75 MHz, CDCl3): ! 13.8 (-CH2CH3), 14.1 (-OCH2CH3), 19.9 (-CH2CH3), 
25.4 (-C=CHCH2-), 28.0 (-C=CHCH2CH2-), 29.3 (-CH2CH2O-ally), 60.1 (-
OCH2CH3), 69.9 (-CH2O-ally), 71.7 (-OCH2CH=CH2), 116.6 (-CH=CH2), 134.1 (-
C=CHCH2-), 134.8 (-CH=CH2), 141.4 (-C=CHCH2-), 167.7 (-C=O) ppm; 
FTIR (neat, cm
-1
): 2933, 2862, 1708, 1458;  
HRMS (EI [M]
+
): m/e calculated for [C14H24O3]
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66 65  
To 66 (21.7 g, 0.09 mol) in dry CH2Cl2 (100 mL) was added diisobutylammonium 
hydride (45.4 mL, 0.23 mol) dropwise at 0 °C. The reaction was allowed to stir for 2 
hours prior to work-up. Saturated Na2SO4 was added at 0 °C to quench the reaction. 
The mixture was passed through a sintered glass funnel and washed with CH2Cl2. The 
filtrate was dried over anhydrous MgSO4. The solvent was removed in vacuo to give 
the product 65 in 86% (15.3 g) yield.  
Rf = 0.52 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.98 (3H, t, J = 7.63 Hz, CH3CH2-), 1.24 (1H, brs, 
OH), 1.36-1.46 (2H, m, -C=CHCH2CH2-), 1.54-1.64 (2H, m, -CH2CH2O CH2-), 2.01-
2.12 (4H, m, -C=CHCH2-, CH3CH2-), 3.41 (2H, t, J = 6.82 Hz, -CH2O-allyl), 3.94 
(2H, d, J = 5.62 Hz, -OCH2CH=CH2-), 4.01 (2H, s, -CH2OH), 5.15 (1H, dd, J = 
10.40, 1.61 Hz, -CH=CH2), 5.35 (1H, t, J = 7.23 Hz, -C=CHCH2), 5.82-5.96 (1H, m, 
-CH=CH2) ppm; 
13
C NMR (75 MHz, CDCl3): ! 13.1 (-CH2CH3), 20.9 (-CH2CH3), 26.2 (-
C=CHCH2CH2-), 26.9 (-C=CHCH2CH2-), 29.3 (-CH2CH2O-ally), 66.7 (-CH2OH), 
70.2 (-CH2O-ally), 71.7 (-OCH2CH=CH2), 116.6 (-CH=CH2), 126.0 (-C=CHCH2-), 
134.9 (-CH=CH2), 140.8 (-C=CHCH2-) ppm; 
FTIR (neat, cm
-1
): 3386, 2937, 2860, 1458, 1430;  
HRMS (EI [M]
+
): m/e calculated for [C12H22O2]
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65 63  
To 4Å molecular sieve (22 g) and silica gel (22 g), both pre-dried in the oven and 
cooled under vacuum, was added pyridium chlorochromate (50 g, 0.23 mol) and dry 
CH2Cl2 (200 mL). The suspension was stirred at 0 °C for 10 minutes prior to addition 
of 65 (15.3 g, 0.08 mol) pre-diluted with dry CH2Cl2 (50 mL) dropwise. The  mixture  
was  allowed to stir at  0 °C for 6 hours prior to work-up. The reaction mixture was 
filtered through a sintered glass funnel packed with silica gel and washed with 
copious CH2Cl2. The filtrate was dried over anhydrous MgSO4. The solvent was 
removed in vacuo. Product 63 was obtained in 84% (13.1 g) yield. 
Rf = 0.52 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.93 (3H, t, J = 7.67 Hz, CH3CH2-), 1.51-1.67 (4H, 
m, -CH2CH2CH2CH2), 2.22 (2H, q, J = 7.67 Hz, -CH2CH3), 2.36 (2H, q, J = 7.15 Hz, 
-C=CHCH2), 3.43 (2H, t, J = 7.42 Hz, -CH2O-allyl), 3.92-3.94 (2H, m, -
OCH2CH=CH2), 5.14 (1H, dd, J = 1.61, 10.2 Hz, -CH=CH2), 5.24 (1H, dd, J = 17.3, 
1.61 Hz, CH=CH2), 5.81-5.95 (1H, m, -CH=CH2), 6.40 (1H, t, J = 7.50 Hz, -
C=CHCH2), 9.32 (1H, s, -CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 13.1 (-CH2CH3), 17.1 (-CH2CH3), 25.3 (-C=CHCH2-), 
28.3 (-C=CHCH2CH2-), 29.3 (-CH2CH2O-ally), 69.6 (-CH2O-ally), 71.7 (-
OCH2CH=CH2), 116.8 (-CH=CH2), 134.7 (-CH=CH2), 145.2  (-C=CHCH2-), 154.2  
(-C=CHCH2-), 194.8  (-CHO) ppm; 
FTIR (neat, cm
-1
): 3420, 2975, 2868, 1710, 1458;  
HRMS (EI [M]
+
): m/e calculated for [C12H20O2]
+ = 196.1463, found = 196.1437; 
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63 (2.66 g, 13 mmol) in a solution of THF:NH4Cl (1/4 v/v) (30 mL) was added 
indium powder mesh (3.1 g, 27 mmol) and methyl 2-(bromomethyl)acrylate (7.25 g, 
40 mmol). The reaction mixture was allowed to stir vigorously for 24 hours at room 
temperature. 6N HCl was added to dissolve the white suspension. The reaction 
mixture was extracted with ethyl acetate (3 x 50 mL), washed with brine (2 x 50 mL) 
and dried over anhydrous MgSO4. The solvent was removed in vacuo. Purification via 
column chromatography with 15% ethyl acetate in hexane gave the product 62 in 79% 
(3.04 g) yield.  
Rf = 0.33 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.03 (3H, t, J = 7.63 Hz, -CH3CH2), 1.37-1.48 (2H, 
m, -C=CHCH2CH2), 1.56-1.65 (2H, m, -CH2CH2OCH2), 1.98-2.19 (4H, m, CH3CH2-
, -C=CHCH2), 2.41-2.49 (1H, m, (OH)CHCH2), 2.61-2.67 (1H, m, (OH)CHCH2), 
3.43 (2H, t, J = 6.42 Hz, CH2O-allyl), 3.76 (3H, s, -OCH3), 3.96 (2H, d, J = 5.63 Hz, 
-OCH2CH=CH2), 4.19 (1H, dd, J = 8.44, 1.60 Hz, -CH(OH)), 5.16 (1H, dd, J = 10.4, 
1.60 Hz, -CH=CH2), 5.27 (1H, dd, J = 10.2, 1.61 Hz, -CH=CH2), 5.41 (1H, t, J = 7.23 
Hz, -C=CHCH2), 5.66 (1H, d, J = 1.20 Hz, -C=CH2), 5.85-5.98 (1H, m, -CH=CH2), 
6.23 (1H, d, J = 1.60 Hz, -C=CH2) ppm; 
13
C NMR (75 MHz, CDCl3): ! 14.2 (-CH2CH3), 20.6 (-CH2CH3), 26.3 (-
C=CHCH2CH2-), 27.0 (-C=CHCH2-), 29.4 (-CH2CH2O-ally), 39.3 (-CH2CCO2Me), 
51.9 (OMe), 70.2 (-CH2O-ally), 71.7 (-OCH2CH=CH2), 74.5 (-CHOH), 116.6 (-
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CH=CH2), 125.6 (-C=CH2), 127.6 (-C=CHCH2-), 135.0 (-CH=CH2), 137.4 (-
C=CH2), 142.8 (-C=CHCH2-), 168.0 (-C=O) ppm; 
FTIR (neat, cm
-1
): 3432, 2933, 2858, 1718, 1438;  
HRMS (ESI [M+Na]
+
): m/e calculated for [C17H28NaO4]
+ = 319.2, found = 318.9;  
[M-OH]
+: m/e calculated for [C15H27O3]
+= 279.2, found = 278.9;   
 










62 61  
Lithium aluminium hydride in powder form (0.57 g, 14.9 mmol) was placed in a two-
neck round bottom flask equipped with a Teflon-coated magnetic stirring bar under 
positive pressure nitrogen gas. Then, dry THF (25 mL) was injected, followed by the 
addition of 62 (2.44 g, 9.9 mmol) pre-diluted in dry THF (10 mL). The reaction 
mixture was refluxed for 2 hours. Saturated Na2SO4 was added to quench the reaction. 
The resulting mixture was stirred until white particles precipitated. The mixture was 
then passed through a sintered glass funnel and washed with CH2Cl2. The filtrate was 
dried over anhydrous MgSO4 and the solvent was removed in vacuo. Purification via 
column chromatography with 50% ethyl acetate in hexane eluted the product 61 in 
93% (2.49 g) yield.  
Rf = 0.23 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.88 (3H, d, J = 6.62 Hz, -CH3CH), 0.98 (3H, t, J = 
7.66 Hz, -CH3CH2), 1.37-1.44 (3H, m, -CHCH3, -C=CHCH2CH2), 1.50-1.62 (2H, m, 
-CH2CH2OCH2), 1.75-1.84 (2H, m, (OH)CHCH2), 1.91-2.11 (4H, m, -CH3CH2, -
C=CHCH2), 2.95 (2H, brs, -OH), 3.39 (2H, t, J = 6.62 Hz, -CH2O-allyl), 3.47-3.53 
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(1H, m, -CHOH), 3.69-3.73 (1H, m, -CH2OH), 3.92 (2H, d, J = 5.57 Hz, -
OCH2CH=CH2), 4.05 (1H, m, -CH2OH), 5.13 (1H, dd, J = 10.5, 1.04 Hz, -CH=CH2), 
5.23 (1H, dd, J = 16.8, 1.75 Hz, -CH=CH2), 5.35 (1H, t, J = 7.32 Hz, -C=CHCH2), 
5.81-5.94 (1H, m, -CH=CH2) ppm; 
13
C NMR (75 MHz, CDCl3): ! 14.3 (-CH2CH3), 17.8 (-CHCH3), 20.3 (-CH2CH3), 
26.2 (-C=CHCH2CH2-), 27.0 (-C=CHCH2-), 29.2 (-CHCH3), 34.4 (-CH2CH2O-ally), 
41.8 (-CH2CHCH3), 68.2 (-CH2OH), 70.1 (-CH2O-ally), 71.6 (-OCH2CH=CH2), 75.1 




): 3386, 2032, 2864, 1451;  
HRMS (ESI) [M+Na]
+
: m/e calculated for [C16H30NaO3]
+ = 293.2, found = 293.3; 
[M-C4H9O]
+
): m/e calculated for [C12H21O2]
+ = 197.2, found = 197.2; [M-
C11H20O]
+
: m/e calculated for [C5H10NaO2]
+ = 102.1, found = 102.2  
 












61 (0.74 g, 2.73 mmol) and 4-dimethylamino pyridine (0.01 g, 0.16 mmol) in a 50 mL 
round bottom flask equipped with a Teflon coated magnetic stirring bar were 
dissolved in dry CH2Cl2 (20 mL). Triethylamine (0.38 mL, 2.73 mmol) was added in 
dropwise, followed by t-butyldiphenylsilylchloride (0.78 mL, 3.00 mmol) under 0 ºC. 
The reaction mixture was stirred for 24 hours at room temperature. The reaction was 
quenched by adding ice water (5 mL). The aqueous layer was extracted with CH2Cl2 
(3 x 10 mL). The combined organic layer was washed with brine (2 x 10 mL) and 
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dried over anhydrous MgSO4. The solvent was removed in vacuo. Purification via 
column chromatography with 5% ethyl acetate in hexane eluted the pure product 74 in 
92% (1.28 g) yield. 
Rf = 0.48 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.93 (3H, d, J = 6.62 Hz, -CH3CH), 1.01 (3H, t, J = 
7.63 Hz, -CH3CH2), 1.06 (9H, s, -C(CH3)3), 1.27 (1H, brs, -OH), 1.39-1.48 (2H, m, 
(OH)CHCH2), 1.56-1.67 (4H, m, -CH2CH2CH2CH2-), 1.82-1.92 (1H, m, -CHCH3), 
2.00-2.12 (4H, m, CH3CH2, -C=CHCH2), 3.43 (2H, t, J = 6.43 Hz, -CH2O-allyl), 3.51 
(2H, d, J = 6.02 Hz, -CH2OTBDPS), 3.96 (2H, d, J = 5.62 Hz, -OCH2CH=CH2), 
4.07-4.11 (1H, m, -CHOH), 5.16 (1H, dd, J = 10.4, 1.60 Hz, -CH=CH2), 5.26 (1H, 
dd, J = 17.4, 1.60 Hz, -CH=CH2), 5.37 (1H, t, J = 7.22 Hz, -C=CHCH2), 5.85-5.98 
(1H, m, -CH=CH2), 7.38-7.43 (6H, m, -Ph-H), 7.66-7.73 (4H, m, -Ph-H) ppm; 
13
C NMR (75 MHz, CDCl3): ! 14.1 (-CH3), 17.2 (-CH3), 19.2 (-C(CH3)3), 20.3 (-
CH2CH3), 26.3 (-C=CHCH2CH2-), 26.5 (-C=CHCH2-), 26.8 (-C(CH3)3), 29.4 (-
CH2CH2O-ally), 33.2 (-CHCH3), 40.7 (-CH2CHCH3), 69.4 (-CH2OTBDPS), 70.2 (-
CH2O-ally), 71.7 (-OCH2CH=CH2), 74.6 (-CHOH), 116.6 (-CH=CH2), 127.5 (-Ph-
Co,p x6), 129.5 (-CH=CH2), 133.6 (-Ph-Cq x2), 134.7 (-C=CHCH2-), 135.5 (-Ph-Cm 
x4) , 144.0 (-C=CHCH2-) ppm; 
FTIR (neat, cm
-1
): 3412, 2930, 2856, 1421;  
HRMS (ESI [M+Na]
+
): m/e calculated for [C32H48NaO3Si]
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74 75  
To a solution of Dess-Martin reagent (3.20 g, 7.5 mmol) in anhydrous CH2Cl2 (15 
mL) was added dropwise of 74 (2.54 g, 5 mmol) prediluted in CH2Cl2 (5 mL) at 0 °C.  
The reaction mixture was stirred under nitrogen at 0 °C for 3 hours. After completion, 
the reaction mixture was diluted with ether and poured slowly into a Na2S2O3 : 
NaHCO3 (1:1) solution and stirred for 10 minutes and extracted with ether.  The 
combined etherate was washed with NaHCO3, brine and dried over anhydrous 
MgSO4.  Solvent was removed by concentration in vacuo. The residue was purified 
by flash chromatography on silica gel to provide 75 as a colorless oil, 1.95 g (77%). 
Rf = 0.52 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.89 (3H, d, J = 7.22 Hz, CH3CH), 0.91 (3H, t, J = 
7.23 Hz, CH3CH2), 1.05 (9H, s, C(CH3)3), 1.50-1.65 (4H, m, CH2CH2CH2CH2), 2.21-
2.37  (6H, m, CH3CH2, C=CHCH2, CHCH3, O=CCH2), 2.95 (1H, dd, J = 4.42, 14.5 
Hz, O=CCH2), 3.42 (2H, t, J = 6.00 Hz, CH2O-allyl), 3.47-3.57 (2H, m, 
CH2OTBDPS), 3.94 (2H, d, J = 5.62 Hz, OCH2CH=CH2), 5.14 (1H, dd, J = 10.4, 
1.61 Hz, CH=CH2), 5.24 (1H, dd, J = 17.3, 1.60 Hz, CH=CH2), 5.82-5.95 (1H, m, 
CH=CH2), 6.55 (1H, t, J = 7.23 Hz, C=CHCH2), 7.31-7.39 (6H, m, -Ph-H), 7.62-7.67 
(4H, m, -Ph-H) ppm; 
13
C NMR (75 MHz, CDCl3): ! 13.8 (-CH3), 16.7 (-CH3), 18.8 (-CH2CH3), 19.2 (-
C(CH3)3), 25.6 (-C=CHCH2CH2-), 26.8 (-C(CH3)3), 28.4 (-C=CHCH2-), 29.4 (-
CH2CH2O-ally), 33.0 (-CHCH3), 40.7 (-CH2CHCH3), 68.3 (-CH2OTBDPS), 69.9 (-
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CH2O-ally), 71.7 (-OCH2CH=CH2), 116.6 (-CH=CH2), 127.5 (-Ph-Co,p x6), 129.5 (-
CH=CH2), 133.6 (-Ph-Cq x2), 135.4 (-Ph-Cm x2), 141.8 (-C=CHCH2-), 143.6 (-
C=CHCH2-), 201.1 (-C=O) ppm; 
FTIR (neat, cm
-1
): 2931, 2857, 1664, 1427;  
HRMS (ESI [M+Na]
+
): m/e calculated for [C32H46NaO3Si]













75 55  
Lithium hexamethyl disilazide (3.64 mL, 3.64 mmol) in THF (25 mL was cooled to -
78 °C for 30 minutes. 75 (0.23 g, 0.46 mmol) prediluted in THF (5 mL) was added 
dropwise into the solution. The resulting mixture was stirred for 6 hours at -78 °C. 
Then, triisopropyl silyl triflate (0.61 mL, 2.28 mmol) was added dropwise under -78 
°C. The reaction mixture was stirred at -78 °C for 30 minutes and gradually warmed 
to room temperature. The reaction was quenched at 0 °C with saturated NaHCO3. A 
quarter of the solvent was removed in vacuo. The residue was extracted with ether (3 
x 20 mL) and the combined organic layer was washed with saturated NaHCO3 
solution (2 x 15 mL) and dried over Mg2SO4. The solvent was removed in vacuo. 
Purification through flash column chromatography with 5% ethyl acetate in hexane 
eluted the pure compound 55 in 90% (0.27 g) yield. 
Rf = 0.60 (Hexane:EtOAc, 4:1); 
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1
H NMR (300 MHz, CDCl3): ! 1.07-1.11 (36H, m, -C(CH3)3, ((CH3)2CH) x3, 
((CH3)2CH) x3, CHCH3, CH2CH3), 1.41-1.51 (2H, m, C=CHCH2CH2), 1.59-1.68 
(2H, m, CH2CH2 CH2O), 2.05-2.22 (4H, m, CH3CH2, C=CHCH2), 2.88-2.97 (1H, m, 
CHCH3), 3.41-3.46 (3H, m, CH2O-allyl, CH2OTBDPS), 3.57-3.62 (1H, m, 
CH2OTBDPS), 3.97 (2H, d, J = 5.57 Hz, OCH2CH=CH2), 4.62 (1H, d, J = 9.41 Hz, 
C=CHCH(CH3)), 5.16 (1H, dd, J = 10.5, 1.40 Hz, CH=CH2), 5.27 (1H, dd, J = 17.1, 
1.75 Hz, CH=CH2), 5.64 (1H, t, J = 7.23 Hz, C=CHCH2), 5.85-5.98 (1H, m, 
CH=CH2), 7.34-7.41 (6H, m, -Ph-H), 7.67-7.70 (4H, m, -Ph-H) ppm; 
13
C NMR (75 MHz, CDCl3): ! 12.3 (-CH(CH3)2), 13.8 (-CH3), 17.7 (-CH(CH3)2), 
18.2 (-C(CH3)3), 19.3 (-C(CH3)3), 21.2 (-CH2-), 26.3 (-CH2-), 26.8 (-CH3), 27.6 (-
CH2-), 29.6 (-CH2-), 68.5 (-CH2OTBDPS), 70.2 (-CH2O-ally), 71.8 (-
OCH2CH=CH2), 111.6 (-CH=C-OTIPS), 116.7 (-CH=CH2), 126.3 (-C=CHCH2-), 
127.5 (-Ph-Co x4), 129.4 (-Ph-Cp x2), 134.1 (-Ph-Cq x2), 135.0 (-CH=CH2), 135.7 (-
Ph-Cm x4), 139.8 (-C=CHCH2-), 150.8 (-CH=C-OTIPS) ppm; 
FTIR (neat, cm
-1
): 1658, 1651, 1634, 1384, 1366;  
HRMS (EI [M+]
+
): m/e calculated for [C41H66O3Si2]
+ = 662.4550, found = 662.4540; 
 
3-(tert-butyldiphenylsilyloxy)propan-1-ol 
HO OH HO OTBDPS
TBDPSCl, Et3N, DMAP
  
CH2Cl2, 0 ºC to rt, 36%  
To a stirred solution of 1,3-propanediol (31.6 g, 0.42 mol) in CH2Cl2 (500 mL) and 
pyridine (300 mL) was added DMAP (10.3 g, 0.084 mol). TBDPSCl (97.2 mL, 0.37 
mol) was then added in dropwise at 0 ºC and left to stir for 3 hours. Saturated copper 
sulfate solution was added to remove the pyridine and the aqueous layer was extracted 
with CH2Cl2 (x3). The combined organic layer was washed with saturated NaHCO3, 
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brine, dried, concentrated in vacuo and chromatographed to give 47.6 g of the mono-
protected alcohol (36%). 
Rf = 0.29 (Hexane:EtOAc 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.11 (9H, s, -C(CH3)3), 1.30 (2H, q, J = 0.2 Hz, -
CH2-), 3.87 (4H, m, -CH2O-), 7.43 (6H, m, -Ph-H), 7.70 (4H, m, -Ph-H) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.0 (-C(CH3)3), 26.7 (-C(CH3)3), 34.2 (-CH2-), 61.8 
(-OCH2-), 63.1 (-OCH2-), 127.5 (-Ph-C x4), 129.7 (-Ph-C x2), 133.2 (-Ph-C x4), 
135.5 (-Ph-Cq x2)  ppm; 
FTIR (neat, cm-1): 3418, 3070, 2989, 2856, 1636, 1472;  
HRMS (EI [M-tBu]
+
): m/e calculated for [C19H26O2Si]




PCC, silica gel, 4A MS,
CH2Cl2, 0 ºC to rt, 72%
HO OTBDPS
H OTBDPS
O 58  
To a mixture of PCC (14.5 g, 66 mmol), 4Å molecular sieve powder (7 g) and silica 
gel (7 g) in anhydrous CH2Cl2 (200 mL) at 0 °C was added monoprotected alcohol (7 
g, 22 mmol) prediluted in anhydrous CH2Cl2 (10 mL). The reaction mixture was 
stirred for 3 hours prior to workup. After completion (monitored by TLC), the 
reaction mixture was filtered through silica gel to afford the product 58 as a yellowish 
oil, 4.92 g (72%). 
Rf = 0.48 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.88 (9H, s, -C(CH3)3), 2.60 (2H, t, J = 6.0 Hz, -
CH2CHO), 3.95 (2H, t, J = 6.0 Hz, -CH2O-), 7.45-7.68 (10H, m, -Ph-H), 9.82 (1H, t, 
J = 2.1 Hz, -CHO) ppm; 
  
Chapter 3 : Synthetic Studies Towards the Total Synthesis of Tuberostemonine 
240 Part II 
13
C NMR (75 MHz, CDCl3) ! 19.9 (-C(CH3)3), 26.7 (-C(CH3)3), 46.3 (-CH2-), 59.5 
(-OCH2-), 127.6 (-Ph-C x4), 129.5 (-Ph-C x2), 133.2 (-Ph-C x4), 135.4 (-Ph-Cq x2), 
202.1 (-C=O) ppm; 
FTIR (neat, cm
-1
): 3446, 3073, 3060, 2958, 2857, 1715, 1636, 1472; 
HRMS (EI [M-tBu]
+
): m/e calculated for [C19H24O2Si]
+ = 255.1072, found = 
255.0858; 
 





O 58 THF, 60 °C  
To (15.0 g, 42 mmol) of preformed stabilized ylide and anhydrous sodium carbornate 
in dry THF (150 mL) was added the aldehyde 58 (8.7 g, 28 mmol) prediluted in dry 
THF (10 mL). The resulting mixture was then refluxed at 60 ºC for 24 hours. THF 
was later removed in vacuo and the residue chromatographed (hexane:ether = 70:30) 
giving 6.42 g of the ",#-unsaturated ester 57 as a yellow liquid (60%). 
Rf = 0.56 (Hexane:EtOAc 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.02 (9H, s, -C(CH3)3), 1.28 (3H, t, J = 6.0 Hz, 
CH3CH2O-), 2.45 (2H, dt, J = 7.0, 6.6 Hz, -CH=CHCH2), 3.80 (2H, q, J = 6.0 Hz, 
CH3CH2O-), 4.19 (2H, m, -CH2O-), 5.85 (1H, d, J = 14.5 Hz, -CH=CH-), 6.95 (1H, 
dt, J = 8.3, 7.0 Hz, -CH=CH-), 7.40-7.66 (10H, m, -Ph-H) ppm 
13
C NMR (75 MHz, CDCl3): ! 14.3 (-CH3), 19.1 (-C(CH3)3), 26.8 (-C(CH3)3), 35.4 
(-CH2-), 60.1 (-OCH2-), 62.3 (-OCH2-), 121.8 (-CH=CH-), 127.6 (-Ph-C x4), 129.5 (-




): 3422, 2931, 1721, 1654, 1427; 
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HRMS (EI [M-tBu]
+
): m/e calculated for [C23H30O3Si]







0 ºC, 60% HO
 
To the ester 57 (2.48 g, 6.49 mmol) in anhydrous CH2Cl2 was added DIBAL (12 mL, 
12 mmol, 1M in hexane solution) dropwise at 0 ºC. The reaction mixture was allowed 
to stir for 3 hours prior to quenching with saturated Na2SO4 at 0 ºC. The resulting 
slurry solution was filtered through a sintered glass funnel and washed with copious 
ether. The organic layers were dried over anhydrous MgSO4 and concentrated in 
vacuo to give 1.33 g of the alcohol as a yellowish liquid (60%). 
Rf = 0.34 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.05 (9H, s, -C(CH3)3), 2.55 (2H, t, J = 7.0 Hz, -
CH2OH), 3.45 (2H, t, J = 7.0 Hz, -CH2O-), 4.03 (2H, m, -CH2O-), 5.67 (2H, t, J = 4.5 
Hz, -CH=CH-,  -CH=CH-),  7.40-7.66 (10H, m, -Ph-H) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.1 (-C(CH3)3), 26.8 (-C(CH3)3), 35.5 (-CH2-), 63.4 
(-OCH2-), 65.4 (-OCH2-), 127.5 (-Ph-C x4), 128.3 (-CH=CH-), 129.5 (-Ph-C x2), 
130.9 (-HC=CH-), 133.8 (-Ph-C x4), 135.5 (-Ph-Cq x2) ppm; 
FTIR (neat, cm
-1
): 3421, 3071, 2958, 2858, 1659, 1472;  
HRMS (EI [M-tBu]
+
): m/e calculated for [C21H28O2Si]
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PCC, silica gel, 4A MS,
CH2Cl2, 0 ºC
 to rt, 75%
HO
 
To a mixture of PCC (2.44 g, 11.33 mmol), 4Å molecular sieve powder (1.5 g) and 
silica gel (1.5 g) in anhydrous CH2Cl2 (15 mL) at 0 °C was added monoprotected 
alcohol (1.5 g, 3.78 mmol) prediluted in anhydrous CH2Cl2 (3 mL). The reaction 
mixture was stirred for 3 hours prior to workup. After completion (monitored by 
TLC), the reaction mixture was filtered through silica gel to afford the product 56 as a 
yellowish liquid, 1.15 g (75%). 
Rf = 0.79 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 1.00 (9H, s, -C(CH3)3), 2.55 (2H, m, -CH=CHCH2-), 
3.83 (2H, t, J = 6.1 Hz, -CH2O-), 6.15 (1H, dd, J = 15.0, 6.0 Hz, -CH=CH-), 6.83 
(1H, dt, J = 15.0, 6.0 Hz, -CH=CH-), 7.40-7.64 (10H, m, -Ph-H), 9.46 (1H, d, J = 6.0 
Hz, -CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 19.2 (-C(CH3)3), 26.8 (-C(CH3)3), 63.5 (-OCH2-), 
127.6 (-Ph-C x4), 129.8 (-Ph-C x2), 133.4 (-Ph-C x4), 133.5 (-CH=CH-), 135.5 (-Ph-
Cq x2), 155.4 (-CH=CH-), 193.9 (-C=O) ppm; 
FTIR (neat, cm
-1
): 3422, 1694, 1654; 
HRMS (EI [M-tBu, -2C6H6]
+
): m/e calculated for [C5H7O2Si]
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General procedure for Diels-Alder reaction: 
To a stirred solution of dienophile (1.0 mmol), a proton scavenger, 2,6-di-tert-
butylpyridine (0.11 mL, 0.5 mmol) and 4Å molecular sieve (100 mg, excess) at -78 
ºC in CH2Cl2 (1 mL) was added dropwise boron trifluoride dietherate (0.03 mL, 0.25 
mmol). Subsequently, the pre-diluted diene (0.5 mmol) in CH2Cl2 (1 mL) was added 
dropwise. The whole reaction was stirred at -78 ºC to -60 ºC for 16 hours prior to 
workup. The reaction was quenched with saturated NaHCO3 (2 mL). The organic 
layer was extracted with CH2Cl2 (3 x 5 mL), washed with saturated NaHCO3 (2 x 5 
mL), and dried over anhydrous MgSO4. The filtrate was filtered and concentrated. 






































Yield = 45%  
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Rf = 0.45 (Hexane:EtOAc, 4:1); 
1H NMR (300 MHz, CDCl3): ! 0.65 (3H, d, J = 6.62 Hz, -CHCH3), 0.86 (3H, t, J = 
7.32 Hz, -CH2CH3), 1.04-1.07 (11H, m, -C(CH3)3), -CH2-CBr-), 1.49-1.69 (6H, m, 
CH2CH2CH2O-allyl, CH2CH3), 1.81-1.90 (2H, m, -CHCH2-), 1.95-2.12 (1H, m, -CH-
C=O), 2.23-2.32 (1H, m, -CH-CH2CH3), 2.33-2.41 (1H, m, -CHCH3), 2.58-2.66 (1H, 
td, J = 9.41, 3.83 Hz, -CH-CBr-), 3.37-3.46 (3H, m, CH2O-allyl, TBDPSOCH2), 
3.55-3.59 (1H, m, TBDPSOCH2), 3.95-3.97 (2H, d, J = 4.18 Hz, OCH2CH=CH2), 
5.18 (1H, dd, J = 10.5, 1.39 Hz, CH=CH2), 5.26 (1H, dd, J = 17.5, 1.39 Hz, -
CH=CH2), 5.85-5.96 (1H, m, -CH=CH2), 7.39-7.43 (6H, m, -Ph-H), 7.62-7.63 (4H, 
m, -Ph-H), 9.51 (1H, s, CHO) ppm; 
13C NMR (75 MHz, CDCl3): ! 11.2 (-CH3), 12.3 (-CH3), 15.9 (-CH2-), 19.2 (-
C(CH3)3), 22.3 (-CH2-), 23.4 (-CH2-), 26.5 (-CH2-), 26.9 (-C(CH3)3), 29.3 (-CH2-), 
34.9 (-CH-), 36.6 (-CH-), 39.1 (-CH-), 42.9 (-CH), 53.8 (-C-CHO), 66.7 (-OCH2-), 
69.9 (-OCH2-), 71.8 (-OCH2-), 116.8 (-CH=CH2), 127.7 (-Ph-Cm x4), 129.6 (-Ph-Co 
x4), 133.6 (-Ph-Cq x2), 134.8 (-CH=CH2), 135.5 (-Ph-Cp x2), 199.5 (-CHO), 213.7 
(-C=O) ppm; 
FTIR (neat, cm-1): 3071, 2932, 2774, 2741, 1724, 1696, 1472;  
HRMS (ESI) [M+Na]+: m/e calculated for [C35H49BrNaO4Si]
+ = 663.3 found = 663.3; 
[M-Br]+: m/e calculated for [C12H21O2]
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Yield = 28%  
Rf = 0.68 (Hexane:EtOAc, 4:1); 
1
H NMR (300 MHz, CDCl3): ! 0.91 (3H, d, J = 3.2 Hz, -CHCH3), 0.98 (3H, t, J = 
7.40 Hz, -CH2CH3), 1.03 (18 H, s, TIPS-), 1.05 (9H, s, -C(CH3)3), 1.08-1.48 (6H, m, 
CH2CH2CH2CH2O-allyl), 1.84-1.90 (1H, m, -CHCH3), 1.95-2.12 (3H, m, -CH-CH2-
CBr-), 2.17-2.54 (5H, m, 3CH(CH3)2, CH2CH3), 2.56 (1H, brs, -CH-CBr-), 3.21 (2H, 
dt, J = 6.25, 1.4 Hz, -CH2O-allyl), 3.35 (1H, t, J = 8.8 Hz, TBDPSOCH2-), 3.59 (1H, 
dd, J = 9.47, 3.25 Hz, TBDPSOCH2-), 3.86 (2H, d, J = 5.5 Hz, -OCH2CH=CH2), 5.15 
(1H, dd, J = 10.15, 1.4 Hz, -CH=CH2), 5.23 (1H, dd, J = 17.1, 1.85 Hz, CH=CH2), 
5.83-5.90 (m, 1H, -CH=CH2), 7.33-7.36 (6H, m, -Ph-H), 7.60-7.62 (4H, m, -Ph-H), 
9.43 (1H,  s, -CHO) ppm; 
13
C NMR (75 MHz, CDCl3): ! 11.9, 12.0, 13.7, 15.2, 18.0, 18.2, 19.2, 22.0, 26.0, 
26.8, 27.2, 29.7, 33.9, 34.9, 41.2, 45.4, 65.2, 69.5, 71.7, 74.3, 116.6, 127.4, 127.5, 
127.6, 129.4, 133.6, 134.8, 135.4, 135.5, 144.8, 167.7, 190.9 ppm; 
FTIR (neat, cm
-1
): 3071, 2932, 2774, 2741, 1724, 1696, 1472;  
HRMS (ESI) [M+Na]
+
: m/e calculated for [C44H69BrNaO4Si2]
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1H NMR (500 MHz, CDCl3): ! 0.58 (3H, t, J = 7.4 Hz, -CH2CH3), 1.03 (29 H, brs, -
C(CH3)3), -CH(CH3)2 x3, -CHCH2CH2CH2CH2Oally), 1.17 (3H, d, J = 6.95 Hz, -
CHCH3), 1.29-1.33 (1H, m, -CH2CH3), 1.31 (3H, t, J = 6.95 Hz, -OCH2CH3), 1.34-
1.64 (7H, m, -CH(CH2)2 x3, -CHCH2CH2CH2CH2Oally), 1.99 (1H, brs, -
CH(CH2)4Oally), 2.05-2.12 (1H, m , -CHCH3), 2.41 (1H, dt, J = 7.4, 13.85 Hz, -
CH2CH3), 3.37-3.42 (3H, m, -CH2O-ally, -OCH-CH-CH3, -CH2OTBDPS), 3.74 (3H, 
s, -CO2Me), 3.75-3.78 (1H, m, -CH2OTBDPS), 3.88 (1H, dd, J = 9.25, 2.8 Hz, -
CH2O-ally), 3.95 (2H, dt, J = 5.5, 1.35 Hz, -OCH2CH=CH2), 4.22 (2H, q, J = 6.95 
Hz, -OCH2CH3), 4.51 (1H, t, J = 2.35 Hz, -OCH-C=C-CO2Et), 5.16 (1H, dq, J = 
10.43, 1.35 Hz, -CH=CH2), 5.26 (1H, dq, J = 17.32, 1.85 Hz, -CH=CH2), 5.87-5.96 
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(1H, m, -CH=CH2), 6.25 (1H, d, J = 2.3 Hz, -C=CH-CO2Et), 7.31-7.38 (6H, m, Ph-
H), 7.61-7.65 (4H, m, Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.1 (-CH3), 13.5 (-CH(CH3)2- x3), 14.1 (-CH3), 
17.9 (-CH(CH3)2 x3), 18.6 (-CH3), 19.3 (-CH2-), 19.5 (-C(CH3)3), 23.3 (-CH2-), 26.9 
(-C(CH3)3), 29.4 (-CH2-), 30.9 (-CH2-), 35.0 (-CH-), 45.5 (-CH-), 52.1 (-OMe), 60.8 
(-O-CH2-), 67.7 (-O-CH2-), 70.3 (-O-CH2-), 71.1 (-O-CH-), 71.7 (-O-CH2-), 74.1 (-O-
CH-), 116.6 (-CH=CH2), 118.5 (-C=C-), 122.0 (-C=CH-), 127.4 (Ph-Cm x4), 129.2 
(Ph-Cp x2), 134.3 (Ph-Cq x2), 135.0 (-C=CH-), 135.5 (Ph-Co x4), 143.4 (-C=C-), 
146.3 (-C=C-), 165.6 (C=O), 166.9 (C=O) ppm; 
FTIR (neat, cm-1): 3426, 2931, 2864, 1730, 1651, 1463, 1428;  
HRMS (ESI) [M+H]+: m/e calculated for [C49H77O8Si2]

















1H NMR (500 MHz, CDCl3): ! 0.91-1.04 (33H, m, -CHCH3, -C(CH3)3), -CH(CH3)2 
x3, -CH(CH3)2 x3), 0.85 (3H, t, J = 7.4 Hz, -CH2CH3), 1.28 (3H, dd, J = 6.95, 7.4 Hz, 
-OCH2CH3), 1.26-1.40 (4H, m, -CHCH2CH2CH2CH2Oally), 1.50 (1H, quintet, J = 
6.95 Hz, -CH2CH2Oally), 1.68-1.78 (2H, m, -CH2CH3, -CH2CH2O-ally), 1.80-1.89 
(1H, m, -CHCH3), 2.12 (1H, dq, J = 14.3, 7.4 Hz, -CH2CH3), 2.43 (1H, brs, -
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CHC(CHO)), 2.48 (1H, dd, J = 5.55, 5.05 Hz, -CHCHCO2Et), 3.37 (2H, t, J = 6.45 
Hz, -CH2Oally), 3.47 (1H, d, J = 10.1 Hz, -CH2OTBDPS), 3.56 (1H, d, J = 5.1 Hz, -
CHCO2Et), 3.63 (1H, dd, J = 10.1, 4.15 Hz, -CH2OTBDPS), 3.76 (3H, s, CO2Me), 
3.94 (2H, dt, J = 5.55, 1.4 Hz, -OCH2CH=CH2), 4.11 (1H, dd, J = 10.65, 6.95 Hz, -
OCH2CH3), 4.22 (1H, dd, J = 10.65, 7.4 Hz, -OCH2CH3), 5.15 (1H, dq, J = 12.02, 1.4 
Hz, -CH=CH2), 5.25 (1H, dq, J = 17.1, 1.35 Hz, -CH=CH2), 5.86-5.94 (1H, m, -
CH=CH2), 7.30-7.39 (6H, m, Ph-H), 7.61-7.68 (4H, m, Ph-H), 10.21 (1H, s, -CHO) 
ppm; 
13C NMR (125 MHz, CDCl3): ! 13.5 (-CH2CH3), 13.7 (-CH(CH3)2 x3), 13.9 (-
OCH2CH3), 17.5 (-CHCH3), 18.1 (-CH(CH3)2 x3), 19.3 (-C(CH3)3), 21.1 (-CH2CH3), 
26.9 (-C(CH3)3), 28.4 (-CHCH2CH2CH2CH2O-ally), 29.3 (-
CHCH2CH2CH2CH2Oally), 29.8 (-CHCH2CH2CH2CH2O-ally), 37.7 (-CHCH3), 44.2 
(-CHCHCO2Et), 45.1 (-HCC-CHO), 52.1 (-CHCO2Et), 52.7 (OMe), 61.0 (-
OCH2CH3), 61.5 (C-CHO), 66.4 (-CH2OTBDPS), 69.9 (-CH2O-ally), 71.8 (-
OCH2CH=CH2), 116.6 (CH=CH2), 119.9 (-C=C-CH2CH3), 127.4 (Ph-Cm x2), 127.5 
(Ph-Cm x2), 129.2 (Ph-Cp), 129.3 (Ph-Cp), 134.0 (Ph-Cq), 134.4 (Ph-Cq), 135.0 
(CH=CH2), 135.6 (Ph-Co x2), 135.7 (Ph-Co x2), 143.3 (C-TIPSO), 172.4 (CO2Et), 
173.0 (CO2Me), 197.6 (-CHO) ppm; 
FTIR (neat, cm-1): 3426, 2931, 2864, 1730, 1651, 1463, 1428;  
HRMS (ESI) [M+Na]+: m/e calculated for [C49H76NaO8Si2]
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Rf = 0.71 (Hexane:EtOAc, 4:1); 
Yield = 77% 
1H NMR (500 MHz, CDCl3): ! 0.81 (3H, t, J = 7.45 Hz, -CH2CH3), 0.95-1.10 (30H, 
m, -C(CH3)3), -CH(CH3)2 x3), 1.22-1.33 (6H, m, -CH2-, -CH-, -CH3), 1.54-1.80 (4H, 
m, -CH2- x2), 1.97-2.15 (3H, m, -CH3), 3.37-3.52 (3H, m, -OCH- x3), 3.66-3.73 (1H, 
m, -OCH-), 3.94 (2H, t, J = 5.55 Hz, -OCH2CH=CH2), 4.02 (1H, d, J = 9.00 Hz, -
OCH-), 4.16 (2H, q, J = 7.05 Hz, -OCH2-), 4.22-4.29 (1H, m, -OCH-), 5.14 (1H, d, J 
= 10.30 Hz, -CH=CH2), 5.26 (1H, d, J = 17.35 Hz, -CH=CH2), 5.86-5.95 (1H, m, -
CH=CH2), 6.10 (1H, dd, J = 15.45, 2.30 Hz, -CH=CH-CO2Et), 6.91-6.98 (1H, m, -
CH=CH-CO2Et), 7.30-7.37 (6H, m, Ph-H), 7.59-7.62 (4H, m, Ph-H) ppm; 
13C NMR (125 MHz, CDCl3): ! 12.6 (-CH3), 13.5 (-CH(CH3)2- x3), 15.5 (-CH3), 
18.0 (-CH(CH3)2 x3), 18.7 (-C(CH3)3), 18.9 (-CH3), 19.0 (-CH2-), 19.1 (-CH2-), 22.3 
(-CH2-), 26.8 (-C(CH3)3), 29.6 (-CH2-), 35.5 (-CH-), 46.3 (-CH-), 60.1 (-OCH2-), 
67.9 (-OCH2-), 70.3 (-OCH2-), 71.7 (-OCH2-), 75.2 (-OCH-), 76.3 (-OCH-), 116.5 (-
CH=CH2), 118.5 (-C=C-), 119.8 (-HC=CH-), 127.4 (Ph-Cm x4), 129.2 (Ph-Cp x2), 
133.9 (Ph-Cq x2), 135.0 (-C=CH-), 135.4 (Ph-Co x4), 144.2 (-C=C-), 147.0 (-








Transfer to Aldehydes 
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A.1 Introduction 
 
The control of the carbon-carbon bonds formation with good and predictable 
control of stereochemistry is one of the most crucial area in organic synthesis, 
especially in natural product synthesis and drug design. The allylation and the 
propargylation/allenylation of aldehydes and ketones (carbonyls) with organometallic 
reagents are among the most fundamental and important reactions for constructing 
carbon-carbon bonds.1 The synthetically attractive point of the methodology using 
propagyl/allenyl as intermediate comes from the tendency of such unique 
nucleophiles to produce mixture of both homopropargylic and allenic species at the 
same time. 
 
Allenic and propargylic alcohols are attractive intermediates in organic 
synthesis because of their unique structural characteristics and versatile nature.1 They 
have been used extensively as important building blocks for the synthesis of many 
biologically active natural products such as 3-deoxy-D-manno-2-octulosonic acids 
(KDO), 3-deoxy-D-glycero-D-galacto-2-ulosonic acids (KDN),2 (±)-9-




                                                
1
 For reviews, see: (a) Marshall, J. A. Chem. Rev. 2000, 100, 3163. (b) Yamamoto, H. in 
Comprehensive Organic Synthesis Vol. 2 Ed.: Trost, B. M., Pergamon  Press, Oxford, 1991, Chapter 
1.3.  (c) Panek, J. S. in Comprehensive Organic Synthesis Vol. 1 Ed.: Schreiber, S. L. Pergamon  Press, 
Oxford, 1991, p.595. 
2
 Li, L. -S.; Wu, Y. -L. Tetrahedron 2002, 58, 9049. 
3
 Friesen, R. W.; Bissada, S. Tetrahedron Lett. 1994, 35, 5615. 
4
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A.2 Propargylic Alcohols as Intermediates in Organic Synthesis 
 
Recently, propargylic alcohols have been used extensively in natural product 
synthesis. In 2001, Wu and coworkers have reported the application of propargylic 
alcohol in the total synthesis of two mono-THF acetogenins, tonkinecin and 
annonacin. In their synthesis strategy, the homopropargylic alcohol 1 served as one of 















































a) PPh3, I2, imidazole, toluene, reflux, 69%; b) LiHMDS, THF, -78 ºC, 95%; c) (i) H2/Pd-C, MeOH; 
ii) acetone, p-TsOH (cat.), 86%; d) (i) 50% AcOH, 60 ºC, 80%; (ii) 60% NaH, N-TsIm, 92%;
(iii) trimethylsilylacetylene, n-BuLi, BF3.OEt2,THF; then n-Bu4NF, THF, 90%
1
 
Scheme A-1 Total synthesis of tonkinecin and annonacin 
 
                                                
4
 Hu, T. -S.; Yu, Q.; Wu, Y. -L.; Wu, Y. -K. J. Org. Chem. 2001, 66, 853. 
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Later in 2002, Wu and coworkers reported the synthesis of 3-deoxy-D-manno-
2-octulosonic acids (KDO) and 4-epi-KDN in the furanose form from the readily 
available sugar in 41% and 35% yield respectively (Scheme A-2 and Scheme A-3).5 
The key step in their synthesis is the introduction of a pyruvate segment by 
asymmetric propargylation and oxidation of terminal alkynes. 
 
3-deoxy-D-manno-2-octulosonic acids (KDO) and 3-deoxy-D-glycero-D-
galacto-2-ulosonic acids (KDN) possess a number of interesting biological activities. 
KDO is an essential constituent of the outer-cell membrane lipopolysaccharide of 
Gram-negative bacteria, and incorporation of KDO is likely to be a key step in the 
growth of these bacteria.6 KDN is a deaminated sialic acid first isolated in 1986 by 
Inoue and co-workers7 from the membrane polysialoglycoproteins of rainbow trout 
eggs. It has been found that KDN is likely to be responsible for protection of the egg 
membrane from attacks by bacterial sialidases.8 A more recent discovery shows that 
free KDN occurs at elevated levels in human fetal cord red blood cells and ovarian 
cancer cells.9 
 
                                                
5
 (a) Li, L. -S.; Wu, Y. -L. Tetrahedron Lett. 2002, 43, 2427. (b) Li, L. -S.; Wu, Y. -L. Tetrahedron 
2002, 58, 9049. 
6 (a) Levin, D. H.; Racker, E. J. Biol. Chem. 1959, 234, 2532-2539. (b) Unger, F. M. Adv. Carbohydr. 
Chem. Biochem. 1981, 38, 323-388. 
7
 Nadano, D.; Iwasaki, M.; Endo, S.; Kitajima, K.; Inoue, S.; Inoue, Y. J. Biol. Chem. 1986, 38, 323. 
8
 Schreiner, E.; Zbiral, E. Liebigs Ann.Chem. 1990, 581. 
9
 Inoue, S.; Lin, S. -L.; Chang, T.; Wu, S. -H.; Yao, C. -W.; Chu, T. -Y.; Troy, F. A.; Inoue, Y. J. Biol. 
Chem. 1998, 273, 27199–27204. 
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Reagents and conditions: (a) Lit 10; (b) 3-bromopropyne, DMF-Et2O, Zn, 83%; 
(c) MOMCl, iPr2NEt, 0 °C to rt, 88%; (d) NBS, AgNO3, acetone, rt, 86%; (e)
KMnO4, NaHCO3, MgSO4, MeOH/H2O (1:1), 0 °C, 87%; (f) conc. HCl,
anhydrous MeOH, rt, 2 days, then Ac2O, Py., DMAP, CH2Cl2, rt, 75% (two



































R1 = H, R2 = H
R1 = H, R2 = TBS
R1 = MOM, R2 = TBS







(a) (i) Conc. H2SO4, acetone, 82%; (ii) LiAlH4, THF, 92%; (b) TBSCl, DMF, Im., rt, 96%; (c) MOMCl, i-Pr2NEr, CH2Cl2, rt,
92%; (d) n-Bu4NF,THF, 93%; (e) (i) oxalyl chloride, DMSO, Et3N; (ii) 3-bromopropyne, Zn, DMF-Et2O, 77%; (f) TBSCl,
DMF, Im., rt, 84%; (g) NBS, AgNO3, acetone, 87%; (h) KMnO4, NaHCO3, MgSO4, CH3OH/H2O (1:1), 0 ºC, 79%; (i) conc. 
























                                                
10
 Regeling, H.; de Rouville, E.; Chittenden, G. J. F. Recl. Trav. Chim. Pays-Bas 1987, 106, 461–464. 
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A.3 Applications of Allenic Alcohols 
 
Allenes are a class of compounds with unique reactivity due to the existence 
of two orthogonal "-bonds, and they also been found to be very useful intermediates 
in organic synthesis.11,12  
 
A.3.1 Addition of Allenic Alcohols and Aldehydes 
 
Recently, Trost and co-workers reported that addition of allenic alcohols and 
aldehydes gave aldol-type adducts formally derived from an !,"-unsaturated ketone 















R' = Ph,       R = CH3,  86%,  syn:anti  (80:20)
R' = i-C3H9, R = CH3,  86%,  syn:anti  (77:23)
R
 
Scheme A-4 Addition of allenic alcohols and aldehydes 
 
                                                
11
 (a) Schuster, H. F.; Coppola, G. M. Allenes in Organic Synthesis; John Wiley & Son: New York, 
1988. (b) The Chemistry of Ketenes, Allens, and Related Compounds; Patai, S. Ed.; John Wiley & Son: 
New York, 1980; Part 1. 
12
 (a) Walkup, R. D.; Kim, S. W.; Wagy, S. D. J. Org. Chem. 1993, 58, 6484. (b) Fox, D. N. A.; 
Lathbury, D.; Mahon, M. F.; Malloy, K. C.; Gallagher, T. J. Am. Chem. Soc. 1991, 113, 2652. (c) 
Kimura, M.; Fugami, K.; Tanaka, S.; Tamaru, Y. J. Org. Chem. 1992, 57, 6377. (d) Yamamoto, Y. Y.; 
Al-Masum, M.; Asao, N. J. Am. Chem. Soc. 1994, 116, 6019. (e) Trost, B. M.; Gerusz, V. J. Am. 
Chem. Soc. 1995, 117. 5156. (f) Wei, L. -L.; Mulder, J. A.; Xiong, H.; Zificsak, C. A.; Douglas, C. J.; 
Hsung, R. P. Tetrahedron 2001, 57, 459. 
13
 Trost, B.  M.; Jonasson, C.; Wuchrer, M. J. Am. Chem. Soc. 2001, 123, 12736. 
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This strategy provided a new synthetic method for the synthesis of unusual 
aldol-type products consisting of both an !,"-unsaturated ketone and a "-
hydroxyketone, which cannot be easily obtained by other methods in an atom 
economical fashion.  
 
The use of InCl3 to promote reaction of allenic carbinols and aldehydes have 
been studied by Yu and co-workers. From their study, they found that in the presence 
















Scheme A-5 InCl3 catalyze addition of allenic alcohols and aldehydes 
 
A.3.2 Addition of Allenic Alcohols and Alkyl Halides 
 
Recently, Miao and Chan found that indium-mediated reaction of propargyl 
bromide and allenic carbinol in the presence of indium tribromide gave E-1-
substituted-2,5-dimethyl heptarien-1-ol (2) in moderate to good yield under ultrasonic 
irradiation (Scheme A-6). It is interesting to note that with parent propargyl bromide 
(R3 = H) the reaction showed a different regioselectivity giving the homopropargyl 
carbometallation adduct 3 (Scheme A-6).15  
                                                
14
 Yu, C. -M.; Kim, Y. -M.; Kim, J. -M. Synlett. 2003, 10, 1518. 
15
 Miao, W.; Chan, T. -H. Synthesis 2003, 5, 785. 
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when, R2 = Me, Ph, R3 = Me, TMS; 2 was the only product









Scheme A-6 Indium-mediated reaction of propargyl bromide and allenic carbinol 
 
A.3.3 Allenic alcohols as intermediates in organic synthesis 
 
In addition, allenic alcohols were also found to be important building blocks in 
the synthesis of biological active natural products. Two natural styryl lactone, (+)-
goniofufurone and (±)-9-deoxygoniopypyrone were derived from allenic alcohols.  
 
(+)-Goniofufurone is one of a key component isolated from the Asia trees of 
the genus Goniothalamus, which found to possess moderate to significant 
cytotoxicities against several human tumors.16 By using the indium-mediated 
allenylation of hemiacetal followed by functional group transformation, Li and co-
workers completed the synthesis of the (+)-goniofufurone (Scheme A-7).17  
 
                                                
16
 Fang, X. -P.; Anderson, J. E.; Chang, C. -J.; Fanwick, P. E.; McLaughlin, J. L. J. Chem. Soc., Perkin 
Trans, 1, 1990, 1655. 
17
 (a) Yi, X, -H.; Meng, Y.; Li, C. -J. Chem. Common. 1998, 449. (b) Yi, X, -H.; Meng, Y.; Hua, X. G.; 
Li, C. -J. J. Org. Chem. 1998, 63, 7472. 
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i) acetone, H2SO4, rt, 5h, 86%; ii) Tf2O, Py, CH2Cl2, -40 ºC, 94%; iii) LiBr, acetone, rt, 1h, 97%;
iv) TFA-H2O (3:1), rt, 4.5h, 98%; v) Phenylpropargyl bromide, In, 0.1N HCl-EtOH (1:9), rt, 14h;
vi) O3, MeOH, -78 ºC, then Me2S; vii) NaBH4, MeOH, -10 ºC, 1/2h, then AcOH quench; viii)
H2SO4, Ac2O, rt, 75% for three steps; ix) Na2SO3, MeOH-H2O, rt, 3h, quant.; x) HCl, MeOH, rt, 
2d, 44% for two steps.
(+)-Goniofufurone
 
Scheme A-7 Total synthesis of (+)-Goniofufurone 
 
Another styryl lactone, (±)-9-Deoxygoniopypyrone, with cytotoxic activity 
isolated from the stem bark of Goniothalamus had also been synthesized using $-
allenic alcohol as starting material. The total synthesis of (±)-9-Deoxygoniopypyrone 
was successfully accomplished in thirteen steps. The relative configuration of the 
three contiguous asymmetric centers were established by the highly diastereoselective 
formation of the syn-vicinal diol via the iodo-cyclofunctionalization reaction of the 
allenic carbamate, and the epoxidation of the olefinic acetonide (Scheme A-8).18 
 
                                                
18
 Friesen, R. W.; Bissada, S. Tetrahedron Lett. 1994, 35, 5618. 
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a) TsCN, Et2O, 0 ºC, 15min; b) I2, Et2O, rt, 45min; Ag2CO3, MeCN-Et2O (1:10), rt,
3h; 6N NaOH, MeOH, rt, 15h, 66%; c) n-Bu3SnH, AIBN, PhMe, reflux, 2h, 81%; d) 2-
methoxypropene, cat. CSA, THF, rt, 2h, 92%; e) Ph3SnH, AIBN, PhMe, reflux, 90min,
87%; f) 3 eq. mCPBA, CH2Cl2, rt, 3 days, 86%; g) lithium acetylide-EDA, THF-HMPA
(4:1), rt, 15h, 81%; h) TBDMSOTf, Et3N, CH2Cl2, 0 ºC to rt, 2h, 96%; i) K2CO3, MeOH,
rt, 24h, 95%; j) MeLi, THF, -78 ºC to 0 ºC, 30min, ClCO2Me, 0 ºC, 91%. k) H2, Lindlar's
catalyst, THF; l) HOAc/1N HCl/THF (1:1:1), 65 ºC, 3h; m) 1%DBU-THF(v/v), rt 24h, 60%.
 
Scheme A-8 Total synthesis of (±)-9-Deoxygoniopypyrone 
 
Accordingly, there has been much interest in the development of new methods 
for the synthesis of these classes of compounds. Among the methods available, the 
metal-mediated propargylation/allenylation of carbonyl compounds is the most 
common approach.19 However, these methods are plagued with problems of poor 
regioselectivities and enantioselectivities. Therefore, a general and efficient method to  
                                                
19
 (a) Lin, M. -J.; Loh, T. -P. J. Am. Chem. Soc. 2003, 125, 13042. (b) Loh, T. -P; Lin, M. -J.; Tan, K. 
L. Tetrahedron Lett. 2003, 44, 507. (c) Marshall, J. A. Chem. Rev. 2000, 100, 3163. (d) Daniels, R. G.; 
Paquette, L. A. Tetrahedron Lett. 1981, 22, 1579. 
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obtain this class of compounds is still highly desirable. Here, we report an efficient 
method for the propargylic transfer to carbonyl compounds based on an unusual 
oxonium-Claisen rearrangement of 2-trialkylsilyl allenic alcohols with aldehydes. 
 
A.4 Results and Discussion 
 
In the previous studies of homopropargylation in the presence of InF3 or 
InBr3,
20 a mixture of homopropargylic 6 and allenic alcohols 7 is formed initially with 
the homopropargylic alcohol 6 observed as the major product. Refluxing the reaction 












I:  In/10mol% InBr3, THF, reflux, 20h
















In addition, introducing $-triisopropylsilyl cyclohexyl allenic alcohol (9) to 
the indium-mediated reaction of propargyl bromide 5 and aldehyde 8 afforded the 
cross-over product 11 in addition to the indium-mediated coupling product 10 
(Scheme A-10). 
 
                                                
20
 Lin Manjing’s PhD Thesis, 2003.  
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+

















Scheme A-10 Cross-over reaction 
 
Although the reaction mechanism is not clear, the observation described above 
indicated that trimethylsilyl allenic alcohol maybe undergoing a retro cleavage 
followed by a rearrangement in the homoproparpylation reaction to afford 
trimethylsilyl homopropargylic alcohols (Scheme A-11). Therefore, it is interesting to 










Scheme A-11 Rearrangement 
 
Recently, it has been demonstrated by Nokami and co-workers that the #-allyl 
adduct underwent a retroene reaction, via a hemiacetal, derived from an aldehyde and 
the allenic alcohol, followed by a six-membered cyclic transition state 2-oxonia [3,3]-
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sigmatropic rearrangement in the presence of Lewis acid to give the corresponding $-
adduct.21 
 
Therefore, it is of great interest to find out whether the allenic alcohols can be 
rearranged to the corresponding homopropargylic alcohols via a similar transition 
state by an acid catalyst or otherwise.  
 
In our initial investigations, THF solutions of two 2-substituted allenic 
alcohols (12,13) in the presence of 10 mol% indium tribromide (InBr3) under reflux 
condition were carried out to investigate whether allenic alcohols can rearrange to 









R = Ph (15), no reaction; 
R = TMS (11), 20% yield
CHO
+
R = Ph (12);





Unfortunately, no desired corresponding homopropargylic alcohols were 
obtained when 2-phenyl-substituted $-allenic alcohols 12 were subjected to various 
aldehydes under these conditions. To our surprise, when one equivalent of the 
corresponding aldehyde21 was introduced to 2-trimethylsilyl allenic alcohol 13 in the 
presence of InBr3 (10 mol%), the desired homopropargylic alcohol 11 was obtained in 
                                                
21
 (a) Nokami, J.; Anthony, L.; Sumida, S. Chem. Eur. J. 2000, 6, 2909. (b) Tan, K. -T.; Chng, S. -S.; 
Cheng, H. -S.; Loh, T. -P. J. Am. Chem. Soc. 2003, 125, 2958. (c) Ripoll, J. L.; Vallée, Y. Synthesis 
1993, 659. 
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20% yield together with the recovery of 30% of the starting allenic alcohol 13. With 
this promising result, the $-trimethylsilyl cyclohexyl allenic alcohol 13 in the 
presence of the corresponding aldehyde, were subjected with various Lewis acids. 
The results are shown in Table A-1. 
 




OH TMSTHF, rt, 1 day




1.0 equiv          1.0 equiv
13  
Entry Lewis Acid Yieldb % 
1 InCl3 - 
2 Cu(OTf)2 - 
3 InBr 5 
4 InBr3 20
c 
5 Sc(OTf)3 26 
6 In(OTf)3 51 
 
a All reactions were carried out on 0.5 mmol scale at room temperature in 
THF (2 mL). b Isolated yield. c Recovered back 30% of the starting 
material. 
 
It is interesting to note that the use of indium triflates with more Lewis acid 
characteristic afforded the desired homopropargylic alcohols in moderate yield (entry 
6). Next, different $-trimethylsilyl allenic alcohols were subjected to the 
rearrangement using this condition (Table A-2). Compared to other $-trimethylsilyl 
allenic alcohols, we found that cyclohexyl allenic alcohol afforded the crossover 
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product in higher yield, probably due to the more sterically hindered cyclohexyl 
allenic alcohol. 
 












1 eq 1 eq  
Entry R Conditions Yieldb % 
1 PhCH2CH2 THF / 24h 30 
2 C8H17 THF / 24h 45 
3 Ph THF / 24h 50 
4 c-C6H11 THF / 24h 51
 
5 c-C6H11 CH2Cl2 / 1h 89 
 
a All reactions were carried out on 0.5 mmol scale at room temperature in 
solvent (2 mL). b Isolated yield. 
 
 
Next, using these optimized conditions, the cross-over reactions of $-
trimethylsilyl cyclohexyl allenic alcohol and various aldehydes were carried out in 
CH2Cl2 in the presence of 1 mol% of In(OTf)3. The results are shown in Table A-3. In 
this reaction, complete conversions of crossover products were obtained. The 
selectivity between cross-over and self-rearranged product could be improved when 
the reaction was carried out using 2 to 4 equivalents of aldehyde in the presence of 1 
mol% of indium triflate.  After the reaction, the excess aldehyde can be recovered in 
quantitative yield through flash column chromatography. The isolated yields were 
good, and only small amounts of the self-rearranged products were detected.  
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 In(OTf)3 (1 mol%)




Entry R Yieldb % 
1 c-C6H11- 98 
2 PhCH2CH2- 79 
3 BnO(CH2)3- 78 
4 C8H17 - 77 
5 C2H5CH=CHC2H4- (cis) 77 
6 BnO(CH2)2- 73
c 
7 (CH3)2CHCH2- 73 
8 C5H11 - 71 
9 CH2=CHCH2O(CH2)4 - 70 
 
a Unless otherwise noted, all reactions were carried out on 0.2 mmol scale in 
CH2Cl2 (0.03M) for 1h at room temperature. 
b Isolated yield. c 100%  recovery 
of the excess aldehyde. 
 
Two possible reaction pathways (Scheme A-13) can be envisaged to occur 
during this rearrangement. Pathway 1 involves the reaction of an intermolecular 
allenic anion (generated in the reaction) to the aldehyde. On the other hand, pathway 
2 involves an unprecedented oxonium [3, 3]-sigmatropic rearrangement of the allenic 
alcohol in the presence of aldehyde and Lewis acid catalyst. In order to further 
understand the mechanism involved in this reaction, we carried out stereochemical 
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studies using enantiomerically enriched allenic alcohol 13 (92% ee).22 The results are 





































Scheme A-13 Proposed mechanism for rearrangement/cross-over of allenic alcohol 
 
The crossover experiments were further performed with selected aldehydes 
under the same conditions. In all cases, the products were obtained in high 
enantioselectivities (88% to 97% ee, corrected based on 92% ee of the starting 
material). Furthermore, the products were obtained in the opposite configuration as 
compared to the starting material. With these results, we believe that this allenic 
alcohol undergoes an 2-oxonia [3,3]-sigmatropic rearrangement in the presence of 
aldehyde to give the homopropargylic adduct. The requirement of the silicon 
substituent at the 2-position of the allenic alcohols was probably due to the more 
stepwise nature of this reaction where the silicon stabilized the #-carbocation. It is 
                                                
22
 It was obtained by chiral resolution with S-(+)-$-acetoxyphenylacetic acid followed by hydrolysis. 
Enantiomeric excess for (-)-1-cyclohexyl-2-trimethylsilanyl-buta-2,3-dien-1-ol was 92 % ee. Whitesell, 
J.K.; Reynolds, D. J. Org. Chem. 1983, 48, 3548. 
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also possible that the rearrangement could be fully concerted where the silicon group 
stabilizes the transition state without a vinyl cation intermediate. 
 
Table A-4 Rearrangement Using Optically Active Allenic Alcohol 1323,24 













Entry R % eea (%)e [$]D
25, CHCl3 confign 
1 PhCH2CH2 85
b (92) -17.7 (c 1.0) Rc 
2 Ph 89b (97) +43.6 (c 0.5) Rd 
3 BnO-C2H4 81
b (88) +13 (c 0.05) Rc 
 
a Enantiomeric excess was determined by chiral HPLC. b determine from (R)-1-
cyclohexyl-2-trimethylsilanyl-buta-2,3-dien-1-ol with 92% ee. c predicted 





In conclusion, a new and efficient method to obtain the homopropargylic 
alcohols via the homopropargylic transfer from the allenic alcohol to various 
aldehydes in the presence of Lewis acid catalysis has been accomplished.25 This 
represents the first hypothesized and tested oxonium [3,3]-sigmatropic rearrangement 
of an allenic alcohol to the homopropargylic alcohols in the presence of aldehydes 
and Lewis acid. The followings are the characteristics of this method: (1) This 
reaction works with a wide variety of aldehydes, affording a wide variety of 
                                                
23
 Compain, P.; Gorè, J.; Vatèle, J. M. Tetrahedron 1996, 52, 10405. 
24
 Brown, H. C.; Khire, U. R.; Narla, G. J. Org. Chem. 1995, 60, 8130. 
25
 Lee, K. -C.; Lin, M. -J.; Loh, T. -P. Chem. Commun., 2004, 2456-2457. 
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homopropargylic alcohols in good to excellent yields. (2) Only 1 mol% of the Lewis 
acid catalyst is required to catalyze the reaction and the excess aldehyde used in the 
reaction can be recovered in quantitative yields. (3) The reaction has also been shown 
to proceed with high enantioselectivities when optically active allenic alcohol was 






















Appendix : Silicon-assisted Propargylic Transfer to Aldehydes 
269 Appendix  
A.6 Experimental  
 
Crossover Reactions of Allenic Alcohols and Aldehydes in CH2Cl2 with In(OTf)3; 
General Procedure: 
The mixture of cyclohexanecarboxyldehyde (89 mg, 0.8 mmol, 4 equiv) and 1-
cyclohexyl-2-trimethylsilanyl-buta-2,3-dien-1-ol (45 mg, 0.2 mmol, 1 equiv) was 
added to a solution of indium triflate (1 mg, 0.002 mmol, 0.01 equiv) in 6 mL dried 
CH2Cl2 at room temperature under an atmosphere of dry nitrogen. The mixture was 
stirred for 1 hour and finally quenched with saturated sodium bicarbonate. 
Purification through flash silica gel column chromatography provides 44.1 mg (98% 
yield) of 1-cyclohexyl-4-trimenthylsilanyl-but-3-yn-ol as a colourless oil. 
 




Rf 0.67 (hexane : ethyl acetate 4:1) 
1
H NMR: (300 MHz, CDCl3) 
! 3.46-3.41 (1H, m, -CHOH), 2.43 (1H, dd, J = 16.71, 3.60 Hz, -C%CCHH), 2.32 
(1H, dd, J = 16.71, 7.65 Hz, -C%CCHH), 2.12 (1H, brs, -CHOH), 1.86-0.96 (11H, m, 
c-C6H11), 0.11 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 103.7 (-C%CSi), 87.3 (-C%CSi), 73.8 (-CHOH), 42.6 (-CHCHOH), 28.9, 28.1, 26.3, 
26.1, 26.0, 25.9 (-CH2), -0.01 (-Si(CH3)3) ppm 
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EIHRMS: Calcd for C13H24OSi : 224.1596, found : 224.1594. 
 




Rf  0.54 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
! 7.31-7.26 (2H, m, -Ph-H), 7.22-7.18 (3H, m, -Ph-H), 3.76 (1H, tt, J = 6.45, 5.55 Hz,  
-CHOH), 2.81 (1H, dt, J = 13.90, 7.35 Hz, -PhCHH), 2.71 (1H, dt, J = 13.90, 8.35 
Hz, -PhCHH), 2.48 (1H, dd, J = 16.65, 5.10 Hz, -C%CCHH), 2.40 (1H, dd, J = 16.65, 
6.95 Hz, -C%CCHH), 2.09 (1H, brs, -CHOH), 1.86 (2H, td, J = 8.35, 6.00 Hz, -
PhCH2CH2), 0.17 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 141.7, 128.3, 125.8 (phenyl), 102.9 (-C%CSi), 87.7 (-C%CSi), 69.0 (-CHOH), 37.7 
(-CH2CHOH), 31.8 (-PhCH2), 28.9 (-CH2C%C), 0.03 (-Si(CH3)3) ppm 
FTIR: 3434, 3020, 2961, 2170, 1718, 1492, 1454, 1411 cm
-1
 
EIHRMS: Calcd for C15H22OSi : 246.1440, found : 246.1396. 
 





Rf  0.40 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
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! 7.19-7.29 (5H, m, -Ph-H), 4.44 (2H, s, -OCH2Ph), 3.70-3.66 (1H, m, -CHOH), 3.45 
(2H, t, J = 6.00 Hz, BnOCH2-), 2.60 (1H, brs, -CHOH), 2.36 (1H, dd, J = 16.65, 5.55 
Hz, -C%CCHH), 2.32 (1H, dd, J = 16.65, 6.50 Hz, -C%CCHH), 1.73-1.47 (4H, m, -
(CH2)2CH2OBn), 0.09 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 138.1, 128.3, 127.6, 127.5 (Phenyl), 103.4 (-C%CSi), 87.2 (-C%CSi), 72.9 (-OCH2-), 
70.2 (-OCH2-), 69.7 (-CHOH), 33.3 (-CH2CHOH), 28.7 (-CH2C%C-), 26.0 
(BnOCH2CH2-), 0.04 (-Si(CH3)3) ppm 
FTIR: 3409, 3088, 3064, 3031, 2957, 2929, 2902, 2859, 2174, 1605, 1454 cm
-1
 
EIHRMS: Calcd for C17H26O2Si : 290.1702, found : 290.1701. 
 





Rf  0.68 (hexane : ethyl acetate 4:1) 
1
H NMR: (300 MHz, CDCl3) 
! 3.71 (1H, tt, J = 6.50, 5.55 Hz, -CHOH), 2.45 (1H, dd, J = 16.71, 4.89 Hz, -
C%CCHH), 2.33 (1H, dd, J = 16.71, 6.96 Hz, -C%CCHH), 1.96 (1H, brs, -CHOH), 
1.48-1.52 (2H, m, -CH2CHOH), 1.27 (12H, m, -(CH2)6), 0.87 (3H, t, J = 5.90 Hz, 
CH3), 0.15 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (75 MHz, CDCl3) 
! 103.4 (-C%CSi), 86.9 (-C%CSi), 70.0 (-CHOH), 36.2 (-CH2CHOH), 31.9, 29.5, 
29.3, 28.9, 25.6, 22.7 (-(CH2)6CH3), 14.1 (-CH3), 0.07 (-Si(CH3)3) ppm 
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EIHRMS: Calcd for C15H30OSi : 254.2066, found : 254.2067. 
 




Rf  0.64 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
! 5.39 (1H, m, HC=CH), 5.32 (1H, m, HC=CH), 3.74 (1H, tt, J = 6.00, 5.55 Hz, 
CHOH), 2.45 (1H, dd, J = 16.65, 4.65 Hz, -C%CCHH), 2.35 (1H, dd, J = 16.65, 6.50 
Hz, -C%CCHH), 2.19-2.10 (2H, m, -C=CCH2CH3), 2.08-2.02 (2H, m, -
C=CCH2CH2), 2.00 (1H, brs, -CHOH), 1.58 (2H, td, J = 7.62, 6.50 Hz, CH2CHOH), 
0.96 (3H, t, J = 7.65 Hz, -CH2CH3), 0.15 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 132.4 (-HC=CH-), 128.1(-HC=CH-), 103.1 (-C%CSi-), 87.6 (-C%CSi-), 69.4 (-
CHOH), 36.1 (-CH2), 28.8 (-CH2C%C-), 23.3 (-CH2), 20.4 (-CH2), 14.2 (-CH2CH3), 
0.03 (-Si(CH3)3) ppm 
FTIR: 3392, 3007, 2962, 2933, 2875, 2856, 2176, 1654, 1453 cm
-1
 
EIHRMS: Calcd for C13H24OSi : 224.1596, found : 246.1600. 
 




Rf  0.46 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
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! 7.30-7.27 (5H, m, -Ph-H), 4.52 (2H, s, -PhCH2O), 3.96 (1H, ttd, J = 6.50, 6.45, 2.75 
Hz, -CHOH), 3.73 (1H, ddd, J = 9.49, 7.88, 4.65 Hz, BnOCHH-), 3.65 (1H, ddd, J = 
10.88, 7.65, 4.65 Hz, BnOCHH-), 2.46 (1H, dd, J = 17.10, 6.05 Hz, C%CCHH), 2.41 
(1H, dd, J = 17.10, 6.45 Hz, -C%CCHH), 1.92 (1H, dddd, J = 14.32, 6.48, 4.65, 3.25 
Hz, BnOCH2CHH-), 1.86-1.79 (1H, m, BnOCH2CHH-), 0.15 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 137.8, 128.4, 127.7, 127.6 (Phenyl), 103.3 (-C%CSi-), 87.0 (-C%CSi-), 73.2 (-
OCH2-), 69.3 (-CHOH), 68.4 (-OCH2-), 35.3 (-CH2CHOH), 28.5 (-CH2C%C-), 0.04 
(-Si(CH3)3) ppm 
FTIR: 3430, 3089, 3065, 3032, 2958, 2926, 2900, 2863, 2175, 1632, 1454 cm
-1
 
EIHRMS: Calcd for C16H23O2Si (M
+
) : 275.1473, found : 275.1466. 
 




Rf  0.61 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
! 3.80 (1H, m, -CHOH), 2.43 (1H, dd, J = 16.62, 4.65 Hz, -C%CCHH), 2.32 (1H, dd, 
J = 16.62, 6.95 Hz, -C%CCHH), 1.77 (1H, m, -CH(CH3)2), 1.45 (1H, ddd, J = 14.20,  
8.88, 8.66 Hz, (CH3)2CHCHH-), 1.29 (1H, ddd, J = 14.20, 8.88, 8.55 Hz, 
(CH3)2CHCHH-), 0.91 (6H, q, J = 3.45 Hz, -CH(CH3)2), 0.15 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 103.3 (-C%CSi-), 87.6 (-C%CSi-), 68.0 (-CHOH), 45.4 ((CH3)2CHCH2-), 29.3 (-
CH2C%C-), 24.6 (-CH(CH3)2), 23.3, (-CHCH3), 22.1 (-CHCH3) 0.05 (-Si(CH3)3) ppm 
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FTIR: 3401, 2958, 2929, 2871, 2176, 1641, 1467 cm
-1
 
EIHRMS: Calcd for C11H22OSi : 198.1440, found : 198.1397. 
 




Yield:  71%. 
Rf:  0.64 (Hexane : Ethyl Acetate = 4:1) 
1
H NMR (500 MHz, CDCl3): 
! 3.72 (1H, tt, J = 6.45, 5.55 Hz, -CHOH), 2.44 (1H, dd, J = 16.75, 4.60 Hz, -
C%CCHH), 2.44 (1H, dd, J = 16.75, 6.95 Hz, -C%CCHH), 1.53-1.49 (2H, m, -CH2), 
1.33-1.27 (6H, m, (-CH2)3), 0.87 (3H, t, J = 6.95 Hz, -CH3), 0.15 (9H, s, -Si(CH3)3) 
ppm 
13
C NMR: (125 MHz, CDCl3) 
! 103.3 (-C%CSi-), 87.5 (-C%CSi-), 69.9 (-CHOH), 36.2 (-CH2CHOH), 31.7, 28.8, 
25.2, 22.5 -(CH2)4CH3), 13.9 (-(CH2)4CH3), 0.04 (-Si(CH3)3) ppm 
FTIR: 3394, 2958, 2932, 2873, 2859, 2176, 1421 cm
-1 
EIHRMS: Calcd for C12H24OSi : 212.1596, found : 212.1596. 
 




Rf  0.42 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
  
Appendix : Silicon-assisted Propargylic Transfer to Aldehydes 
275 Appendix  
! 5.89 (1H, tdd, J = 11.47, 10.53, 5.55 Hz, -CH=CH2), 5.25 (1H, ddt, J = 10.53, 3.25, 
1.85 Hz, -CH=CHH), 5.15 (1H, ddt, J = 11.47, 3.00, 1.40 Hz, -CH=CHH), 3.95 (2H, 
dt, J = 6.00, 1.40 Hz, -CH2=CHCH2O), 3.72 (1H, quintet, J = 6.00 Hz, -CHOH), 3.42 
(2H, t, J = 6.50 Hz, AllyOCH2-), 2.44 (1H, dd, J = 16.62, 5.10 Hz, -C%CCHH), 2.34 
(1H, dd, J = 16.62, 6.95 Hz, -C%CCHH), 2.07 (1H, brs, -CHOH), 1.37-1.66 (6H, m, 
AllyOCH2(CH2)3-), 0.14 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 134.9 (-CH=CH2), 116.7 (-CH=CH2), 103.2 (-C%CSi-), 87.5 (-C%CSi-), 71.8 (-
OCH2-), 70.1 (-OCH2-), 69.7 (-CHOH), 35.9 (-CH2CHOH), 29.5 (-CH2-), 28.8 (-
CH2C%C-), 22.2 (-CH2-) 0.03 (-Si(CH3)3) ppm 
FTIR: 3427, 3081, 2939, 2863, 2175, 1420 cm
-1
 
ESIHRMS: Calcd for C14H26O2SiNa : 277.1600, found : 277.1599. 
 
Chiral resolution of 13 was carried out with S-(+)-$-acetoxyphenylacetic acid 
followed by hydrolysis. For the standard procedure, refer to Whitesell, J.K.; 
Reynolds, D. J. Org. Chem. 1983, 48, 3548. (Note: the separation of the S-(+)-$-
acetoxyphenylacetic-ester of 13 was done by silica gel column chromatography with 
Hexane:Acetone = 250:0.5 as mobile phase). 
Enantiomeric excess for (-)-1-cyclohexyl-2-trimethylsilanyl-buta-2,3-dien-1-ol was 
92 % by NMR (500 MHz, CDCl3) analysis. 
The configurations were determined based on literature: 
Brown, H.C.; Khire, U.R.; Narla, G. J. Org. Chem. 1995, 60, 8130-8131. 
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Selectivity: 92 % ee 
Opt. Rot.: [$]D
25
 -16.95 (c = 7.8 in CHCl3) 
Rf  0.75 (hexane : ethyl acetate 4:1) 
1
H NMR: (500 MHz, CDCl3) 
! 4.54 (1H, dd, J = 11.10, 2.3 Hz, -C=C=CHH), 4.50 (1H, dd, J = 11.10, 2.3 Hz, -
C=C=CHH), 3.91 (1H, m, -CHOH), 1.85-0.96 (11H, m, c-C6H11), 0.14 (9H, s, -
Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 207.5 (-C=C=CH2), 99.5 (-C=C=CH2), 75.1 (-CHOH), 71.5 (-C=C=CH2), 43.6 (-
CHCHOH), 30.4, 26.8, 26.4, 26.3, 26.0 (-CH2-), -0.8 (-Si(CH3)3) ppm 
FTIR: 3436, 2929, 2855, 1925, 1716, 1666, 1449 cm
-1
 
EIHRMS: Calcd for C13H24OSi : 224.1596, found : 224.1592. 
 




Selectivity: 84 % ee 
Opt. Rot.: [$]D
25
 +15.8 (c = 0.9 in CHCl3) 
HPLC analysis employing a Daicel Chiracel OD column 
(Hexane: i-propanol 99:1, 0.3 mL/min: t1 = 14.08, t2 = 19.72. 
1
H NMR: (500 MHz, CDCl3) 
  
Appendix : Silicon-assisted Propargylic Transfer to Aldehydes 
277 Appendix  
! 7.30-7.27 (2H, m, -Ph-H), 7.21-7.17 (3H, m, -Ph-H), 3.75 (1H, quintet, J = 6.00 Hz, 
-CHOH), 2.81 (1H, dt, J = 13.63, 7.85 Hz, -PhCHH), 2.70 (dt, J = 13.63, 8.35 Hz, 
1H, -PhCHH), 2.48 (1H, dd, J = 16.65, 4.65 Hz, -C%CCHH), 2.38 (1H, dd, J = 16.65, 
6.05 Hz, -C%CCHH), 1.98 (1H, brs, -CHOH), 1.85 (2H, td, J = 7.70, 6.50 Hz, -
PhCH2CH2), 0.16 (9H, s, -Si(CH3)3) ppm 
 
13
C NMR: (125 MHz, CDCl3) 
! 141.7, 128.4, 125.8 (phenyl), 102.9 (-C%CSi-), 87.8 (-C%CSi-), 69.0 (-CHOH), 37.7 
(-CH2CHOH), 31.8 (PhCH2-), 28.9 (-CH2C%C-), 0.05 (-Si(CH3)3) ppm 
FTIR: 3434, 3020, 2961, 2170, 1718, 1492, 1454, 1411 cm
-1
 
EIHRMS: Calcd for C15H22OSi : 246.1440, found : 246.1396. 
 




Yield:  44%. 
Selectivity: 89 % ee 
Opt. Rot.: [$]D
25
  = +43.6 (c = 0.5 in CHCl3) 
HPLC analysis employing a Daicel Chiracel OD-H column 
(Hexane: i-propanol 99:1, 1 mL/min: t1 = 10.67, t2 = 14.00) 
Rf 0.51 (Hexane : Ethyl Acetate = 4:1) 
1
H NMR: (300 MHz, CDCl3) 
! 7.38-7.26 (5H, m, -Ph-H), 4.84 (1H, t, J = 6.27 Hz, -PhCHOH), 2.65 (2H, d, J = 
6.27 Hz, -CH2C%CSi-), 2.45 (1H, brd, -CHOH), 0.17 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (75 MHz, CDCl3) 
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! 142.5, 128.9, 127.8, 125.7, 103.0, 87.8 (-CH2C%CSi-), 72.3 (-CHOH), 31.0 (-
CHCH2C-), 0.06 (-Si(CH3)3) ppm 
FTIR: 3396, 3033, 2960, 2902, 2177, 1724, 1604, 1494, 1454 cm
-1
 
EIHRMS: Calcd for C13H18OSi : 218.1127, found: 218.1125. 
 




Rf 0.46 (hexane : ethyl acetate 4:1) 
Selectivity: 81 % ee 
Opt. Rot.: [$]D
26
  = +13 (c = 0.05 in CHCl3) 
HPLC analysis employing a Daicel Chiracel OD-H column 
(Hexane: i-propanol 99:1, 0.3 mL/min: t1 = 27.64, t2 = 30.71) 
1
H NMR: (500 MHz, CDCl3) 
! 7.30-7.27 (5H, m, -PH-H), 4.52 (2H, s, -PhCH2O), 3.96 (1H, tq, J = 9.03, 3.25 Hz, -
CHOH), 3.73 (1H, ddd, J = 10.18, 7.88, 4.65 Hz, BnOCHH-), 3.65 (1H, ddd, J = 
10.18, 7.65, 4.65 Hz, BnOCHH-), 2.46 (1H, dd, J = 17.10, 6.05 Hz, -C%CCHH), 2.41 
(1H, dd, J = 17.10, 6.45 Hz, -C%CCHH), 1.92 (1H, dddd, J = 14.32, 6.48, 4.63, 3.25 
Hz, BnOCH2CHH-), 1.86-1.79 (1H, m, BnOCH2CHH-), 0.15 (9H, s, -Si(CH3)3) ppm 
13
C NMR: (125 MHz, CDCl3) 
! 137.8, 128.4, 127.7, 127.6 (Phenyl), 103.3 (-C%CSi), 87.0 (C%CSi), 73.2 (OCH2) 
69.3 (CHOH), 68.4 (OCH2), 35.3 (CH2CHOH), 28.5 (CH2C%C), 0.04 (Si(CH3)3) 
ppm 
FTIR: 3430, 3089, 3065, 3032, 2958, 2926, 2900, 2863, 2175, 1632, 1454 cm
-1
 
EIHRMS: Calcd for C16H24O2Si : 276.1546, found : 276.1506; 
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